<!DOCTYPE html>
<html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-sticky-header-enabled vector-toc-available" lang="en" dir="ltr">
<head>
<meta charset="UTF-8">
<title>Eli Lilly and Company - Wikipedia</title>
<script>(function(){var className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-enabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-sticky-header-enabled vector-toc-available";var cookie=document.cookie.match(/(?:^|; )enwikimwclientpreferences=([^;]+)/);if(cookie){cookie[1].split('%2C').forEach(function(pref){className=className.replace(new RegExp('(^| )'+pref.replace(/-clientpref-\w+$|[^\w-]+/g,'')+'-clientpref-\\w+( |$)'),'$1'+pref+'$2');});}document.documentElement.className=className;}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"51dee488-eef0-43da-a2ad-7a709ca89d3c","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Eli_Lilly_and_Company","wgTitle":"Eli Lilly and Company","wgCurRevisionId":1286104250,"wgRevisionId":1286104250,"wgArticleId":758905,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Pages with non-numeric formatnum arguments","CS1 maint: location missing publisher","Source attribution","All articles with dead external links","Articles with dead external links from September 2017","Articles with permanently dead external links","CS1: unfit URL","All articles with unsourced statements","Articles with unsourced statements from July 2018","Webarchive template wayback links","Pages containing links to subscription-only content","Articles with short description","Short description matches Wikidata","Use dmy dates from June 2024","Use American English from June 2024","All Wikipedia articles written in American English","Articles with unsourced statements from March 2022","Commons category link is on Wikidata","Eli Lilly and Company","1876 establishments in Indiana","American companies established in 1876","Biotechnology companies of the United States","Clinical trial organizations","Companies formerly listed on the Tokyo Stock Exchange","Companies listed on the New York Stock Exchange","Life sciences industry","Manufacturing companies based in Indianapolis","Multinational companies headquartered in the United States","Pharmaceutical companies established in 1876","Research and development in the United States","Technology companies established in 1876"],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Eli_Lilly_and_Company","wgRelevantArticleId":758905,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":200000,"wgEditSubmitButtonLabelPublish":true,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":false,"wgVector2022LanguageInHeader":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q632240","wgCheckUserClientHintsHeadersJsApi":["brands","architecture","bitness","fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGELevelingUpEnabledForUser":false};
RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.search.codex.styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.wikimediamessages.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","mediawiki.page.media","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.switcher","ext.urlShortener.toolbar","ext.centralauth.centralautologin","mmv.bootstrap","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.echo.centralauth","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.checkUser.clientHints","ext.quicksurveys.init","ext.growthExperiments.SuggestedEditSession"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.impl(function(){return["user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
}];});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cext.wikimediamessages.styles%7Cjquery.makeCollapsible.styles%7Cskins.vector.icons%2Cstyles%7Cskins.vector.search.codex.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022">
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022"></script>
<meta name="ResourceLoaderDynamicStyles" content="">
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022">
<meta name="generator" content="MediaWiki 1.44.0-wmf.25">
<meta name="referrer" content="origin">
<meta name="referrer" content="origin-when-cross-origin">
<meta name="robots" content="max-image-preview:standard">
<meta name="format-detection" content="telephone=no">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/1200px-Eli_Lilly_and_Company.svg.png">
<meta property="og:image:width" content="1200">
<meta property="og:image:height" content="680">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/800px-Eli_Lilly_and_Company.svg.png">
<meta property="og:image:width" content="800">
<meta property="og:image:height" content="454">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/640px-Eli_Lilly_and_Company.svg.png">
<meta property="og:image:width" content="640">
<meta property="og:image:height" content="363">
<meta name="viewport" content="width=1120">
<meta property="og:title" content="Eli Lilly and Company - Wikipedia">
<meta property="og:type" content="website">
<link rel="preconnect" href="//upload.wikimedia.org">
<link rel="alternate" media="only screen and (max-width: 640px)" href="//en.m.wikipedia.org/wiki/Eli_Lilly_and_Company">
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit">
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png">
<link rel="icon" href="/static/favicon/wikipedia.ico">
<link rel="search" type="application/opensearchdescription+xml" href="/w/rest.php/v1/search" title="Wikipedia (en)">
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd">
<link rel="canonical" href="https://en.wikipedia.org/wiki/Eli_Lilly_and_Company">
<link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en">
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom">
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<link rel="dns-prefetch" href="auth.wikimedia.org">
</head>
<body class="skin--responsive skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Eli_Lilly_and_Company rootpage-Eli_Lilly_and_Company skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a>
<div class="vector-header-container">
	<header class="vector-header mw-header">
		<div class="vector-header-start">
			<nav class="vector-main-menu-landmark" aria-label="Site">
				
<div id="vector-main-menu-dropdown" class="vector-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right"  title="Main menu" >
	<input type="checkbox" id="vector-main-menu-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-main-menu-dropdown" class="vector-dropdown-checkbox "  aria-label="Main menu"  >
	<label id="vector-main-menu-dropdown-label" for="vector-main-menu-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true"  ><span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span>

<span class="vector-dropdown-label-text">Main menu</span>
	</label>
	<div class="vector-dropdown-content">


				<div id="vector-main-menu-unpinned-container" class="vector-unpinned-container">
		
<div id="vector-main-menu" class="vector-main-menu vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="main-menu-pinned"
	data-pinnable-element-id="vector-main-menu"
	data-pinned-container-id="vector-main-menu-pinned-container"
	data-unpinned-container-id="vector-main-menu-unpinned-container"
>
	<div class="vector-pinnable-header-label">Main menu</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button>
</div>

	
<div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation"  >
	<div class="vector-menu-heading">
		Navigation
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li>
		</ul>
		
	</div>
</div>

	
	
<div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction"  >
	<div class="vector-menu-heading">
		Contribute
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li><li id="n-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages"><span>Special pages</span></a></li>
		</ul>
		
	</div>
</div>

</div>

				</div>

	</div>
</div>

		</nav>
			
<a href="/wiki/Main_Page" class="mw-logo">
	<img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt="" aria-hidden="true" height="50" width="50">
	<span class="mw-logo-container skin-invert">
		<img class="mw-logo-wordmark" alt="Wikipedia" src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;">
		<img class="mw-logo-tagline" alt="The Free Encyclopedia" src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;">
	</span>
</a>

		</div>
		<div class="vector-header-end">
			
<div id="p-search" role="search" class="vector-search-box-vue  vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box">
	<a href="/wiki/Special:Search" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle" title="Search Wikipedia [f]" accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span>

<span>Search</span>
	</a>
	<div class="vector-typeahead-search-container">
		<div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width">
			<form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button">
				<div id="simpleSearch" class="cdx-search-input__input-wrapper"  data-search-loc="header-moved">
					<div class="cdx-text-input cdx-text-input--has-start-icon">
						<input
							class="cdx-text-input__input"
							 type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput"
							>
						<span class="cdx-text-input__icon cdx-text-input__start-icon"></span>
					</div>
					<input type="hidden" name="title" value="Special:Search">
				</div>
				<button class="cdx-button cdx-search-input__end-button">Search</button>
			</form>
		</div>
	</div>
</div>

			<nav class="vector-user-links vector-user-links-wide" aria-label="Personal tools">
	<div class="vector-user-links-main">
	
<div id="p-vector-user-menu-preferences" class="vector-menu mw-portlet emptyPortlet"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			
		</ul>
		
	</div>
</div>

	
<div id="p-vector-user-menu-userpage" class="vector-menu mw-portlet emptyPortlet"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			
		</ul>
		
	</div>
</div>

	<nav class="vector-appearance-landmark" aria-label="Appearance">
		
<div id="vector-appearance-dropdown" class="vector-dropdown "  title="Change the appearance of the page&#039;s font size, width, and color" >
	<input type="checkbox" id="vector-appearance-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-appearance-dropdown" class="vector-dropdown-checkbox "  aria-label="Appearance"  >
	<label id="vector-appearance-dropdown-label" for="vector-appearance-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true"  ><span class="vector-icon mw-ui-icon-appearance mw-ui-icon-wikimedia-appearance"></span>

<span class="vector-dropdown-label-text">Appearance</span>
	</label>
	<div class="vector-dropdown-content">


			<div id="vector-appearance-unpinned-container" class="vector-unpinned-container">
				
			</div>
		
	</div>
</div>

	</nav>
	
<div id="p-vector-user-menu-notifications" class="vector-menu mw-portlet emptyPortlet"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			
		</ul>
		
	</div>
</div>

	
<div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="pt-sitesupport-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="https://donate.wikimedia.org/?wmf_source=donate&amp;wmf_medium=sidebar&amp;wmf_campaign=en.wikipedia.org&amp;uselang=en" class=""><span>Donate</span></a>
</li>
<li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:CreateAccount&amp;returnto=Eli+Lilly+and+Company" title="You are encouraged to create an account and log in; however, it is not mandatory" class=""><span>Create account</span></a>
</li>
<li id="pt-login-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:UserLogin&amp;returnto=Eli+Lilly+and+Company" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o" class=""><span>Log in</span></a>
</li>

			
		</ul>
		
	</div>
</div>

	</div>
	
<div id="vector-user-links-dropdown" class="vector-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out"  title="Log in and more options" >
	<input type="checkbox" id="vector-user-links-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-user-links-dropdown" class="vector-dropdown-checkbox "  aria-label="Personal tools"  >
	<label id="vector-user-links-dropdown-label" for="vector-user-links-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true"  ><span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span>

<span class="vector-dropdown-label-text">Personal tools</span>
	</label>
	<div class="vector-dropdown-content">


		
<div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item"  title="User menu" >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li id="pt-sitesupport" class="user-links-collapsible-item mw-list-item"><a href="https://donate.wikimedia.org/?wmf_source=donate&amp;wmf_medium=sidebar&amp;wmf_campaign=en.wikipedia.org&amp;uselang=en"><span>Donate</span></a></li><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Eli+Lilly+and+Company" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Eli+Lilly+and+Company" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li>
		</ul>
		
	</div>
</div>

<div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor"  >
	<div class="vector-menu-heading">
		Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a>
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li>
		</ul>
		
	</div>
</div>

	
	</div>
</div>

</nav>

		</div>
	</header>
</div>
<div class="mw-page-container">
	<div class="mw-page-container-inner">
		<div class="vector-sitenotice-container">
			<div id="siteNotice"><!-- CentralNotice --></div>
		</div>
		<div class="vector-column-start">
			<div class="vector-main-menu-container">
		<div id="mw-navigation">
			<nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site">
				<div id="vector-main-menu-pinned-container" class="vector-pinned-container">
				
				</div>
		</nav>
		</div>
	</div>
	<div class="vector-sticky-pinned-container">
				<nav id="mw-panel-toc" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark">
					<div id="vector-toc-pinned-container" class="vector-pinned-container">
					<div id="vector-toc" class="vector-toc vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned"
	data-feature-name="toc-pinned"
	data-pinnable-element-id="vector-toc"
	
	
>
	<h2 class="vector-pinnable-header-label">Contents</h2>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button>
</div>


	<ul class="vector-toc-contents" id="mw-panel-toc-list">
		<li id="toc-mw-content-text"
			class="vector-toc-list-item vector-toc-level-1">
			<a href="#" class="vector-toc-link">
				<div class="vector-toc-text">(Top)</div>
			</a>
		</li>
		<li id="toc-History"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#History">
			<div class="vector-toc-text">
				<span class="vector-toc-numb">1</span>
				<span>History</span>
			</div>
		</a>
		
			<button aria-controls="toc-History-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle History subsection</span>
			</button>
		
		<ul id="toc-History-sublist" class="vector-toc-list">
			<li id="toc-Founding"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Founding">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">1.1</span>
					<span>Founding</span>
				</div>
			</a>
			
			<ul id="toc-Founding-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-19th_century"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#19th_century">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">1.2</span>
					<span>19th century</span>
				</div>
			</a>
			
			<ul id="toc-19th_century-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-20th_century"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#20th_century">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">1.3</span>
					<span>20th century</span>
				</div>
			</a>
			
			<ul id="toc-20th_century-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-21st_century"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#21st_century">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">1.4</span>
					<span>21st century</span>
				</div>
			</a>
			
			<ul id="toc-21st_century-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Acquisition_history"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Acquisition_history">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">1.5</span>
					<span>Acquisition history</span>
				</div>
			</a>
			
			<ul id="toc-Acquisition_history-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Collaborative_research"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Collaborative_research">
			<div class="vector-toc-text">
				<span class="vector-toc-numb">2</span>
				<span>Collaborative research</span>
			</div>
		</a>
		
			<button aria-controls="toc-Collaborative_research-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Collaborative research subsection</span>
			</button>
		
		<ul id="toc-Collaborative_research-sublist" class="vector-toc-list">
			<li id="toc-Publicly_funded_research"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Publicly_funded_research">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">2.1</span>
					<span>Publicly funded research</span>
				</div>
			</a>
			
			<ul id="toc-Publicly_funded_research-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Public-private_engagement"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Public-private_engagement">
			<div class="vector-toc-text">
				<span class="vector-toc-numb">3</span>
				<span>Public-private engagement</span>
			</div>
		</a>
		
			<button aria-controls="toc-Public-private_engagement-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Public-private engagement subsection</span>
			</button>
		
		<ul id="toc-Public-private_engagement-sublist" class="vector-toc-list">
			<li id="toc-Academia"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Academia">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">3.1</span>
					<span>Academia</span>
				</div>
			</a>
			
			<ul id="toc-Academia-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Conferences_and_summits"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Conferences_and_summits">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">3.2</span>
					<span>Conferences and summits</span>
				</div>
			</a>
			
			<ul id="toc-Conferences_and_summits-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Media"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Media">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">3.3</span>
					<span>Media</span>
				</div>
			</a>
			
			<ul id="toc-Media-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Medical_societies"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Medical_societies">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">3.4</span>
					<span>Medical societies</span>
				</div>
			</a>
			
			<ul id="toc-Medical_societies-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Non-governmental_organizations"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Non-governmental_organizations">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">3.5</span>
					<span>Non-governmental organizations</span>
				</div>
			</a>
			
			<ul id="toc-Non-governmental_organizations-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Political_lobbying"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Political_lobbying">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">3.6</span>
					<span>Political lobbying</span>
				</div>
			</a>
			
			<ul id="toc-Political_lobbying-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Professional_associations"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Professional_associations">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">3.7</span>
					<span>Professional associations</span>
				</div>
			</a>
			
			<ul id="toc-Professional_associations-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Public_health"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Public_health">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">3.8</span>
					<span>Public health</span>
				</div>
			</a>
			
			<ul id="toc-Public_health-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Research_and_development"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Research_and_development">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">3.9</span>
					<span>Research and development</span>
				</div>
			</a>
			
			<ul id="toc-Research_and_development-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Pharmaceutical_brands"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Pharmaceutical_brands">
			<div class="vector-toc-text">
				<span class="vector-toc-numb">4</span>
				<span>Pharmaceutical brands</span>
			</div>
		</a>
		
			<button aria-controls="toc-Pharmaceutical_brands-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Pharmaceutical brands subsection</span>
			</button>
		
		<ul id="toc-Pharmaceutical_brands-sublist" class="vector-toc-list">
			<li id="toc-Cialis"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Cialis">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">4.1</span>
					<span>Cialis</span>
				</div>
			</a>
			
			<ul id="toc-Cialis-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Cymbalta"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Cymbalta">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">4.2</span>
					<span>Cymbalta</span>
				</div>
			</a>
			
			<ul id="toc-Cymbalta-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Kisunla"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Kisunla">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">4.3</span>
					<span>Kisunla</span>
				</div>
			</a>
			
			<ul id="toc-Kisunla-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Gemzar"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Gemzar">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">4.4</span>
					<span>Gemzar</span>
				</div>
			</a>
			
			<ul id="toc-Gemzar-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Methadone"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Methadone">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">4.5</span>
					<span>Methadone</span>
				</div>
			</a>
			
			<ul id="toc-Methadone-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Prozac"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Prozac">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">4.6</span>
					<span>Prozac</span>
				</div>
			</a>
			
			<ul id="toc-Prozac-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Secobarbital"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Secobarbital">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">4.7</span>
					<span>Secobarbital</span>
				</div>
			</a>
			
			<ul id="toc-Secobarbital-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Thiomersal"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Thiomersal">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">4.8</span>
					<span>Thiomersal</span>
				</div>
			</a>
			
			<ul id="toc-Thiomersal-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Zyprexa"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Zyprexa">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">4.9</span>
					<span>Zyprexa</span>
				</div>
			</a>
			
			<ul id="toc-Zyprexa-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Leadership"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Leadership">
			<div class="vector-toc-text">
				<span class="vector-toc-numb">5</span>
				<span>Leadership</span>
			</div>
		</a>
		
			<button aria-controls="toc-Leadership-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Leadership subsection</span>
			</button>
		
		<ul id="toc-Leadership-sublist" class="vector-toc-list">
			<li id="toc-Community_service"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Community_service">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">5.1</span>
					<span>Community service</span>
				</div>
			</a>
			
			<ul id="toc-Community_service-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Lilly_Endowment"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Lilly_Endowment">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">5.2</span>
					<span>Lilly Endowment</span>
				</div>
			</a>
			
			<ul id="toc-Lilly_Endowment-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Eli_Lilly_and_Company_Foundation"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Eli_Lilly_and_Company_Foundation">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">5.3</span>
					<span>Eli Lilly and Company Foundation</span>
				</div>
			</a>
			
			<ul id="toc-Eli_Lilly_and_Company_Foundation-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Controversies"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Controversies">
			<div class="vector-toc-text">
				<span class="vector-toc-numb">6</span>
				<span>Controversies</span>
			</div>
		</a>
		
			<button aria-controls="toc-Controversies-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Controversies subsection</span>
			</button>
		
		<ul id="toc-Controversies-sublist" class="vector-toc-list">
			<li id="toc-BGH"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#BGH">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">6.1</span>
					<span>BGH</span>
				</div>
			</a>
			
			<ul id="toc-BGH-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-340B"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#340B">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">6.2</span>
					<span>340B</span>
				</div>
			</a>
			
			<ul id="toc-340B-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Prozac_2"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Prozac_2">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">6.3</span>
					<span>Prozac</span>
				</div>
			</a>
			
			<ul id="toc-Prozac_2-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Illegal_marketing_of_Zyprexa"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Illegal_marketing_of_Zyprexa">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">6.4</span>
					<span>Illegal marketing of Zyprexa</span>
				</div>
			</a>
			
			<ul id="toc-Illegal_marketing_of_Zyprexa-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Discrimination"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Discrimination">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">6.5</span>
					<span>Discrimination</span>
				</div>
			</a>
			
			<ul id="toc-Discrimination-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Canada_patent_lawsuit"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Canada_patent_lawsuit">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">6.6</span>
					<span>Canada patent lawsuit</span>
				</div>
			</a>
			
			<ul id="toc-Canada_patent_lawsuit-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Illegal_marketing_of_Evista"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Illegal_marketing_of_Evista">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">6.7</span>
					<span>Illegal marketing of Evista</span>
				</div>
			</a>
			
			<ul id="toc-Illegal_marketing_of_Evista-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Insulin_pricing"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Insulin_pricing">
				<div class="vector-toc-text">
					<span class="vector-toc-numb">6.8</span>
					<span>Insulin pricing</span>
				</div>
			</a>
			
			<ul id="toc-Insulin_pricing-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-References"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#References">
			<div class="vector-toc-text">
				<span class="vector-toc-numb">7</span>
				<span>References</span>
			</div>
		</a>
		
		<ul id="toc-References-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Bibliography"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Bibliography">
			<div class="vector-toc-text">
				<span class="vector-toc-numb">8</span>
				<span>Bibliography</span>
			</div>
		</a>
		
		<ul id="toc-Bibliography-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-External_links"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#External_links">
			<div class="vector-toc-text">
				<span class="vector-toc-numb">9</span>
				<span>External links</span>
			</div>
		</a>
		
		<ul id="toc-External_links-sublist" class="vector-toc-list">
		</ul>
	</li>
</ul>
</div>

					</div>
		</nav>
			</div>
		</div>
		<div class="mw-content-container">
			<main id="content" class="mw-body">
				<header class="mw-body-header vector-page-titlebar">
					<nav aria-label="Contents" class="vector-toc-landmark">
						
<div id="vector-page-titlebar-toc" class="vector-dropdown vector-page-titlebar-toc vector-button-flush-left"  title="Table of Contents" >
	<input type="checkbox" id="vector-page-titlebar-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-titlebar-toc" class="vector-dropdown-checkbox "  aria-label="Toggle the table of contents"  >
	<label id="vector-page-titlebar-toc-label" for="vector-page-titlebar-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true"  ><span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span>

<span class="vector-dropdown-label-text">Toggle the table of contents</span>
	</label>
	<div class="vector-dropdown-content">


							<div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container">
			</div>
		
	</div>
</div>

					</nav>
					<h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">Eli Lilly and Company</span></h1>
							
<div id="p-lang-btn" class="vector-dropdown mw-portlet mw-portlet-lang"  >
	<input type="checkbox" id="p-lang-btn-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-p-lang-btn" class="vector-dropdown-checkbox mw-interlanguage-selector" aria-label="Go to an article in another language. Available in 34 languages"   >
	<label id="p-lang-btn-label" for="p-lang-btn-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-34" aria-hidden="true"  ><span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span>

<span class="vector-dropdown-label-text">34 languages</span>
	</label>
	<div class="vector-dropdown-content">

		<div class="vector-menu-content">
			
			<ul class="vector-menu-content-list">
				
				<li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D8%A5%D9%8A%D9%84%D9%8A_%D9%84%D9%8A%D9%84%D9%8A_%D9%88%D8%B4%D8%B1%D9%83%D8%A7%D8%A1%D9%87" title="إيلي ليلي وشركاءه – Arabic" lang="ar" hreflang="ar" data-title="إيلي ليلي وشركاءه" data-language-autonym="العربية" data-language-local-name="Arabic" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-azb mw-list-item"><a href="https://azb.wikipedia.org/wiki/%D8%A7%DB%8C%D9%84%D8%A7%DB%8C_%D9%84%DB%8C%E2%80%8C%D9%84%DB%8C_%D8%A7%D9%86%D8%AF_%DA%A9%D8%A7%D9%85%D9%BE%D9%86%DB%8C" title="ایلای لی‌لی اند کامپنی – South Azerbaijani" lang="azb" hreflang="azb" data-title="ایلای لی‌لی اند کامپنی" data-language-autonym="تۆرکجه" data-language-local-name="South Azerbaijani" class="interlanguage-link-target"><span>تۆرکجه</span></a></li><li class="interlanguage-link interwiki-bg mw-list-item"><a href="https://bg.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Bulgarian" lang="bg" hreflang="bg" data-title="Eli Lilly and Company" data-language-autonym="Български" data-language-local-name="Bulgarian" class="interlanguage-link-target"><span>Български</span></a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Catalan" lang="ca" hreflang="ca" data-title="Eli Lilly and Company" data-language-autonym="Català" data-language-local-name="Catalan" class="interlanguage-link-target"><span>Català</span></a></li><li class="interlanguage-link interwiki-cs mw-list-item"><a href="https://cs.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Czech" lang="cs" hreflang="cs" data-title="Eli Lilly and Company" data-language-autonym="Čeština" data-language-local-name="Czech" class="interlanguage-link-target"><span>Čeština</span></a></li><li class="interlanguage-link interwiki-da mw-list-item"><a href="https://da.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Danish" lang="da" hreflang="da" data-title="Eli Lilly and Company" data-language-autonym="Dansk" data-language-local-name="Danish" class="interlanguage-link-target"><span>Dansk</span></a></li><li class="interlanguage-link interwiki-de mw-list-item"><a href="https://de.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – German" lang="de" hreflang="de" data-title="Eli Lilly and Company" data-language-autonym="Deutsch" data-language-local-name="German" class="interlanguage-link-target"><span>Deutsch</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Spanish" lang="es" hreflang="es" data-title="Eli Lilly and Company" data-language-autonym="Español" data-language-local-name="Spanish" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-eo mw-list-item"><a href="https://eo.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Esperanto" lang="eo" hreflang="eo" data-title="Eli Lilly and Company" data-language-autonym="Esperanto" data-language-local-name="Esperanto" class="interlanguage-link-target"><span>Esperanto</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%A7%DB%8C%D9%84%D8%A7%DB%8C_%D9%84%DB%8C%E2%80%8C%D9%84%DB%8C_%D8%A7%D9%86%D8%AF_%DA%A9%D8%A7%D9%85%D9%BE%D9%86%DB%8C" title="ایلای لی‌لی اند کامپنی – Persian" lang="fa" hreflang="fa" data-title="ایلای لی‌لی اند کامپنی" data-language-autonym="فارسی" data-language-local-name="Persian" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – French" lang="fr" hreflang="fr" data-title="Eli Lilly and Company" data-language-autonym="Français" data-language-local-name="French" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-ko mw-list-item"><a href="https://ko.wikipedia.org/wiki/%EC%9D%BC%EB%9D%BC%EC%9D%B4_%EB%A6%B4%EB%A6%AC_%EC%95%A4%EB%93%9C_%EC%BB%B4%ED%8D%BC%EB%8B%88" title="일라이 릴리 앤드 컴퍼니 – Korean" lang="ko" hreflang="ko" data-title="일라이 릴리 앤드 컴퍼니" data-language-autonym="한국어" data-language-local-name="Korean" class="interlanguage-link-target"><span>한국어</span></a></li><li class="interlanguage-link interwiki-id mw-list-item"><a href="https://id.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Indonesian" lang="id" hreflang="id" data-title="Eli Lilly and Company" data-language-autonym="Bahasa Indonesia" data-language-local-name="Indonesian" class="interlanguage-link-target"><span>Bahasa Indonesia</span></a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Italian" lang="it" hreflang="it" data-title="Eli Lilly and Company" data-language-autonym="Italiano" data-language-local-name="Italian" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%90%D7%9C%D7%99_%D7%9C%D7%99%D7%9C%D7%99" title="אלי לילי – Hebrew" lang="he" hreflang="he" data-title="אלי לילי" data-language-autonym="עברית" data-language-local-name="Hebrew" class="interlanguage-link-target"><span>עברית</span></a></li><li class="interlanguage-link interwiki-ml mw-list-item"><a href="https://ml.wikipedia.org/wiki/%E0%B4%8E%E0%B4%B2%E0%B4%BF_%E0%B4%B2%E0%B4%BF%E0%B4%B2%E0%B5%8D%E0%B4%B2%E0%B4%BF_%E0%B4%86%E0%B5%BB%E0%B4%A1%E0%B5%8D_%E0%B4%95%E0%B4%AE%E0%B5%8D%E0%B4%AA%E0%B4%A8%E0%B4%BF" title="എലി ലില്ലി ആൻഡ് കമ്പനി – Malayalam" lang="ml" hreflang="ml" data-title="എലി ലില്ലി ആൻഡ് കമ്പനി" data-language-autonym="മലയാളം" data-language-local-name="Malayalam" class="interlanguage-link-target"><span>മലയാളം</span></a></li><li class="interlanguage-link interwiki-arz mw-list-item"><a href="https://arz.wikipedia.org/wiki/%D8%A7%D9%8A%D9%84%D9%89_%D9%84%D9%8A%D9%84%D9%89_%D9%88_%D8%B4%D8%B1%D9%83%D8%A7%D9%87" title="ايلى ليلى و شركاه – Egyptian Arabic" lang="arz" hreflang="arz" data-title="ايلى ليلى و شركاه" data-language-autonym="مصرى" data-language-local-name="Egyptian Arabic" class="interlanguage-link-target"><span>مصرى</span></a></li><li class="interlanguage-link interwiki-ms mw-list-item"><a href="https://ms.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Malay" lang="ms" hreflang="ms" data-title="Eli Lilly and Company" data-language-autonym="Bahasa Melayu" data-language-local-name="Malay" class="interlanguage-link-target"><span>Bahasa Melayu</span></a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Dutch" lang="nl" hreflang="nl" data-title="Eli Lilly and Company" data-language-autonym="Nederlands" data-language-local-name="Dutch" class="interlanguage-link-target"><span>Nederlands</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E3%82%A4%E3%83%BC%E3%83%A9%E3%82%A4%E3%83%AA%E3%83%AA%E3%83%BC%E3%83%BB%E3%82%A2%E3%83%B3%E3%83%89%E3%83%BB%E3%82%AB%E3%83%B3%E3%83%91%E3%83%8B%E3%83%BC" title="イーライリリー・アンド・カンパニー – Japanese" lang="ja" hreflang="ja" data-title="イーライリリー・アンド・カンパニー" data-language-autonym="日本語" data-language-local-name="Japanese" class="interlanguage-link-target"><span>日本語</span></a></li><li class="interlanguage-link interwiki-no mw-list-item"><a href="https://no.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Norwegian Bokmål" lang="nb" hreflang="nb" data-title="Eli Lilly and Company" data-language-autonym="Norsk bokmål" data-language-local-name="Norwegian Bokmål" class="interlanguage-link-target"><span>Norsk bokmål</span></a></li><li class="interlanguage-link interwiki-pl mw-list-item"><a href="https://pl.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Polish" lang="pl" hreflang="pl" data-title="Eli Lilly and Company" data-language-autonym="Polski" data-language-local-name="Polish" class="interlanguage-link-target"><span>Polski</span></a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Portuguese" lang="pt" hreflang="pt" data-title="Eli Lilly and Company" data-language-autonym="Português" data-language-local-name="Portuguese" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-ro mw-list-item"><a href="https://ro.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Romanian" lang="ro" hreflang="ro" data-title="Eli Lilly and Company" data-language-autonym="Română" data-language-local-name="Romanian" class="interlanguage-link-target"><span>Română</span></a></li><li class="interlanguage-link interwiki-ru badge-Q17559452 badge-recommendedarticle mw-list-item" title="recommended article"><a href="https://ru.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Russian" lang="ru" hreflang="ru" data-title="Eli Lilly and Company" data-language-autonym="Русский" data-language-local-name="Russian" class="interlanguage-link-target"><span>Русский</span></a></li><li class="interlanguage-link interwiki-sah mw-list-item"><a href="https://sah.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Yakut" lang="sah" hreflang="sah" data-title="Eli Lilly and Company" data-language-autonym="Саха тыла" data-language-local-name="Yakut" class="interlanguage-link-target"><span>Саха тыла</span></a></li><li class="interlanguage-link interwiki-simple mw-list-item"><a href="https://simple.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Simple English" lang="en-simple" hreflang="en-simple" data-title="Eli Lilly and Company" data-language-autonym="Simple English" data-language-local-name="Simple English" class="interlanguage-link-target"><span>Simple English</span></a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Serbian" lang="sr" hreflang="sr" data-title="Eli Lilly and Company" data-language-autonym="Српски / srpski" data-language-local-name="Serbian" class="interlanguage-link-target"><span>Српски / srpski</span></a></li><li class="interlanguage-link interwiki-sh mw-list-item"><a href="https://sh.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Serbo-Croatian" lang="sh" hreflang="sh" data-title="Eli Lilly and Company" data-language-autonym="Srpskohrvatski / српскохрватски" data-language-local-name="Serbo-Croatian" class="interlanguage-link-target"><span>Srpskohrvatski / српскохрватски</span></a></li><li class="interlanguage-link interwiki-fi mw-list-item"><a href="https://fi.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Finnish" lang="fi" hreflang="fi" data-title="Eli Lilly and Company" data-language-autonym="Suomi" data-language-local-name="Finnish" class="interlanguage-link-target"><span>Suomi</span></a></li><li class="interlanguage-link interwiki-sv mw-list-item"><a href="https://sv.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Swedish" lang="sv" hreflang="sv" data-title="Eli Lilly and Company" data-language-autonym="Svenska" data-language-local-name="Swedish" class="interlanguage-link-target"><span>Svenska</span></a></li><li class="interlanguage-link interwiki-tr mw-list-item"><a href="https://tr.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Turkish" lang="tr" hreflang="tr" data-title="Eli Lilly and Company" data-language-autonym="Türkçe" data-language-local-name="Turkish" class="interlanguage-link-target"><span>Türkçe</span></a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company – Ukrainian" lang="uk" hreflang="uk" data-title="Eli Lilly and Company" data-language-autonym="Українська" data-language-local-name="Ukrainian" class="interlanguage-link-target"><span>Українська</span></a></li><li class="interlanguage-link interwiki-zh mw-list-item"><a href="https://zh.wikipedia.org/wiki/%E7%A4%BC%E6%9D%A5%E5%85%AC%E5%8F%B8" title="礼来公司 – Chinese" lang="zh" hreflang="zh" data-title="礼来公司" data-language-autonym="中文" data-language-local-name="Chinese" class="interlanguage-link-target"><span>中文</span></a></li>
			</ul>
			<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q632240#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
		</div>

	</div>
</div>
</header>
				<div class="vector-page-toolbar">
					<div class="vector-page-toolbar-container">
						<div id="left-navigation">
							<nav aria-label="Namespaces">
								
<div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Eli_Lilly_and_Company" title="View the content page [c]" accesskey="c"><span>Article</span></a></li><li id="ca-talk" class="vector-tab-noicon mw-list-item"><a href="/wiki/Talk:Eli_Lilly_and_Company" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t"><span>Talk</span></a></li>
		</ul>
		
	</div>
</div>

								
<div id="vector-variants-dropdown" class="vector-dropdown emptyPortlet"  >
	<input type="checkbox" id="vector-variants-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-variants-dropdown" class="vector-dropdown-checkbox " aria-label="Change language variant"   >
	<label id="vector-variants-dropdown-label" for="vector-variants-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true"  ><span class="vector-dropdown-label-text">English</span>
	</label>
	<div class="vector-dropdown-content">


					
<div id="p-variants" class="vector-menu mw-portlet mw-portlet-variants emptyPortlet"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			
		</ul>
		
	</div>
</div>

				
	</div>
</div>

							</nav>
						</div>
						<div id="right-navigation" class="vector-collapsible">
							<nav aria-label="Views">
								
<div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/Eli_Lilly_and_Company"><span>Read</span></a></li><li id="ca-edit" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-history" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=history" title="Past revisions of this page [h]" accesskey="h"><span>View history</span></a></li>
		</ul>
		
	</div>
</div>

							</nav>
				
							<nav class="vector-page-tools-landmark" aria-label="Page tools">
								
<div id="vector-page-tools-dropdown" class="vector-dropdown vector-page-tools-dropdown"  >
	<input type="checkbox" id="vector-page-tools-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-tools-dropdown" class="vector-dropdown-checkbox "  aria-label="Tools"  >
	<label id="vector-page-tools-dropdown-label" for="vector-page-tools-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true"  ><span class="vector-dropdown-label-text">Tools</span>
	</label>
	<div class="vector-dropdown-content">


									<div id="vector-page-tools-unpinned-container" class="vector-unpinned-container">
						
<div id="vector-page-tools" class="vector-page-tools vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="page-tools-pinned"
	data-pinnable-element-id="vector-page-tools"
	data-pinned-container-id="vector-page-tools-pinned-container"
	data-unpinned-container-id="vector-page-tools-unpinned-container"
>
	<div class="vector-pinnable-header-label">Tools</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button>
</div>

	
<div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items"  title="More options" >
	<div class="vector-menu-heading">
		Actions
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Eli_Lilly_and_Company"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=history"><span>View history</span></a></li>
		</ul>
		
	</div>
</div>

<div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb"  >
	<div class="vector-menu-heading">
		General
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Eli_Lilly_and_Company" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Eli_Lilly_and_Company" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;oldid=1286104250" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Eli_Lilly_and_Company&amp;id=1286104250&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-urlshortener" class="mw-list-item"><a href="/w/index.php?title=Special:UrlShortener&amp;url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FEli_Lilly_and_Company"><span>Get shortened URL</span></a></li><li id="t-urlshortener-qrcode" class="mw-list-item"><a href="/w/index.php?title=Special:QrCode&amp;url=https%3A%2F%2Fen.wikipedia.org%2Fwiki%2FEli_Lilly_and_Company"><span>Download QR code</span></a></li>
		</ul>
		
	</div>
</div>

<div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export"  >
	<div class="vector-menu-heading">
		Print/export
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Eli_Lilly_and_Company&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li>
		</ul>
		
	</div>
</div>

<div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects"  >
	<div class="vector-menu-heading">
		In other projects
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			
			<li class="wb-otherproject-link wb-otherproject-commons mw-list-item"><a href="https://commons.wikimedia.org/wiki/Category:Eli_Lilly_and_Company" hreflang="en"><span>Wikimedia Commons</span></a></li><li id="t-wikibase" class="wb-otherproject-link wb-otherproject-wikibase-dataitem mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q632240" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li>
		</ul>
		
	</div>
</div>

</div>

									</div>
				
	</div>
</div>

							</nav>
						</div>
					</div>
				</div>
				<div class="vector-column-end">
					<div class="vector-sticky-pinned-container">
						<nav class="vector-page-tools-landmark" aria-label="Page tools">
							<div id="vector-page-tools-pinned-container" class="vector-pinned-container">
				
							</div>
		</nav>
						<nav class="vector-appearance-landmark" aria-label="Appearance">
							<div id="vector-appearance-pinned-container" class="vector-pinned-container">
				<div id="vector-appearance" class="vector-appearance vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-appearance-pinnable-header vector-pinnable-header-pinned"
	data-feature-name="appearance-pinned"
	data-pinnable-element-id="vector-appearance"
	data-pinned-container-id="vector-appearance-pinned-container"
	data-unpinned-container-id="vector-appearance-unpinned-container"
>
	<div class="vector-pinnable-header-label">Appearance</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-appearance.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-appearance.unpin">hide</button>
</div>


</div>

							</div>
		</nav>
					</div>
				</div>
				<div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container>
					<div class="vector-body-before-content">
							<div class="mw-indicators">
		</div>

						<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
					</div>
					<div id="contentSub"><div id="mw-content-subtitle"></div></div>
					
					
					<div id="mw-content-text" class="mw-body-content"><div class="mw-content-ltr mw-parser-output" lang="en" dir="ltr"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">American pharmaceutical company</div>
<style data-mw-deduplicate="TemplateStyles:r1236090951">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}@media print{body.ns-0 .mw-parser-output .hatnote{display:none!important}}</style><div role="note" class="hatnote navigation-not-searchable">For other uses, see <a href="/wiki/Eli_Lilly_(disambiguation)" class="mw-disambig" title="Eli Lilly (disambiguation)">Eli Lilly (disambiguation)</a>.</div>
<p class="mw-empty-elt">


</p>
<style data-mw-deduplicate="TemplateStyles:r1257001546">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}@media screen{html.skin-theme-clientpref-night .mw-parser-output .infobox-full-data:not(.notheme)>div:not(.notheme)[style]{background:#1f1f23!important;color:#f8f9fa}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .infobox-full-data:not(.notheme) div:not(.notheme){background:#1f1f23!important;color:#f8f9fa}}@media(min-width:640px){body.skin--responsive .mw-parser-output .infobox-table{display:table!important}body.skin--responsive .mw-parser-output .infobox-table>caption{display:table-caption!important}body.skin--responsive .mw-parser-output .infobox-table>tbody{display:table-row-group}body.skin--responsive .mw-parser-output .infobox-table tr{display:table-row!important}body.skin--responsive .mw-parser-output .infobox-table th,body.skin--responsive .mw-parser-output .infobox-table td{padding-left:inherit;padding-right:inherit}}</style><style data-mw-deduplicate="TemplateStyles:r1242257876">.mw-parser-output .ib-company .infobox-label{padding-right:0.5em}.mw-parser-output .ib-company .infobox-data,.mw-parser-output .ib-company .infobox-below{line-height:1.35em}.mw-parser-output .ib-company-logo img{background-color:#f8f9fa}.mw-parser-output .ib-company-locality,.mw-parser-output .ib-company-country{display:inline}</style><table class="infobox ib-company vcard"><caption class="infobox-title fn org" style="font-size: 125%;">Eli Lilly and Company</caption><tbody><tr><td colspan="2" class="infobox-image ib-company-logo logo"><span class="mw-default-size" typeof="mw:File/Frameless"><a href="/wiki/File:Eli_Lilly_and_Company.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/250px-Eli_Lilly_and_Company.svg.png" decoding="async" width="250" height="142" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/375px-Eli_Lilly_and_Company.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2b/Eli_Lilly_and_Company.svg/500px-Eli_Lilly_and_Company.svg.png 2x" data-file-width="97" data-file-height="55" /></a></span></td></tr><tr><th scope="row" class="infobox-label">Company type</th><td class="infobox-data category"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></div></th><td class="infobox-data"><style data-mw-deduplicate="TemplateStyles:r1126788409">.mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}</style><div class="plainlist"><ul><li><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>:&#160;<a rel="nofollow" class="external text" href="https://www.nyse.com/quote/XNYS:LLY">LLY</a></li><li><a href="/wiki/S%26P_100" title="S&amp;P 100">S&amp;P 100</a> component</li><li><a href="/wiki/S%26P_500" title="S&amp;P 500">S&amp;P 500</a> component</li></ul></div></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td class="infobox-data"><span class="plainlinks"><a class="external text" href="https://isin.toolforge.org/?language=en&amp;isin=US5324571083">US5324571083</a></span></td></tr><tr><th scope="row" class="infobox-label">Industry</th><td class="infobox-data category"><a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">Pharmaceutical</a></td></tr><tr><th scope="row" class="infobox-label">Founded</th><td class="infobox-data">1876<span class="noprint">&#59;&#32;149&#160;years ago</span><span style="display:none">&#160;(<span class="bday dtstart published updated">1876</span>)</span></td></tr><tr><th scope="row" class="infobox-label">Founder</th><td class="infobox-data agent"><a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a></td></tr><tr><th scope="row" class="infobox-label">Headquarters</th><td class="infobox-data label"><a href="/wiki/Indianapolis" title="Indianapolis">Indianapolis</a>, Indiana, U.S.</td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;">Key people</div></th><td class="infobox-data agent"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409" /><div class="plainlist"><ul><li>David A. Ricks (<a href="/wiki/Chair_(officer)" title="Chair (officer)">chair</a>, <a href="/wiki/President_(corporate_title)" title="President (corporate title)">president</a>, &amp; <a href="/wiki/Chief_Executive_Officer" class="mw-redirect" title="Chief Executive Officer">CEO</a>)</li></ul></div></td></tr><tr><th scope="row" class="infobox-label">Products</th><td class="infobox-data"><a href="/wiki/Medication" title="Medication">Pharmaceutical drugs</a></td></tr><tr><th scope="row" class="infobox-label">Revenue</th><td class="infobox-data"><span typeof="mw:File"><span title="Increase"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /></span></span> <span style="white-space: nowrap"><a href="/wiki/United_States_dollar" title="United States dollar">US$</a>45.04 billion</span> (2024)</td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td class="infobox-data"><span typeof="mw:File"><span title="Increase"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /></span></span> <span style="white-space: nowrap">US$12.90 billion</span> (2024)</td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td class="infobox-data"><span typeof="mw:File"><span title="Increase"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /></span></span> <span style="white-space: nowrap">US$10.59 billion</span> (2024)</td></tr><tr><th scope="row" class="infobox-label"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td class="infobox-data"><span typeof="mw:File"><span title="Increase"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /></span></span> <span style="white-space: nowrap">US$78.71 billion</span> (2024)</td></tr><tr><th scope="row" class="infobox-label"><span class="nowrap"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td class="infobox-data"><span typeof="mw:File"><span title="Increase"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/20px-Increase2.svg.png" decoding="async" width="11" height="11" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/40px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300" /></span></span> <span style="white-space: nowrap">US$14.19 billion</span> (2024)</td></tr><tr><th scope="row" class="infobox-label">Owner</th><td class="infobox-data"><a href="/wiki/Lilly_Endowment" title="Lilly Endowment">Lilly Endowment</a> (10.8%)</td></tr><tr><th scope="row" class="infobox-label"><div style="display: inline-block; line-height: 1.2em; padding: .1em 0;">Number of employees</div></th><td class="infobox-data">47,000 (2024)</td></tr><tr><th scope="row" class="infobox-label">Website</th><td class="infobox-data"><span class="url"><a rel="nofollow" class="external text" href="https://lilly.com">lilly<wbr />.com</a></span></td></tr><tr><td colspan="2" class="infobox-below"><b>Footnotes&#160;/&#32;references</b><br /><sup id="cite_ref-1" class="reference"><a href="#cite_note-1"><span class="cite-bracket">&#91;</span>1<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-10K_2-0" class="reference"><a href="#cite_note-10K-2"><span class="cite-bracket">&#91;</span>2<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span class="cite-bracket">&#91;</span>3<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span class="cite-bracket">&#91;</span>4<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-proxy_5-0" class="reference"><a href="#cite_note-proxy-5"><span class="cite-bracket">&#91;</span>5<span class="cite-bracket">&#93;</span></a></sup></td></tr></tbody></table>
<p><b>Eli Lilly and Company</b>, <a href="/wiki/Trade_name" title="Trade name">doing business as</a> <b>Lilly</b>, is an American multinational <a href="/wiki/Medication" title="Medication">pharmaceutical</a> company headquartered in <a href="/wiki/Indianapolis" title="Indianapolis">Indianapolis</a>, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a>, a pharmaceutical <a href="/wiki/Chemist" title="Chemist">chemist</a> and <a href="/wiki/Union_army" title="Union army">Union army</a> veteran during the <a href="/wiki/American_Civil_War" title="American Civil War">American Civil War</a> for whom the company was later named.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span class="cite-bracket">&#91;</span>6<span class="cite-bracket">&#93;</span></a></sup>
</p><p>As of October 2024, Lilly is the most valuable drug company in the world with a $842 billion market capitalization, the highest valuation ever achieved to date by a drug company.<sup id="cite_ref-Barnes_7-0" class="reference"><a href="#cite_note-Barnes-7"><span class="cite-bracket">&#91;</span>7<span class="cite-bracket">&#93;</span></a></sup>  The company is ranked 127th on the <a href="/wiki/Fortune_500" title="Fortune 500"><i>Fortune</i> 500</a> with revenue of $34.12 billion.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span class="cite-bracket">&#91;</span>8<span class="cite-bracket">&#93;</span></a></sup> It is ranked 221st on the <a href="/wiki/Forbes_Global_2000" title="Forbes Global 2000"><i>Forbes</i> Global 2000</a> list of the world's largest publicly-traded companies<sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span class="cite-bracket">&#91;</span>9<span class="cite-bracket">&#93;</span></a></sup> and 252nd on <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i><span class="nowrap" style="padding-left:0.1em;">&#39;</span> list of "America's Best Employers".<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span class="cite-bracket">&#91;</span>10<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Lilly is known for its <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">clinical depression</a> drugs Prozac (<a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a>) (1986), Cymbalta (<a href="/wiki/Duloxetine" title="Duloxetine">duloxetine</a>) (2004), and its <a href="/wiki/Antipsychotic" title="Antipsychotic">antipsychotic</a> medication Zyprexa (<a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a>) (1996). The company's primary revenue drivers are the <a href="/wiki/Diabetes" title="Diabetes">diabetes</a> drugs Humalog (<a href="/wiki/Insulin_lispro" title="Insulin lispro">insulin lispro</a>) (1996) and Trulicity (<a href="/wiki/Dulaglutide" title="Dulaglutide">dulaglutide</a>) (2014).<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span class="cite-bracket">&#91;</span>11<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Lilly was the first company to mass-produce both the <a href="/wiki/Polio_vaccine" title="Polio vaccine">polio vaccine</a>, developed in 1955 by <a href="/wiki/Jonas_Salk" title="Jonas Salk">Jonas Salk</a>, and <a href="/wiki/Insulin" title="Insulin">insulin</a>. It was one of the first pharmaceutical companies to produce human <a href="/wiki/Insulin" title="Insulin">insulin</a> using <a href="/wiki/Recombinant_DNA" title="Recombinant DNA">recombinant DNA</a>,  including Humulin (<a href="/wiki/Insulin_(medication)" title="Insulin (medication)">insulin medication</a>), Humalog (<a href="/wiki/Insulin_lispro" title="Insulin lispro">insulin lispro</a>), and the first approved <a href="/wiki/Biosimilar" title="Biosimilar">biosimilar</a> insulin product in the U.S., Basaglar (<a href="/wiki/Insulin_glargine" title="Insulin glargine">insulin glargine</a>).<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span class="cite-bracket">&#91;</span>12<span class="cite-bracket">&#93;</span></a></sup>  Lilly brought <a href="/wiki/Exenatide" title="Exenatide">exenatide</a> to market—the first of the <a href="/wiki/GLP-1_receptor_agonist" title="GLP-1 receptor agonist">GLP-1 receptor agonists</a><sup id="cite_ref-Pollack2_13-0" class="reference"><a href="#cite_note-Pollack2-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup>—followed by blockbuster drugs in the same class such as Mounjaro and Zepbound (<a href="/wiki/Tirzepatide" title="Tirzepatide">tirzepatide</a>).<sup id="cite_ref-Barnes_7-1" class="reference"><a href="#cite_note-Barnes-7"><span class="cite-bracket">&#91;</span>7<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>As of 1997, it was both the largest corporation and the largest charitable benefactor in Indiana.<sup id="cite_ref-p58_14-0" class="reference"><a href="#cite_note-p58-14"><span class="cite-bracket">&#91;</span>14<span class="cite-bracket">&#93;</span></a></sup> In 2009, Lilly pleaded guilty for illegally marketing Zyprexa and agreed to pay a $1.415 billion penalty that included a criminal fine of $515 million, the largest ever in a healthcare case and the largest criminal fine for an individual corporation ever imposed in a U.S. criminal prosecution of any kind at the time.<sup id="cite_ref-usdoj-2009_15-0" class="reference"><a href="#cite_note-usdoj-2009-15"><span class="cite-bracket">&#91;</span>15<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-:1_16-0" class="reference"><a href="#cite_note-:1-16"><span class="cite-bracket">&#91;</span>16<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Lilly is a full member of the <a href="/wiki/Pharmaceutical_Research_and_Manufacturers_of_America" title="Pharmaceutical Research and Manufacturers of America">Pharmaceutical Research and Manufacturers of America</a><sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span class="cite-bracket">&#91;</span>17<span class="cite-bracket">&#93;</span></a></sup> and the <a href="/wiki/European_Federation_of_Pharmaceutical_Industries_and_Associations" title="European Federation of Pharmaceutical Industries and Associations">European Federation of Pharmaceutical Industries and Associations</a> (EFPIA).<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span class="cite-bracket">&#91;</span>18<span class="cite-bracket">&#93;</span></a></sup>
</p>
<meta property="mw:PageProp/toc" />
<div class="mw-heading mw-heading2"><h2 id="History">History</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=1" title="Edit section: History"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<div class="mw-heading mw-heading3"><h3 id="Founding">Founding</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=2" title="Edit section: Founding"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a></div>
<figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Colonel_eli_lilly_in_1885-full.JPG" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/0/06/Colonel_eli_lilly_in_1885-full.JPG/250px-Colonel_eli_lilly_in_1885-full.JPG" decoding="async" width="250" height="300" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/06/Colonel_eli_lilly_in_1885-full.JPG/500px-Colonel_eli_lilly_in_1885-full.JPG 1.5x" data-file-width="1507" data-file-height="1810" /></a><figcaption><a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a> (1838–1898), a <a href="/wiki/Union_army" title="Union army">Union army</a> officer who founded the company in 1876</figcaption></figure>
<p>The company was founded by Colonel <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a>, a <a href="/wiki/Pharmacist" title="Pharmacist">pharmaceutical chemist</a> and <a href="/wiki/Union_army" title="Union army">Union army</a> veteran of the <a href="/wiki/American_Civil_War" title="American Civil War">American Civil War</a>. Lilly served as the company president until his death in 1898.<sup id="cite_ref-IHSHBR1_19-0" class="reference"><a href="#cite_note-IHSHBR1-19"><span class="cite-bracket">&#91;</span>19<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1869, after working for drugstores in Indiana, Lilly became a partner in a <a href="/wiki/Paris,_Illinois" title="Paris, Illinois">Paris, Illinois</a>-based drugstore with James W. Binford.<sup id="cite_ref-b911_20-0" class="reference"><a href="#cite_note-b911-20"><span class="cite-bracket">&#91;</span>20<span class="cite-bracket">&#93;</span></a></sup> Four years later, in 1873, Lilly left the partnership with Binford, and returned to <a href="/wiki/Indianapolis" title="Indianapolis">Indianapolis</a>. In 1874, Lilly partnered with John F. Johnston, and opened a drug manufacturing operation called Johnston and Lilly. 
</p><p>Two years later, in 1876, Lilly dissolved the partnership, and used his share of the assets to open his own pharmaceutical manufacturing business, Eli Lilly and Company, in Indianapolis.<sup id="cite_ref-LillyBio_21-0" class="reference"><a href="#cite_note-LillyBio-21"><span class="cite-bracket">&#91;</span>21<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-m6_22-0" class="reference"><a href="#cite_note-m6-22"><span class="cite-bracket">&#91;</span>22<span class="cite-bracket">&#93;</span></a></sup> The sign outside, above the shop's door, read: "Eli Lilly, Chemist."<sup id="cite_ref-IHSHBR1_19-1" class="reference"><a href="#cite_note-IHSHBR1-19"><span class="cite-bracket">&#91;</span>19<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-b540_23-0" class="reference"><a href="#cite_note-b540-23"><span class="cite-bracket">&#91;</span>23<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span class="cite-bracket">&#91;</span>24<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>Lilly began his manufacturing venture with three employees, including his son, <a href="/wiki/Josiah_K._Lilly_Sr." title="Josiah K. Lilly Sr.">Josiah</a> (J. K.).<sup id="cite_ref-p59_25-0" class="reference"><a href="#cite_note-p59-25"><span class="cite-bracket">&#91;</span>25<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-m6_22-1" class="reference"><a href="#cite_note-m6-22"><span class="cite-bracket">&#91;</span>22<span class="cite-bracket">&#93;</span></a></sup> One of the first medicines that Lilly produced was <a href="/wiki/Quinine" title="Quinine">quinine</a>, a drug used to treat <a href="/wiki/Malaria" title="Malaria">malaria</a>, a <a href="/wiki/Mosquito-borne_disease" title="Mosquito-borne disease">mosquito-borne disease</a>.<sup id="cite_ref-p57_26-0" class="reference"><a href="#cite_note-p57-26"><span class="cite-bracket">&#91;</span>26<span class="cite-bracket">&#93;</span></a></sup> By the end of 1876, sales reached $4,470.<sup id="cite_ref-p57_26-1" class="reference"><a href="#cite_note-p57-26"><span class="cite-bracket">&#91;</span>26<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="19th_century">19th century</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=3" title="Edit section: 19th century"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<p>In 1878, Lilly hired his brother, James, as his first full-time salesman, and the subsequent sales team marketed the company's drugs nationally.<sup id="cite_ref-Kahn23_27-0" class="reference"><a href="#cite_note-Kahn23-27"><span class="cite-bracket">&#91;</span>27<span class="cite-bracket">&#93;</span></a></sup> By 1879, the company had grown to $48,000 in sales.<sup id="cite_ref-p57_26-2" class="reference"><a href="#cite_note-p57-26"><span class="cite-bracket">&#91;</span>26<span class="cite-bracket">&#93;</span></a></sup>
</p><p>The company moved its Indianapolis headquarters from Pearl Street to larger quarters at 36 South <a href="/wiki/Meridian_Street_(Indianapolis)" title="Meridian Street (Indianapolis)">Meridian Street</a>. In 1881, the company moved to its current headquarters in Indianapolis's south-side industrial area, and the company later purchased additional facilities for research and production.<sup id="cite_ref-IHSHBR14_28-0" class="reference"><a href="#cite_note-IHSHBR14-28"><span class="cite-bracket">&#91;</span>28<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-m27_29-0" class="reference"><a href="#cite_note-m27-29"><span class="cite-bracket">&#91;</span>29<span class="cite-bracket">&#93;</span></a></sup> The same year, Lilly incorporated the business as Eli Lilly and Company, elected a board of directors, and issued stock to family members and close associates.<sup id="cite_ref-Kahn23_27-1" class="reference"><a href="#cite_note-Kahn23-27"><span class="cite-bracket">&#91;</span>27<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Lilly's first innovative product was <a href="/wiki/Gelatin" title="Gelatin">gelatin</a>-coating for pills and capsules. The company's other early innovations included fruit flavorings and sugarcoated pills, which made the medicines easier to swallow.<sup id="cite_ref-p59_25-1" class="reference"><a href="#cite_note-p59-25"><span class="cite-bracket">&#91;</span>25<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1882, Colonel Lilly's only son, <a href="/wiki/Josiah_K._Lilly_Sr." title="Josiah K. Lilly Sr.">Josiah K. Lilly Sr.</a> (J. K.), a pharmaceutical chemist, graduated from the <a href="/wiki/University_of_the_Sciences" title="University of the Sciences">Philadelphia College of Pharmacy</a> in <a href="/wiki/Philadelphia" title="Philadelphia">Philadelphia</a>, and returned to Indianapolis to join the family business as a superintendent of its laboratory.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span class="cite-bracket">&#91;</span>30<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-b911_20-1" class="reference"><a href="#cite_note-b911-20"><span class="cite-bracket">&#91;</span>20<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-PriceLegends59_31-0" class="reference"><a href="#cite_note-PriceLegends59-31"><span class="cite-bracket">&#91;</span>31<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1883, the company contracted to mix and sell Succus Alteran, its first widely successful product and one its best sellers. The product was marketed as a "blood purifier" and as a treatment for <a href="/wiki/Syphilis" title="Syphilis">syphilis</a>, some types of <a href="/wiki/Rheumatism" title="Rheumatism">rheumatism</a>, and skin diseases such as <a href="/wiki/Dermatitis" title="Dermatitis">eczema</a> and <a href="/wiki/Psoriasis" title="Psoriasis">psoriasis</a>.<sup id="cite_ref-m27_29-1" class="reference"><a href="#cite_note-m27-29"><span class="cite-bracket">&#91;</span>29<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-MadisonM72_32-0" class="reference"><a href="#cite_note-MadisonM72-32"><span class="cite-bracket">&#91;</span>32<span class="cite-bracket">&#93;</span></a></sup> Sales from the product provided funds for Lilly to expand its manufacturing and research facilities.<sup id="cite_ref-IHSHBR2_33-0" class="reference"><a href="#cite_note-IHSHBR2-33"><span class="cite-bracket">&#91;</span>33<span class="cite-bracket">&#93;</span></a></sup> By the late 1880s, Colonel Lilly was one of the Indianapolis area's leading businessmen, whose company had over 100 employees and $200,000 ($5,276,296 in 2015 chained dollars) in annual sales.<sup id="cite_ref-b911_20-2" class="reference"><a href="#cite_note-b911-20"><span class="cite-bracket">&#91;</span>20<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1890, Colonel Lilly fully turned over the day-to-day management of the business to J. K., who ran the company for 34 years. The 1890s were a tumultuous decade economically, but the company flourished.<sup id="cite_ref-b911_20-3" class="reference"><a href="#cite_note-b911-20"><span class="cite-bracket">&#91;</span>20<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-p60_34-0" class="reference"><a href="#cite_note-p60-34"><span class="cite-bracket">&#91;</span>34<span class="cite-bracket">&#93;</span></a></sup> In 1894, Lilly purchased a manufacturing plant to be used solely for creating capsules. The company also made several technological advances in the manufacturing process, including automating its capsule production. Over the next few years the company annually created tens of millions of capsules and pills.<sup id="cite_ref-PodczekJones_35-0" class="reference"><a href="#cite_note-PodczekJones-35"><span class="cite-bracket">&#91;</span>35<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1898, Lilly's son, J. K. Lilly, inherited the company and became its president following Colonel Lilly's death.<sup id="cite_ref-b913_36-0" class="reference"><a href="#cite_note-b913-36"><span class="cite-bracket">&#91;</span>36<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-IHSHBR3_37-0" class="reference"><a href="#cite_note-IHSHBR3-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> At the time of Colonel Lilly's death, the company had a product line of 2,005 items and annual sales of more than $300,000 ($8,547,600 in 2015 chained dollars).<sup id="cite_ref-bb912_38-0" class="reference"><a href="#cite_note-bb912-38"><span class="cite-bracket">&#91;</span>38<span class="cite-bracket">&#93;</span></a></sup> Colonel Lilly was a pioneer in the modern pharmaceutical industry, with many of his early innovations later becoming standard practice. His ethical reforms in a trade that was marked by outlandish claims of miracle medicines began a period of rapid advancement in the development of medicinal drugs.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span class="cite-bracket">&#91;</span>39<span class="cite-bracket">&#93;</span></a></sup> J. K. Lilly continued to advocate for federal regulation on medicines.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span class="cite-bracket">&#91;</span>40<span class="cite-bracket">&#93;</span></a></sup>
</p><p>As the Lilly company grew, other businesses set up operations near the plant on Indianapolis's near south side. The area developed into one of the city's major business and industrial hubs. Lilly's production, manufacturing, research, and administrative operations in Indianapolis eventually occupied a complex of more than two dozen buildings, which covered 15-block area, in addition to its production plants along Kentucky Avenue.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41"><span class="cite-bracket">&#91;</span>41<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In addition to Colonel Lilly, his brother, James, and son, Josiah (J. K.), the growing company employed other Lilly family. Colonel Lilly's cousin, Evan Lilly, was hired as a bookkeeper.<sup id="cite_ref-p60_34-1" class="reference"><a href="#cite_note-p60-34"><span class="cite-bracket">&#91;</span>34<span class="cite-bracket">&#93;</span></a></sup> As young boys, Lilly's grandsons, <a href="/wiki/Eli_Lilly_(industrialist,_born_1885)" title="Eli Lilly (industrialist, born 1885)">Eli</a> and <a href="/wiki/Josiah_K._Lilly_Jr." title="Josiah K. Lilly Jr.">Josiah Jr.</a> (Joe), ran errands and performed other odd jobs. Eli and Joe joined the family business after college. Eventually, each grandson served as company president and chairman of the board.<sup id="cite_ref-IHSHBR256_42-0" class="reference"><a href="#cite_note-IHSHBR256-42"><span class="cite-bracket">&#91;</span>42<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Under J. K.'s leadership, the company introduced scientific management concepts, organized the company's research department, increased its sales force, and began international distribution of its products.<sup id="cite_ref-IHSindustry3_43-0" class="reference"><a href="#cite_note-IHSindustry3-43"><span class="cite-bracket">&#91;</span>43<span class="cite-bracket">&#93;</span></a></sup>
</p><p>For the rest of the late 19th century, Lilly operated in Indianapolis and the surrounding area as many other pharmaceutical businesses did, manufacturing and selling "sugar-coated pills, fluid extracts, elixirs, and syrups".<sup id="cite_ref-MadisonM72_32-1" class="reference"><a href="#cite_note-MadisonM72-32"><span class="cite-bracket">&#91;</span>32<span class="cite-bracket">&#93;</span></a></sup> The company used plants for its raw materials and produced its products by hand. One historian noted, "Although the Indianapolis firm was more careful in making and promoting drugs than the patent medicine men of the era, the company remained ambivalent about scientific research."<sup id="cite_ref-MadisonM72_32-2" class="reference"><a href="#cite_note-MadisonM72-32"><span class="cite-bracket">&#91;</span>32<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="20th_century">20th century</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=4" title="Edit section: 20th century"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Eli_Lilly_Medicines,_1906.jpg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ea/Eli_Lilly_Medicines%2C_1906.jpg/250px-Eli_Lilly_Medicines%2C_1906.jpg" decoding="async" width="250" height="287" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ea/Eli_Lilly_Medicines%2C_1906.jpg/500px-Eli_Lilly_Medicines%2C_1906.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/e/ea/Eli_Lilly_Medicines%2C_1906.jpg 2x" data-file-width="500" data-file-height="574" /></a><figcaption>An assortment of Lilly's <a href="/wiki/Throat_lozenge" title="Throat lozenge">throat lozenges</a> from a 1906 sales book</figcaption></figure>
<figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Josiah_K._Lilly.jpg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/4/42/Josiah_K._Lilly.jpg" decoding="async" width="202" height="315" class="mw-file-element" data-file-width="202" data-file-height="315" /></a><figcaption><a href="/wiki/Josiah_K._Lilly_Sr." title="Josiah K. Lilly Sr.">Josiah K. Lilly Sr.</a> (1861&#8211;1948), the company's second president</figcaption></figure>
<figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png/250px-Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png" decoding="async" width="250" height="160" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png/500px-Eli_Lilly_and_Company_Headquarters_ca1919_b1007511_003_tif_zs25x9459.png 1.5x" data-file-width="4850" data-file-height="3112" /></a><figcaption>Eli Lilly and Company's corporate headquarters in <a href="/wiki/Indianapolis" title="Indianapolis">Indianapolis</a>, <abbr title="circa">c.</abbr><span style="white-space:nowrap;">&#8201;1919</span></figcaption></figure>
<figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff/lossless-page1-250px-Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff.png" decoding="async" width="250" height="411" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff/lossless-page1-375px-Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e5/Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff/lossless-page1-500px-Views_in_Elastic_Filled_Capsule_Department_b1007511_008_tif_bn999778q.tiff.png 2x" data-file-width="2946" data-file-height="4849" /></a><figcaption>Men and women workers preparing drug capsules at Eli Lilly and Company in 1919</figcaption></figure>
<figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff/lossless-page1-250px-Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff.png" decoding="async" width="250" height="387" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff/lossless-page1-375px-Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/ab/Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff/lossless-page1-500px-Belladonna_cultivation_Hand_book_of_pharmacy_and_therapeutics_b1007511_005_tif_5x21tg304.tiff.png 2x" data-file-width="3704" data-file-height="5737" /></a><figcaption><i><a href="/wiki/Amaryllis_belladonna" title="Amaryllis belladonna">Amaryllis belladonna</a></i> cultivation at Eli Lilly and Company in 1919</figcaption></figure>
<figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Eli_Lilly_global_manufacturing_plants.png" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/7/79/Eli_Lilly_global_manufacturing_plants.png/250px-Eli_Lilly_global_manufacturing_plants.png" decoding="async" width="250" height="110" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/79/Eli_Lilly_global_manufacturing_plants.png/500px-Eli_Lilly_global_manufacturing_plants.png 1.5x" data-file-width="1425" data-file-height="625" /></a><figcaption>Eli Lilly's present-day global manufacturing plants</figcaption></figure>
<p>In 1905, J. K. Lilly oversaw a large expansion of the company, and it reached annual sales of $1 million ($26,381,481 in 2015 chained dollars).<sup id="cite_ref-IHSHBR3_37-1" class="reference"><a href="#cite_note-IHSHBR3-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Before and after <a href="/wiki/World_War_I" title="World War I">World War I</a>, the company experienced rapid growth,<sup id="cite_ref-MadisonM72_32-3" class="reference"><a href="#cite_note-MadisonM72-32"><span class="cite-bracket">&#91;</span>32<span class="cite-bracket">&#93;</span></a></sup> including expanded manufacturing facilities at its McCarty Street plant, which improved production capacity with a new Science Building (Building 14), opened in 1911, and a new capsule plant (Building 15) in 1913.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span class="cite-bracket">&#91;</span>44<span class="cite-bracket">&#93;</span></a></sup> In 1913, the company began construction of <a href="/wiki/Lilly_Biological_Laboratories" title="Lilly Biological Laboratories">Lilly Biological Laboratories</a>, a research and manufacturing plant on 150 acres near <a href="/wiki/Greenfield,_Indiana" title="Greenfield, Indiana">Greenfield, Indiana</a>.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45"><span class="cite-bracket">&#91;</span>45<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-SHAARD_46-0" class="reference"><a href="#cite_note-SHAARD-46"><span class="cite-bracket">&#91;</span>46<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In addition to development of new medicines, the company achieved several technological advances, including automation of its production facilities. Lilly was also an innovator in pill capsule manufacturing. It was among the first manufacturers to insert medications into empty gelatin capsules, which provided a more exact dosage.<sup id="cite_ref-IHSHBR1_19-2" class="reference"><a href="#cite_note-IHSHBR1-19"><span class="cite-bracket">&#91;</span>19<span class="cite-bracket">&#93;</span></a></sup> Lilly manufactured capsules for its own needs and sold its excess capacity to others.<sup id="cite_ref-MadisonM73_47-0" class="reference"><a href="#cite_note-MadisonM73-47"><span class="cite-bracket">&#91;</span>47<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In 1917, <i><a href="/wiki/Scientific_American" title="Scientific American">Scientific American</a></i> described Lilly as "the largest capsule factory in the world" and reported that the company was "capable of producing 2.5 million capsules a day".<sup id="cite_ref-MadisonM73_47-1" class="reference"><a href="#cite_note-MadisonM73-47"><span class="cite-bracket">&#91;</span>47<span class="cite-bracket">&#93;</span></a></sup> One of Lilly's early innovations was fruit flavoring for medicines and sugar-coated pills to make their medicines easier to swallow.<sup id="cite_ref-p59_25-2" class="reference"><a href="#cite_note-p59-25"><span class="cite-bracket">&#91;</span>25<span class="cite-bracket">&#93;</span></a></sup> Over the next few years, the company began to create tens of millions of capsules and pills annually.<sup id="cite_ref-PodczekJones_35-1" class="reference"><a href="#cite_note-PodczekJones-35"><span class="cite-bracket">&#91;</span>35<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Other advances improved plant efficiency and eliminated production errors. In 1909, <a href="/wiki/Eli_Lilly_(industrialist,_born_1885)" title="Eli Lilly (industrialist, born 1885)">Eli Lilly</a>, grandson of the company's founder, introduced a method for blueprinting manufacturing tickets,<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span class="cite-bracket">&#91;</span>48<span class="cite-bracket">&#93;</span></a></sup> which created multiples copies of a drug formula and helped eliminate manufacturing and transcription errors.<sup id="cite_ref-MadisonM73_47-2" class="reference"><a href="#cite_note-MadisonM73-47"><span class="cite-bracket">&#91;</span>47<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In 1919, Josiah hired biochemist <a href="/wiki/George_Henry_Alexander_Clowes" title="George Henry Alexander Clowes">George Henry Alexander Clowes</a> as director of biochemical research.
</p><p>In the 1920s, Eli introduced the new concept of straight-line production to the pharmaceutical industry, where raw materials entered at one end of the facility and the finished product came out the other end, in the company's manufacturing process. Under Eli's supervision, the design for Building 22, a new five-floor plant that opened in Indianapolis in 1926, implemented the straight-line concept to improve production efficiency and lower production costs.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span class="cite-bracket">&#91;</span>49<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-MadisonM74_50-0" class="reference"><a href="#cite_note-MadisonM74-50"><span class="cite-bracket">&#91;</span>50<span class="cite-bracket">&#93;</span></a></sup> One historian noted, "It was probably the most sophisticated production system in the American pharmaceutical industry."<sup id="cite_ref-MadisonM74_50-1" class="reference"><a href="#cite_note-MadisonM74-50"><span class="cite-bracket">&#91;</span>50<span class="cite-bracket">&#93;</span></a></sup> This more efficient manufacturing process also allowed the company to hire a regular workforce. Instead of recalling workers at peak times and laying them off when production demand fell, Lilly's regular workforce produced less-costly medicines in off-peak times using the same manufacturing facilities.<sup id="cite_ref-IHSHBR256_42-1" class="reference"><a href="#cite_note-IHSHBR256-42"><span class="cite-bracket">&#91;</span>42<span class="cite-bracket">&#93;</span></a></sup>
</p><p>During the 1920s, the introduction of new products brought the company financial success.<sup id="cite_ref-MadisonM72_32-4" class="reference"><a href="#cite_note-MadisonM72-32"><span class="cite-bracket">&#91;</span>32<span class="cite-bracket">&#93;</span></a></sup> In 1921, three <a href="/wiki/University_of_Toronto" title="University of Toronto">University of Toronto</a> scientists, <a href="/wiki/John_Macleod_(physiologist)" title="John Macleod (physiologist)">John Macleod</a>, <a href="/wiki/Frederick_Banting" title="Frederick Banting">Frederick Banting</a>, and <a href="/wiki/Charles_Best_(medical_scientist)" title="Charles Best (medical scientist)">Charles Best</a>, were working on the development of <a href="/wiki/Insulin" title="Insulin">insulin</a> for treatment of diabetes.<sup id="cite_ref-MadisonM76_51-0" class="reference"><a href="#cite_note-MadisonM76-51"><span class="cite-bracket">&#91;</span>51<span class="cite-bracket">&#93;</span></a></sup> Clowes proposed a collaboration with the researchers in December 1921, and then again March and May 1922. The researchers were hesitant to work with a commercial drug firm, particularly since they had the <a href="/wiki/Connaught_Laboratories" title="Connaught Laboratories">Connaught Laboratories</a>' non-commercial facilities at hand. But as limits were reached at the scale to which Connaught could produce insulin, Clowes and Eli Lilly met with the researchers in 1922 to negotiate an agreement with the University of Toronto scientists to mass-produce insulin.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52"><span class="cite-bracket">&#91;</span>52<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-53" class="reference"><a href="#cite_note-53"><span class="cite-bracket">&#91;</span>53<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-54" class="reference"><a href="#cite_note-54"><span class="cite-bracket">&#91;</span>54<span class="cite-bracket">&#93;</span></a></sup> The collaboration greatly accelerated the large-scale production of the extract.<sup id="cite_ref-Roberts_55-0" class="reference"><a href="#cite_note-Roberts-55"><span class="cite-bracket">&#91;</span>55<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1923, the company began selling Iletin, the company's tradename for the first commercially available insulin product in the U.S for the treatment of diabetes.<sup id="cite_ref-MLilly61_56-0" class="reference"><a href="#cite_note-MLilly61-56"><span class="cite-bracket">&#91;</span>56<span class="cite-bracket">&#93;</span></a></sup> Numerous objections were registered by the Insulin Committee of the University of Toronto in regard to Lilly's use of the term "Iletin", although production continued under this name and the objection was later dropped "as a concession".<sup id="cite_ref-57" class="reference"><a href="#cite_note-57"><span class="cite-bracket">&#91;</span>57<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-58" class="reference"><a href="#cite_note-58"><span class="cite-bracket">&#91;</span>58<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Also in 1923, Banting and Macleod were awarded the <a href="/wiki/Nobel_Prize" title="Nobel Prize">Nobel Prize</a> for their research, which they subsequently shared with co-discoverers <a href="/wiki/Charles_Best_(medical_scientist)" title="Charles Best (medical scientist)">Charles Best</a> and <a href="/wiki/James_Collip" title="James Collip">James Collip</a>.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span class="cite-bracket">&#91;</span>59<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span class="cite-bracket">&#91;</span>60<span class="cite-bracket">&#93;</span></a></sup> Insulin, "the most important drug" in the company's history, did "more than any other" to make Lilly "one of the major pharmaceutical manufacturers in the world."<sup id="cite_ref-MadisonM76_51-1" class="reference"><a href="#cite_note-MadisonM76-51"><span class="cite-bracket">&#91;</span>51<span class="cite-bracket">&#93;</span></a></sup> Eli Lilly and Company enjoyed an effective monopoly on the sale of insulin in the U.S. for almost two years, until the first of the new American licensees, Frederick Stearns &amp; Co., entered the market in June 1924.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span class="cite-bracket">&#91;</span>61<span class="cite-bracket">&#93;</span></a></sup>
</p><p>The success of insulin enabled the company to attract scientists and, with them, make more medical advances. By the company's 50th anniversary in 1926, its sales had reached $9 million and it was producing over 2,800 products.<sup id="cite_ref-IHSHBR256_42-2" class="reference"><a href="#cite_note-IHSHBR256-42"><span class="cite-bracket">&#91;</span>42<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1928, Lilly introduced Liver Extract 343 for the treatment of <a href="/wiki/Pernicious_anemia" title="Pernicious anemia">pernicious anemia</a>, a blood disorder, in a joint venture with two <a href="/wiki/Harvard_University" title="Harvard University">Harvard University</a> scientists, <a href="/wiki/George_Minot" title="George Minot">George Minot</a> and <a href="/wiki/William_P._Murphy" title="William P. Murphy">William P. Murphy</a>. In 1930, Lilly introduced Liver Extract No. 55 in collaboration with <a href="/wiki/George_Whipple" title="George Whipple">George Whipple</a>, a <a href="/wiki/University_of_Rochester" title="University of Rochester">University of Rochester</a> scientist.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span class="cite-bracket">&#91;</span>62<span class="cite-bracket">&#93;</span></a></sup> Four years later, in 1934, Minot, Murphy, and Whipple were awarded the <a href="/wiki/Nobel_Prize_in_Physiology_or_Medicine" title="Nobel Prize in Physiology or Medicine">Nobel Prize in Physiology or Medicine</a> for their research.<sup id="cite_ref-MLilly67_63-0" class="reference"><a href="#cite_note-MLilly67-63"><span class="cite-bracket">&#91;</span>63<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In the 1930s, the company also continued expansion overseas.<sup id="cite_ref-MLilly111_64-0" class="reference"><a href="#cite_note-MLilly111-64"><span class="cite-bracket">&#91;</span>64<span class="cite-bracket">&#93;</span></a></sup> In 1934, Eli Lilly and Company Limited, the company's first overseas subsidiary was established in <a href="/wiki/London" title="London">London</a>, and a manufacturing plant was opened in <a href="/wiki/Basingstoke" title="Basingstoke">Basingstoke</a>.<sup id="cite_ref-IHSHBR5_65-0" class="reference"><a href="#cite_note-IHSHBR5-65"><span class="cite-bracket">&#91;</span>65<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-MLilly111_64-1" class="reference"><a href="#cite_note-MLilly111-64"><span class="cite-bracket">&#91;</span>64<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1932, despite the economic challenges of the <a href="/wiki/Great_Depression" title="Great Depression">Great Depression</a>, Lilly's sales rose to $13 million.<sup id="cite_ref-IHSHBR5_65-1" class="reference"><a href="#cite_note-IHSHBR5-65"><span class="cite-bracket">&#91;</span>65<span class="cite-bracket">&#93;</span></a></sup> The same year, Eli Lilly, eldest grandson of Col. Lilly who had joined the company in 1909, was named as the company's president, succeeding his father, who remained as chairman of the board until 1948.<sup id="cite_ref-IHSHBR3_37-2" class="reference"><a href="#cite_note-IHSHBR3-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> In his early years at the company, Eli was especially interested in improving production efficiency and introduced a number of labor-saving devices. He also introduced scientific management principles, implemented cost-savings measures that modernized the company,<sup id="cite_ref-66" class="reference"><a href="#cite_note-66"><span class="cite-bracket">&#91;</span>66<span class="cite-bracket">&#93;</span></a></sup> and expanded the company's research efforts and collaborations with university researchers.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span class="cite-bracket">&#91;</span>67<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1934, the firm opened two new facilities on the McCarty Street complex: a replica of Lilly's 1876 laboratory and the new Lilly Research Laboratories, "one of the most fully equipped facilities in the world."<sup id="cite_ref-68" class="reference"><a href="#cite_note-68"><span class="cite-bracket">&#91;</span>68<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>During <a href="/wiki/World_War_II" title="World War II">World War II</a>, the company expanded production to a new high, manufacturing <a href="/wiki/Thiomersal" title="Thiomersal">merthiolate</a>, an <a href="/wiki/Organomercury_chemistry" title="Organomercury chemistry">organomercury</a> compound, and <a href="/wiki/Penicillin" title="Penicillin">penicillin</a>, a <a href="/wiki/Beta-lactam_antibiotics" class="mw-redirect" title="Beta-lactam antibiotics">beta-lactam antibiotic</a>. Lilly also cooperated with the <a href="/wiki/American_Red_Cross" title="American Red Cross">American Red Cross</a> to process <a href="/wiki/Blood_plasma" title="Blood plasma">blood plasma</a>. By the end of World War II, the company had dried over two million pints of blood, "about 20 percent of the United States' total".<sup id="cite_ref-Madison,_Eli_Lilly,_p._105_69-0" class="reference"><a href="#cite_note-Madison,_Eli_Lilly,_p._105-69"><span class="cite-bracket">&#91;</span>69<span class="cite-bracket">&#93;</span></a></sup> Merthiolate, first introduced in 1930, was an "antiseptic and germicide" that became a <a href="/wiki/United_States_Army" title="United States Army">U.S. Army</a> standard issue during World War II.<sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span class="cite-bracket">&#91;</span>70<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-MLilly65_71-0" class="reference"><a href="#cite_note-MLilly65-71"><span class="cite-bracket">&#91;</span>71<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-72" class="reference"><a href="#cite_note-72"><span class="cite-bracket">&#91;</span>72<span class="cite-bracket">&#93;</span></a></sup>
</p><p>International operations expanded even further during World War II.<sup id="cite_ref-MLilly111_64-2" class="reference"><a href="#cite_note-MLilly111-64"><span class="cite-bracket">&#91;</span>64<span class="cite-bracket">&#93;</span></a></sup> In 1943, Eli Lilly International Corp. was formed as a subsidiary to encourage business trade abroad. By 1948, Lilly employees worked in 35 countries, most of them as sales representatives in <a href="/wiki/Latin_America" title="Latin America">Latin America</a>, <a href="/wiki/Asia" title="Asia">Asia</a>, and <a href="/wiki/Africa" title="Africa">Africa</a>.<sup id="cite_ref-MLilly111_64-3" class="reference"><a href="#cite_note-MLilly111-64"><span class="cite-bracket">&#91;</span>64<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1945, Lilly began a major expansion effort that included two manufacturing operations in Indianapolis. The company purchased the massive Curtiss-Wright propeller plant on Kentucky Avenue, west of the company's McCarty Street operation. When renovation was completed in mid-1947, the Kentucky Avenue location manufactured <a href="/wiki/Antibiotics" class="mw-redirect" title="Antibiotics">antibiotics</a> and capsules and housed the company's shipping department.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73"><span class="cite-bracket">&#91;</span>73<span class="cite-bracket">&#93;</span></a></sup> By 1948, Lilly employed nearly 7,000 people.<sup id="cite_ref-b540_23-1" class="reference"><a href="#cite_note-b540-23"><span class="cite-bracket">&#91;</span>23<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1948, Eli Lilly, who served as the company's president since 1932, retired from active management, became chairman of the board, and relinquished the presidency to his brother, <a href="/wiki/Josiah_K._Lilly_Jr." title="Josiah K. Lilly Jr.">Josiah K. Lilly Jr.</a> (Joe).<sup id="cite_ref-74" class="reference"><a href="#cite_note-74"><span class="cite-bracket">&#91;</span>74<span class="cite-bracket">&#93;</span></a></sup> During Eli's 16-year presidency, sales rose from $13 million in 1932 to $117 million in 1948. Joe joined the company in 1914 and concentrated on the company's personnel and marketing efforts.<sup id="cite_ref-bb912_38-1" class="reference"><a href="#cite_note-bb912-38"><span class="cite-bracket">&#91;</span>38<span class="cite-bracket">&#93;</span></a></sup> He served as company president from 1948 to 1953, then became chairman of the board, and remained in that capacity until his death in 1966.<sup id="cite_ref-75" class="reference"><a href="#cite_note-75"><span class="cite-bracket">&#91;</span>75<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Throughout the mid-20th century, Lilly continued to expand its production facilities outside of Indianapolis. In 1950, Lilly launched Tippecanoe Laboratories in <a href="/wiki/Lafayette,_Indiana" title="Lafayette, Indiana">Lafayette, Indiana</a>,<sup id="cite_ref-b541_76-0" class="reference"><a href="#cite_note-b541-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup> and increased <a href="/wiki/Antibiotic" title="Antibiotic">antibiotic</a> production with its patent on <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>. 
</p><p>In the 1950s, Lilly introduced two new antibiotics, <a href="/wiki/Vancomycin" title="Vancomycin">vancomycin</a>, a <a href="/wiki/Glycopeptide_antibiotic" title="Glycopeptide antibiotic">glycopeptide antibiotic</a>, and <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>.<sup id="cite_ref-77" class="reference"><a href="#cite_note-77"><span class="cite-bracket">&#91;</span>77<span class="cite-bracket">&#93;</span></a></sup>  In the 1950s and 1960s, as generic drugs began flooding the marketplace after the expiration of patents, Lilly diversified into other areas, including <a href="/wiki/Agrochemical" title="Agrochemical">agricultural chemicals</a>, <a href="/wiki/Veterinary_medicine" title="Veterinary medicine">veterinary medicine</a> products, <a href="/wiki/Cosmetics" title="Cosmetics">cosmetics</a>, and <a href="/wiki/Medical_device" title="Medical device">medical instruments</a>.
</p><p>In 1952, the company offered its first public shares of stock, which are traded on the <a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">New York Stock Exchange</a>.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78"><span class="cite-bracket">&#91;</span>78<span class="cite-bracket">&#93;</span></a></sup> In 1953, Eugene N. Beesley was named the company's new president, the first non-family member to run the company.<sup id="cite_ref-79" class="reference"><a href="#cite_note-79"><span class="cite-bracket">&#91;</span>79<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1953, following a company reorganization and transition to non-family management, Lilly continued to expand its global presence. In 1954, Lilly formed <a href="/wiki/Elanco" title="Elanco">Elanco Products Company</a>, named after its parent company, for the production of <a href="/wiki/Veterinary_medicine" title="Veterinary medicine">veterinary pharmaceuticals</a>.
</p><p>Also in 1954, the National Foundation for Infantile Paralysis, now the <a href="/wiki/March_of_Dimes" title="March of Dimes">March of Dimes</a>, contracted with five pharmaceutical companies, Lilly, <a href="/wiki/Cutter_Laboratories" title="Cutter Laboratories">Cutter Laboratories</a>, <a href="/wiki/Parke-Davis" title="Parke-Davis">Parke, Davis and Company</a>, Pitman-Moore Company, and <a href="/wiki/Wyeth" title="Wyeth">Wyeth Laboratories</a> to produce Salk's polio vaccine for <a href="/wiki/Clinical_trials" class="mw-redirect" title="Clinical trials">clinical trials</a>.<sup id="cite_ref-IHSpolio5_80-0" class="reference"><a href="#cite_note-IHSpolio5-80"><span class="cite-bracket">&#91;</span>80<span class="cite-bracket">&#93;</span></a></sup> Lilly's selection to produce the vaccine was, in part, due to its previous experience in collaborations with university researchers.<sup id="cite_ref-IHSpolio6_81-0" class="reference"><a href="#cite_note-IHSpolio6-81"><span class="cite-bracket">&#91;</span>81<span class="cite-bracket">&#93;</span></a></sup> In 1955, Lilly manufactured 60 percent of Salk's polio vaccine.
</p><p>In the 1960s, Lilly operated 13 affiliate companies outside the United States.<sup id="cite_ref-IHSHBR6_82-0" class="reference"><a href="#cite_note-IHSHBR6-82"><span class="cite-bracket">&#91;</span>82<span class="cite-bracket">&#93;</span></a></sup> In 1962, the company acquired <a href="/wiki/The_Distillers_Company" title="The Distillers Company">The Distillers Company</a> and established a major factory in <a href="/wiki/Liverpool" title="Liverpool">Liverpool</a>, England. In 1968, Lilly built its first research facility outside the United States, the <a href="/wiki/Lilly_Research_Centre" title="Lilly Research Centre">Lilly Research Centre</a>, in <a href="/wiki/Surrey" title="Surrey">Surrey</a>, England. In 1969, the company opened a new plant in <a href="/wiki/Clinton,_Indiana" title="Clinton, Indiana">Clinton, Indiana</a>.<sup id="cite_ref-b541_76-1" class="reference"><a href="#cite_note-b541-76"><span class="cite-bracket">&#91;</span>76<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>During the 1970s and 1980s, Eli Lilly and Company underwent a flurry of drug production, including <a href="/wiki/Cefalexin" title="Cefalexin">Keflex</a>, an antibiotic, in 1971, <a href="/wiki/Dobutamine" title="Dobutamine">Dobutrex</a>, a <a href="/wiki/Cardiogenic_shock" title="Cardiogenic shock">cardiogenic shock</a> heart drug in 1977, <a href="/wiki/Cefaclor" title="Cefaclor">Ceclore</a>, which ultimately became the world's top selling oral antibiotic, in 1979, <a href="/wiki/Vindesine" title="Vindesine">Eldisine</a>, a <a href="/wiki/Leukemia" title="Leukemia">leukemia</a> drug, <a href="/wiki/Benoxaprofen" title="Benoxaprofen">Oraflex</a>, an <a href="/wiki/Arthritis" title="Arthritis">arthritis</a> drug, and <a href="/wiki/Dextropropoxyphene" title="Dextropropoxyphene">Darvon</a>, an <a href="/wiki/Opioid" title="Opioid">opioid</a> drug used in pain management.
</p><p>In 1971, the company became a component of the <a href="/wiki/S%26P_500_Index" class="mw-redirect" title="S&amp;P 500 Index">S&amp;P 500 Index</a>. To further diversify its product line, Lilly made an uncharacteristic, but ultimately profitable move in 1971, acquiring cosmetic manufacturer <a href="/wiki/Elizabeth_Arden,_Inc." title="Elizabeth Arden, Inc.">Elizabeth Arden, Inc.</a> for $38 million. Although Arden continued to lose money for five years after Lilly acquired it, executive management changes at Arden helped to ultimately turn it into a financial success. By 1982, Arden's "sales were up 90 percent from 1978, with profits doubling to nearly $30 million." In 1987, 16 years after acquiring it, Lilly sold Arden to <a href="/wiki/Faberg%C3%A9_(cosmetics)" title="Fabergé (cosmetics)">Fabergé</a> for $657 million.<sup id="cite_ref-IHSHBR7_83-0" class="reference"><a href="#cite_note-IHSHBR7-83"><span class="cite-bracket">&#91;</span>83<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1977, Lilly ventured into medical instruments with the acquisition of IVAC Corporation, which manufactures <a href="/wiki/Vital_signs" title="Vital signs">vital signs</a> and <a href="/wiki/Intravenous" class="mw-redirect" title="Intravenous">intravenous</a> fluid infusion monitoring systems.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84"><span class="cite-bracket">&#91;</span>84<span class="cite-bracket">&#93;</span></a></sup> The same year, Lilly acquired <a href="/wiki/Cardiac_Pacemakers,_Inc." title="Cardiac Pacemakers, Inc.">Cardiac Pacemakers, Inc.</a>, a manufacturer of <a href="/wiki/Artificial_pacemaker" class="mw-redirect" title="Artificial pacemaker">heart pacemakers</a>. In 1980, Lilly acquired <a href="/wiki/Physio-Control" title="Physio-Control">Physio-Control</a>, a pioneering company in <a href="/wiki/Defibrillation" title="Defibrillation">defibrillation</a>. Other acquisitions included Advance Cardiovascular Systems in 1984, <a href="/wiki/Beckman_Coulter" title="Beckman Coulter">Hybritech</a> in 1986, Devices for Vascular Intervention, in 1989, Pacific Biotech in 1990, and Origin Medsystems and Heart Rhythm Technologies, in 1992. In the early 1990s, Lilly combined its newly acquired medical equipment companies into a Medical Devices and Diagnostics Division that "contributed about 20 percent" of Lilly's annual revenues.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>&#93;</sup>
</p><p>In 1989, a joint <a href="/wiki/Agrochemical" title="Agrochemical">agrochemical</a> venture between <a href="/wiki/Elanco" title="Elanco">Elanco</a> and <a href="/wiki/Dow_Chemical" class="mw-redirect" title="Dow Chemical">Dow Chemical</a> created DowElanco. In 1997, Lilly sold its 40% share in the company to Dow Chemical for $1.2 billion and the name was changed to <a href="/wiki/Dow_AgroSciences" title="Dow AgroSciences">Dow AgroSciences</a>.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85"><span class="cite-bracket">&#91;</span>85<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1991, Vaughn Bryson was named <a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a> of Eli Lilly and Company. During Bryson's 20-month tenure, the company reported its first quarterly loss as a publicly traded company.<sup id="cite_ref-KokomoTrib62893_86-0" class="reference"><a href="#cite_note-KokomoTrib62893-86"><span class="cite-bracket">&#91;</span>86<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In 1993, <a href="/wiki/Randall_L._Tobias" title="Randall L. Tobias">Randall L. Tobias</a>, vice chairman of <a href="/wiki/AT%26T_Corporation" title="AT&amp;T Corporation">AT&amp;T Corporation</a> and a Lilly board member, was named Lilly's chairman, president, and CEO after "product and competitive pressures" had "steadily eroded Lilly's stock price since early 1992."<sup id="cite_ref-KokomoTrib62693_87-0" class="reference"><a href="#cite_note-KokomoTrib62693-87"><span class="cite-bracket">&#91;</span>87<span class="cite-bracket">&#93;</span></a></sup> Tobias was the first president and CEO recruited from outside of the company. Under Tobias's leadership, the company "cut costs and narrowed its mission".<sup id="cite_ref-IHSHBR89_88-0" class="reference"><a href="#cite_note-IHSHBR89-88"><span class="cite-bracket">&#91;</span>88<span class="cite-bracket">&#93;</span></a></sup> Lilly sold companies in its Medical Device and Diagnostics Division, expanded international sales, made new acquisitions, and funded additional research and product development. 
</p><p>In 1994, Lilly acquired PCS Systems, the largest drug benefits <a href="/wiki/Health_maintenance_organization" title="Health maintenance organization">health maintenance organization</a> at the time, for $4 billion, and later added two similar organizations to its holdings.<sup id="cite_ref-IHSHBR8_89-0" class="reference"><a href="#cite_note-IHSHBR8-89"><span class="cite-bracket">&#91;</span>89<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Kokomo73194_90-0" class="reference"><a href="#cite_note-Kokomo73194-90"><span class="cite-bracket">&#91;</span>90<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1998, <a href="/wiki/Sidney_Taurel" title="Sidney Taurel">Sidney Taurel</a>, Lilly's former chief operating officer, was named CEO, replacing Tobias. Also in 1998, Lilly formed a joint venture with <a href="/wiki/Icos" title="Icos">Icos Corporation</a> (ICOS), a <a href="/wiki/Bothell,_Washington" title="Bothell, Washington">Bothell, Washington</a>-based biotechnology company, to develop and commercialize <a href="/wiki/Tadalafil" title="Tadalafil">Cialis</a>, a product for the treatment of <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>. In January 1999, Taurel was named chairman. In 2000, Lilly reported $10.86 billion in net sales.
</p>
<div class="mw-heading mw-heading3"><h3 id="21st_century">21st century</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=5" title="Edit section: 21st century"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:Eli_Lilly_Corporate_Center,_Indianapolis,_Indiana,_USA.jpg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/0/05/Eli_Lilly_Corporate_Center%2C_Indianapolis%2C_Indiana%2C_USA.jpg/250px-Eli_Lilly_Corporate_Center%2C_Indianapolis%2C_Indiana%2C_USA.jpg" decoding="async" width="250" height="188" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/05/Eli_Lilly_Corporate_Center%2C_Indianapolis%2C_Indiana%2C_USA.jpg/500px-Eli_Lilly_Corporate_Center%2C_Indianapolis%2C_Indiana%2C_USA.jpg 1.5x" data-file-width="4032" data-file-height="3024" /></a><figcaption>Eli Lilly and Company's corporate headquarters in <a href="/wiki/Indianapolis" title="Indianapolis">Indianapolis</a>, in 2019</figcaption></figure>
<p>In September 2002, Lilly agreed to partner with <a href="/wiki/Amylin_Pharmaceuticals" title="Amylin Pharmaceuticals">Amylin Pharmaceuticals</a> to develop and commercialize Amylin's exotic new drug based on exendin-4, a novel substance isolated from the venom of the <a href="/wiki/Gila_monster" title="Gila monster">Gila monster</a>.<sup id="cite_ref-Pollack_91-0" class="reference"><a href="#cite_note-Pollack-91"><span class="cite-bracket">&#91;</span>91<span class="cite-bracket">&#93;</span></a></sup> Exenatide, the first of the GLP-1 receptor agonists, was approved by the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> in April 2005.<sup id="cite_ref-Pollack2_13-1" class="reference"><a href="#cite_note-Pollack2-13"><span class="cite-bracket">&#91;</span>13<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In October 2006, Lilly announced its intention to acquire Icos for $2.1 billion, or $32 per share.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92"><span class="cite-bracket">&#91;</span>92<span class="cite-bracket">&#93;</span></a></sup> After its initial attempt to acquire Icos failed under pressure from large institutional shareholders, Lilly increased its offer to $34 per share. <a href="/wiki/Institutional_Shareholder_Services" title="Institutional Shareholder Services">Institutional Shareholder Services</a> (ISS), a proxy advisory firm, advised Icos shareholders to reject the proposal as undervalued.<sup id="cite_ref-93" class="reference"><a href="#cite_note-93"><span class="cite-bracket">&#91;</span>93<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-TimmermanProposed_94-0" class="reference"><a href="#cite_note-TimmermanProposed-94"><span class="cite-bracket">&#91;</span>94<span class="cite-bracket">&#93;</span></a></sup> But Lilly's offer was approved by Icos' shareholders, and Lilly completed the acquisition of the company in January 2007.<sup id="cite_ref-95" class="reference"><a href="#cite_note-95"><span class="cite-bracket">&#91;</span>95<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-96" class="reference"><a href="#cite_note-96"><span class="cite-bracket">&#91;</span>96<span class="cite-bracket">&#93;</span></a></sup> Lilly subsequently closed Icos' manufacturing operations, terminated nearly 500 Icos employees, leaving 127 employees working at the biologics facility.<sup id="cite_ref-Tartakoff_97-0" class="reference"><a href="#cite_note-Tartakoff-97"><span class="cite-bracket">&#91;</span>97<span class="cite-bracket">&#93;</span></a></sup> In December 2007, CMC Biopharmaceuticals A/S (CMC), a <a href="/wiki/Copenhagen" title="Copenhagen">Copenhagen</a>-based provider of contract biomanufacturing services, bought the <a href="/wiki/Bothell,_Washington" title="Bothell, Washington">Bothell, Washington</a>-based biologics facility from Lilly and retained the existing 127 employees.<sup id="cite_ref-TimmermanProposed_94-1" class="reference"><a href="#cite_note-TimmermanProposed-94"><span class="cite-bracket">&#91;</span>94<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Tartakoff_97-1" class="reference"><a href="#cite_note-Tartakoff-97"><span class="cite-bracket">&#91;</span>97<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-98" class="reference"><a href="#cite_note-98"><span class="cite-bracket">&#91;</span>98<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In January 2009, the largest criminal <a href="/wiki/Fine_(penalty)" title="Fine (penalty)">fine</a> in U.S. history, totaling $1.415 billion, was imposed on Lilly for illegal marketing of its best-selling product, the <a href="/wiki/Atypical_antipsychotic" title="Atypical antipsychotic">atypical antipsychotic</a> medication, <a href="/wiki/Olanzapine" title="Olanzapine">Zyprexa</a>.<sup id="cite_ref-99" class="reference"><a href="#cite_note-99"><span class="cite-bracket">&#91;</span>99<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-usdoj-2009_15-1" class="reference"><a href="#cite_note-usdoj-2009-15"><span class="cite-bracket">&#91;</span>15<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-:1_16-1" class="reference"><a href="#cite_note-:1-16"><span class="cite-bracket">&#91;</span>16<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In January 2011, <a href="/wiki/Boehringer_Ingelheim" title="Boehringer Ingelheim">Boehringer Ingelheim</a> and Lilly announced a global agreement to jointly develop and market new <a href="/wiki/API" title="API">APIs</a> for diabetes therapy. Lilly could receive more than $1 billion for their work on the project, while Boehringer Ingelheim could receive more than $800 million from development of the new drugs.<sup id="cite_ref-100" class="reference"><a href="#cite_note-100"><span class="cite-bracket">&#91;</span>100<span class="cite-bracket">&#93;</span></a></sup> Boehringer Ingelheim's oral anti-diabetic <a href="/wiki/Linagliptin" title="Linagliptin">Linagliptin</a>, BI 1077, and two of Lilly's <a href="/wiki/Insulin_analog" class="mw-redirect" title="Insulin analog">insulin analogs</a>, LY2605541 and LY2963016, were in phase II and III of clinical development at that time.
</p><p>In April 2014, Lilly announced plans to acquire <a href="/wiki/Switzerland" title="Switzerland">Switzerland</a>-based <a href="/wiki/Novartis_AG" class="mw-redirect" title="Novartis AG">Novartis AG</a>'s animal health business for $5.4 billion in cash to strengthen and diversify its Elanco unit. Lilly said it planned to fund the deal with about $3.4 billion of cash on hand and $2 billion of loans.<sup id="cite_ref-101" class="reference"><a href="#cite_note-101"><span class="cite-bracket">&#91;</span>101<span class="cite-bracket">&#93;</span></a></sup> As a condition of the acquisition, the <a href="/wiki/Milbemycin_oxime/lufenuron" title="Milbemycin oxime/lufenuron">Sentinel heartworm treatment</a> was divested to <a href="/wiki/Virbac" title="Virbac">Virbac</a> in order to avoid a monopoly in a subsector of the heartworm (<a href="/wiki/Dirofilaria_immitis" title="Dirofilaria immitis">Dirofilaria immitis</a>) treatment market.<sup id="cite_ref-102" class="reference"><a href="#cite_note-102"><span class="cite-bracket">&#91;</span>102<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In March 2015, the company announced it would join <a href="/wiki/Hanmi_Pharmaceutical" class="mw-redirect" title="Hanmi Pharmaceutical">Hanmi Pharmaceutical</a> in developing and commercializing Hanmi's phase I <a href="/wiki/Bruton%27s_tyrosine_kinase" title="Bruton&#39;s tyrosine kinase">Bruton's tyrosine kinase</a> inhibitor <a href="/wiki/HM71224" class="mw-redirect" title="HM71224">HM71224</a> in a deal that could yield $690 million.<sup id="cite_ref-103" class="reference"><a href="#cite_note-103"><span class="cite-bracket">&#91;</span>103<span class="cite-bracket">&#93;</span></a></sup> A day later, however, the company announced another deal with <a href="/wiki/China" title="China">China</a>'s Innovent Biologics to co-develop and commercialize at least three of Innovent's treatments over the next decade, in a deal which could generate up to $456 million; the collaboration was subsequently expanded in 2022, according to Innovent. As part of the deal, the company contributed its c-Met monoclonal antibody, and Innovent contributed a monoclonal antibody, which targets <a href="/wiki/CD20" title="CD20">CD-20</a>. The second compound from Innovent is a preclinical <a href="/wiki/Cancer_immunotherapy" title="Cancer immunotherapy">immunooncology</a> molecule.<sup id="cite_ref-104" class="reference"><a href="#cite_note-104"><span class="cite-bracket">&#91;</span>104<span class="cite-bracket">&#93;</span></a></sup> The following week, the company announced it would restart its collaboration with <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a> surrounding the Phase III trial of <a href="/wiki/Tanezumab" title="Tanezumab">Tanezumab</a>. Pfizer is expected to receive an upfront sum of $200 million from the company.<sup id="cite_ref-105" class="reference"><a href="#cite_note-105"><span class="cite-bracket">&#91;</span>105<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In April 2015, Lilly engaged <a href="/wiki/CBRE_Group" title="CBRE Group">CBRE Group</a> to sell its <a href="/wiki/Biomanufacturing" title="Biomanufacturing">biomanufacturing</a> facility in <a href="/wiki/Vacaville,_California" title="Vacaville, California">Vacaville, California</a>,<sup id="cite_ref-plantsale2015_106-0" class="reference"><a href="#cite_note-plantsale2015-106"><span class="cite-bracket">&#91;</span>106<span class="cite-bracket">&#93;</span></a></sup> a 52 acres (0.21&#160;km<sup>2</sup>) campus and facility that is one of the largest biopharmaceutical manufacturing centers in the U.S.<sup id="cite_ref-plantsale2015_106-1" class="reference"><a href="#cite_note-plantsale2015-106"><span class="cite-bracket">&#91;</span>106<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In January 2017, Elanco Animal Health, a subsidiary of the company completed the acquisition of Boehringer Ingelheim Vetmedica, Inc., a subsidiary of Boehringer Ingelheim's U.S. feline, canine, and rabies vaccines portfolio. 
</p><p>In March 2017, Lilly acquired CoLucid Pharmaceuticals for $960 million, obtaining the late clinical-stage <a href="/wiki/Migraine" title="Migraine">migraine</a> therapy candidate, <a href="/wiki/Lasmiditan" title="Lasmiditan">lasmiditan</a>.<sup id="cite_ref-107" class="reference"><a href="#cite_note-107"><span class="cite-bracket">&#91;</span>107<span class="cite-bracket">&#93;</span></a></sup> In August 2017, Lilly and <a href="/wiki/Shionogi" title="Shionogi">Shionogi</a> jointly licensed their product <a href="/wiki/Varespladib" title="Varespladib">varespladib</a> to Ophirex for Ophirex's novel <a href="/wiki/Snakebite" title="Snakebite">snakebite</a> treatment program.<sup id="cite_ref-108" class="reference"><a href="#cite_note-108"><span class="cite-bracket">&#91;</span>108<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In May 2018, Lilly acquired <a href="/wiki/Armo_Biosciences" class="mw-redirect" title="Armo Biosciences">Armo Biosciences</a> for $1.6 billion.<sup id="cite_ref-109" class="reference"><a href="#cite_note-109"><span class="cite-bracket">&#91;</span>109<span class="cite-bracket">&#93;</span></a></sup> Days later, the company announced it would acquire <a href="/wiki/Aurora_kinase_A" title="Aurora kinase A">Aurora kinase A</a> inhibitor developer AurKa Pharma, and control over the lead compound, AK-01, for up to $575 million.<sup id="cite_ref-110" class="reference"><a href="#cite_note-110"><span class="cite-bracket">&#91;</span>110<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-111" class="reference"><a href="#cite_note-111"><span class="cite-bracket">&#91;</span>111<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In January 2019, Lilly announced it would acquire Loxo Oncology for $235 per share, valuing the business at around $8 billion,which significantly expanded the business's <a href="/wiki/Oncology" title="Oncology">oncology</a> offerings. The deal gave Lilly Loxo's oral <a href="/wiki/Trk_receptor" title="Trk receptor">TRK</a> inhibitor, <a href="/wiki/Vitrakvi" class="mw-redirect" title="Vitrakvi">Vitrakvi</a> (Larotrectinib), LOXO-292, an oral proto-<a href="/wiki/Oncogene" title="Oncogene">oncogene</a> <a href="/wiki/Receptor_tyrosine_kinase" title="Receptor tyrosine kinase">receptor tyrosine kinase</a> rearranged during transfection (RET) inhibitor, LOXO-305, an oral <a href="/wiki/Bruton%27s_tyrosine_kinase" title="Bruton&#39;s tyrosine kinase">Bruton's tyrosine kinase</a> (BTK) inhibitor, and LOXO-195, a follow-on TRK inhibitor.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112"><span class="cite-bracket">&#91;</span>112<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-113" class="reference"><a href="#cite_note-113"><span class="cite-bracket">&#91;</span>113<span class="cite-bracket">&#93;</span></a></sup> In August 2019, Elanco acquired the <a href="/wiki/Bayer" title="Bayer">Bayer</a> animal health business for $7.6 billion.<sup id="cite_ref-114" class="reference"><a href="#cite_note-114"><span class="cite-bracket">&#91;</span>114<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-115" class="reference"><a href="#cite_note-115"><span class="cite-bracket">&#91;</span>115<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In January 2020, the company announced its acquisition of Dermira for $1.1 billion, gaining control of <a href="/wiki/Lebrikizumab" title="Lebrikizumab">lebrikizumab</a>,<a href="/wiki/Glycopyrronium" class="mw-redirect" title="Glycopyrronium">glycopyrronium</a> cloth used in the treatment of  <a href="/wiki/Hyperhidrosis" title="Hyperhidrosis">hyperhidrosis</a>, and other assets.<sup id="cite_ref-116" class="reference"><a href="#cite_note-116"><span class="cite-bracket">&#91;</span>116<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-117" class="reference"><a href="#cite_note-117"><span class="cite-bracket">&#91;</span>117<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-118" class="reference"><a href="#cite_note-118"><span class="cite-bracket">&#91;</span>118<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In June 2020, Lilly announced that, in collaboration with <a href="/wiki/Vancouver" title="Vancouver">Vancouver</a>-based <a href="/wiki/AbCellera" title="AbCellera">AbCellera</a>, it had begun the world's first study of a potential <a href="/wiki/Monoclonal_antibody_therapy" title="Monoclonal antibody therapy">monoclonal antibody treatment</a> for treatment of <a href="/wiki/COVID-19" title="COVID-19">COVID-19</a>, with a Phase 1 trial of LY-CoV555.<sup id="cite_ref-119" class="reference"><a href="#cite_note-119"><span class="cite-bracket">&#91;</span>119<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-120" class="reference"><a href="#cite_note-120"><span class="cite-bracket">&#91;</span>120<span class="cite-bracket">&#93;</span></a></sup> By August 2020, the challenging aspects of running a clinical trial in a long-term care facility during a pandemic prompted Lilly to create the first of many customized recreational vehicles into mobile research units (MRU) to meet people where they were and support mobile labs and clinical trial material preparation. A trailer truck could escort the MRU with supplies to create an on-site infusion clinic. Lilly deployed the mobile research unit fleet in response to outbreaks of the virus at long-term care facilities across the U.S. In September 2020, <a href="/wiki/Amgen" title="Amgen">Amgen</a> announced that they had partnered with Lilly to manufacture their COVID-19 antibody therapies.<sup id="cite_ref-121" class="reference"><a href="#cite_note-121"><span class="cite-bracket">&#91;</span>121<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In October 2020, Lilly announced that its cocktail was effective and that it had filed with the FDA for an <a href="/wiki/Emergency_use_authorization" class="mw-redirect" title="Emergency use authorization">emergency use authorization</a> (EUA) for it.<sup id="cite_ref-122" class="reference"><a href="#cite_note-122"><span class="cite-bracket">&#91;</span>122<span class="cite-bracket">&#93;</span></a></sup> The same day, Lilly's corporate rival <a href="/wiki/Regeneron_Pharmaceuticals" title="Regeneron Pharmaceuticals">Regeneron</a> also filed for an EUA for its own monoclonal antibody treatment.<sup id="cite_ref-123" class="reference"><a href="#cite_note-123"><span class="cite-bracket">&#91;</span>123<span class="cite-bracket">&#93;</span></a></sup> The same month, Lilly announced it would acquire Disarm Therapeutics and its experimental treatments for axonal degeneration, via <a href="/wiki/SARM1" title="SARM1">SARM1</a> inhibitors, for $135 million plus a further $1.225 billion based on regulatory and commercial milestones.<sup id="cite_ref-124" class="reference"><a href="#cite_note-124"><span class="cite-bracket">&#91;</span>124<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>Also in October 2020, Lilly announced that the <a href="/wiki/National_Institutes_of_Health" title="National Institutes of Health">National Institutes of Health</a> (NIH) ACTIV-3 clinical trial evaluating its monoclonal antibody, <a href="/wiki/Bamlanivimab" title="Bamlanivimab">bamlanivimab</a> (LYCoV555), found that bamlanivimab was not effective in treating people hospitalized with COVID-19,<sup id="cite_ref-Lilly_20201016_125-0" class="reference"><a href="#cite_note-Lilly_20201016-125"><span class="cite-bracket">&#91;</span>125<span class="cite-bracket">&#93;</span></a></sup> but data showed bamlanivimab might be effective in treating COVID-19 by reducing viral load, symptoms, and the risk of hospitalization in outpatients. Other studies, including the NIH ACTIV-2 trial and its own BLAZE-1 trial, continued to evaluate bamlanivimab.<sup id="cite_ref-Lilly_20201016_125-1" class="reference"><a href="#cite_note-Lilly_20201016-125"><span class="cite-bracket">&#91;</span>125<span class="cite-bracket">&#93;</span></a></sup> In November 2020, the FDA issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126"><span class="cite-bracket">&#91;</span>126<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-FDA_bamlanivimab_EUA_127-0" class="reference"><a href="#cite_note-FDA_bamlanivimab_EUA-127"><span class="cite-bracket">&#91;</span>127<span class="cite-bracket">&#93;</span></a></sup> In December 2020, Lilly announced it would acquire Prevail Therapeutics Inc. for $1 billion, boosting its pipeline in neurodegenerative disease gene therapies.<sup id="cite_ref-128" class="reference"><a href="#cite_note-128"><span class="cite-bracket">&#91;</span>128<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In April 2021, the FDA revoked the emergency use authorization (EUA) that allowed and signaled FDA agreement for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.<sup id="cite_ref-FDA_PR_20210416_129-0" class="reference"><a href="#cite_note-FDA_PR_20210416-129"><span class="cite-bracket">&#91;</span>129<span class="cite-bracket">&#93;</span></a></sup> On 18 May 2021, the FDA accepted Lilly's application for Tyvyt (<a href="/wiki/Sintilimab" title="Sintilimab">sintilimab</a>), in combination with Lilly's own Alimta (<a href="/wiki/Pemetrexed" title="Pemetrexed">pemetrexed</a>) and <a href="/wiki/Platinum-based_antineoplastic" title="Platinum-based antineoplastic">platinum chemotherapy</a> for newly diagnosed nonsquamous <a href="/wiki/Non-small_cell_lung_cancer" class="mw-redirect" title="Non-small cell lung cancer">non-small cell lung cancer</a>.<sup id="cite_ref-130" class="reference"><a href="#cite_note-130"><span class="cite-bracket">&#91;</span>130<span class="cite-bracket">&#93;</span></a></sup> In July 2021, the company announced it would acquire Protomer Technologies for more than $1 billion.<sup id="cite_ref-131" class="reference"><a href="#cite_note-131"><span class="cite-bracket">&#91;</span>131<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In January 2022, distribution of Lilly's COVID-19 antibody drug was paused due to lack of efficacy against the emerging omicron variant.<sup id="cite_ref-132" class="reference"><a href="#cite_note-132"><span class="cite-bracket">&#91;</span>132<span class="cite-bracket">&#93;</span></a></sup> A second COVID-19 monoclonal antibody therapy, <a href="/wiki/Bebtelovimab" title="Bebtelovimab">bebtelovimab</a>, developed with <a href="/wiki/AbCellera" title="AbCellera">AbCellera</a>, was granted <a href="/wiki/Emergency_Use_Authorization" title="Emergency Use Authorization">Emergency Use Authorization</a> in February 2022, with the <a href="/wiki/Federal_government_of_the_United_States" title="Federal government of the United States">U.S. government</a> committing to a $720 million purchase of up to 600,000 doses.<sup id="cite_ref-133" class="reference"><a href="#cite_note-133"><span class="cite-bracket">&#91;</span>133<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In May 2022, the FDA approved Lilly's <a href="/wiki/Type_2_diabetes" title="Type 2 diabetes">type 2 diabetes</a> drug Mounjaro (<a href="/wiki/Tirzepatide" title="Tirzepatide">tirzepatide</a>). In August 2022, following the overturning of <i><a href="/wiki/Roe_v._Wade" title="Roe v. Wade">Roe v. Wade</a></i> in the <i><a href="/wiki/Dobbs_v._Jackson_Women%27s_Health_Organization" title="Dobbs v. Jackson Women&#39;s Health Organization">Dobbs</a></i> decision, the state of Indiana passed a near total ban on abortion, and Lilly said the move would make it difficult to attract talent to the state and that it would be forced to look for "more employment growth" elsewhere.<sup id="cite_ref-134" class="reference"><a href="#cite_note-134"><span class="cite-bracket">&#91;</span>134<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In October 2022, the business announced it would acquire Akouos Inc. for $487 million in upfront and $123 million deferred payments.<sup id="cite_ref-135" class="reference"><a href="#cite_note-135"><span class="cite-bracket">&#91;</span>135<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-136" class="reference"><a href="#cite_note-136"><span class="cite-bracket">&#91;</span>136<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In early 2020, Lilly introduced the Lilly Insulin Value Program, where people who have commercial insurance or no insurance can receive a savings card to fill their entire monthly prescription of any Lilly insulin for $35.<sup id="cite_ref-137" class="reference"><a href="#cite_note-137"><span class="cite-bracket">&#91;</span>137<span class="cite-bracket">&#93;</span></a></sup> In 2023, the <a href="/wiki/Inflation_Reduction_Act" title="Inflation Reduction Act">Inflation Reduction Act</a> extended a similar concept across all insulin suppliers by capping out-of-pocket costs for insulin at $35 per monthly prescription among Medicare Parts B and D enrollees.
</p><p>In January 2023, Lilly and TRexBio announced a collaboration and license agreement for three assets to treat <a href="/wiki/Immune-mediated_disease" class="mw-redirect" title="Immune-mediated disease">immune-mediated diseases</a>.<sup id="cite_ref-138" class="reference"><a href="#cite_note-138"><span class="cite-bracket">&#91;</span>138<span class="cite-bracket">&#93;</span></a></sup> TRexBio received an upfront payment of $55 million as part of this deal.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139"><span class="cite-bracket">&#91;</span>139<span class="cite-bracket">&#93;</span></a></sup> In June the company announced it would acquire startup Emergence Therapeutics<sup id="cite_ref-140" class="reference"><a href="#cite_note-140"><span class="cite-bracket">&#91;</span>140<span class="cite-bracket">&#93;</span></a></sup> for an undisclosed sum and Sigilon Therapeutics for $300 million.<sup id="cite_ref-141" class="reference"><a href="#cite_note-141"><span class="cite-bracket">&#91;</span>141<span class="cite-bracket">&#93;</span></a></sup> The company's 2023 research and development focus has been reported to be on drugs in the obesity, diabetes, Alzheimer's and autoimmune areas.<sup id="cite_ref-142" class="reference"><a href="#cite_note-142"><span class="cite-bracket">&#91;</span>142<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In July 2023, Lilly announced it would acquire Versanis for $1.93 billion.<sup id="cite_ref-143" class="reference"><a href="#cite_note-143"><span class="cite-bracket">&#91;</span>143<span class="cite-bracket">&#93;</span></a></sup> In October 2023, Eli Lilly acquired Point Biopharma for $1.4 billion.<sup id="cite_ref-144" class="reference"><a href="#cite_note-144"><span class="cite-bracket">&#91;</span>144<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In November 2023, the FDA approved tirzepatide for the treatment of <a href="/wiki/Obesity" title="Obesity">obesity</a> under the brand name Zepbound.<sup id="cite_ref-145" class="reference"><a href="#cite_note-145"><span class="cite-bracket">&#91;</span>145<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In March 2024, Lilly announced a deal with <a href="/wiki/Amazon_(company)" title="Amazon (company)">Amazon</a> to offer home delivery of certain medications for diabetes, obesity, and migraines, on behalf of LillyDirect.<sup id="cite_ref-146" class="reference"><a href="#cite_note-146"><span class="cite-bracket">&#91;</span>146<span class="cite-bracket">&#93;</span></a></sup>
</p><p>As of October 2024, tirzepatide's success as a blockbuster weight-loss drug had transformed Eli Lilly into the most valuable drug company in the world with a $842 billion market capitalization, the highest valuation ever achieved by a drug company to date, followed only by <a href="/wiki/Novo_Nordisk" title="Novo Nordisk">Novo Nordisk</a>.<sup id="cite_ref-Barnes_7-2" class="reference"><a href="#cite_note-Barnes-7"><span class="cite-bracket">&#91;</span>7<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Acquisition_history">Acquisition history</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=6" title="Edit section: Acquisition history"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<style data-mw-deduplicate="TemplateStyles:r1214851843">.mw-parser-output .hidden-begin{box-sizing:border-box;width:100%;padding:5px;border:none;font-size:95%}.mw-parser-output .hidden-title{font-weight:bold;line-height:1.6;text-align:left}.mw-parser-output .hidden-content{text-align:left}@media all and (max-width:500px){.mw-parser-output .hidden-begin{width:auto!important;clear:none!important;float:none!important}}</style><div class="hidden-begin mw-collapsible mw-collapsed" style="border:1px #aaa solid;"><div class="hidden-title skin-nightmode-reset-color" style="text-align:center;">Eli Lilly and Company acquisitions</div><div class="hidden-content mw-collapsible-content" style="">
<style data-mw-deduplicate="TemplateStyles:r1116488514">.mw-parser-output .treeview ul{padding:0;margin:0}.mw-parser-output .treeview li{padding:0;margin:0;list-style-type:none;list-style-image:none}.mw-parser-output .treeview li li{background:url("https://upload.wikimedia.org/wikipedia/commons/f/f2/Treeview-grey-line.png")no-repeat 0 -2981px;padding-left:21px;text-indent:0.3em}.mw-parser-output .treeview li li:last-child{background-position:0 -5971px}.mw-parser-output .treeview li.emptyline>ul>.mw-empty-elt:first-child+.emptyline,.mw-parser-output .treeview li.emptyline>ul>li:first-child{background-position:0 9px}</style><div class="treeview">
<ul><li><b>Eli Lilly and Company</b> <small>(founded 1876)</small>
<ul><li>Eli Lilly and Company
<ul><li>Distillers Company <small>(acq. 1962)</small></li>
<li><a href="/wiki/Elizabeth_Arden,_Inc." title="Elizabeth Arden, Inc.">Elizabeth Arden, Inc.</a> <small>(acq. 1971, sold <a href="/wiki/Faberg%C3%A9_(cosmetics)" title="Fabergé (cosmetics)">Fabergé</a> in 1987)</small></li>
<li>IVAC Corporation <small>(acq. 1977)</small></li>
<li>Cardiac Pacemakers Inc. <small>(acq. 1977)</small></li>
<li>Physio-Control Inc <small>(acq. 1980)</small></li>
<li>Advance Cardiovasular Systems Inc. <small>(acq. 1984)</small></li>
<li>Hybritech <small>(acq. 1986)</small></li>
<li>Devices for Vascular Intervention Inc. <small>(acq. 1986)</small></li>
<li>Pacific Biotech <small>(acq. 1990)</small></li>
<li>Origin Medsystems <small>(acq. 1992)</small></li>
<li>Heart Rhythm Technologies, Inc. <small>(acq. 1992)</small></li>
<li>PCS System <small>(acq. 1994)</small></li>
<li><a href="/wiki/Icos_Corporation" class="mw-redirect" title="Icos Corporation">Icos Corporation</a> <small>(acq. 2007)</small></li>
<li>Hypnion, Inc</li>
<li><a href="/wiki/ImClone_Systems" title="ImClone Systems">ImClone Systems</a></li>
<li>SGX Pharmaceuticals, Inc <small>(acq. 2008)</small></li>
<li>Avid Radiopharmaceuticals <small>(acq. 2010)</small></li>
<li>Alnara Pharmaceuticals<small>(acq. 2010)</small></li>
<li>CoLucid Pharmaceuticals <small>(acq. 2017)</small></li>
<li>Armo Biosciences <small>(acq. 2018)</small></li>
<li>AurKa Pharma <small>(acq. 2018)</small></li>
<li>Loxo Oncology <small>(acq. 2019)</small></li>
<li>Disarm Therapeutics <small>(acq. 2020)</small></li>
<li>Prevail Therapeutics Inc <small>(acq. 2020)</small></li></ul></li>
<li>Elanco Products Company <small>(established 1954 as a division of Eli Lilly and Company)</small>
<ul><li><a href="/wiki/Dow_AgroSciences" title="Dow AgroSciences">DowElanco</a> <small>(established 1989 as joint venture with <a href="/wiki/Dow_Chemical" class="mw-redirect" title="Dow Chemical">Dow Chemical</a>, sold stake 1999 to Dow)</small></li>
<li>Ivy Animal Health <small>(acq. 2007)</small></li>
<li><a href="/wiki/Pfizer" title="Pfizer">Pfizer Animal Health</a> <small>(acq. 2010)</small></li>
<li><a href="/wiki/Janssen_Pharmaceutica" class="mw-redirect" title="Janssen Pharmaceutica">Janssen Pharmaceutica Animal Health</a> <small>(acq. 2011)</small></li>
<li>ChemGen Corp<small>(acq. 2012)</small></li>
<li>Lohmann SE<small>(acq. 2014)</small></li>
<li><a href="/wiki/Novartis" title="Novartis">Novartis Animal Health</a> <small>(acq. 2014)</small></li>
<li><a href="/wiki/Bayer" title="Bayer">Bayer Animal Health</a> <small>(acq. 2019)</small></li></ul></li>
<li>Protomer Technologies <small>(acq. 2021)</small></li>
<li>Akouos Inc <small>(acq. 2022)</small></li>
<li>Dice Therapeutics<sup id="cite_ref-147" class="reference"><a href="#cite_note-147"><span class="cite-bracket">&#91;</span>147<span class="cite-bracket">&#93;</span></a></sup> <small>(acq. 2023)</small></li>
<li>Emergence Therapeutics <small>(acq. 2023)</small></li>
<li>Sigilon Therapeutics <small>(acq. 2023)</small></li>
<li>Versanis Bio<small> (acq. 2023)</small><sup id="cite_ref-148" class="reference"><a href="#cite_note-148"><span class="cite-bracket">&#91;</span>148<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Mablink Bioscience <small>(acq. 2023)</small></li>
<li>Point Biopharma <small>(acq. 2023)</small></li></ul></li></ul>
</div>
</div></div>
<div class="mw-heading mw-heading2"><h2 id="Collaborative_research">Collaborative research</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=7" title="Edit section: Collaborative research"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<p>Eli Lilly and Company has a long history of collaboration with research scientists. In 1886, Ernest G. Eberhardt, a chemist, joined the company as its first full-time research scientist.<sup id="cite_ref-IHSHBR12_149-0" class="reference"><a href="#cite_note-IHSHBR12-149"><span class="cite-bracket">&#91;</span>149<span class="cite-bracket">&#93;</span></a></sup> Lilly also hired two botanists, Walter H. Evans and John S. Wright, to join its early research efforts.<sup id="cite_ref-IHSHBR2_33-1" class="reference"><a href="#cite_note-IHSHBR2-33"><span class="cite-bracket">&#91;</span>33<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-150" class="reference"><a href="#cite_note-150"><span class="cite-bracket">&#91;</span>150<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>After <a href="/wiki/World_War_I" title="World War I">World War I</a>, the company's expanded production facilities and introduction of new management methods set the stage for Lilly's next crucial phase&#8212;its "aggressive entry into scientific research and development."<sup id="cite_ref-b540_23-2" class="reference"><a href="#cite_note-b540-23"><span class="cite-bracket">&#91;</span>23<span class="cite-bracket">&#93;</span></a></sup> The first big step came in 1919 when Josiah Lilly hired biochemist <a href="/wiki/George_Henry_Alexander_Clowes" title="George Henry Alexander Clowes">George Henry Alexander Clowes</a> as director of biochemical research.<sup id="cite_ref-151" class="reference"><a href="#cite_note-151"><span class="cite-bracket">&#91;</span>151<span class="cite-bracket">&#93;</span></a></sup> Clowes had extensive medical research expertise and links to the scientific research community, which led to the company's collaborations with researchers in the U.S. and elsewhere.<sup id="cite_ref-MLilly55_152-0" class="reference"><a href="#cite_note-MLilly55-152"><span class="cite-bracket">&#91;</span>152<span class="cite-bracket">&#93;</span></a></sup> Clowes's first major collaboration with researchers who developed <a href="/wiki/Insulin" title="Insulin">insulin</a> at the <a href="/wiki/University_of_Toronto" title="University of Toronto">University of Toronto</a> significantly impacted the company's future.<sup id="cite_ref-MLilly55_152-1" class="reference"><a href="#cite_note-MLilly55-152"><span class="cite-bracket">&#91;</span>152<span class="cite-bracket">&#93;</span></a></sup> Lilly's success with insulin production secured the company's position as a leading research-based pharmaceutical manufacturer, allowing it to attract and hire more research scientists and to collaborate with other universities in additional medical research.<sup id="cite_ref-153" class="reference"><a href="#cite_note-153"><span class="cite-bracket">&#91;</span>153<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In 1934, the company built a new research laboratory in Indianapolis.<sup id="cite_ref-MadisonM76_51-2" class="reference"><a href="#cite_note-MadisonM76-51"><span class="cite-bracket">&#91;</span>51<span class="cite-bracket">&#93;</span></a></sup> As part of its research and product development process Lilly also conducted clinical studies at <a href="/wiki/Sidney_%26_Lois_Eskenazi_Hospital" title="Sidney &amp; Lois Eskenazi Hospital">Indianapolis City Hospital</a>. Lilly continues to conduct clinical studies to test medications before their introduction to the market. 
</p><p>In 1949, Eli Lilly went into partnership with the <a href="/wiki/United_States_Army_Reserve" title="United States Army Reserve">United States Army Reserve</a>, setting up a local Strategic Intelligence Research and Analysis (SIRA) Unit to allow employees to research company data for the scientific logistics and Eurasian fields of study. 
</p><p>In 1998, the company dedicated new laboratories for clinical research at the <a href="/wiki/Indiana_University_Health_Methodist_Hospital" title="Indiana University Health Methodist Hospital">Indiana University Medical Center</a> in Indianapolis.
</p>
<div class="mw-heading mw-heading3"><h3 id="Publicly_funded_research">Publicly funded research</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=8" title="Edit section: Publicly funded research"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<p>Lilly is involved in publicly funded research projects with other industrial and academic partners. One example is <a href="/wiki/Pre-clinical_development" class="mw-redirect" title="Pre-clinical development">non-clinical</a> safety assessment is the InnoMed PredTox, a collaboration with pharmaceutical companies, research organizations, and the <a href="/wiki/European_Commission" title="European Commission">European Commission</a> to improve the safety of drugs.<sup id="cite_ref-154" class="reference"><a href="#cite_note-154"><span class="cite-bracket">&#91;</span>154<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-Consortium_155-0" class="reference"><a href="#cite_note-Consortium-155"><span class="cite-bracket">&#91;</span>155<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In 2008, this consortium, which included Lilly S.A. in <a href="/wiki/Switzerland" title="Switzerland">Switzerland</a>, secured an €8 million budget for a 40-month project that was coordinated by the European Federation of Pharmaceutical Industries and Associations (<a href="/wiki/EFPIA" class="mw-redirect" title="EFPIA">EFPIA</a>), an organization who represents the research-based pharmaceutical industry and biotech companies operating in Europe.<sup id="cite_ref-Consortium_155-1" class="reference"><a href="#cite_note-Consortium-155"><span class="cite-bracket">&#91;</span>155<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-156" class="reference"><a href="#cite_note-156"><span class="cite-bracket">&#91;</span>156<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-InnoMed_PredTox_official_project_website_157-0" class="reference"><a href="#cite_note-InnoMed_PredTox_official_project_website-157"><span class="cite-bracket">&#91;</span>157<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>In 2008, Lilly's activities included research projects within the framework of the <a href="/wiki/Innovative_Medicines_Initiative" title="Innovative Medicines Initiative">Innovative Medicines Initiative</a>, a public-private research initiative in Europe that is a joint effort of the <a href="/wiki/EFPIA" class="mw-redirect" title="EFPIA">EFPIA</a> and the <a href="/wiki/European_Commission" title="European Commission">European Commission</a>.<sup id="cite_ref-158" class="reference"><a href="#cite_note-158"><span class="cite-bracket">&#91;</span>158<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-159" class="reference"><a href="#cite_note-159"><span class="cite-bracket">&#91;</span>159<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-IMI_Call_Topics_2008_160-0" class="reference"><a href="#cite_note-IMI_Call_Topics_2008-160"><span class="cite-bracket">&#91;</span>160<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="Public-private_engagement">Public-private engagement</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=9" title="Edit section: Public-private engagement"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<div class="mw-heading mw-heading3"><h3 id="Academia">Academia</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=10" title="Edit section: Academia"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li><a href="/wiki/Northern_Ontario_School_of_Medicine" class="mw-redirect" title="Northern Ontario School of Medicine">Northern Ontario School of Medicine</a> (NOSM), donor<sup id="cite_ref-161" class="reference"><a href="#cite_note-161"><span class="cite-bracket">&#91;</span>161<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Population_Health_Research_Institute" class="mw-redirect" title="Population Health Research Institute">Population Health Research Institute</a> (PHRI) at <a href="/wiki/McMaster_University" title="McMaster University">McMaster University</a>, partner<sup id="cite_ref-162" class="reference"><a href="#cite_note-162"><span class="cite-bracket">&#91;</span>162<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/University_of_Toronto" title="University of Toronto">University of Toronto</a>, donor to the Boundless Campaign<sup id="cite_ref-163" class="reference"><a href="#cite_note-163"><span class="cite-bracket">&#91;</span>163<span class="cite-bracket">&#93;</span></a></sup> and member of the President's Circle<sup id="cite_ref-164" class="reference"><a href="#cite_note-164"><span class="cite-bracket">&#91;</span>164<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/University_of_Washington" title="University of Washington">University of Washington</a>, member of the Honor Roll of Donors, having contributed between $10 million and $50 million to funding the school as of 2020<sup id="cite_ref-165" class="reference"><a href="#cite_note-165"><span class="cite-bracket">&#91;</span>165<span class="cite-bracket">&#93;</span></a></sup></li></ul>
<div class="mw-heading mw-heading3"><h3 id="Conferences_and_summits">Conferences and summits</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=11" title="Edit section: Conferences and summits"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li>World Neuroscience Innovation Forum, stakeholder sponsor<sup id="cite_ref-166" class="reference"><a href="#cite_note-166"><span class="cite-bracket">&#91;</span>166<span class="cite-bracket">&#93;</span></a></sup></li></ul>
<div class="mw-heading mw-heading3"><h3 id="Media">Media</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=12" title="Edit section: Media"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li><a href="/wiki/National_Press_Foundation" title="National Press Foundation">National Press Foundation</a>, donor<sup id="cite_ref-167" class="reference"><a href="#cite_note-167"><span class="cite-bracket">&#91;</span>167<span class="cite-bracket">&#93;</span></a></sup></li></ul>
<div class="mw-heading mw-heading3"><h3 id="Medical_societies">Medical societies</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=13" title="Edit section: Medical societies"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li><a href="/wiki/American_Society_of_Hematology" title="American Society of Hematology">American Society of Hematology</a>, sponsor<sup id="cite_ref-168" class="reference"><a href="#cite_note-168"><span class="cite-bracket">&#91;</span>168<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Arthritis Society, national partner<sup id="cite_ref-169" class="reference"><a href="#cite_note-169"><span class="cite-bracket">&#91;</span>169<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Endocrine_Society" title="Endocrine Society">Endocrine Society</a>, corporate Liaison Board member<sup id="cite_ref-170" class="reference"><a href="#cite_note-170"><span class="cite-bracket">&#91;</span>170<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/European_Society_of_Cardiology" title="European Society of Cardiology">European Society of Cardiology</a>, sponsor of the EURObservational Research Programme<sup id="cite_ref-171" class="reference"><a href="#cite_note-171"><span class="cite-bracket">&#91;</span>171<span class="cite-bracket">&#93;</span></a></sup></li></ul>
<div class="mw-heading mw-heading3"><h3 id="Non-governmental_organizations">Non-governmental organizations</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=14" title="Edit section: Non-governmental organizations"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li><a href="/wiki/HOPE_Worldwide" class="mw-redirect" title="HOPE Worldwide">HOPE Worldwide</a>, partner<sup id="cite_ref-172" class="reference"><a href="#cite_note-172"><span class="cite-bracket">&#91;</span>172<span class="cite-bracket">&#93;</span></a></sup></li></ul>
<div class="mw-heading mw-heading3"><h3 id="Political_lobbying">Political lobbying</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=15" title="Edit section: Political lobbying"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li>Alliance for Competitive Taxation, member<sup id="cite_ref-173" class="reference"><a href="#cite_note-173"><span class="cite-bracket">&#91;</span>173<span class="cite-bracket">&#93;</span></a></sup></li>
<li>BIOTECanada, member company.<sup id="cite_ref-174" class="reference"><a href="#cite_note-174"><span class="cite-bracket">&#91;</span>174<span class="cite-bracket">&#93;</span></a></sup> BIOTECanada lobbies the <a href="/wiki/Canadian_government" class="mw-redirect" title="Canadian government">Canadian government</a> for policies favorable to the <a href="/wiki/Pharmaceutical_industry_in_Canada" title="Pharmaceutical industry in Canada">pharmaceutical industry</a>.<sup id="cite_ref-175" class="reference"><a href="#cite_note-175"><span class="cite-bracket">&#91;</span>175<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Foundation_for_the_National_Institutes_of_Health" title="Foundation for the National Institutes of Health">Foundation for the National Institutes of Health</a> (FNIH), donor, given between $5,000,000 and $9,999,999 between 1997 and 2020, contributing to funding the activities of the <a href="/wiki/National_Institutes_of_Health" title="National Institutes of Health">National Institutes of Health</a><sup id="cite_ref-176" class="reference"><a href="#cite_note-176"><span class="cite-bracket">&#91;</span>176<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Innovative_Medicines_Canada" title="Innovative Medicines Canada">Innovative Medicines Canada</a>, member<sup id="cite_ref-177" class="reference"><a href="#cite_note-177"><span class="cite-bracket">&#91;</span>177<span class="cite-bracket">&#93;</span></a></sup> The group lobbies the <a href="/wiki/Government_of_Ontario" title="Government of Ontario">Government of Ontario</a> and <a href="/wiki/House_of_Commons_of_Canada" title="House of Commons of Canada">House of Commons of Canada</a> through Rubicon Strategy, a firm owned by <a href="/wiki/Progressive_Conservative_Party_of_Ontario" title="Progressive Conservative Party of Ontario">Progressive Conservative Party of Ontario</a> campaign manager <a href="/wiki/Kory_Teneycke" title="Kory Teneycke">Kory Teneycke</a>.<sup id="cite_ref-178" class="reference"><a href="#cite_note-178"><span class="cite-bracket">&#91;</span>178<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-179" class="reference"><a href="#cite_note-179"><span class="cite-bracket">&#91;</span>179<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-180" class="reference"><a href="#cite_note-180"><span class="cite-bracket">&#91;</span>180<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/International_Federation_of_Pharmaceutical_Manufacturers_%26_Associations" title="International Federation of Pharmaceutical Manufacturers &amp; Associations">International Federation of Pharmaceutical Manufacturers &amp; Associations</a>, member<sup id="cite_ref-181" class="reference"><a href="#cite_note-181"><span class="cite-bracket">&#91;</span>181<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/National_Health_Council" title="National Health Council">National Health Council</a> (NHC), member organization. NHC is a non-profit organization that lobbies the <a href="/wiki/Federal_government_of_the_United_States" title="Federal government of the United States">U.S. federal government</a> on issues related to <a href="/wiki/Healthcare_reform_in_the_United_States" title="Healthcare reform in the United States">healthcare reform</a>.<sup id="cite_ref-182" class="reference"><a href="#cite_note-182"><span class="cite-bracket">&#91;</span>182<span class="cite-bracket">&#93;</span></a></sup></li>
<li>National Pharmaceutical Council (NPC), member company. NPC is a non-profit that advocates for expanded research funding and innovation.<sup id="cite_ref-183" class="reference"><a href="#cite_note-183"><span class="cite-bracket">&#91;</span>183<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Personalized Medicine Coalition (PMC), member. PMC is a lobbying group with ties to members of the <a href="/wiki/United_States_Congress" title="United States Congress">United States Congress</a>.<sup id="cite_ref-184" class="reference"><a href="#cite_note-184"><span class="cite-bracket">&#91;</span>184<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-185" class="reference"><a href="#cite_note-185"><span class="cite-bracket">&#91;</span>185<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Pharmaceutical_Research_and_Manufacturers_of_America" title="Pharmaceutical Research and Manufacturers of America">Pharmaceutical Research and Manufacturers of America</a> (PhRMA), member company. PhRMA is a trade association that lobbies the U.S. federal government on behalf of the <a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">pharmaceutical industry</a>.<sup id="cite_ref-186" class="reference"><a href="#cite_note-186"><span class="cite-bracket">&#91;</span>186<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-187" class="reference"><a href="#cite_note-187"><span class="cite-bracket">&#91;</span>187<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Research!America, member organization. Research!America is a medical research advocacy group.<sup id="cite_ref-188" class="reference"><a href="#cite_note-188"><span class="cite-bracket">&#91;</span>188<span class="cite-bracket">&#93;</span></a></sup></li></ul>
<div class="mw-heading mw-heading3"><h3 id="Professional_associations">Professional associations</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=16" title="Edit section: Professional associations"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li><a href="/wiki/AdvaMed" title="AdvaMed">AdvaMed</a>, member<sup id="cite_ref-189" class="reference"><a href="#cite_note-189"><span class="cite-bracket">&#91;</span>189<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Canadian Rheumatology Association, sponsor<sup id="cite_ref-190" class="reference"><a href="#cite_note-190"><span class="cite-bracket">&#91;</span>190<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Canadian Urological Association, sponsor<sup id="cite_ref-191" class="reference"><a href="#cite_note-191"><span class="cite-bracket">&#91;</span>191<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Mood Disorders Association of Ontario (MDAO), donor<sup id="cite_ref-192" class="reference"><a href="#cite_note-192"><span class="cite-bracket">&#91;</span>192<span class="cite-bracket">&#93;</span></a></sup></li></ul>
<div class="mw-heading mw-heading3"><h3 id="Public_health">Public health</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=17" title="Edit section: Public health"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li><a href="/wiki/Centre_for_Addiction_and_Mental_Health" title="Centre for Addiction and Mental Health">Centre for Addiction and Mental Health</a> (CAMH), donor<sup id="cite_ref-193" class="reference"><a href="#cite_note-193"><span class="cite-bracket">&#91;</span>193<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Hospital_for_Sick_Children_(Toronto)" class="mw-redirect" title="Hospital for Sick Children (Toronto)">Hospital for Sick Children (SickKids)</a>, donor to the SickKids Foundation<sup id="cite_ref-194" class="reference"><a href="#cite_note-194"><span class="cite-bracket">&#91;</span>194<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Princess_Margaret_Cancer_Centre" title="Princess Margaret Cancer Centre">Princess Margaret Cancer Centre</a> (PMCC), conference sponsor<sup id="cite_ref-195" class="reference"><a href="#cite_note-195"><span class="cite-bracket">&#91;</span>195<span class="cite-bracket">&#93;</span></a></sup> and donor to the Princess Margaret Cancer Foundation<sup id="cite_ref-196" class="reference"><a href="#cite_note-196"><span class="cite-bracket">&#91;</span>196<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Scarborough_Health_Network" title="Scarborough Health Network">Scarborough Health Network</a> (SHN), donor to the SHN Foundation<sup id="cite_ref-197" class="reference"><a href="#cite_note-197"><span class="cite-bracket">&#91;</span>197<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Sinai_Health_System" title="Sinai Health System">Sinai Health Foundation</a>, donor. The foundation funds <a href="/wiki/Mount_Sinai_Hospital_(Toronto)" title="Mount Sinai Hospital (Toronto)">Mount Sinai Hospital</a>, <a href="/wiki/Bridgepoint_Active_Healthcare" class="mw-redirect" title="Bridgepoint Active Healthcare">Bridgepoint Active Healthcare</a>, and the <a href="/wiki/Lunenfeld-Tanenbaum_Research_Institute" title="Lunenfeld-Tanenbaum Research Institute">Lunenfeld-Tanenbaum Research Institute</a> in <a href="/wiki/Toronto" title="Toronto">Toronto</a>, Ontario.<sup id="cite_ref-198" class="reference"><a href="#cite_note-198"><span class="cite-bracket">&#91;</span>198<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Sunnybrook_Health_Sciences_Centre" title="Sunnybrook Health Sciences Centre">Sunnybrook Health Sciences Centre</a>, donor<sup id="cite_ref-199" class="reference"><a href="#cite_note-199"><span class="cite-bracket">&#91;</span>199<span class="cite-bracket">&#93;</span></a></sup></li></ul>
<div class="mw-heading mw-heading3"><h3 id="Research_and_development">Research and development</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=18" title="Edit section: Research and development"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li><a href="/wiki/Arthritis_Australia" title="Arthritis Australia">Arthritis Australia</a>, sponsor<sup id="cite_ref-200" class="reference"><a href="#cite_note-200"><span class="cite-bracket">&#91;</span>200<span class="cite-bracket">&#93;</span></a></sup></li>
<li>BioFIT, sponsor<sup id="cite_ref-201" class="reference"><a href="#cite_note-201"><span class="cite-bracket">&#91;</span>201<span class="cite-bracket">&#93;</span></a></sup> BioFIT holds events to connect academia, pharmaceutical companies, and investors in the field of <a href="/wiki/Life_sciences" class="mw-redirect" title="Life sciences">life sciences</a> and <a href="/wiki/Biotechnology" title="Biotechnology">biotechnology</a>.</li>
<li>Canadian Consortium on Neurodegeneration and Aging, partner organization<sup id="cite_ref-202" class="reference"><a href="#cite_note-202"><span class="cite-bracket">&#91;</span>202<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Colorectal Cancer Canada, sponsor<sup id="cite_ref-203" class="reference"><a href="#cite_note-203"><span class="cite-bracket">&#91;</span>203<span class="cite-bracket">&#93;</span></a></sup></li>
<li>COVID-19 Therapeutics Accelerator, collaborator<sup id="cite_ref-204" class="reference"><a href="#cite_note-204"><span class="cite-bracket">&#91;</span>204<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Diabetes_Canada" title="Diabetes Canada">Diabetes Canada</a>, corporate partner<sup id="cite_ref-205" class="reference"><a href="#cite_note-205"><span class="cite-bracket">&#91;</span>205<span class="cite-bracket">&#93;</span></a></sup></li>
<li>GIANT Health, event sponsor<sup id="cite_ref-206" class="reference"><a href="#cite_note-206"><span class="cite-bracket">&#91;</span>206<span class="cite-bracket">&#93;</span></a></sup></li>
<li><a href="/wiki/Juvenile_Diabetes_Research_Foundation" class="mw-redirect" title="Juvenile Diabetes Research Foundation">Juvenile Diabetes Research Foundation</a> (JDRF), corporate partner<sup id="cite_ref-207" class="reference"><a href="#cite_note-207"><span class="cite-bracket">&#91;</span>207<span class="cite-bracket">&#93;</span></a></sup></li>
<li>New Brunswick Health Research Foundation (NBHRF), sponsor<sup id="cite_ref-208" class="reference"><a href="#cite_note-208"><span class="cite-bracket">&#91;</span>208<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Pinnacle Research Group, sponsor<sup id="cite_ref-209" class="reference"><a href="#cite_note-209"><span class="cite-bracket">&#91;</span>209<span class="cite-bracket">&#93;</span></a></sup></li>
<li>Radcliffe Cardiology, industry partner<sup id="cite_ref-210" class="reference"><a href="#cite_note-210"><span class="cite-bracket">&#91;</span>210<span class="cite-bracket">&#93;</span></a></sup></li></ul>
<div class="mw-heading mw-heading2"><h2 id="Pharmaceutical_brands">Pharmaceutical brands</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=19" title="Edit section: Pharmaceutical brands"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<p>The company's most important products introduced prior to <a href="/wiki/World_War_II" title="World War II">World War II</a> included <a href="/wiki/Insulin" title="Insulin">insulin</a>, which Lilly marketed as Iletin (Insulin, Lilly), Amytal, Merthiolate, <a href="/wiki/Ephedrine" title="Ephedrine">ephedrine</a>, and liver extracts.<sup id="cite_ref-MLilly65_71-1" class="reference"><a href="#cite_note-MLilly65-71"><span class="cite-bracket">&#91;</span>71<span class="cite-bracket">&#93;</span></a></sup> 
</p><p>During World War II, Lilly produced <a href="/wiki/Penicillin" title="Penicillin">penicillin</a> and other <a href="/wiki/Antibiotics" class="mw-redirect" title="Antibiotics">antibiotics</a>. In addition to penicillin, other wartime production included "antimalarials," blood plasma, encephalitis vaccine, typhus and influenza vaccine, <a href="/wiki/Gas_gangrene" title="Gas gangrene">gas gangrene</a> antitoxin, Merthiolate, and Iletin (Insulin, Lilly).<sup id="cite_ref-211" class="reference"><a href="#cite_note-211"><span class="cite-bracket">&#91;</span>211<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Among the company's other pharmaceutical developments are <a href="/wiki/Cephalosporin" title="Cephalosporin">cephalosporin</a>, <a href="/wiki/Erythromycin" title="Erythromycin">erythromycin</a>, and <a href="/wiki/Fluoxetine" title="Fluoxetine">Prozac</a> (fluoxetine), a <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitor</a> (SSRI) for the treatment of <a href="/wiki/Clinical_depression" class="mw-redirect" title="Clinical depression">clinical depression</a>. Ceclor, introduced in the 1970s, was an oral cephalosporin antibiotic. Prozac, introduced in the 1980s, quickly became the company's best-selling product for treatment of depression, but Lilly lost its U.S. patent protection for the product in 2001. Among other distinctions, Lilly is the world's largest manufacturer and distributor of medications used in a broad range of <a href="/wiki/Psychiatry" title="Psychiatry">psychiatric</a> and <a href="/wiki/Mental_health" title="Mental health">mental health</a>-related conditions, including <a href="/wiki/Clinical_depression" class="mw-redirect" title="Clinical depression">clinical depression</a>, <a href="/wiki/Generalized_anxiety_disorder" title="Generalized anxiety disorder">generalized anxiety disorder</a>, <a href="/wiki/Narcotic" title="Narcotic">narcotic</a> addiction, <a href="/wiki/Insomnia" title="Insomnia">insomnia</a>, <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a>, <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>, and others.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>&#93;</sup>
</p><p>In March 2023, Eli Lilly announced a $35 cap on the price of monthly insulin to be put in place immediately in order to be in line with the <a href="/wiki/Inflation_Reduction_Act" title="Inflation Reduction Act">Inflation Reduction Act</a>.<sup id="cite_ref-212" class="reference"><a href="#cite_note-212"><span class="cite-bracket">&#91;</span>212<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Medications that provide significant revenue for Lilly include Trulicity, Mounjaro, Verzenio, Taltz, Jardiance, Humalog, Cyramza, Olumiant, Emgality, Tyvyt, Retevmo, Alimta, and Zepbound.<sup id="cite_ref-10K_2-1" class="reference"><a href="#cite_note-10K-2"><span class="cite-bracket">&#91;</span>2<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Cialis">Cialis</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=20" title="Edit section: Cialis"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Tadalafil" title="Tadalafil">Tadalafil</a></div>
<p>In 2003, Eli Lilly and Company introduced <a href="/wiki/Tadalafil" title="Tadalafil">Cialis</a> (tadalafil), a competitor to <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a>'s blockbuster <a href="/wiki/Viagra" class="mw-redirect" title="Viagra">Viagra</a> for <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>. Cialis maintains an active period of 36 hours, causing it sometimes to be dubbed the "weekend pill". Cialis was developed in a partnership with <a href="/wiki/Biotechnology" title="Biotechnology">biotechnology</a> company Icos Corporation. In December 2006, Lilly bought Icos in order to gain full control of the product.<sup id="cite_ref-213" class="reference"><a href="#cite_note-213"><span class="cite-bracket">&#91;</span>213<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Cymbalta">Cymbalta</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=21" title="Edit section: Cymbalta"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Duloxetine" title="Duloxetine">Duloxetine</a></div>
<p>Another Lilly manufactured anti-depressant, <a href="/wiki/Duloxetine" title="Duloxetine">Cymbalta</a>, a <a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" class="mw-redirect" title="Serotonin-norepinephrine reuptake inhibitor">serotonin-norepinephrine reuptake inhibitor</a> used predominantly in the treatment of major depressive disorders and generalized anxiety disorder, ranks with Prozac as one of the most financially successful pharmaceuticals in industry history. It is also used in the treatment of <a href="/wiki/Fibromyalgia" title="Fibromyalgia">fibromyalgia</a>, <a href="/wiki/Neuropathy" class="mw-redirect" title="Neuropathy">neuropathy</a>, <a href="/wiki/Chronic_pain" title="Chronic pain">chronic pain</a> and <a href="/wiki/Osteoarthritis" title="Osteoarthritis">osteoarthritis</a>.<sup id="cite_ref-214" class="reference"><a href="#cite_note-214"><span class="cite-bracket">&#91;</span>214<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-215" class="reference"><a href="#cite_note-215"><span class="cite-bracket">&#91;</span>215<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Kisunla">Kisunla</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=22" title="Edit section: Kisunla"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Donanemab" title="Donanemab">Donanemab</a></div>
<p>Donanemab, sold under the brand name Kisunla, is a <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibody</a> used for the treatment of <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's disease</a>. Kisunla was approved by the US FDA in 2024.<sup id="cite_ref-216" class="reference"><a href="#cite_note-216"><span class="cite-bracket">&#91;</span>216<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-217" class="reference"><a href="#cite_note-217"><span class="cite-bracket">&#91;</span>217<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Gemzar">Gemzar</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=23" title="Edit section: Gemzar"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Gemcitabine" title="Gemcitabine">Gemcitabine</a></div>
<p>In 1996, the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> approved <a href="/wiki/Gemcitabine" title="Gemcitabine">gemcitabine</a> (Gemzar) for the treatment of <a href="/wiki/Pancreatic_cancer" title="Pancreatic cancer">pancreatic cancer</a>. Gemzar is commonly used in the treatment of pancreatic cancer, usually in coordination with 5-FU <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> and radiation therapy. Gemzar also is routinely used in the treatment of non-small cell <a href="/wiki/Lung_cancer" title="Lung cancer">lung cancer</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>&#93;</sup><sup id="cite_ref-218" class="reference"><a href="#cite_note-218"><span class="cite-bracket">&#91;</span>218<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Methadone">Methadone</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=24" title="Edit section: Methadone"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Methadone" title="Methadone">Methadone</a></div>
<p>Lilly was the first distributor of <a href="/wiki/Methadone" title="Methadone">methadone</a> in the United States, an <a href="/wiki/Analgesic" title="Analgesic">analgesic</a> used frequently in the treatment of <a href="/wiki/Heroin" title="Heroin">heroin</a>, <a href="/wiki/Opium" title="Opium">opium</a> and other <a href="/wiki/Opioid" title="Opioid">opioid</a> and <a href="/wiki/Narcotic" title="Narcotic">narcotic</a> <a href="/wiki/Drug_addiction" class="mw-redirect" title="Drug addiction">drug addictions</a>.<sup id="cite_ref-219" class="reference"><a href="#cite_note-219"><span class="cite-bracket">&#91;</span>219<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-220" class="reference"><a href="#cite_note-220"><span class="cite-bracket">&#91;</span>220<span class="cite-bracket">&#93;</span></a></sup> Eli Lilly was able to acquire the right to produce the drug commercially for just $1 because the patent rights of the original patent holders, <a href="/wiki/IG_Farben" title="IG Farben">IG Farben</a> and <a href="/wiki/Farbwerke_Hoechst" class="mw-redirect" title="Farbwerke Hoechst">Farbwerke Hoechst</a>, were not protected after the <a href="/wiki/Allies_of_World_War_II" title="Allies of World War II">Allies of World War II</a> seized all German patents, research records and trade names. Eli Lilly introduced the drug to the United States in 1947, marketed under the trade name "Dolophine".<sup id="cite_ref-221" class="reference"><a href="#cite_note-221"><span class="cite-bracket">&#91;</span>221<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Prozac">Prozac</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=25" title="Edit section: Prozac"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Fluoxetine" title="Fluoxetine">Fluoxetine</a></div>
<p>Prozac was one of the first therapies in its class to treat clinical depression by blocking the uptake of <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> within the <a href="/wiki/Human_brain" title="Human brain">human brain</a>. Prozac was approved by the US FDA in 1987 for use in treating depression, with generic versions appearing after 2002.
</p>
<div class="mw-heading mw-heading3"><h3 id="Secobarbital">Secobarbital</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=26" title="Edit section: Secobarbital"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Secobarbital" title="Secobarbital">Secobarbital</a></div>
<p>Lilly has manufactured <a href="/wiki/Secobarbital" title="Secobarbital">Secobarbital</a>, a <a href="/wiki/Barbiturate" title="Barbiturate">barbiturate</a> derivative with <a href="/wiki/Anesthetic" title="Anesthetic">anesthetic</a>, <a href="/wiki/Anticonvulsant" title="Anticonvulsant">anticonvulsant</a>, <a href="/wiki/Sedative" title="Sedative">sedative</a> and <a href="/wiki/Hypnosis" title="Hypnosis">hypnotic</a> properties. Lilly marketed Secobarbital under the brand name Seconal. Secobarbital is indicated for the treatment of <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a>, temporary <a href="/wiki/Insomnia" title="Insomnia">insomnia</a> and as a pre-operative medication to produce anesthesia and <a href="/wiki/Anxiolysis" class="mw-redirect" title="Anxiolysis">anxiolysis</a> in short surgical, diagnostic, or therapeutic procedures which are minimally painful. With the onset of new therapies for the treatment of these conditions, Secobarbital has been less utilized, and Lilly ceased manufacturing it in 1999.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>&#93;</sup>
</p><p>Secobarbital gained considerable attention during the 1970s, when it gained wide popularity as a <a href="/wiki/Recreational_drug_use" title="Recreational drug use">recreational drug</a>. In September 1970, <a href="/wiki/Rock_music" title="Rock music">rock</a> guitarist legend <a href="/wiki/Jimi_Hendrix" title="Jimi Hendrix">Jimi Hendrix</a> died from a secobarbital overdose. In June 1969, secobarbital overdose was the cause of death of actress <a href="/wiki/Judy_Garland" title="Judy Garland">Judy Garland</a>. The drug was a central part of the plot of the hugely popular novel <i><a href="/wiki/Valley_of_the_Dolls_(novel)" title="Valley of the Dolls (novel)">Valley of the Dolls</a></i> (1966) by <a href="/wiki/Jacqueline_Susann" title="Jacqueline Susann">Jacqueline Susann</a> in which three highly successful <a href="/wiki/Hollywood,_California" class="mw-redirect" title="Hollywood, California">Hollywood</a> women each fall victim, in various ways, to the drug. The novel was later released as a film by the same name.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>&#93;</sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Thiomersal">Thiomersal</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=27" title="Edit section: Thiomersal"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Thiomersal" title="Thiomersal">Thiomersal</a></div>
<p>Lilly has developed the <a href="/wiki/Vaccine" title="Vaccine">vaccine</a> preservative <a href="/wiki/Thiomersal" title="Thiomersal">thiomersal</a> (also called merthiolate and thimerosal). Thiomersal is effective by causing susceptible bacteria to <a href="/wiki/Autolysis_(biology)" title="Autolysis (biology)">autolyze</a>. Launched in 1930, merthiolate was a mercury-based antiseptic and germicide that "had been formulated at the <a href="/wiki/University_of_Maryland" class="mw-redirect" title="University of Maryland">University of Maryland</a> with support of a Lilly research fellowship."<sup id="cite_ref-MLilly65_71-2" class="reference"><a href="#cite_note-MLilly65-71"><span class="cite-bracket">&#91;</span>71<span class="cite-bracket">&#93;</span></a></sup> In November 2002,<sup id="cite_ref-222" class="reference"><a href="#cite_note-222"><span class="cite-bracket">&#91;</span>222<span class="cite-bracket">&#93;</span></a></sup> congressional Republicans inserted a provision into a domestic security bill that President <a href="/wiki/George_W._Bush" title="George W. Bush">George W. Bush</a> signed into a law, protecting Eli Lilly from all suits in the federal courts, alleging that the drug, <a href="/wiki/Thiomersal" title="Thiomersal">Thiomersal</a> caused <a href="/wiki/Autism" title="Autism">autism</a> and other neurological disorders in children, such that all such matters be heard by a special master appointed for the purpose, rather than regular federal courts. Its toxicology was that it metabolized into <a href="/wiki/Ethylmercury" title="Ethylmercury">ethylmercury</a> (C2H5Hg+) and <a href="/wiki/Thiosalicylate" class="mw-redirect" title="Thiosalicylate">thiosalicylate</a>, in the body. However, since the mid 2000’s it has mostly fallen out of use.
</p>
<div class="mw-heading mw-heading3"><h3 id="Zyprexa">Zyprexa</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=28" title="Edit section: Zyprexa"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a></div>
<p>Zyprexa (<a href="/wiki/Olanzapine" title="Olanzapine">Olanzapine</a>) (for <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a> and <a href="/wiki/Bipolar_disorder" title="Bipolar disorder">bipolar disorder</a>, as well as <a href="/wiki/Off-label" class="mw-redirect" title="Off-label">off-label</a> uses) Released in 1996, (see <a href="#Illegal_marketing_of_Zyprexa">Illegal marketing of Zyprexa</a>) it was the company's best selling drug through 2010, when the <a href="/wiki/Patent" title="Patent">patent</a> expired.<sup id="cite_ref-223" class="reference"><a href="#cite_note-223"><span class="cite-bracket">&#91;</span>223<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="Leadership">Leadership</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=29" title="Edit section: Leadership"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<figure class="mw-default-size" typeof="mw:File/Thumb"><a href="/wiki/File:President_Trump_Delivers_Remarks_on_Protecting_Seniors_with_Diabetes_(49941277593)_(cropped).jpg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a4/President_Trump_Delivers_Remarks_on_Protecting_Seniors_with_Diabetes_%2849941277593%29_%28cropped%29.jpg/250px-President_Trump_Delivers_Remarks_on_Protecting_Seniors_with_Diabetes_%2849941277593%29_%28cropped%29.jpg" decoding="async" width="250" height="272" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/a4/President_Trump_Delivers_Remarks_on_Protecting_Seniors_with_Diabetes_%2849941277593%29_%28cropped%29.jpg/500px-President_Trump_Delivers_Remarks_on_Protecting_Seniors_with_Diabetes_%2849941277593%29_%28cropped%29.jpg 1.5x" data-file-width="570" data-file-height="620" /></a><figcaption>David Ricks, Lilly CEO since 2016</figcaption></figure>
<p>After three generations of Lilly family leadership under company founder, Col. Eli Lilly, his son, Josiah K. Lilly Sr., and two grandsons, Eli Lilly Jr. and Josiah K. Lilly Jr., the company announced a reorganization in 1944 that prepared the way for future expansion and the eventual separation of company management from its ownership.<sup id="cite_ref-MLilly112_224-0" class="reference"><a href="#cite_note-MLilly112-224"><span class="cite-bracket">&#91;</span>224<span class="cite-bracket">&#93;</span></a></sup> The large, complex corporation was divided into smaller groups headed by vice presidents and in 1953 Eugene N. Beesley was named the first non-family member to become the company's president.<sup id="cite_ref-IHSHBR6_82-1" class="reference"><a href="#cite_note-IHSHBR6-82"><span class="cite-bracket">&#91;</span>82<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Although Lilly family members continued to serve as chairman of the board until 1969, Beesley's appointment began the transition to non-family management.<sup id="cite_ref-IHSHBR6_82-2" class="reference"><a href="#cite_note-IHSHBR6-82"><span class="cite-bracket">&#91;</span>82<span class="cite-bracket">&#93;</span></a></sup> In 1972 Richard Donald Wood<sup id="cite_ref-wsj_225-0" class="reference"><a href="#cite_note-wsj-225"><span class="cite-bracket">&#91;</span>225<span class="cite-bracket">&#93;</span></a></sup> became Lilly's president and CEO after the retirement of Burton E. Beck.<sup id="cite_ref-226" class="reference"><a href="#cite_note-226"><span class="cite-bracket">&#91;</span>226<span class="cite-bracket">&#93;</span></a></sup> In 1991 Vaughn Bryson became president and CEO<sup id="cite_ref-wsj_225-1" class="reference"><a href="#cite_note-wsj-225"><span class="cite-bracket">&#91;</span>225<span class="cite-bracket">&#93;</span></a></sup> and Wood became board chairman.<sup id="cite_ref-227" class="reference"><a href="#cite_note-227"><span class="cite-bracket">&#91;</span>227<span class="cite-bracket">&#93;</span></a></sup> During Bryson's 20-month tenure as Lilly's president and CEO, the company reported its first quarterly loss as a publicly traded company.<sup id="cite_ref-KokomoTrib62893_86-1" class="reference"><a href="#cite_note-KokomoTrib62893-86"><span class="cite-bracket">&#91;</span>86<span class="cite-bracket">&#93;</span></a></sup>
</p><p><a href="/wiki/Randall_L._Tobias" title="Randall L. Tobias">Randall L. Tobias</a>, a vice chairman of <a href="/wiki/AT%26T_Corporation" title="AT&amp;T Corporation">AT&amp;T Corporation</a>, was named chairman, president, and CEO in June 1993. Tobias, a Lilly board member since 1986, was recruited from outside the company's executive ranks<sup id="cite_ref-KokomoTrib62893_86-2" class="reference"><a href="#cite_note-KokomoTrib62893-86"><span class="cite-bracket">&#91;</span>86<span class="cite-bracket">&#93;</span></a></sup> first to replace Lilly's president and CEO, Vaughn Bryson, at Bryson's predecessor and then board chairman Richard Wood's urging and then, in short order, also Wood.<sup id="cite_ref-wsj_225-2" class="reference"><a href="#cite_note-wsj-225"><span class="cite-bracket">&#91;</span>225<span class="cite-bracket">&#93;</span></a></sup> Tobias later became the US director of Foreign Assistance and administrator of the <a href="/wiki/United_States_Agency_for_International_Development" title="United States Agency for International Development">United States Agency for International Development</a> (USAID), with the rank of ambassador.<sup id="cite_ref-228" class="reference"><a href="#cite_note-228"><span class="cite-bracket">&#91;</span>228<span class="cite-bracket">&#93;</span></a></sup>
</p><p><a href="/wiki/Sidney_Taurel" title="Sidney Taurel">Sidney Taurel</a>, former chief operating officer of Lilly, was named CEO in July 1998 to replace Tobias, who retired. Taurel became chairman of the board in January 1999.<sup id="cite_ref-IHSHBR9_229-0" class="reference"><a href="#cite_note-IHSHBR9-229"><span class="cite-bracket">&#91;</span>229<span class="cite-bracket">&#93;</span></a></sup> Taurel retired as CEO in March 2008, but remained as chairman of the board until 31 December 2008. <a href="/wiki/John_C._Lechleiter" title="John C. Lechleiter">John C. Lechleiter</a> was elected as Lilly's CEO and president, effective 1 April 2008. Lechleiter had served as Lilly's president and chief operating officer since October 2005.<sup id="cite_ref-TaurelRetires_230-0" class="reference"><a href="#cite_note-TaurelRetires-230"><span class="cite-bracket">&#91;</span>230<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In July 2016 it was announced that Lechleiter would be retiring. David Ricks was voted to succeed his position.<sup id="cite_ref-231" class="reference"><a href="#cite_note-231"><span class="cite-bracket">&#91;</span>231<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Community_service">Community service</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=30" title="Edit section: Community service"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<p>The Lilly family as well as Eli Lilly and Company has a long history of community service. Around 1890 Col. Lilly turned over operation of the family business to his son, Josiah, who ran the company for the next several decades.<sup id="cite_ref-IHSHBR2_33-2" class="reference"><a href="#cite_note-IHSHBR2-33"><span class="cite-bracket">&#91;</span>33<span class="cite-bracket">&#93;</span></a></sup> Col. Lilly remained active in civic affairs and assisted a number of local organizations, including the Commercial Club of Indianapolis, which later became the Indianapolis Chamber of Commerce,<sup id="cite_ref-b399_232-0" class="reference"><a href="#cite_note-b399-232"><span class="cite-bracket">&#91;</span>232<span class="cite-bracket">&#93;</span></a></sup> and the <a href="/wiki/Charity_Organization_Society" class="mw-redirect" title="Charity Organization Society">Charity Organization Society</a>, a forerunner to the Family Services Association of Central Indiana, an organization supported by <a href="/wiki/United_Way_of_America" class="mw-redirect" title="United Way of America">United Way</a>.<sup id="cite_ref-IHSHBR2_33-3" class="reference"><a href="#cite_note-IHSHBR2-33"><span class="cite-bracket">&#91;</span>33<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-233" class="reference"><a href="#cite_note-233"><span class="cite-bracket">&#91;</span>233<span class="cite-bracket">&#93;</span></a></sup> Josiah's sons, Eli and Joe, were also philanthropists who supported numerous cultural and educational organizations.<sup id="cite_ref-b91012_234-0" class="reference"><a href="#cite_note-b91012-234"><span class="cite-bracket">&#91;</span>234<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Josiah Sr. continued his father's civic mindedness and began the company tradition of sending aid to disaster victims.<sup id="cite_ref-IHSHBR3_37-3" class="reference"><a href="#cite_note-IHSHBR3-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> Following the <a href="/wiki/1906_San_Francisco_earthquake" title="1906 San Francisco earthquake">1906 San Francisco earthquake</a>, the company sent much needed medicine to support recovery efforts and provided relief after the 1936 <a href="/wiki/Johnstown_Flood" title="Johnstown Flood">Johnstown Flood</a>.<sup id="cite_ref-IHSHBR3_37-4" class="reference"><a href="#cite_note-IHSHBR3-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 1917, Lilly Field Hospital 32, named in Josiah's honor, was equipped in Indianapolis and moved overseas to Contrexville, France, during World War I, where it remained in operation until 1919.<sup id="cite_ref-IHSHBR3_37-5" class="reference"><a href="#cite_note-IHSHBR3-37"><span class="cite-bracket">&#91;</span>37<span class="cite-bracket">&#93;</span></a></sup> Throughout World War II, Lilly manufactured more than two hundred products for military use, including aviator survival kits and seasickness medications for the D-Day invasion.<sup id="cite_ref-IHSHBR5_65-2" class="reference"><a href="#cite_note-IHSHBR5-65"><span class="cite-bracket">&#91;</span>65<span class="cite-bracket">&#93;</span></a></sup> In addition Lilly dried more than two million pints of blood plasma by the war's end.<sup id="cite_ref-Madison,_Eli_Lilly,_p._105_69-1" class="reference"><a href="#cite_note-Madison,_Eli_Lilly,_p._105-69"><span class="cite-bracket">&#91;</span>69<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Lilly_Endowment">Lilly Endowment</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=31" title="Edit section: Lilly Endowment"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Lilly_Endowment" title="Lilly Endowment">Lilly Endowment</a></div>
<p>In 1937, Josiah K. Lilly Sr. and his two sons, Eli and Joe, founded the <a href="/wiki/Lilly_Endowment" title="Lilly Endowment">Lilly Endowment</a>, a private charitable foundation, with gifts of Lilly stock.<sup id="cite_ref-MLilly20506_235-0" class="reference"><a href="#cite_note-MLilly20506-235"><span class="cite-bracket">&#91;</span>235<span class="cite-bracket">&#93;</span></a></sup> The endowment still owns 11.3% of the company.<sup id="cite_ref-proxy_5-1" class="reference"><a href="#cite_note-proxy-5"><span class="cite-bracket">&#91;</span>5<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Eli_Lilly_and_Company_Foundation">Eli Lilly and Company Foundation</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=32" title="Edit section: Eli Lilly and Company Foundation"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<p>The Eli Lilly and Company Foundation, which is separate from the Lilly Endowment, operates as a tax-exempt private charitable foundation that the company established in 1968. The Foundation is funded through Lilly's corporate profits.<sup id="cite_ref-236" class="reference"><a href="#cite_note-236"><span class="cite-bracket">&#91;</span>236<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="Controversies">Controversies</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=33" title="Edit section: Controversies"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<div class="mw-heading mw-heading3"><h3 id="BGH">BGH</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=34" title="Edit section: BGH"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Bovine_somatotropin" title="Bovine somatotropin">bovine growth hormone</a></div>
<p>In August 2008, Eli Lilly purchased the right to manufacture <a href="/wiki/Bovine_somatotropin" title="Bovine somatotropin">bovine growth hormone</a>, used to increase milk production in dairy cattle, from <a href="/wiki/Monsanto" title="Monsanto">Monsanto</a>.<sup id="cite_ref-237" class="reference"><a href="#cite_note-237"><span class="cite-bracket">&#91;</span>237<span class="cite-bracket">&#93;</span></a></sup> Use of the supplement has become controversial due to the <a href="/wiki/Animal_ethics" title="Animal ethics">animal ethics</a> and <a href="/wiki/Beef_hormone_controversy" title="Beef hormone controversy">human health concerns</a>.<sup id="cite_ref-238" class="reference"><a href="#cite_note-238"><span class="cite-bracket">&#91;</span>238<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="340B">340B</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=35" title="Edit section: 340B"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/340B_Drug_Pricing_Program" title="340B Drug Pricing Program">340B Drug Pricing Program</a></div>
<p>In 2021, Eli Lilly filed a court motion against in response to an advisory opinion of the <a href="/wiki/United_States_Department_of_Health_and_Human_Services" title="United States Department of Health and Human Services">Department of Health and Human Services</a> indicating that Eli Lilly and other drug manufacturers must continue to offer reduced pricing to covered outpatient drugs through pharmacies contracted to hospitals rather than only to the hospitals themselves.<sup id="cite_ref-:0_239-0" class="reference"><a href="#cite_note-:0-239"><span class="cite-bracket">&#91;</span>239<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-240" class="reference"><a href="#cite_note-240"><span class="cite-bracket">&#91;</span>240<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-241" class="reference"><a href="#cite_note-241"><span class="cite-bracket">&#91;</span>241<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Prozac_2">Prozac</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=36" title="Edit section: Prozac"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Standard_Gravure_shooting" title="Standard Gravure shooting">Standard Gravure shooting</a> and <a href="/wiki/Fluoxetine" title="Fluoxetine">Fluoxetine</a></div>
<p>In September 1989, <a href="/wiki/Standard_Gravure_shooting" title="Standard Gravure shooting">Joseph T. Wesbecker</a> killed eight people and injured twelve before committing suicide.<sup id="cite_ref-242" class="reference"><a href="#cite_note-242"><span class="cite-bracket">&#91;</span>242<span class="cite-bracket">&#93;</span></a></sup> His relatives and victims blamed his actions on the Prozac medication he had begun taking a month prior. The incident set off a chain of lawsuits and public outcries.<sup id="cite_ref-243" class="reference"><a href="#cite_note-243"><span class="cite-bracket">&#91;</span>243<span class="cite-bracket">&#93;</span></a></sup> Lawyers began using Prozac to justify the abnormal behaviors of their clients.<sup id="cite_ref-244" class="reference"><a href="#cite_note-244"><span class="cite-bracket">&#91;</span>244<span class="cite-bracket">&#93;</span></a></sup> Eli Lilly was accused of not doing enough to warn patients and doctors about the adverse effects, which it had described as <a href="/wiki/Activation_syndrome" title="Activation syndrome">"activation"</a>, years prior to the incident.<sup id="cite_ref-245" class="reference"><a href="#cite_note-245"><span class="cite-bracket">&#91;</span>245<span class="cite-bracket">&#93;</span></a></sup> The link between suicide and antidepressants remains a subject of public and academic dispute.
</p><p>In October 2004, the FDA added a <a href="/wiki/Boxed_warning" title="Boxed warning">boxed warning</a> to all antidepressant drugs regarding use in children.<sup id="cite_ref-246" class="reference"><a href="#cite_note-246"><span class="cite-bracket">&#91;</span>246<span class="cite-bracket">&#93;</span></a></sup> In 2006, the FDA included adults aged 25 or younger.<sup id="cite_ref-247" class="reference"><a href="#cite_note-247"><span class="cite-bracket">&#91;</span>247<span class="cite-bracket">&#93;</span></a></sup> In February 2018, the FDA ordered an update to the warnings based on statistical evidence from twenty-four trials in which the risk of such events increased from two percent to four percent relative to the placebo trials.<sup id="cite_ref-248" class="reference"><a href="#cite_note-248"><span class="cite-bracket">&#91;</span>248<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Illegal_marketing_of_Zyprexa">Illegal marketing of Zyprexa</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=37" title="Edit section: Illegal marketing of Zyprexa"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Olanzapine#Controversy,_lawsuits_and_settlements" title="Olanzapine">Olanzapine §&#160;Controversy, lawsuits and settlements</a>; and <a href="/wiki/James_Gottstein#Eli_Lilly_memos" title="James Gottstein">James Gottstein §&#160;Eli Lilly memos</a></div>
<p>Eli Lilly has faced many lawsuits from people who claimed they developed diabetes or other diseases after taking <a href="/wiki/Olanzapine" title="Olanzapine">olanzapine</a> (branded Zyprexa), an <a href="/wiki/Antipsychotic" title="Antipsychotic">antipsychotic</a> medication, as well as by various governmental entities, insurance companies, and others. Internal documents provided to <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i> revealed that Lilly had downplayed the risks of Zyprexa. According to the documents, 16 percent of people taking Zyprexa gained more than 66 pounds in their first year, a much larger figure than Eli Lilly had shared with doctors.<sup id="cite_ref-NYT200101_249-0" class="reference"><a href="#cite_note-NYT200101-249"><span class="cite-bracket">&#91;</span>249<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In 2006, Lilly paid $700 million to settle around 8,000 of these lawsuits,<sup id="cite_ref-250" class="reference"><a href="#cite_note-250"><span class="cite-bracket">&#91;</span>250<span class="cite-bracket">&#93;</span></a></sup> and in early 2007, Lilly settled around 18,000 suits for $500 million, which brought the total Lilly had paid to settle suits related to the drug to $1.2 billion.<sup id="cite_ref-NYT200101_249-1" class="reference"><a href="#cite_note-NYT200101-249"><span class="cite-bracket">&#91;</span>249<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-timeso_251-0" class="reference"><a href="#cite_note-timeso-251"><span class="cite-bracket">&#91;</span>251<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In March 2008, Lilly settled a suit with the state of Alaska,<sup id="cite_ref-252" class="reference"><a href="#cite_note-252"><span class="cite-bracket">&#91;</span>252<span class="cite-bracket">&#93;</span></a></sup> and in October 2008, Lilly agreed to pay $62 million to 32 states and the District of Columbia to settle suits brought under state <a href="/wiki/Consumer_protection" title="Consumer protection">consumer protection</a> laws.<sup id="cite_ref-NYT2009-01_253-0" class="reference"><a href="#cite_note-NYT2009-01-253"><span class="cite-bracket">&#91;</span>253<span class="cite-bracket">&#93;</span></a></sup> In 2009, four sales representatives for Eli Lilly filed separate <i><a href="/wiki/Qui_tam" title="Qui tam">qui tam</a></i> lawsuits against the company for illegally marketing Zyprexa for uses not approved by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>.
</p><p>Eli Lilly pleaded guilty to a US federal criminal <a href="/wiki/Misdemeanor" title="Misdemeanor">misdemeanor</a> charge of illegally marketing Zyprexa, actively promoting the drug for <a href="/wiki/Off-label" class="mw-redirect" title="Off-label">off-label</a> uses, particularly for the treatment of dementia in the elderly.<sup id="cite_ref-254" class="reference"><a href="#cite_note-254"><span class="cite-bracket">&#91;</span>254<span class="cite-bracket">&#93;</span></a></sup> The $1.415 billion penalty included an $800 million civil settlement, a $515 million criminal fine, and forfeit assets of $100 million.<sup id="cite_ref-usdoj-2009_15-2" class="reference"><a href="#cite_note-usdoj-2009-15"><span class="cite-bracket">&#91;</span>15<span class="cite-bracket">&#93;</span></a></sup> The <a href="/wiki/US_Justice_Department" class="mw-redirect" title="US Justice Department">US Justice Department</a> said the criminal fine of $515 million was the largest ever in a healthcare case and the largest criminal fine for an individual corporation ever imposed in a US criminal prosecution of any kind.<sup id="cite_ref-usdoj-2009_15-3" class="reference"><a href="#cite_note-usdoj-2009-15"><span class="cite-bracket">&#91;</span>15<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-:1_16-2" class="reference"><a href="#cite_note-:1-16"><span class="cite-bracket">&#91;</span>16<span class="cite-bracket">&#93;</span></a></sup> "That was a blemish for us," <a href="/wiki/John_C._Lechleiter" title="John C. Lechleiter">John C. Lechleiter</a>, CEO of Lilly, said. "We don't ever want that to happen again. We put measures in place to assure that not only do we have the right intentions in integrity and compliance, but we have systems in place to support that."<sup id="cite_ref-255" class="reference"><a href="#cite_note-255"><span class="cite-bracket">&#91;</span>255<span class="cite-bracket">&#93;</span></a></sup> In an internal email, Lechleiter had stated "we must seize the opportunity to expand our work with <a href="/wiki/Olanzapine" title="Olanzapine">Zyprexa</a> in this same child-adolescent population" for <a href="/wiki/Off-label" class="mw-redirect" title="Off-label">off-label</a> use.<sup id="cite_ref-Berenson_256-0" class="reference"><a href="#cite_note-Berenson-256"><span class="cite-bracket">&#91;</span>256<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In January 2020, lawyer <a href="/wiki/James_Gottstein" title="James Gottstein">James Gottstein</a> published a book titled <i>The Zyprexa Papers</i> summarizing the legal activities surrounding Zyprexa, and their impact on the political landscape of psychiatry and antipsychiatry in the US.<sup id="cite_ref-257" class="reference"><a href="#cite_note-257"><span class="cite-bracket">&#91;</span>257<span class="cite-bracket">&#93;</span></a></sup> The book details of how he obtained the Zyprexa papers, including how <a href="/wiki/Will_Hall_(writer)" title="Will Hall (writer)">Will Hall</a> and a small group of "psychiatric survivors" untraceably spread the Zyprexa Papers on the Internet and his battles on behalf of Bill Bigley, the psychiatric patient whose ordeal made possible the exposure of the Zyprexa Papers.<sup id="cite_ref-258" class="reference"><a href="#cite_note-258"><span class="cite-bracket">&#91;</span>258<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Discrimination">Discrimination</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=38" title="Edit section: Discrimination"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<p>In March 2021, Eli Lilly and Company was accused of sex discrimination by a former lobbyist who claimed she was forced to work in a sexually hostile work environment.<sup id="cite_ref-259" class="reference"><a href="#cite_note-259"><span class="cite-bracket">&#91;</span>259<span class="cite-bracket">&#93;</span></a></sup> The parties involved settled for an undisclosed amount in June 2021.<sup id="cite_ref-260" class="reference"><a href="#cite_note-260"><span class="cite-bracket">&#91;</span>260<span class="cite-bracket">&#93;</span></a></sup>
</p><p>In September 2021, Eli Lilly and Company was accused in a <a href="/wiki/Federal_judiciary_of_the_United_States" title="Federal judiciary of the United States">federal court</a> lawsuit of discriminating against older applicants for sales positions based on their implementation of hiring quotas for millennials.<sup id="cite_ref-261" class="reference"><a href="#cite_note-261"><span class="cite-bracket">&#91;</span>261<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Canada_patent_lawsuit">Canada patent lawsuit</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=39" title="Edit section: Canada patent lawsuit"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<p>In September 2013, Eli Lilly sued <a href="/wiki/Canada" title="Canada">Canada</a> for violating its obligations to foreign investors under the <a href="/wiki/North_American_Free_Trade_Agreement" title="North American Free Trade Agreement">North American Free Trade Agreement</a> by allowing its courts to invalidate patents for <a href="/wiki/Atomoxetine" title="Atomoxetine">Strattera</a> and <a href="/wiki/Olanzapine" title="Olanzapine">Zyprexa</a>.<sup id="cite_ref-262" class="reference"><a href="#cite_note-262"><span class="cite-bracket">&#91;</span>262<span class="cite-bracket">&#93;</span></a></sup> Canadian courts found <a href="/wiki/Atomoxetine" title="Atomoxetine">Strattera's</a> seven-week long study of twenty-two patients, too short and too narrow in scope to qualify for the patent. The <a href="/wiki/Olanzapine" title="Olanzapine">Zyprexa</a> patent was invalidated because it had not achieved its promised <a href="/wiki/Utility_in_Canadian_patent_law" title="Utility in Canadian patent law">utility</a>. The company sought damages in the amount of $500 million for lost profits. They ultimately lost the case in 2017.<sup id="cite_ref-263" class="reference"><a href="#cite_note-263"><span class="cite-bracket">&#91;</span>263<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Illegal_marketing_of_Evista">Illegal marketing of Evista</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=40" title="Edit section: Illegal marketing of Evista"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236090951" /><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Raloxifene" title="Raloxifene">Evista</a></div>
<p><a href="/wiki/Raloxifene" title="Raloxifene">Evista</a> is a medication typically used to prevent and treat <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> in <a href="/wiki/Menopause" title="Menopause">postmenopausal</a> women.
</p><p>In December 2005, Eli Lilly and Company agreed to plead guilty and pay $36 million in connection with the illegal promotion of the drug.<sup id="cite_ref-264" class="reference"><a href="#cite_note-264"><span class="cite-bracket">&#91;</span>264<span class="cite-bracket">&#93;</span></a></sup> Sales representatives were trained to promote <a href="/wiki/Raloxifene" title="Raloxifene">Evista</a> for breast cancer and cardiovascular disease, to prompt or bait questions by doctors, and to send them unsolicited letters promoting <a href="/wiki/Raloxifene" title="Raloxifene">Evista</a> for unapproved use. The company distributed a videotape in which a sales representative declared that "Evista truly is the best drug for the prevention of all these diseases." Some sales representatives had also been instructed to conceal the disclosure page which stated that the effectiveness of the drug in reducing breast cancer risks had not yet been established.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (March 2022)">citation needed</span></a></i>&#93;</sup>
</p>
<div class="mw-heading mw-heading3"><h3 id="Insulin_pricing">Insulin pricing</h3><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=41" title="Edit section: Insulin pricing"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<p>In January 2019, lawmakers from the <a href="/wiki/United_States_House_of_Representatives" title="United States House of Representatives">United States House of Representatives</a> sent letters to Eli Lilly and other insulin manufacturers asking for explanations for their rapidly raising insulin prices. The annual cost of insulin for people with type 1 diabetes in the US almost doubled from $2,900 to $5,700 over the period from 2012 to 2016.<sup id="cite_ref-265" class="reference"><a href="#cite_note-265"><span class="cite-bracket">&#91;</span>265<span class="cite-bracket">&#93;</span></a></sup>
</p><p>Renewed attention was brought to Eli Lilly's pricing of insulin in November 2022, after a <a href="/wiki/Twitter_verification" title="Twitter verification">verified Twitter account</a> impersonating Eli Lilly posted on Twitter that insulin would now be free.<sup id="cite_ref-thestar_266-0" class="reference"><a href="#cite_note-thestar-266"><span class="cite-bracket">&#91;</span>266<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-forbes1_267-0" class="reference"><a href="#cite_note-forbes1-267"><span class="cite-bracket">&#91;</span>267<span class="cite-bracket">&#93;</span></a></sup><sup id="cite_ref-forbes2_268-0" class="reference"><a href="#cite_note-forbes2-268"><span class="cite-bracket">&#91;</span>268<span class="cite-bracket">&#93;</span></a></sup> The following year, the company announced that it would be reducing the out-of-pocket price of insulin to $35 a month. The company also stated that it would lower the price of Humalog from $275 a month to $66 and that it would offer <a href="/wiki/Insulin_glargine" title="Insulin glargine">insulin glargine</a> at a 78% discount compared to rival company <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a>. Despite this, the reduced costs will not apply to Eli Lilly's newer brands of insulin, and the company's pricing is still significantly higher than it was several decades prior.<sup id="cite_ref-Robbins_2023_269-0" class="reference"><a href="#cite_note-Robbins_2023-269"><span class="cite-bracket">&#91;</span>269<span class="cite-bracket">&#93;</span></a></sup>
</p>
<div class="mw-heading mw-heading2"><h2 id="References">References</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=42" title="Edit section: References"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<style data-mw-deduplicate="TemplateStyles:r1239543626">.mw-parser-output .reflist{margin-bottom:0.5em;list-style-type:decimal}@media screen{.mw-parser-output .reflist{font-size:90%}}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1238218222">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free.id-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited.id-lock-limited a,.mw-parser-output .id-lock-registration.id-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription.id-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-free a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-limited a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-registration a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .id-lock-subscription a,body:not(.skin-timeless):not(.skin-minerva) .mw-parser-output .cs1-ws-icon a{background-size:contain;padding:0 1em 0 0}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:var(--color-error,#d33)}.mw-parser-output .cs1-visible-error{color:var(--color-error,#d33)}.mw-parser-output .cs1-maint{display:none;color:#085;margin-left:0.3em}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}@media screen{.mw-parser-output .cs1-format{font-size:95%}html.skin-theme-clientpref-night .mw-parser-output .cs1-maint{color:#18911f}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .cs1-maint{color:#18911f}}</style><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.msn.com/en-us/money/companies/google-parent-alphabet-poaches-eli-lilly-finance-chief-ashkenazi/ar-BB1nG8FK">"Google Parent Alphabet Poaches Eli Lilly Finance Chief Ashkenazi"</a>. <i>MSN</i>. 5 June 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">16 June</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MSN&amp;rft.atitle=Google+Parent+Alphabet+Poaches+Eli+Lilly+Finance+Chief+Ashkenazi&amp;rft.date=2024-06-05&amp;rft_id=https%3A%2F%2Fwww.msn.com%2Fen-us%2Fmoney%2Fcompanies%2Fgoogle-parent-alphabet-poaches-eli-lilly-finance-chief-ashkenazi%2Far-BB1nG8FK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-10K-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-10K_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-10K_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm">"Eli Lilly and Company 2024 Annual Report (Form 10-K)"</a>. <a href="/wiki/U.S._Securities_and_Exchange_Commission" title="U.S. Securities and Exchange Commission">U.S. Securities and Exchange Commission</a>. 19 February 2025.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+and+Company+2024+Annual+Report+%28Form+10-K%29&amp;rft.pub=U.S.+Securities+and+Exchange+Commission&amp;rft.date=2025-02-19&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2Fix%3Fdoc%3D%2FArchives%2Fedgar%2Fdata%2F59478%2F000005947825000067%2Flly-20241231.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://investor.lilly.com/static-files/b5c56281-bc31-48c3-9e63-5e6cd588dff5">"Eli Lilly and Company 2023 Annual Report on Form 10-K"</a> <span class="cs1-format">(PDF)</span>. Eli Lilly. 21 February 2024.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+and+Company+2023+Annual+Report+on+Form+10-K&amp;rft.pub=Eli+Lilly&amp;rft.date=2024-02-21&amp;rft_id=https%3A%2F%2Finvestor.lilly.com%2Fstatic-files%2Fb5c56281-bc31-48c3-9e63-5e6cd588dff5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/0000059478/000005947823000120/lly-20230317.htm">"Eli Lilly and Company 2023 Proxy Statement (Form DEF 14A)"</a>. <a href="/wiki/U.S._Securities_and_Exchange_Commission" title="U.S. Securities and Exchange Commission">U.S. Securities and Exchange Commission</a>. 17 March 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">21 February</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+and+Company+2023+Proxy+Statement+%28Form+DEF+14A%29&amp;rft.pub=U.S.+Securities+and+Exchange+Commission&amp;rft.date=2023-03-17&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2Fixviewer%2Fix.html%3Fdoc%3D%2FArchives%2Fedgar%2Fdata%2F0000059478%2F000005947823000120%2Flly-20230317.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-proxy-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-proxy_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-proxy_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLee2021" class="citation web cs1">Lee, Jaimy (9 February 2021). <a rel="nofollow" class="external text" href="https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09">"Lilly promotes Anat Ashkenazi to CFO, says previous CFO had 'inappropriate' communication with employees"</a>. <i>MarketWatch</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210209212406/https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09">Archived</a> from the original on 9 February 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MarketWatch&amp;rft.atitle=Lilly+promotes+Anat+Ashkenazi+to+CFO%2C+says+previous+CFO+had+%27inappropriate%27+communication+with+employees&amp;rft.date=2021-02-09&amp;rft.aulast=Lee&amp;rft.aufirst=Jaimy&amp;rft_id=https%3A%2F%2Fwww.marketwatch.com%2Fstory%2Flilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHannahBlake2013" class="citation web cs1">HannahBlake (29 July 2013). <a rel="nofollow" class="external text" href="https://pharmaphorum.com/views-and-analysis/a-history-of-eli-lilly-co/">"A history of... Eli Lilly &amp; Co -"</a>. <i>pharmaphorum.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022705/https://pharmaphorum.com/views-and-analysis/a-history-of-eli-lilly-co/">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">14 May</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=pharmaphorum.com&amp;rft.atitle=A+history+of...+Eli+Lilly+%26+Co+-&amp;rft.date=2013-07-29&amp;rft.au=HannahBlake&amp;rft_id=https%3A%2F%2Fpharmaphorum.com%2Fviews-and-analysis%2Fa-history-of-eli-lilly-co%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-Barnes-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Barnes_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Barnes_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Barnes_7-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBarnes2024" class="citation news cs1">Barnes, Oliver (2 October 2024). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://www.ft.com/content/ed81ca79-1fd6-48ea-8e50-246d0849c3f5">"Can Eli Lilly become the first $1tn drugmaker?"</a></span>. <i>Financial Times</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Financial+Times&amp;rft.atitle=Can+Eli+Lilly+become+the+first+%241tn+drugmaker%3F&amp;rft.date=2024-10-02&amp;rft.aulast=Barnes&amp;rft.aufirst=Oliver&amp;rft_id=https%3A%2F%2Fwww.ft.com%2Fcontent%2Fed81ca79-1fd6-48ea-8e50-246d0849c3f5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://fortune.com/company/eli-lilly/">"Eli Lilly"</a>. <i><a href="/wiki/Fortune_(magazine)" title="Fortune (magazine)">Fortune</a></i>. 17 December 2023. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20240616224442/https://fortune.com/company/eli-lilly/">Archived</a> from the original on 16 June 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">16 June</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fortune&amp;rft.atitle=Eli+Lilly&amp;rft.date=2023-12-17&amp;rft_id=https%3A%2F%2Ffortune.com%2Fcompany%2Feli-lilly%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.forbes.com/companies/eli-lilly-co/">"Forbes: The World's Biggest Public Companies"</a>. <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200410222044/https://www.forbes.com/companies/eli-lilly-co/">Archived</a> from the original on 10 April 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">13 November</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Forbes%3A+The+World%27s+Biggest+Public+Companies&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fcompanies%2Feli-lilly-co%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.forbes.com/companies/lilly/">"Forbes: America's Best Employers"</a>. <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20171104051654/https://www.forbes.com/companies/lilly/">Archived</a> from the original on 4 November 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">13 November</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Forbes%3A+America%27s+Best+Employers&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fcompanies%2Flilly%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://fortune.com/company/eli-lilly/">"Eli Lilly Company Profile"</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220426045633/https://fortune.com/company/eli-lilly/">Archived</a> from the original on 26 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">23 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+Company+Profile&amp;rft_id=https%3A%2F%2Ffortune.com%2Fcompany%2Feli-lilly%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSwiatek2015" class="citation news cs1">Swiatek, Jeff (28 December 2015). <a rel="nofollow" class="external text" href="https://www.indystar.com/story/money/2015/12/28/10-all-time-greatest-eli-lilly-drugs/76070470/">"10 all-time greatest Eli Lilly drugs"</a>. <i><a href="/wiki/The_Indianapolis_Star" title="The Indianapolis Star">The Indianapolis Star</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022704/https://www.indystar.com/story/money/2015/12/28/10-all-time-greatest-eli-lilly-drugs/76070470/">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">13 November</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Indianapolis+Star&amp;rft.atitle=10+all-time+greatest+Eli+Lilly+drugs&amp;rft.date=2015-12-28&amp;rft.aulast=Swiatek&amp;rft.aufirst=Jeff&amp;rft_id=https%3A%2F%2Fwww.indystar.com%2Fstory%2Fmoney%2F2015%2F12%2F28%2F10-all-time-greatest-eli-lilly-drugs%2F76070470%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-Pollack2-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pollack2_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pollack2_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPollack2005" class="citation news cs1">Pollack, Andrew (30 April 2005). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2005/04/30/business/lizardderived-diabetes-drug-is-approved-by-the-fda.html">"Lizard-Derived Diabetes Drug Is Approved by the F.D.A."</a></span>. <i>The New York Times</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2 November</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Lizard-Derived+Diabetes+Drug+Is+Approved+by+the+F.D.A.&amp;rft.date=2005-04-30&amp;rft.aulast=Pollack&amp;rft.aufirst=Andrew&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2005%2F04%2F30%2Fbusiness%2Flizardderived-diabetes-drug-is-approved-by-the-fda.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-p58-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-p58_14-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPrice1997" class="citation book cs1">Price, Nelson (1997). <i>Indiana Legends: Famous Hoosiers from Johnny Appleseed to David Letterman</i>. Carmel, Indiana: Guild Press of Indiana. p.&#160;58. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-57860-006-9" title="Special:BookSources/978-1-57860-006-9"><bdi>978-1-57860-006-9</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana+Legends%3A+Famous+Hoosiers+from+Johnny+Appleseed+to+David+Letterman&amp;rft.place=Carmel%2C+Indiana&amp;rft.pages=58&amp;rft.pub=Guild+Press+of+Indiana&amp;rft.date=1997&amp;rft.isbn=978-1-57860-006-9&amp;rft.aulast=Price&amp;rft.aufirst=Nelson&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-usdoj-2009-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-usdoj-2009_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-usdoj-2009_15-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-usdoj-2009_15-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-usdoj-2009_15-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.justice.gov/opa/pr/2009/January/09-civ-038.html">"Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa"</a>. <i>09-civ-038</i>. United States Department of Justice. 15 January 2009. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160313044330/https://www.justice.gov/opa/pr/2009/January/09-civ-038.html">Archived</a> from the original on 13 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">22 November</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=09-civ-038&amp;rft.atitle=Eli+Lilly+and+Company+Agrees+to+Pay+%241.415+Billion+to+Resolve+Allegations+of+Off-label+Promotion+of+Zyprexa&amp;rft.date=2009-01-15&amp;rft_id=https%3A%2F%2Fwww.justice.gov%2Fopa%2Fpr%2F2009%2FJanuary%2F09-civ-038.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-:1-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-:1_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:1_16-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20121017203119/http://www.justice.gov/usao/pae/News/Pr/2009/jan/lillyrelease.pdf">"Pharmaceutical Company Eli Lilly to Pay Record $1.415 Billion for Off-Label Drug Marketing"</a> <span class="cs1-format">(PDF)</span>. <i>United States Attorney, Eastern District of Pennsylvania</i>. United States Department of Justice. 15 January 2009. Archived from <a rel="nofollow" class="external text" href="https://www.justice.gov/usao/pae/News/Pr/2009/jan/lillyrelease.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 17 October 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=United+States+Attorney%2C+Eastern+District+of+Pennsylvania&amp;rft.atitle=Pharmaceutical+Company+Eli+Lilly+to+Pay+Record+%241.415+Billion+for+Off-Label+Drug+Marketing&amp;rft.date=2009-01-15&amp;rft_id=https%3A%2F%2Fwww.justice.gov%2Fusao%2Fpae%2FNews%2FPr%2F2009%2Fjan%2Flillyrelease.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.phrma.org/about/members">"Members"</a>. Pharmaceutical Research and Manufacturers of America. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190219001842/https://www.phrma.org/about/members">Archived</a> from the original on 19 February 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">14 February</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Members&amp;rft.pub=Pharmaceutical+Research+and+Manufacturers+of+America&amp;rft_id=https%3A%2F%2Fwww.phrma.org%2Fabout%2Fmembers&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20171114145122/http://www.sdggroup.com/en/lilly">"SDG Group Customers: Eli Lilly"</a>. SDG Group. Archived from <a rel="nofollow" class="external text" href="http://www.sdggroup.com/en/lilly">the original</a> on 14 November 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">13 November</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=SDG+Group+Customers%3A+Eli+Lilly&amp;rft_id=http%3A%2F%2Fwww.sdggroup.com%2Fen%2Flilly&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSHBR1-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR1_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR1_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR1_19-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: <a href="/wiki/Indiana_Historical_Society" title="Indiana Historical Society">Indiana Historical Society</a>. p.&#160;1. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.place=Indianapolis&amp;rft.pages=1&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-b911-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-b911_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-b911_20-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-b911_20-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-b911_20-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBodenhamerBarrows1994" class="citation book cs1">Bodenhamer, David J.; Barrows, Robert G., eds. (1994). <i>The Encyclopedia of Indianapolis</i>. Bloomington and Indianapolis: Indiana University Press. p.&#160;911. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-253-31222-8" title="Special:BookSources/978-0-253-31222-8"><bdi>978-0-253-31222-8</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Encyclopedia+of+Indianapolis&amp;rft.place=Bloomington+and+Indianapolis&amp;rft.pages=911&amp;rft.pub=Indiana+University+Press&amp;rft.date=1994&amp;rft.isbn=978-0-253-31222-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-LillyBio-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-LillyBio_21-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.in.gov/governorhistory/mitchdaniels/files/Press/lillybio.pdf">"Colonel Eli Lilly (1838–1898)"</a> <span class="cs1-format">(PDF)</span>. Lilly Archives. January 2008. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161118043556/http://www.in.gov/governorhistory/mitchdaniels/files/Press/lillybio.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 18 November 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Colonel+Eli+Lilly+%281838%E2%80%931898%29&amp;rft.pub=Lilly+Archives&amp;rft.date=2008-01&amp;rft_id=http%3A%2F%2Fwww.in.gov%2Fgovernorhistory%2Fmitchdaniels%2Ffiles%2FPress%2Flillybio.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-m6-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-m6_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-m6_22-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMadison1989" class="citation book cs1">Madison, James H. (1989). <a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi/page/6"><i>Eli Lilly: A Life, 1885&#8211;1977</i></a>. Indianapolis: Indiana Historical Society. p.&#160;<a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi/page/6">6</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-87195-047-5" title="Special:BookSources/978-0-87195-047-5"><bdi>978-0-87195-047-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Eli+Lilly%3A+A+Life%2C+1885%26ndash%3B1977&amp;rft.place=Indianapolis&amp;rft.pages=6&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-047-5&amp;rft.aulast=Madison&amp;rft.aufirst=James+H.&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Felilillylife188500madi%2Fpage%2F6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-b540-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-b540_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-b540_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-b540_23-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Bodenhamer and Barrows, p. 540.</span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text">The <a href="/wiki/Indiana_Historical_Society" title="Indiana Historical Society">Indiana Historical Society</a> recreated a replica of the first Lilly laboratory on Pearl Street for its exhibition, "You Are There: <i>Eli Lilly at the Beginning</i>," at the <a href="/wiki/Indiana_Historical_Society" title="Indiana Historical Society">Eugene and Marilyn Glick Indiana History Center</a> in Indianapolis. The temporary exhibition (1 October 2016, to 20 January 2018) also included costumed interpreters portraying Colonel Lilly and others. See <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="http://kpcnews.com/features/life/kpcnews/article_1d087ec0-abcb-5641-844d-4ceeaa6b4c5a.html">"The Man Behind State's Most Successful Startup"</a>. <i>Kendallville New Sun</i>. Kendallville, Indiana: KPC News. 9 September 2016. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200804181012/https://www.kpcnews.com/features/life/kpcnews/article_1d087ec0-abcb-5641-844d-4ceeaa6b4c5a.html">Archived</a> from the original on 4 August 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">21 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kendallville+New+Sun&amp;rft.atitle=The+Man+Behind+State%27s+Most+Successful+Startup&amp;rft.date=2016-09-09&amp;rft_id=http%3A%2F%2Fkpcnews.com%2Ffeatures%2Flife%2Fkpcnews%2Farticle_1d087ec0-abcb-5641-844d-4ceeaa6b4c5a.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span> See also <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAlvarez2016" class="citation journal cs1">Alvarez, Tom, ed. (Fall 2016). <a rel="nofollow" class="external text" href="https://issuu.com/unitemagazine/docs/indy_fall_2016_web">"Fall Arts Guide"</a>. <i>UNITE Indianapolis</i>. Indianapolis: Joey Amato: 32. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170112050826/https://issuu.com/unitemagazine/docs/indy_fall_2016_web">Archived</a> from the original on 12 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=UNITE+Indianapolis&amp;rft.atitle=Fall+Arts+Guide&amp;rft.ssn=fall&amp;rft.pages=32&amp;rft.date=2016&amp;rft_id=https%3A%2F%2Fissuu.com%2Funitemagazine%2Fdocs%2Findy_fall_2016_web&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-p59-25"><span class="mw-cite-backlink">^ <a href="#cite_ref-p59_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-p59_25-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-p59_25-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Price, <i>Indiana Legends</i>, p. 59.</span>
</li>
<li id="cite_note-p57-26"><span class="mw-cite-backlink">^ <a href="#cite_ref-p57_26-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-p57_26-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-p57_26-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Price, <i>Indiana Legends</i>, p. 57.</span>
</li>
<li id="cite_note-Kahn23-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kahn23_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kahn23_27-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKahn1975" class="citation book cs1">Kahn, E. J. (1975). <i>All In A Century: The First 100 Years of Eli Lilly and Company</i>. West Cornwall, CT. p.&#160;23. <a href="/wiki/OCLC_(identifier)" class="mw-redirect" title="OCLC (identifier)">OCLC</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/oclc/5288809">5288809</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=All+In+A+Century%3A+The+First+100+Years+of+Eli+Lilly+and+Company&amp;rft.place=West+Cornwall%2C+CT&amp;rft.pages=23&amp;rft.date=1975&amp;rft_id=info%3Aoclcnum%2F5288809&amp;rft.aulast=Kahn&amp;rft.aufirst=E.+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_book" title="Template:Cite book">cite book</a>}}</code>:  CS1 maint: location missing publisher (<a href="/wiki/Category:CS1_maint:_location_missing_publisher" title="Category:CS1 maint: location missing publisher">link</a>)</span></span>
</li>
<li id="cite_note-IHSHBR14-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR14_28-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p.&#160;1 and 4. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pd">the original</a> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=1+and+4&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pd&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-m27-29"><span class="mw-cite-backlink">^ <a href="#cite_ref-m27_29-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-m27_29-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 27.</span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAlbert_Nelson_Marquis1916" class="citation encyclopaedia cs1">Albert Nelson Marquis, ed. (1916). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=OlIlod0IyTkC">"Lilly, Josiah Kirby"</a>. <i>Who's Who in America: A Biographical Dictionary of Notable Living Men and Women of the United States</i>. A. N. Marquis &amp; Company. p.&#160;1482.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Lilly%2C+Josiah+Kirby&amp;rft.btitle=Who%27s+Who+in+America%3A+A+Biographical+Dictionary+of+Notable+Living+Men+and+Women+of+the+United+States&amp;rft.pages=1482&amp;rft.pub=A.+N.+Marquis+%26+Company&amp;rft.date=1916&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DOlIlod0IyTkC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-PriceLegends59-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-PriceLegends59_31-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFNelson_Price1997" class="citation book cs1">Nelson Price (1997). <i>Indiana Legends: Famous Hoosiers From Johnny Appleseed to David Letterman</i>. Carmel, IN: Guild Press of Indiana. p.&#160;59. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-57860-006-5" title="Special:BookSources/1-57860-006-5"><bdi>1-57860-006-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana+Legends%3A+Famous+Hoosiers+From+Johnny+Appleseed+to+David+Letterman&amp;rft.place=Carmel%2C+IN&amp;rft.pages=59&amp;rft.pub=Guild+Press+of+Indiana&amp;rft.date=1997&amp;rft.isbn=1-57860-006-5&amp;rft.au=Nelson+Price&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-MadisonM72-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-MadisonM72_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MadisonM72_32-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MadisonM72_32-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MadisonM72_32-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-MadisonM72_32-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFJames_H._Madison1989" class="citation journal cs1">James H. Madison (1989). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130514134313/http://thebhc.org/publications/BEHprint/v018/p0072-p0078.pdf">"Manufacturing Pharmaceuticals: Eli Lilly and Company, 1876–1948"</a> <span class="cs1-format">(PDF)</span>. <i>Business and Economic History</i>. <b>18</b>. Business History Conference: 72. Archived from <a rel="nofollow" class="external text" href="https://www.thebhc.org/publications/BEHprint/v018/p0072-p0078.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 14 May 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+and+Economic+History&amp;rft.atitle=Manufacturing+Pharmaceuticals%3A+Eli+Lilly+and+Company%2C+1876%E2%80%931948&amp;rft.volume=18&amp;rft.pages=72&amp;rft.date=1989&amp;rft.au=James+H.+Madison&amp;rft_id=http%3A%2F%2Fwww.thebhc.org%2Fpublications%2FBEHprint%2Fv018%2Fp0072-p0078.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSHBR2-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR2_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR2_33-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR2_33-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-IHSHBR2_33-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p.&#160;2. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=2&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-p60-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-p60_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-p60_34-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Price, <i>Indiana Legends</i>, p. 60.</span>
</li>
<li id="cite_note-PodczekJones-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-PodczekJones_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PodczekJones_35-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPodczeckJones2004" class="citation book cs1">Podczeck, Fridrun; Jones, Brian E. (2004). <i>Pharmaceutical Capsules</i>. Chicago: Pharmaceutical Press. pp.&#160;<span class="nowrap">12–</span>13. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-85369-568-4" title="Special:BookSources/978-0-85369-568-4"><bdi>978-0-85369-568-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmaceutical+Capsules&amp;rft.place=Chicago&amp;rft.pages=12-13&amp;rft.pub=Pharmaceutical+Press&amp;rft.date=2004&amp;rft.isbn=978-0-85369-568-4&amp;rft.aulast=Podczeck&amp;rft.aufirst=Fridrun&amp;rft.au=Jones%2C+Brian+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-b913-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-b913_36-0">^</a></b></span> <span class="reference-text">Bodenhamer and Barrows, eds., p. 913.</span>
</li>
<li id="cite_note-IHSHBR3-37"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR3_37-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR3_37-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR3_37-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-IHSHBR3_37-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-IHSHBR3_37-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-IHSHBR3_37-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indiana Historical Society. p.&#160;3. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=3&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-bb912-38"><span class="mw-cite-backlink">^ <a href="#cite_ref-bb912_38-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bb912_38-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Bodenhamer and Barrows, eds., p. 912.</span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, pp. 17–18, 21.</span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, pp. 51, 112–15.</span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTaylor_Jr.StevensPonderBrockman1989" class="citation book cs1">Taylor Jr., Robert M.; Stevens, Errol Wayne; Ponder, Mary Ann; Brockman, Paul (1989). <i>Indiana: A New Historical Guide</i>. Indianapolis: Indiana Historical Society. p.&#160;423. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-87195-048-2" title="Special:BookSources/978-0-87195-048-2"><bdi>978-0-87195-048-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana%3A+A+New+Historical+Guide&amp;rft.place=Indianapolis&amp;rft.pages=423&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-048-2&amp;rft.aulast=Taylor+Jr.&amp;rft.aufirst=Robert+M.&amp;rft.au=Stevens%2C+Errol+Wayne&amp;rft.au=Ponder%2C+Mary+Ann&amp;rft.au=Brockman%2C+Paul&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSHBR256-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR256_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR256_42-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR256_42-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. pp.&#160;2, 5 and 6. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=2%2C+5+and+6&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSindustry3-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSindustry3_43-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130608203946/http://www.indianahistory.org/teachers-students/plan-a-field-trip/The%20Pharmaceutical%20Industry%20in%20Indiana.pdf">"The Pharmaceutical Industry in Indiana"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: Indiana Historical Society. p.&#160;3. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/teachers-students/plan-a-field-trip/The%20Pharmaceutical%20Industry%20in%20Indiana.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 8 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Pharmaceutical+Industry+in+Indiana&amp;rft.place=Indianapolis&amp;rft.pages=3&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Fteachers-students%2Fplan-a-field-trip%2FThe%2520Pharmaceutical%2520Industry%2520in%2520Indiana.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 30.</span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTaylor" class="citation book cs1">Taylor; et&#160;al. <i>Indiana: A New Historical Guide</i>. p.&#160;481.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana%3A+A+New+Historical+Guide&amp;rft.pages=481&amp;rft.au=Taylor&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-SHAARD-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-SHAARD_46-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://secure.in.gov/apps/dnr/shaard/welcome.html">"Indiana State Historic Architectural and Archaeological Research Database (SHAARD)"</a> <span class="cs1-format">(Searchable database)</span>. Department of Natural Resources, Division of Historic Preservation and Archaeology. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20181123193539/https://secure.in.gov/apps/dnr/shaard/welcome.html">Archived</a> from the original on 23 November 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">1 April</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Indiana+State+Historic+Architectural+and+Archaeological+Research+Database+%28SHAARD%29&amp;rft.pub=Department+of+Natural+Resources%2C+Division+of+Historic+Preservation+and+Archaeology&amp;rft_id=https%3A%2F%2Fsecure.in.gov%2Fapps%2Fdnr%2Fshaard%2Fwelcome.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span> <i>Note:</i> This includes <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFEugene_F._Rodman1976" class="citation web cs1">Eugene F. Rodman (April 1976). <a rel="nofollow" class="external text" href="https://secure.in.gov/apps/dnr/shaard/r/1b3be/N/Lilly_Biological_Labs_Hancock_CO_Nom.pdf">"National Register of Historic Places Inventory Nomination Form: Lilly Biological Laboratories"</a> <span class="cs1-format">(PDF)</span>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170228165733/https://secure.in.gov/apps/dnr/shaard/r/1b3be/N/Lilly_Biological_Labs_Hancock_CO_Nom.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 28 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">1 April</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=National+Register+of+Historic+Places+Inventory+Nomination+Form%3A+Lilly+Biological+Laboratories&amp;rft.date=1976-04&amp;rft.au=Eugene+F.+Rodman&amp;rft_id=https%3A%2F%2Fsecure.in.gov%2Fapps%2Fdnr%2Fshaard%2Fr%2F1b3be%2FN%2FLilly_Biological_Labs_Hancock_CO_Nom.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span> and Accompanying photographs.</span>
</li>
<li id="cite_note-MadisonM73-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-MadisonM73_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MadisonM73_47-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MadisonM73_47-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Madison, "Manufacturing Pharmaceuticals," <i>Business and Economic History</i>, p. 73.</span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 29.</span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 46.</span>
</li>
<li id="cite_note-MadisonM74-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-MadisonM74_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MadisonM74_50-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Madison, "Manufacturing Pharmaceuticals," <i>Business and Economic History</i>, p. 74.</span>
</li>
<li id="cite_note-MadisonM76-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-MadisonM76_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MadisonM76_51-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MadisonM76_51-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 76.</span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBliss1984" class="citation book cs1">Bliss, Michael (1984). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=7uhtHQAACAAJ"><i>The Discovery of Insulin</i></a>. University of Chicago Press. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780226058986" title="Special:BookSources/9780226058986"><bdi>9780226058986</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022704/https://books.google.com/books?id=7uhtHQAACAAJ">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">28 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Discovery+of+Insulin&amp;rft.pub=University+of+Chicago+Press&amp;rft.date=1984&amp;rft.isbn=9780226058986&amp;rft.aulast=Bliss&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D7uhtHQAACAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFRutty" class="citation web cs1">Rutty, Christopher J. <a rel="nofollow" class="external text" href="http://connaught.research.utoronto.ca/history/article3/">"Connaught Laboratories &amp; The Making of Insulin"</a>. <i>Connaught Fund</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190628233926/http://connaught.research.utoronto.ca/history/article3/">Archived</a> from the original on 28 June 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">20 June</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Connaught+Fund&amp;rft.atitle=Connaught+Laboratories+%26+The+Making+of+Insulin&amp;rft.aulast=Rutty&amp;rft.aufirst=Christopher+J.&amp;rft_id=http%3A%2F%2Fconnaught.research.utoronto.ca%2Fhistory%2Farticle3%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 55&#8211;57.</span>
</li>
<li id="cite_note-Roberts-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-Roberts_55-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFRoberts2015" class="citation journal cs1">Roberts, Jacob (2015). <a rel="nofollow" class="external text" href="https://www.sciencehistory.org/distillations/magazine/sickening-sweet">"Sickening sweet"</a>. <i>Distillations</i>. <b>1</b> (4): <span class="nowrap">12–</span>15. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20191113141421/https://www.sciencehistory.org/distillations/magazine/sickening-sweet">Archived</a> from the original on 13 November 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Distillations&amp;rft.atitle=Sickening+sweet&amp;rft.volume=1&amp;rft.issue=4&amp;rft.pages=12-15&amp;rft.date=2015&amp;rft.aulast=Roberts&amp;rft.aufirst=Jacob&amp;rft_id=https%3A%2F%2Fwww.sciencehistory.org%2Fdistillations%2Fmagazine%2Fsickening-sweet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-MLilly61-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-MLilly61_56-0">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 61.</span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBliss1984" class="citation book cs1">Bliss, Michael (1984). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=7uhtHQAACAAJ"><i>The Discovery of Insulin</i></a>. University of Chicago Press. pp.&#160;<span class="nowrap">174–</span>175. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780226058986" title="Special:BookSources/9780226058986"><bdi>9780226058986</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220128071854/https://books.google.com/books?id=7uhtHQAACAAJ">Archived</a> from the original on 28 January 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">28 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Discovery+of+Insulin&amp;rft.pages=174-175&amp;rft.pub=University+of+Chicago+Press&amp;rft.date=1984&amp;rft.isbn=9780226058986&amp;rft.aulast=Bliss&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D7uhtHQAACAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHutchison1924" class="citation web cs1">Hutchison, F. Lorne (18 October 1924). <a rel="nofollow" class="external text" href="https://insulin.library.utoronto.ca/islandora/object/insulin%3AW10044">"Notes on the history of the Insulin Committee's objection to Lilly's use of the term Iletin"</a>. <i>University of Toronto Libraries</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190620180057/https://insulin.library.utoronto.ca/islandora/object/insulin:W10044">Archived</a> from the original on 20 June 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">20 June</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=University+of+Toronto+Libraries&amp;rft.atitle=Notes+on+the+history+of+the+Insulin+Committee%27s+objection+to+Lilly%27s+use+of+the+term+Iletin&amp;rft.date=1924-10-18&amp;rft.aulast=Hutchison&amp;rft.aufirst=F.+Lorne&amp;rft_id=https%3A%2F%2Finsulin.library.utoronto.ca%2Fislandora%2Fobject%2Finsulin%253AW10044&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://insulin.library.utoronto.ca/islandora/object/insulin%3AT10091">"Insulin wins a great prize"</a>. <i>University of Toronto Libraries</i>. New York, NY: Literary Digest. 8 December 1923. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190620180101/https://insulin.library.utoronto.ca/islandora/object/insulin:T10091">Archived</a> from the original on 20 June 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">20 June</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=University+of+Toronto+Libraries&amp;rft.atitle=Insulin+wins+a+great+prize&amp;rft.date=1923-12-08&amp;rft_id=https%3A%2F%2Finsulin.library.utoronto.ca%2Fislandora%2Fobject%2Finsulin%253AT10091&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://insulin.library.utoronto.ca/islandora/object/insulin%3AA10013">"Citation to F. G. Banting and J. J. R. Macleod accompanying the Nobel Prize"</a>. <i>University of Toronto Libraries</i>. Stockholm, Sweden: Royal Karolinska Institute. 1923. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190530192615/https://insulin.library.utoronto.ca/islandora/object/insulin%3AA10013">Archived</a> from the original on 30 May 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">20 June</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=University+of+Toronto+Libraries&amp;rft.atitle=Citation+to+F.+G.+Banting+and+J.+J.+R.+Macleod+accompanying+the+Nobel+Prize&amp;rft.date=1923&amp;rft_id=https%3A%2F%2Finsulin.library.utoronto.ca%2Fislandora%2Fobject%2Finsulin%253AA10013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBliss1984" class="citation book cs1">Bliss, Michael (1984). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=7uhtHQAACAAJ"><i>The Discovery of Insulin</i></a>. University of Chicago Press. p.&#160;181. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780226058986" title="Special:BookSources/9780226058986"><bdi>9780226058986</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220128071854/https://books.google.com/books?id=7uhtHQAACAAJ">Archived</a> from the original on 28 January 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">28 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Discovery+of+Insulin&amp;rft.pages=181&amp;rft.pub=University+of+Chicago+Press&amp;rft.date=1984&amp;rft.isbn=9780226058986&amp;rft.aulast=Bliss&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D7uhtHQAACAAJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 66&#8211;67.</span>
</li>
<li id="cite_note-MLilly67-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-MLilly67_63-0">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 67.</span>
</li>
<li id="cite_note-MLilly111-64"><span class="mw-cite-backlink">^ <a href="#cite_ref-MLilly111_64-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MLilly111_64-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MLilly111_64-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MLilly111_64-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 111.</span>
</li>
<li id="cite_note-IHSHBR5-65"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR5_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR5_65-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR5_65-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: Indiana Historical Society. p.&#160;5. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.place=Indianapolis&amp;rft.pages=5&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 28&#8211;34.</span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 62&#8211;65.</span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 91.</span>
</li>
<li id="cite_note-Madison,_Eli_Lilly,_p._105-69"><span class="mw-cite-backlink">^ <a href="#cite_ref-Madison,_Eli_Lilly,_p._105_69-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Madison,_Eli_Lilly,_p._105_69-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 105.</span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 65 and 106.</span>
</li>
<li id="cite_note-MLilly65-71"><span class="mw-cite-backlink">^ <a href="#cite_ref-MLilly65_71-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MLilly65_71-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MLilly65_71-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMadison1989" class="citation book cs1">Madison, James H. (1989). <a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi/page/65"><i>Eli Lilly: A Life, 1885&#8211;1977</i></a>. Indianapolis: Indiana Historical Society. p.&#160;<a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi/page/65">65</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-87195-047-5" title="Special:BookSources/978-0-87195-047-5"><bdi>978-0-87195-047-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Eli+Lilly%3A+A+Life%2C+1885%26ndash%3B1977&amp;rft.place=Indianapolis&amp;rft.pages=65&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-047-5&amp;rft.aulast=Madison&amp;rft.aufirst=James+H.&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Felilillylife188500madi%2Fpage%2F65&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 107&#8211;8.</span>
</li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 110.</span>
</li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 91, 119&#8211;20.</span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 120 and 249.</span>
</li>
<li id="cite_note-b541-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-b541_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-b541_76-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Bodenhamer and Barrows, p. 541.</span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFNicolaouRigol2018" class="citation journal cs1">Nicolaou, Kyriacos C.; Rigol, Stephan (1 February 2018). <a rel="nofollow" class="external text" href="https://www.nature.com/articles/ja201762">"A brief history of antibiotics and select advances in their synthesis"</a>. <i>The Journal of Antibiotics</i>. <b>71</b> (2): <span class="nowrap">153–</span>184. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fja.2017.62">10.1038/ja.2017.62</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/1881-1469">1881-1469</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28676714">28676714</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Antibiotics&amp;rft.atitle=A+brief+history+of+antibiotics+and+select+advances+in+their+synthesis&amp;rft.volume=71&amp;rft.issue=2&amp;rft.pages=153-184&amp;rft.date=2018-02-01&amp;rft.issn=1881-1469&amp;rft_id=info%3Apmid%2F28676714&amp;rft_id=info%3Adoi%2F10.1038%2Fja.2017.62&amp;rft.aulast=Nicolaou&amp;rft.aufirst=Kyriacos+C.&amp;rft.au=Rigol%2C+Stephan&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fja201762&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text">Price, <i>Indiana Legends</i>, p. 61.</span>
</li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/1976/02/09/archives/eugene-n-beesley-dead-at-67-exchairman-of-eli-lilly-co.html">"Eugene N. Beesley Dead at 67;Ex-Chairman of Eli Lilly &amp;Co"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. 9 February 1976. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0362-4331">0362-4331</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022705/https://www.nytimes.com/1976/02/09/archives/eugene-n-beesley-dead-at-67-exchairman-of-eli-lilly-co.html">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">21 July</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Eugene+N.+Beesley+Dead+at+67%3BEx-Chairman+of+Eli+Lilly+%26Co.&amp;rft.date=1976-02-09&amp;rft.issn=0362-4331&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1976%2F02%2F09%2Farchives%2Feugene-n-beesley-dead-at-67-exchairman-of-eli-lilly-co.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSpolio5-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSpolio5_80-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130608203902/http://www.indianahistory.org/teachers-students/plan-a-field-trip/Polio%20and%20Lilly%20background%20essay.pdf">"Polio and Eli Lilly and Company"</a> <span class="cs1-format">(PDF)</span>. Indiana Historical Society. p.&#160;5. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/teachers-students/plan-a-field-trip/Polio%20and%20Lilly%20background%20essay.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 8 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Polio+and+Eli+Lilly+and+Company&amp;rft.pages=5&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Fteachers-students%2Fplan-a-field-trip%2FPolio%2520and%2520Lilly%2520background%2520essay.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSpolio6-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSpolio6_81-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130608203902/http://www.indianahistory.org/teachers-students/plan-a-field-trip/Polio%20and%20Lilly%20background%20essay.pdf">"Polio and Eli Lilly and Company"</a> <span class="cs1-format">(PDF)</span>. Indiana Historical Society. p.&#160;6. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/teachers-students/plan-a-field-trip/Polio%20and%20Lilly%20background%20essay.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 8 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Polio+and+Eli+Lilly+and+Company&amp;rft.pages=6&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Fteachers-students%2Fplan-a-field-trip%2FPolio%2520and%2520Lilly%2520background%2520essay.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSHBR6-82"><span class="mw-cite-backlink">^ <a href="#cite_ref-IHSHBR6_82-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IHSHBR6_82-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IHSHBR6_82-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indianapolis: Indiana Historical Society. p.&#160;6. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.place=Indianapolis&amp;rft.pages=6&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSHBR7-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR7_83-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p.&#160;7. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=7&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/1977/10/14/archives/eli-lilly-signs-agreement-to-acquire-ivac-corp.html">"Eli Lilly Signs Agreement To Acquire Ivac Corp"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. 14 October 1977. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180615053126/https://www.nytimes.com/1977/10/14/archives/eli-lilly-signs-agreement-to-acquire-ivac-corp.html">Archived</a> from the original on 15 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">17 August</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Eli+Lilly+Signs+Agreement+To+Acquire+Ivac+Corp.&amp;rft.date=1977-10-14&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1977%2F10%2F14%2Farchives%2Feli-lilly-signs-agreement-to-acquire-ivac-corp.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.latimes.com/archives/la-xpm-1997-05-16-fi-59266-story.html">"Dow to Buy Lilly's 40% Stake in Dow Elanco"</a>. <i><a href="/wiki/Los_Angeles_Times" title="Los Angeles Times">Los Angeles Times</a></i>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>. 16 May 1997. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022705/https://www.latimes.com/archives/la-xpm-1997-05-16-fi-59266-story.html">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">13 November</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Dow+to+Buy+Lilly%27s+40%25+Stake+in+Dow+Elanco&amp;rft.date=1997-05-16&amp;rft_id=https%3A%2F%2Fwww.latimes.com%2Farchives%2Fla-xpm-1997-05-16-fi-59266-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-KokomoTrib62893-86"><span class="mw-cite-backlink">^ <a href="#cite_ref-KokomoTrib62893_86-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-KokomoTrib62893_86-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-KokomoTrib62893_86-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAssociated_Press1993" class="citation news cs1">Associated Press (26 June 1993). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://www.newspapers.com/newspage/2578015/">"New Lilly Chief Doesn't Have Own 'Agenda'<span class="cs1-kern-right"></span>"</a></span>. <i><a href="/wiki/Kokomo_Tribune" title="Kokomo Tribune">Kokomo Tribune</a></i>. Kokomi, IN. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20151121142348/https://www.newspapers.com/newspage/2578015/">Archived</a> from the original on 21 November 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=New+Lilly+Chief+Doesn%27t+Have+Own+%27Agenda%27&amp;rft.date=1993-06-26&amp;rft.au=Associated+Press&amp;rft_id=https%3A%2F%2Fwww.newspapers.com%2Fnewspage%2F2578015%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-KokomoTrib62693-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-KokomoTrib62693_87-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAssociated_Press1993" class="citation news cs1">Associated Press (26 June 1993). "Eli Lilly CEO Resigns in Dispute". <i>Kokomo Tribune</i>. Kokomi, IN.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=Eli+Lilly+CEO+Resigns+in+Dispute&amp;rft.date=1993-06-26&amp;rft.au=Associated+Press&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSHBR89-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR89_88-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p.&#160;8 and 9. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=8+and+9&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSHBR8-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR8_89-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p.&#160;8. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=8&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-Kokomo73194-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kokomo73194_90-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFArmor1994" class="citation news cs1">Armor, Nancy (31 July 1994). "New Lilly Chief Nurtures Change". <i>Kokomo Tribune</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=New+Lilly+Chief+Nurtures+Change&amp;rft.date=1994-07-31&amp;rft.aulast=Armor&amp;rft.aufirst=Nancy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-Pollack-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pollack_91-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPollack2002" class="citation news cs1">Pollack, Andrew (21 September 2002). <span class="id-lock-subscription" title="Paid subscription required"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2002/09/21/business/eli-lilly-in-deal-for-the-rights-to-a-new-drug-for-diabetes.html">"Eli Lilly in Deal For the Rights To a New Drug For Diabetes"</a></span>. <i>The New York Times</i>. p.&#160;C1.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Eli+Lilly+in+Deal+For+the+Rights+To+a+New+Drug+For+Diabetes&amp;rft.pages=C1&amp;rft.date=2002-09-21&amp;rft.aulast=Pollack&amp;rft.aufirst=Andrew&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2002%2F09%2F21%2Fbusiness%2Feli-lilly-in-deal-for-the-rights-to-a-new-drug-for-diabetes.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.nytimes.com/2006/12/19/business/19drug.html">"Lilly Increases Offer for Icos; Shareholders' Vote Is Put Off"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. Associated Press. 19 December 2006. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130603003107/http://www.nytimes.com/2006/12/19/business/19drug.html">Archived</a> from the original on 3 June 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Lilly+Increases+Offer+for+Icos%3B+Shareholders%27+Vote+Is+Put+Off&amp;rft.date=2006-12-19&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F19%2Fbusiness%2F19drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTimmerman2007" class="citation news cs1">Timmerman, Luke (13 January 2007). <a rel="nofollow" class="external text" href="http://seattletimes.nwsource.com/html/businesstechnology/2003523029_icos13.html">"Reject Icos Offer, Holders of Shares Advised"</a>. <i><a href="/wiki/The_Seattle_Times" title="The Seattle Times">The Seattle Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110524140456/http://seattletimes.nwsource.com/html/businesstechnology/2003523029_icos13.html">Archived</a> from the original on 24 May 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Seattle+Times&amp;rft.atitle=Reject+Icos+Offer%2C+Holders+of+Shares+Advised&amp;rft.date=2007-01-13&amp;rft.aulast=Timmerman&amp;rft.aufirst=Luke&amp;rft_id=http%3A%2F%2Fseattletimes.nwsource.com%2Fhtml%2Fbusinesstechnology%2F2003523029_icos13.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-TimmermanProposed-94"><span class="mw-cite-backlink">^ <a href="#cite_ref-TimmermanProposed_94-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-TimmermanProposed_94-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTimmerman2006" class="citation news cs1">Timmerman, Luke (7 November 2006). <a rel="nofollow" class="external text" href="https://archive.seattletimes.com/archive/20061107/icos07/proposed-icos-sale-gets-more-criticism-payouts-for-execs-called-overkill">"Proposed Icos Sale Gets More Criticism: Payouts for Execs Called 'Overkill'<span class="cs1-kern-right"></span>"</a>. <i><a href="/wiki/The_Seattle_Times" title="The Seattle Times">The Seattle Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120612013230/http://community.seattletimes.nwsource.com/archive/?date=20061107&amp;slug=icos07">Archived</a> from the original on 12 June 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Seattle+Times&amp;rft.atitle=Proposed+Icos+Sale+Gets+More+Criticism%3A+Payouts+for+Execs+Called+%27Overkill%27&amp;rft.date=2006-11-07&amp;rft.aulast=Timmerman&amp;rft.aufirst=Luke&amp;rft_id=https%3A%2F%2Farchive.seattletimes.com%2Farchive%2F20061107%2Ficos07%2Fproposed-icos-sale-gets-more-criticism-payouts-for-execs-called-overkill&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFJames2007" class="citation news cs1">James, Andrea (26 January 2007). <a rel="nofollow" class="external text" href="http://www.seattlepi.com/business/301248_icos26.html">"Icos Voters Approve Buyout by Eli Lilly"</a>. <i><a href="/wiki/Seattle_Post-Intelligencer" title="Seattle Post-Intelligencer">Seattle Post-Intelligencer</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022705/https://www.seattlepi.com/business/article/Icos-voters-approve-buyout-by-Eli-Lilly-1226465.php">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seattle+Post-Intelligencer&amp;rft.atitle=Icos+Voters+Approve+Buyout+by+Eli+Lilly&amp;rft.date=2007-01-26&amp;rft.aulast=James&amp;rft.aufirst=Andrea&amp;rft_id=http%3A%2F%2Fwww.seattlepi.com%2Fbusiness%2F301248_icos26.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="http://seattletimes.nwsource.com/html/businesstechnology/2003547114_bizbriefs30.html">"Eli Lilly Completes Icos Takeover"</a>. <i><a href="/wiki/The_Seattle_Times" title="The Seattle Times">The Seattle Times</a></i>. 30 January 2007. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110524140502/http://seattletimes.nwsource.com/html/businesstechnology/2003547114_bizbriefs30.html">Archived</a> from the original on 24 May 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Seattle+Times&amp;rft.atitle=Eli+Lilly+Completes+Icos+Takeover&amp;rft.date=2007-01-30&amp;rft_id=http%3A%2F%2Fseattletimes.nwsource.com%2Fhtml%2Fbusinesstechnology%2F2003547114_bizbriefs30.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-Tartakoff-97"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tartakoff_97-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tartakoff_97-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTartakoff2007" class="citation news cs1">Tartakoff, Joseph (5 December 2007). <a rel="nofollow" class="external text" href="http://www.seattlepi.com/business/342288_icos05.html">"New Owner Will Invest $50&#160;Million in Icos Facility"</a>. <i><a href="/wiki/Seattle_Post-Intelligencer" title="Seattle Post-Intelligencer">Seattle Post-Intelligencer</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022706/https://www.seattlepi.com/business/article/New-owner-will-invest-50-million-in-Icos-facility-1257765.php">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seattle+Post-Intelligencer&amp;rft.atitle=New+Owner+Will+Invest+%2450+Million+in+Icos+Facility&amp;rft.date=2007-12-05&amp;rft.aulast=Tartakoff&amp;rft.aufirst=Joseph&amp;rft_id=http%3A%2F%2Fwww.seattlepi.com%2Fbusiness%2F342288_icos05.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTimmerman2006" class="citation news cs1">Timmerman, Luke (12 December 2006). <a rel="nofollow" class="external text" href="http://seattletimes.nwsource.com/html/businesstechnology/2003473217_icos12.html">"All Icos Workers Losing Their Jobs"</a>. <i><a href="/wiki/The_Seattle_Times" title="The Seattle Times">The Seattle Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110524140516/http://seattletimes.nwsource.com/html/businesstechnology/2003473217_icos12.html">Archived</a> from the original on 24 May 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">16 January</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Seattle+Times&amp;rft.atitle=All+Icos+Workers+Losing+Their+Jobs&amp;rft.date=2006-12-12&amp;rft.aulast=Timmerman&amp;rft.aufirst=Luke&amp;rft_id=http%3A%2F%2Fseattletimes.nwsource.com%2Fhtml%2Fbusinesstechnology%2F2003473217_icos12.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110828050559/http://medheadlines.com/2009/02/eli-lilly-gets-14b-fine-for-zyprexa-off-label-marketing/">"Eli Lilly Gets $1.4B Fine for Zyprexa Off-Label Marketing"</a>. <i>medheadlines.com</i>. Archived from <a rel="nofollow" class="external text" href="http://medheadlines.com/2009/02/eli-lilly-gets-14b-fine-for-zyprexa-off-label-marketing/">the original</a> on 28 August 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">30 August</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=medheadlines.com&amp;rft.atitle=Eli+Lilly+Gets+%241.4B+Fine+for+Zyprexa+Off-Label+Marketing&amp;rft_id=http%3A%2F%2Fmedheadlines.com%2F2009%2F02%2Feli-lilly-gets-14b-fine-for-zyprexa-off-label-marketing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMurphy2011" class="citation news cs1">Murphy, Tom (12 January 2011). "Lilly, Boehringer Collaborate on Diabetes Drugs". <i>Anderson Herald Bulletin</i>. Anderson, IN. p.&#160;A7.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Anderson+Herald+Bulletin&amp;rft.atitle=Lilly%2C+Boehringer+Collaborate+on+Diabetes+Drugs&amp;rft.pages=A7&amp;rft.date=2011-01-12&amp;rft.aulast=Murphy&amp;rft.aufirst=Tom&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSen2014" class="citation news cs1">Sen, Arnab (22 April 2014). Warrier, Gopakumar (ed.). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-novartis-divestiture-eli-lilly-idUSBREA3L08020140422">"Eli Lilly to buy Novartis' animal health unit for $5.4 billion"</a>. Reuters. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20151228154040/http://www.reuters.com/article/us-novartis-divestiture-eli-lilly-idUSBREA3L08020140422">Archived</a> from the original on 28 December 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Eli+Lilly+to+buy+Novartis%27+animal+health+unit+for+%245.4+billion&amp;rft.date=2014-04-22&amp;rft.aulast=Sen&amp;rft.aufirst=Arnab&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-novartis-divestiture-eli-lilly-idUSBREA3L08020140422&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBartz2014" class="citation news cs1">Bartz, Diane (22 December 2014). Benkoe, Jeffrey; Baum, Bernadette (eds.). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-lilly-novartis-deal-idUSKBN0K01HX20141222">"Lilly must divest Sentinel products after FTC nod on Novartis deal"</a>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220128103910/https://www.reuters.com/article/us-lilly-novartis-deal-idUSKBN0K01HX20141222">Archived</a> from the original on 28 January 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">5 July</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lilly+must+divest+Sentinel+products+after+FTC+nod+on+Novartis+deal&amp;rft.date=2014-12-22&amp;rft.aulast=Bartz&amp;rft.aufirst=Diane&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-lilly-novartis-deal-idUSKBN0K01HX20141222&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/eli-lilly-to-co-develop-hanmi-btk-inhibitor-for-up-to-690m/81251050/">"Eli Lilly to Co-Develop Hanmi BTK Inhibitor for Up-to-$690M"</a>. GEN News Highlights. <i><a href="/wiki/Mary_Ann_Liebert,_Inc." class="mw-redirect" title="Mary Ann Liebert, Inc.">Mary Ann Liebert, Inc.</a></i> 19 March 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mary+Ann+Liebert%2C+Inc.&amp;rft.atitle=Eli+Lilly+to+Co-Develop+Hanmi+BTK+Inhibitor+for+Up-to-%24690M&amp;rft.date=2015-03-19&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Feli-lilly-to-co-develop-hanmi-btk-inhibitor-for-up-to-690m%2F81251050%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/lilly-joins-innovent-in-up-to-456m-cancer-collaboration/81251053/">"Lilly Joins Innovent in Up-to-$456M+ Cancer Collaboration"</a>. GEN News Highlights. <i><a href="/wiki/Gen._Eng._Biotechnol._News" class="mw-redirect" title="Gen. Eng. Biotechnol. News">Genetic Engineering &amp; Biotechnology News</a></i>. 20 March 2015. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150423012331/http://www.genengnews.com/gen-news-highlights/lilly-joins-innovent-in-up-to-456m-cancer-collaboration/81251053">Archived</a> from the original on 23 April 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=Lilly+Joins+Innovent+in+Up-to-%24456M%2B+Cancer+Collaboration&amp;rft.date=2015-03-20&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Flilly-joins-innovent-in-up-to-456m-cancer-collaboration%2F81251053%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPhilippidis2015" class="citation news cs1">Philippidis, Alex (23 March 2015). <a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/pfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program/81251059/">"Pfizer, Lilly to Resume Phase III Tanezumab Clinical Program"</a>. GEN News Highlights. <i><a href="/wiki/Mary_Ann_Liebert,_Inc." class="mw-redirect" title="Mary Ann Liebert, Inc.">Mary Ann Liebert, Inc.</a></i> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20171114202440/https://www.genengnews.com/gen-news-highlights/pfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program/81251059/">Archived</a> from the original on 14 November 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">21 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mary+Ann+Liebert%2C+Inc.&amp;rft.atitle=Pfizer%2C+Lilly+to+Resume+Phase+III+Tanezumab+Clinical+Program&amp;rft.date=2015-03-23&amp;rft.aulast=Philippidis&amp;rft.aufirst=Alex&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fpfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program%2F81251059%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-plantsale2015-106"><span class="mw-cite-backlink">^ <a href="#cite_ref-plantsale2015_106-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-plantsale2015_106-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://archive.today/20150422022322/http://www.pharmpro.com/news/2015/04/eli-lilly-biomanufacturing-plant-sale">"Eli Lilly Biomanufacturing Plant For Sale"</a>. <i><a href="/wiki/Advantage_Business_Media" class="mw-redirect" title="Advantage Business Media">Advantage Business Media</a></i>. 21 April 2015. Archived from <a rel="nofollow" class="external text" href="http://www.pharmpro.com/news/2015/04/eli-lilly-biomanufacturing-plant-sale">the original</a> on 22 April 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advantage+Business+Media&amp;rft.atitle=Eli+Lilly+Biomanufacturing+Plant+For+Sale&amp;rft.date=2015-04-21&amp;rft_id=http%3A%2F%2Fwww.pharmpro.com%2Fnews%2F2015%2F04%2Feli-lilly-biomanufacturing-plant-sale&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/lilly-to-buy-colucid-for-960m-to-acquire-late-stage-migraine-drug/81253729">"Lilly to Buy CoLucid for $960M to Acquire Late-Stage Migraine Drug - GEN Genetic Engineering &amp; Biotechnology News - Biotech from Bench to Business - GEN"</a>. 18 January 2017. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170119045525/http://www.genengnews.com/gen-news-highlights/lilly-to-buy-colucid-for-960m-to-acquire-late-stage-migraine-drug/81253729">Archived</a> from the original on 19 January 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">18 January</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Buy+CoLucid+for+%24960M+to+Acquire+Late-Stage+Migraine+Drug+-+GEN+Genetic+Engineering+%26+Biotechnology+News+-+Biotech+from+Bench+to+Business+-+GEN&amp;rft.date=2017-01-18&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Flilly-to-buy-colucid-for-960m-to-acquire-late-stage-migraine-drug%2F81253729&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLewin2017" class="citation news cs1">Lewin, Matthew (28 August 2017). <a rel="nofollow" class="external text" href="https://www.bloomberg.com/press-releases/2017-08-28/ophirex-licenses-lilly-shionogi-data-for-novel-snakebite-treatment-development-program">"Ophirex Licenses Lilly - Shionogi Data for Novel Snakebite Treatment Development Program"</a>. <i><a href="/wiki/Bloomberg_L.P." title="Bloomberg L.P.">Bloomberg</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg&amp;rft.atitle=Ophirex+Licenses+Lilly+-+Shionogi+Data+for+Novel+Snakebite+Treatment+Development+Program&amp;rft.date=2017-08-28&amp;rft.aulast=Lewin&amp;rft.aufirst=Matthew&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fpress-releases%2F2017-08-28%2Fophirex-licenses-lilly-shionogi-data-for-novel-snakebite-treatment-development-program&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMishra2018" class="citation news cs1">Mishra, Manas (10 May 2018). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-armo-biosciences-m-a/lilly-to-buy-armo-biosciences-for-16-billion-to-bolster-cancer-pipeline-idUSKBN1IB1KV">"Lilly to buy Armo Biosciences for $1.6 billion to bolster cancer..."</a> Reuters. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180609084027/https://www.reuters.com/article/us-armo-biosciences-m-a/lilly-to-buy-armo-biosciences-for-16-billion-to-bolster-cancer-pipeline-idUSKBN1IB1KV">Archived</a> from the original on 9 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lilly+to+buy+Armo+Biosciences+for+%241.6+billion+to+bolster+cancer...&amp;rft.date=2018-05-10&amp;rft.aulast=Mishra&amp;rft.aufirst=Manas&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-armo-biosciences-m-a%2Flilly-to-buy-armo-biosciences-for-16-billion-to-bolster-cancer-pipeline-idUSKBN1IB1KV&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.genengnews.com/gen-news-highlights/lilly-continues-oncology-expansion-with-plans-to-buy-aurka-pharma-for-up-to-575m/81255814">"Lilly Continues Oncology Expansion with Plans to Buy AurKa Pharma for Up to $575M - GEN"</a>. <i>GEN</i>. 14 May 2018. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180612142655/https://www.genengnews.com/gen-news-highlights/lilly-continues-oncology-expansion-with-plans-to-buy-aurka-pharma-for-up-to-575m/81255814">Archived</a> from the original on 12 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Lilly+Continues+Oncology+Expansion+with+Plans+to+Buy+AurKa+Pharma+for+Up+to+%24575M+-+GEN&amp;rft.date=2018-05-14&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Flilly-continues-oncology-expansion-with-plans-to-buy-aurka-pharma-for-up-to-575m%2F81255814&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20180612143623/https://uk.reuters.com/article/us-aurka-pharma-m-a-lilly/lilly-to-buy-cancer-drug-developer-aurka-pharma-idUKKCN1IF1IE">"Lilly to buy cancer drug developer AurKa Pharma"</a>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>. 14 May 2018. Archived from <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/us-aurka-pharma-m-a-lilly/lilly-to-buy-cancer-drug-developer-aurka-pharma-idUKKCN1IF1IE">the original</a> on 12 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">8 June</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lilly+to+buy+cancer+drug+developer+AurKa+Pharma&amp;rft.date=2018-05-14&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-aurka-pharma-m-a-lilly%2Flilly-to-buy-cancer-drug-developer-aurka-pharma-idUKKCN1IF1IE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/-eli-lilly-buys-loxo-oncology-for-8-billion/?s=79">"Eli Lilly Deepens its Oncology Offerings with an $8 Billion Acquisition of Loxo Oncology"</a>. 7 January 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190108100829/https://www.biospace.com/article/-eli-lilly-buys-loxo-oncology-for-8-billion/?s=79">Archived</a> from the original on 8 January 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">7 January</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+Deepens+its+Oncology+Offerings+with+an+%248+Billion+Acquisition+of+Loxo+Oncology&amp;rft.date=2019-01-07&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2F-eli-lilly-buys-loxo-oncology-for-8-billion%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/releases/lilly-announces-agreement-to-acquire-loxo-oncology/?s=79">"Lilly Announces Agreement to Acquire Loxo Oncology"</a>. 7 January 2019. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190108100722/https://www.biospace.com/article/releases/lilly-announces-agreement-to-acquire-loxo-oncology/?s=79">Archived</a> from the original on 8 January 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">7 January</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Announces+Agreement+to+Acquire+Loxo+Oncology&amp;rft.date=2019-01-07&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Freleases%2Flilly-announces-agreement-to-acquire-loxo-oncology%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBurger2019" class="citation news cs1">Burger, Ludwig (20 August 2019). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-bayer-divestiture-elanco-animal/elanco-to-buy-bayers-animal-health-unit-for-7-6-billion-idUSKCN1VA0UI">"Elanco to buy Bayer's animal health unit for $7.6 billion"</a>. Reuters. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190820110943/https://www.reuters.com/article/us-bayer-divestiture-elanco-animal/elanco-to-buy-bayers-animal-health-unit-for-7-6-billion-idUSKCN1VA0UI">Archived</a> from the original on 20 August 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">20 August</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Elanco+to+buy+Bayer%27s+animal+health+unit+for+%247.6+billion&amp;rft.date=2019-08-20&amp;rft.aulast=Burger&amp;rft.aufirst=Ludwig&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-bayer-divestiture-elanco-animal%2Felanco-to-buy-bayers-animal-health-unit-for-7-6-billion-idUSKCN1VA0UI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20200730233157/https://uk.reuters.com/article/uk-bayer-divestiture-elanco-animal-idUKKCN1VA0UE">"Elanco to become No.2 in animal health with $7.6 billion Bayer deal"</a>. Reuters. 20 August 2019. Archived from <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/uk-bayer-divestiture-elanco-animal-idUKKCN1VA0UE">the original</a> on 30 July 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">17 July</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Elanco+to+become+No.2+in+animal+health+with+%247.6+billion+Bayer+deal&amp;rft.date=2019-08-20&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fuk-bayer-divestiture-elanco-animal-idUKKCN1VA0UE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/eupli-lilly-bags-dermatology-company-dermira-for-1-1-billion/">"Eli Lilly Bags Dermatology Company Dermira for $1.1 Billion"</a>. <i>BioSpace</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200717165433/https://www.biospace.com/article/eli-lilly-bags-dermatology-company-dermira-for-1-1-billion/">Archived</a> from the original on 17 July 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">17 July</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Eli+Lilly+Bags+Dermatology+Company+Dermira+for+%241.1+Billion&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Feupli-lilly-bags-dermatology-company-dermira-for-1-1-billion%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/lilly-announces-agreement-to-acquire-dermira/">"Lilly Announces Agreement to Acquire Dermira"</a>. <i>BioSpace</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200717164209/https://www.biospace.com/article/lilly-announces-agreement-to-acquire-dermira/">Archived</a> from the original on 17 July 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">17 July</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Lilly+Announces+Agreement+to+Acquire+Dermira&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Flilly-announces-agreement-to-acquire-dermira%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/lilly-completes-acquisition-of-dermira/">"Lilly Completes Acquisition of Dermira"</a>. <i>BioSpace</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200303085838/https://www.biospace.com/article/lilly-completes-acquisition-of-dermira/">Archived</a> from the original on 3 March 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Lilly+Completes+Acquisition+of+Dermira&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Flilly-completes-acquisition-of-dermira%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://investor.lilly.com/news-releases/news-release-details/lilly-begins-worlds-first-study-potential-covid-19-antibody">"Lilly Begins World's First Study of a Potential COVID-19 Antibody Treatment in Humans"</a>. Lilly. 1 June 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200604003428/https://investor.lilly.com/news-releases/news-release-details/lilly-begins-worlds-first-study-potential-covid-19-antibody">Archived</a> from the original on 4 June 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">4 June</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lilly+Begins+World%27s+First+Study+of+a+Potential+COVID-19+Antibody+Treatment+in+Humans&amp;rft.date=2020-06-01&amp;rft_id=https%3A%2F%2Finvestor.lilly.com%2Fnews-releases%2Fnews-release-details%2Flilly-begins-worlds-first-study-potential-covid-19-antibody&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ourcommons.ca/DocumentViewer/en/43-2/CIIT/meeting-25/evidence">"Evidence - CIIT (43-2) - No. 25"</a>. <i><a href="/wiki/House_of_Commons_of_Canada" title="House of Commons of Canada">House of Commons of Canada</a></i>. 23 April 2021. <a rel="nofollow" class="external text" href="https://archive.today/20220308002228/https://www.ourcommons.ca/DocumentViewer/en/43-2/CIIT/meeting-25/evidence">Archived</a> from the original on 8 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=House+of+Commons+of+Canada&amp;rft.atitle=Evidence+-+CIIT+%2843-2%29+-+No.+25&amp;rft.date=2021-04-23&amp;rft_id=https%3A%2F%2Fwww.ourcommons.ca%2FDocumentViewer%2Fen%2F43-2%2FCIIT%2Fmeeting-25%2Fevidence&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTaylor2020" class="citation web cs1">Taylor, Mark (17 September 2020). <a rel="nofollow" class="external text" href="https://www.amgen.com/newsroom/press-releases/2020/09/lilly-and-amgen-announce-manufacturing-collaboration-for-covid-19-antibody-therapies">"Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies"</a>. <i><a href="/wiki/Amgen" title="Amgen">Amgen</a></i>. <a rel="nofollow" class="external text" href="https://archive.today/20220112213722/https://www.amgen.com/newsroom/press-releases/2020/09/lilly-and-amgen-announce-manufacturing-collaboration-for-covid-19-antibody-therapies">Archived</a> from the original on 12 January 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Amgen&amp;rft.atitle=Lilly+and+Amgen+Announce+Manufacturing+Collaboration+for+COVID-19+Antibody+Therapies&amp;rft.date=2020-09-17&amp;rft.aulast=Taylor&amp;rft.aufirst=Mark&amp;rft_id=https%3A%2F%2Fwww.amgen.com%2Fnewsroom%2Fpress-releases%2F2020%2F09%2Flilly-and-amgen-announce-manufacturing-collaboration-for-covid-19-antibody-therapies&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHerper2020" class="citation web cs1">Herper, Matthew (7 October 2020). <a rel="nofollow" class="external text" href="https://www.statnews.com/2020/10/07/eli-lilly-monoclonal-antibody-cocktail-covid-19/">"Eli Lilly says its monoclonal antibody cocktail is effective against Covid-19"</a>. <i><a href="/wiki/Stat_(website)" title="Stat (website)">Stat News</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201008001230/https://www.statnews.com/2020/10/07/eli-lilly-monoclonal-antibody-cocktail-covid-19/">Archived</a> from the original on 8 October 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">8 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Stat+News&amp;rft.atitle=Eli+Lilly+says+its+monoclonal+antibody+cocktail+is+effective+against+Covid-19&amp;rft.date=2020-10-07&amp;rft.aulast=Herper&amp;rft.aufirst=Matthew&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F10%2F07%2Feli-lilly-monoclonal-antibody-cocktail-covid-19%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFThomas2020" class="citation news cs1">Thomas, Katie (8 October 2020). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2020/10/07/health/trump-covid-regeneron.html">"Regeneron Asks F.D.A. for Emergency Approval for Drug That Trump C7laimed Cured Him"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0362-4331">0362-4331</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20201008020031/https://www.nytimes.com/2020/10/07/health/trump-covid-regeneron.html">Archived</a> from the original on 8 October 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">8 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Regeneron+Asks+F.D.A.+for+Emergency+Approval+for+Drug+That+Trump+C7laimed+Cured+Him&amp;rft.date=2020-10-08&amp;rft.issn=0362-4331&amp;rft.aulast=Thomas&amp;rft.aufirst=Katie&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F10%2F07%2Fhealth%2Ftrump-covid-regeneron.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/lilly-announces-agreement-to-acquire-disarm-therapeutics/">"Lilly Announces Agreement to Acquire Disarm Therapeutics"</a>. <i>BioSpace</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210508172309/https://www.biospace.com/article/lilly-announces-agreement-to-acquire-disarm-therapeutics/">Archived</a> from the original on 8 May 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">8 May</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioSpace&amp;rft.atitle=Lilly+Announces+Agreement+to+Acquire+Disarm+Therapeutics&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Flilly-announces-agreement-to-acquire-disarm-therapeutics%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-Lilly_20201016-125"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lilly_20201016_125-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lilly_20201016_125-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.lilly.com/news/stories/statement-activ3-clinical-trial-nih-covid19">"Lilly Statement Regarding NIH's ACTIV-3 Clinical Trial"</a>. <i>Eli Lilly and Company</i> (Press release). 26 October 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210116153319/https://www.lilly.com/news/stories/statement-activ3-clinical-trial-nih-covid19">Archived</a> from the original on 16 January 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">26 October</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Statement+Regarding+NIH%27s+ACTIV-3+Clinical+Trial&amp;rft.date=2020-10-26&amp;rft_id=https%3A%2F%2Fwww.lilly.com%2Fnews%2Fstories%2Fstatement-activ3-clinical-trial-nih-covid19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFRizkForthalKalantar-ZadehMehra2020" class="citation journal cs1">Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; et&#160;al. (November 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694556">"Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic"</a>. <i>Drug Discovery Today</i>. <b>26</b> (2): <span class="nowrap">593–</span>603. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.drudis.2020.11.025">10.1016/j.drudis.2020.11.025</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694556">7694556</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33253920">33253920</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drug+Discovery+Today&amp;rft.atitle=Expanded+Access+Programs%2C+compassionate+drug+use%2C+and+Emergency+Use+Authorizations+during+the+COVID-19+pandemic.&amp;rft.volume=26&amp;rft.issue=2&amp;rft.pages=593-603&amp;rft.date=2020-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7694556%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33253920&amp;rft_id=info%3Adoi%2F10.1016%2Fj.drudis.2020.11.025&amp;rft.aulast=Rizk&amp;rft.aufirst=John+G.&amp;rft.au=Forthal%2C+Donald+N.&amp;rft.au=Kalantar-Zadeh%2C+Kamyar&amp;rft.au=Mehra%2C+Mandeep+R.&amp;rft.au=Lavie%2C+Carl+J.&amp;rft.au=Rizk%2C+Youssef&amp;rft.au=Pfeiffer%2C+JoAnn+P.&amp;rft.au=Lewin%2C+John+C.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7694556&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-FDA_bamlanivimab_EUA-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA_bamlanivimab_EUA_127-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19">"Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i> (Press release). 9 November 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210111094724/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19">Archived</a> from the original on 11 January 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">9 November</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus+%28COVID-19%29+Update%3A+FDA+Authorizes+Monoclonal+Antibody+for+Treatment+of+COVID-19&amp;rft.date=2020-11-09&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Fcoronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span> <span class="noviewer" typeof="mw:File"><span><img alt="Public Domain" src="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/20px-PD-icon.svg.png" decoding="async" width="12" height="12" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/40px-PD-icon.svg.png 2x" data-file-width="196" data-file-height="196" /></span></span> This article incorporates text from this source, which is in the <a href="/wiki/Public_domain" title="Public domain">public domain</a>.</span>
</li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20201216115007/https://uk.reuters.com/article/prevail-m-a-lilly/eli-lilly-to-buy-gene-therapy-developer-prevail-in-about-1-billion-deal-idUKKBN28P1CU">"Eli Lilly to buy gene therapy developer Prevail in about $1 billion deal"</a>. Reuters. 15 December 2020. Archived from <a rel="nofollow" class="external text" href="https://uk.reuters.com/article/prevail-m-a-lilly/eli-lilly-to-buy-gene-therapy-developer-prevail-in-about-1-billion-deal-idUKKBN28P1CU">the original</a> on 16 December 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">15 December</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+to+buy+gene+therapy+developer+Prevail+in+about+%241+billion+deal&amp;rft.pub=Reuters&amp;rft.date=2020-12-15&amp;rft_id=https%3A%2F%2Fuk.reuters.com%2Farticle%2Fprevail-m-a-lilly%2Feli-lilly-to-buy-gene-therapy-developer-prevail-in-about-1-billion-deal-idUKKBN28P1CU&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-FDA_PR_20210416-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA_PR_20210416_129-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab">"Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab"</a>. <i>U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA)</i> (Press release). 16 April 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210416204530/https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab">Archived</a> from the original on 16 April 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">16 April</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Coronavirus+%28COVID-19%29+Update%3A+FDA+Revokes+Emergency+Use+Authorization+for+Monoclonal+Antibody+Bamlanivimab&amp;rft.date=2021-04-16&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Fcoronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span> <span class="noviewer" typeof="mw:File"><span><img alt="Public Domain" src="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/20px-PD-icon.svg.png" decoding="async" width="12" height="12" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/6/62/PD-icon.svg/40px-PD-icon.svg.png 2x" data-file-width="196" data-file-height="196" /></span></span> This article incorporates text from this source, which is in the <a href="/wiki/Public_domain" title="Public domain">public domain</a>.</span>
</li>
<li id="cite_note-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-130">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/fda-sets-countdown-to-lilly-innovent-s-pd-1-front-line-lung-cancer-what-to-expect">"Lilly, Innovent's Tyvyt nabs FDA review in front-line lung cancer. Could price pressure finally reach the PD-1/L1 class?"</a>. <i>Fierce Pharma</i>. 18 May 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210820161014/https://www.fiercepharma.com/pharma/fda-sets-countdown-to-lilly-innovent-s-pd-1-front-line-lung-cancer-what-to-expect">Archived</a> from the original on 20 August 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">23 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fierce+Pharma&amp;rft.atitle=Lilly%2C+Innovent%27s+Tyvyt+nabs+FDA+review+in+front-line+lung+cancer.+Could+price+pressure+finally+reach+the+PD-1%2FL1+class%3F&amp;rft.date=2021-05-18&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Ffda-sets-countdown-to-lilly-innovent-s-pd-1-front-line-lung-cancer-what-to-expect&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/releases/lilly-announces-acquisition-of-protomer-technologies/?s=79">"Lilly Announces Acquisition of Protomer Technologies"</a>. 14 July 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210717201444/https://www.biospace.com/article/releases/lilly-announces-acquisition-of-protomer-technologies/?s=79">Archived</a> from the original on 17 July 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">17 July</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Announces+Acquisition+of+Protomer+Technologies&amp;rft.date=2021-07-14&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Freleases%2Flilly-announces-acquisition-of-protomer-technologies%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-132">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biopharmadive.com/news/covid-antibody-pause-distribution-omicron-lilly-regeneron/616555/">"US pauses distribution of Regeneron, Lilly antibodies over omicron concerns"</a>. <i>BioPharma Dive</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220118212153/https://www.biopharmadive.com/news/covid-antibody-pause-distribution-omicron-lilly-regeneron/616555/">Archived</a> from the original on 18 January 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">18 January</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioPharma+Dive&amp;rft.atitle=US+pauses+distribution+of+Regeneron%2C+Lilly+antibodies+over+omicron+concerns&amp;rft_id=https%3A%2F%2Fwww.biopharmadive.com%2Fnews%2Fcovid-antibody-pause-distribution-omicron-lilly-regeneron%2F616555%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-133">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTong2022" class="citation web cs1">Tong, Amber (14 February 2022). <a rel="nofollow" class="external text" href="https://endpts.com/as-omicron-rages-fda-clears-eli-lilly-abcelleras-new-antibody-days-after-720m-supply-deal/">"As Omicron rages, FDA clears Eli Lilly/AbCellera's new antibody days after $720M supply deal"</a>. <i>Endpoints News</i>. <a rel="nofollow" class="external text" href="https://archive.today/20220215130659/https://endpts.com/as-omicron-rages-fda-clears-eli-lilly-abcelleras-new-antibody-days-after-720m-supply-deal/">Archived</a> from the original on 15 February 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Endpoints+News&amp;rft.atitle=As+Omicron+rages%2C+FDA+clears+Eli+Lilly%2FAbCellera%27s+new+antibody+days+after+%24720M+supply+deal&amp;rft.date=2022-02-14&amp;rft.aulast=Tong&amp;rft.aufirst=Amber&amp;rft_id=https%3A%2F%2Fendpts.com%2Fas-omicron-rages-fda-clears-eli-lilly-abcelleras-new-antibody-days-after-720m-supply-deal%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-134">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKelley2022" class="citation news cs1">Kelley, Lora (6 August 2022). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2022/08/06/business/indiana-companies-abortion.html">"Major Indiana Employers Criticize State's New Abortion Law"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0362-4331">0362-4331</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220807201745/https://www.nytimes.com/2022/08/06/business/indiana-companies-abortion.html">Archived</a> from the original on 7 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">7 August</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Major+Indiana+Employers+Criticize+State%27s+New+Abortion+Law&amp;rft.date=2022-08-06&amp;rft.issn=0362-4331&amp;rft.aulast=Kelley&amp;rft.aufirst=Lora&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2022%2F08%2F06%2Fbusiness%2Findiana-companies-abortion.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-135">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20221019114001/https://www.reuters.com/markets/deals/eli-lilly-buy-genetic-medicine-developer-akouos-487-million-2022-10-18/">"Eli Lilly to buy gene therapy company Akouos for $487 mln"</a>. <a href="/wiki/Reuters" title="Reuters">Reuters</a>. 18 October 2022. Archived from <a rel="nofollow" class="external text" href="https://www.reuters.com/markets/deals/eli-lilly-buy-genetic-medicine-developer-akouos-487-million-2022-10-18/">the original</a> on 19 October 2022.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+to+buy+gene+therapy+company+Akouos+for+%24487+mln&amp;rft.pub=Reuters&amp;rft.date=2022-10-18&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fmarkets%2Fdeals%2Feli-lilly-buy-genetic-medicine-developer-akouos-487-million-2022-10-18%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/lilly-continues-foray-into-gene-therapies-with-487m-akouos-buyout/?s=79">"Lilly Continues Foray into Gene Therapies with $487M Akouos Buyout &#124; BioSpace"</a>. 18 October 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221020051503/https://www.biospace.com/article/lilly-continues-foray-into-gene-therapies-with-487m-akouos-buyout/?s=79">Archived</a> from the original on 20 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">19 October</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+Continues+Foray+into+Gene+Therapies+with+%24487M+Akouos+Buyout+%26%23124%3B+BioSpace&amp;rft.date=2022-10-18&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Flilly-continues-foray-into-gene-therapies-with-487m-akouos-buyout%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.congress.gov/event/118th-congress/senate-event/LC72553/text">"S.Hrg. 118-198 The Need to Make Insulin Affordable for All Americans"</a>. 10 May 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">18 February</span> 2025</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=S.Hrg.+118-198+The+Need+to+Make+Insulin+Affordable+for+All+Americans&amp;rft.date=2023-05-10&amp;rft_id=https%3A%2F%2Fwww.congress.gov%2Fevent%2F118th-congress%2Fsenate-event%2FLC72553%2Ftext&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://scrip.pharmaintelligence.informa.com/SC147648/Deal-Watch-AbbVie-Leads-JP-Morgan-Deal-Rush-But-BI-Genentech-And-Lilly-Also-Big-Players">"Deal Watch: AbbVie Leads J.P. Morgan Deal Rush, But BI, Genentech And Lilly Also Big Players"</a>. <i>Script</i>. 11 January 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">18 June</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Script&amp;rft.atitle=Deal+Watch%3A+AbbVie+Leads+J.P.+Morgan+Deal+Rush%2C+But+BI%2C+Genentech+And+Lilly+Also+Big+Players&amp;rft.date=2023-01-11&amp;rft_id=https%3A%2F%2Fscrip.pharmaintelligence.informa.com%2FSC147648%2FDeal-Watch-AbbVie-Leads-JP-Morgan-Deal-Rush-But-BI-Genentech-And-Lilly-Also-Big-Players&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://trex.bio/trexbio-announces-collaboration-and-license-agreement-with-lilly/">"TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases"</a>. <i>TRex Bio</i>. 9 January 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">18 June</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=TRex+Bio&amp;rft.atitle=TRexBio+Announces+Collaboration+and+License+Agreement+with+Lilly+to+Develop+and+Commercialize+Novel+Therapies+for+Immune-Mediated+Diseases&amp;rft.date=2023-01-09&amp;rft_id=https%3A%2F%2Ftrex.bio%2Ftrexbio-announces-collaboration-and-license-agreement-with-lilly%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/lilly-to-buy-european-adc-player-emergence-therapeutics/?s=79">"Lilly to Buy European ADC Player Emergence Therapeutics"</a>. 30 June 2023.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Buy+European+ADC+Player+Emergence+Therapeutics&amp;rft.date=2023-06-30&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Flilly-to-buy-european-adc-player-emergence-therapeutics%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-141">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biospace.com/article/lilly-to-buy-diabetes-cell-therapy-partner-sigilon-for-300m-/?s=79">"Lilly to Buy Diabetes Cell Therapy Partner Sigilon for Just over $300M"</a>. 29 June 2023.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Buy+Diabetes+Cell+Therapy+Partner+Sigilon+for+Just+over+%24300M&amp;rft.date=2023-06-29&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Flilly-to-buy-diabetes-cell-therapy-partner-sigilon-for-300m-%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGardner2022" class="citation news cs1">Gardner, Jonathan (14 December 2022). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221215030605/https://www.biopharmadive.com/news/lilly-2023-guidance-diabetes-obesity/638733/">"Lilly lays out ambitious plans for 2023"</a>. <i>BiopharmaDive</i>. Archived from <a rel="nofollow" class="external text" href="https://www.biopharmadive.com/news/lilly-2023-guidance-diabetes-obesity/638733/">the original</a> on 15 December 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">14 December</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BiopharmaDive&amp;rft.atitle=Lilly+lays+out+ambitious+plans+for+2023&amp;rft.date=2022-12-14&amp;rft.aulast=Gardner&amp;rft.aufirst=Jonathan&amp;rft_id=https%3A%2F%2Fwww.biopharmadive.com%2Fnews%2Flilly-2023-guidance-diabetes-obesity%2F638733%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFConstantino2023" class="citation web cs1">Constantino, Annika Kim (14 July 2023). <a rel="nofollow" class="external text" href="https://www.cnbc.com/2023/07/14/eli-lilly-to-acquire-obesity-drug-maker-versanis-for-1point9-billion.html">"Obesity drug maker Versanis to be bought by Eli Lilly for $1.9 billion"</a>. <i>CNBC</i><span class="reference-accessdate">. Retrieved <span class="nowrap">14 July</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNBC&amp;rft.atitle=Obesity+drug+maker+Versanis+to+be+bought+by+Eli+Lilly+for+%241.9+billion&amp;rft.date=2023-07-14&amp;rft.aulast=Constantino&amp;rft.aufirst=Annika+Kim&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2F2023%2F07%2F14%2Feli-lilly-to-acquire-obesity-drug-maker-versanis-for-1point9-billion.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-144">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.reuters.com/markets/deals/eli-lilly-buy-point-biopharma-14-billion-2023-10-03/">"Eli Lilly to buy cancer-focused Point Biopharma for $1.4 billion"</a>. Reuters. 3 October 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">3 October</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Eli+Lilly+to+buy+cancer-focused+Point+Biopharma+for+%241.4+billion&amp;rft.date=2023-10-03&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fmarkets%2Fdeals%2Feli-lilly-buy-point-biopharma-14-billion-2023-10-03%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management">"FDA Approves New Medication for Chronic Weight Management"</a>. <i>FDA</i>. 3 November 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">7 April</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FDA&amp;rft.atitle=FDA+Approves+New+Medication+for+Chronic+Weight+Management&amp;rft.date=2023-11-03&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-approves-new-medication-chronic-weight-management&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-146"><span class="mw-cite-backlink"><b><a href="#cite_ref-146">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFDattiloNathan-Kazis2024" class="citation news cs1">Dattilo, Emily; Nathan-Kazis, Josh (13 March 2024). <a rel="nofollow" class="external text" href="https://www.barrons.com/articles/eli-lilly-amazon-weight-loss-drug-e064a274?mod=RTA">"Amazon Will Now Deliver Eli Lilly Weight-Loss Drug Zepbound"</a>. <i>Barron's</i>. Dow Jones<span class="reference-accessdate">. Retrieved <span class="nowrap">14 March</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Barron%27s&amp;rft.atitle=Amazon+Will+Now+Deliver+Eli+Lilly+Weight-Loss+Drug+Zepbound&amp;rft.date=2024-03-13&amp;rft.aulast=Dattilo&amp;rft.aufirst=Emily&amp;rft.au=Nathan-Kazis%2C+Josh&amp;rft_id=https%3A%2F%2Fwww.barrons.com%2Farticles%2Feli-lilly-amazon-weight-loss-drug-e064a274%3Fmod%3DRTA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-147"><span class="mw-cite-backlink"><b><a href="#cite_ref-147">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.reuters.com/markets/deals/eli-lilly-buy-dice-therapeutics-24-billion-deal-2023-06-20/">"Eli Lilly boosts immunology business with $2.4 billion deal for Dice"</a>. Reuters. 20 June 2023.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Eli+Lilly+boosts+immunology+business+with+%242.4+billion+deal+for+Dice&amp;rft.date=2023-06-20&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fmarkets%2Fdeals%2Feli-lilly-buy-dice-therapeutics-24-billion-deal-2023-06-20%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-148">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-versanis-improve-patient-outcomes-cardiometabolic">"Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases"</a> (Press release). Eli Lilly. 14 July 2023<span class="reference-accessdate">. Retrieved <span class="nowrap">14 July</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly+to+Acquire+Versanis+to+Improve+Patient+Outcomes+in+Cardiometabolic+Diseases&amp;rft.pub=Eli+Lilly&amp;rft.date=2023-07-14&amp;rft_id=https%3A%2F%2Finvestor.lilly.com%2Fnews-releases%2Fnews-release-details%2Flilly-acquire-versanis-improve-patient-outcomes-cardiometabolic&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSHBR12-149"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR12_149-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p.&#160;1 and 2. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=1+and+2&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-150"><span class="mw-cite-backlink"><b><a href="#cite_ref-150">^</a></b></span> <span class="reference-text">Eberhardt and Evans were <a href="/wiki/Purdue_University" title="Purdue University">Purdue University</a> graduates. See <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p.&#160;2. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=2&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-151">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 53.</span>
</li>
<li id="cite_note-MLilly55-152"><span class="mw-cite-backlink">^ <a href="#cite_ref-MLilly55_152-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MLilly55_152-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 55.</span>
</li>
<li id="cite_note-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-153">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 63.</span>
</li>
<li id="cite_note-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-154">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.genedata.com/alliances.html">"Alliances"</a>. Basel, Switzerland: Genedata<span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Alliances&amp;rft.place=Basel%2C+Switzerland&amp;rft.pub=Genedata&amp;rft_id=http%3A%2F%2Fwww.genedata.com%2Falliances.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span> <sup class="noprint Inline-Template"><span style="white-space: nowrap;">&#91;<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title="&#160;Dead link tagged September 2017">permanent dead link</span></a></i>&#93;</span></sup></span>
</li>
<li id="cite_note-Consortium-155"><span class="mw-cite-backlink">^ <a href="#cite_ref-Consortium_155-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Consortium_155-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://archive.today/20130411003210/http://www.genedata.com/index.php?id=211&amp;L=0&amp;tx_ttnews%5BpS%5D=1259741735&amp;tx_ttnews%5Btt_news%5D=22&amp;cHash=139a0c79812ccfccf9dbf2a79a1001ab">"InnoMed PredTox Consortium Members Present Preliminary Study Results"</a>. Basel, Switzerland: Genedata. 15 May 2008. Archived from <a rel="nofollow" class="external text" href="http://www.genedata.com/index.php?id=211&amp;L=0&amp;tx_ttnews%5bpS%5d=1259741735&amp;tx_ttnews%5btt_news%5d=22&amp;cHash=139a0c79812ccfccf9dbf2a79a1001ab">the original</a> on 11 April 2013.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=InnoMed+PredTox+Consortium+Members+Present+Preliminary+Study+Results&amp;rft.place=Basel%2C+Switzerland&amp;rft.pub=Genedata&amp;rft.date=2008-05-15&amp;rft_id=http%3A%2F%2Fwww.genedata.com%2Findex.php%3Fid%3D211%26L%3D0%26tx_ttnews%255bpS%255d%3D1259741735%26tx_ttnews%255btt_news%255d%3D22%26cHash%3D139a0c79812ccfccf9dbf2a79a1001ab&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-156"><span class="mw-cite-backlink"><b><a href="#cite_ref-156">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMattes2008" class="citation book cs1">Mattes, William B. (2008). "Public Consortium Efforts in Toxicogenomics". In Mendrick, Donna L.; Mattes, William B. (eds.). <i>Essential Concepts in Toxicogenomics</i>. <a href="/wiki/Methods_in_Molecular_Biology" title="Methods in Molecular Biology">Methods in Molecular Biology</a>. Vol.&#160;460. pp.&#160;<span class="nowrap">221–</span>238. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-1-60327-048-9_11">10.1007/978-1-60327-048-9_11</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-58829-638-2" title="Special:BookSources/978-1-58829-638-2"><bdi>978-1-58829-638-2</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18449490">18449490</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Public+Consortium+Efforts+in+Toxicogenomics&amp;rft.btitle=Essential+Concepts+in+Toxicogenomics&amp;rft.series=Methods+in+Molecular+Biology&amp;rft.pages=221-238&amp;rft.date=2008&amp;rft_id=info%3Apmid%2F18449490&amp;rft_id=info%3Adoi%2F10.1007%2F978-1-60327-048-9_11&amp;rft.isbn=978-1-58829-638-2&amp;rft.aulast=Mattes&amp;rft.aufirst=William+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-InnoMed_PredTox_official_project_website-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-InnoMed_PredTox_official_project_website_157-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20080926214522/http://www.innomed-predtox.com/consortium/members/">"InnoMed PredTox Member Organizations"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.innomed-predtox.com/consortium/members/">the original</a> on 26 September 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">25 August</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=InnoMed+PredTox+Member+Organizations&amp;rft_id=http%3A%2F%2Fwww.innomed-predtox.com%2Fconsortium%2Fmembers%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-158">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.imi.europa.eu/content/home#&amp;panel1-1">"The Innovative Medicines Initiative"</a>. Innovative Medicines Initiative. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130120170631/http://www.imi.europa.eu/content/home#&amp;panel1-1">Archived</a> from the original on 20 January 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+Innovative+Medicines+Initiative&amp;rft.pub=Innovative+Medicines+Initiative&amp;rft_id=http%3A%2F%2Fwww.imi.europa.eu%2Fcontent%2Fhome%23%26panel1-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-159"><span class="mw-cite-backlink"><b><a href="#cite_ref-159">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130121005243/http://www.imi.europa.eu/content/1st-call-2008">"IMI 1st Call 2008"</a>. Innovative Medicines Initiative. Archived from <a rel="nofollow" class="external text" href="http://www.imi.europa.eu/content/1st-call-2008">the original</a> on 21 January 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">27 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=IMI+1st+Call+2008&amp;rft.pub=Innovative+Medicines+Initiative&amp;rft_id=http%3A%2F%2Fwww.imi.europa.eu%2Fcontent%2F1st-call-2008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IMI_Call_Topics_2008-160"><span class="mw-cite-backlink"><b><a href="#cite_ref-IMI_Call_Topics_2008_160-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFInnovative_Medicines_Initiative" class="citation web cs1">Innovative Medicines Initiative. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20091015122459/http://imi.europa.eu/docs/calls01_en.zip">"IMI Call Topics 2008"</a>. <i>IMI-GB-018v2-24042008-CallTopics.pdf</i>. European Commission. Archived from <a rel="nofollow" class="external text" href="http://imi.europa.eu/docs/calls01_en.zip">the original</a> on 15 October 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">25 August</span> 2008</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=IMI-GB-018v2-24042008-CallTopics.pdf&amp;rft.atitle=IMI+Call+Topics+2008&amp;rft.au=Innovative+Medicines+Initiative&amp;rft_id=http%3A%2F%2Fimi.europa.eu%2Fdocs%2Fcalls01_en.zip&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-161"><span class="mw-cite-backlink"><b><a href="#cite_ref-161">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nosm.ca/advancement/giving/yourimpact/donor-wall/">"Donor Wall"</a>. <i><a href="/wiki/Northern_Ontario_School_of_Medicine" class="mw-redirect" title="Northern Ontario School of Medicine">Northern Ontario School of Medicine</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220619175928/https://www.nosm.ca/advancement/giving/yourimpact/donor-wall/">Archived</a> from the original on 19 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Northern+Ontario+School+of+Medicine&amp;rft.atitle=Donor+Wall&amp;rft_id=https%3A%2F%2Fwww.nosm.ca%2Fadvancement%2Fgiving%2Fyourimpact%2Fdonor-wall%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-162"><span class="mw-cite-backlink"><b><a href="#cite_ref-162">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.phri.ca/collaborations/">"Collaborations"</a>. <i><a href="/wiki/Population_Health_Research_Institute" class="mw-redirect" title="Population Health Research Institute">Population Health Research Institute of Canada</a></i>. 2022. <a rel="nofollow" class="external text" href="https://archive.today/20220612052154/https://www.phri.ca/collaborations/">Archived</a> from the original on 12 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Population+Health+Research+Institute+of+Canada&amp;rft.atitle=Collaborations&amp;rft.date=2022&amp;rft_id=https%3A%2F%2Fwww.phri.ca%2Fcollaborations%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-163"><span class="mw-cite-backlink"><b><a href="#cite_ref-163">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://boundless.utoronto.ca/our-supporters/donor-listing/">"Donor Listing"</a>. <i><a href="/wiki/University_of_Toronto" title="University of Toronto">University of Toronto</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220530223142/https://boundless.utoronto.ca/our-supporters/donor-listing/">Archived</a> from the original on 30 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=University+of+Toronto&amp;rft.atitle=Donor+Listing&amp;rft_id=https%3A%2F%2Fboundless.utoronto.ca%2Four-supporters%2Fdonor-listing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-164"><span class="mw-cite-backlink"><b><a href="#cite_ref-164">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://engage.utoronto.ca/site/SPageServer?pagename=presidents_circle_member_listing">"Presidents' Circle Member Listing"</a>. <i><a href="/wiki/University_of_Toronto" title="University of Toronto">University of Toronto</a></i>. 1 May 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220516225544/https://engage.utoronto.ca/site/SPageServer?pagename=presidents_circle_member_listing">Archived</a> from the original on 16 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=University+of+Toronto&amp;rft.atitle=Presidents%27+Circle+Member+Listing&amp;rft.date=2022-05-01&amp;rft_id=https%3A%2F%2Fengage.utoronto.ca%2Fsite%2FSPageServer%3Fpagename%3Dpresidents_circle_member_listing&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-165"><span class="mw-cite-backlink"><b><a href="#cite_ref-165">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://uw-s3-cdn.s3.us-west-2.amazonaws.com/wp-content/uploads/sites/83/2020/10/29094302/RTC_HonorRoll_2020.pdf">"Honor Roll of Donors"</a> <span class="cs1-format">(PDF)</span>. <i><a href="/wiki/University_of_Washington" title="University of Washington">University of Washington</a>; <a href="/wiki/Amazon_Web_Services" title="Amazon Web Services">Amazon Web Services</a></i>. October 2020. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220610164520/https://uw-s3-cdn.s3.us-west-2.amazonaws.com/wp-content/uploads/sites/83/2020/10/29094302/RTC_HonorRoll_2020.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 10 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">10 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=University+of+Washington%3B+Amazon+Web+Services&amp;rft.atitle=Honor+Roll+of+Donors&amp;rft.date=2020-10&amp;rft_id=https%3A%2F%2Fuw-s3-cdn.s3.us-west-2.amazonaws.com%2Fwp-content%2Fuploads%2Fsites%2F83%2F2020%2F10%2F29094302%2FRTC_HonorRoll_2020.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-166"><span class="mw-cite-backlink"><b><a href="#cite_ref-166">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1 cs1-prop-unfit"><a rel="nofollow" class="external text" href="https://archive.today/20220615052144/https://neuroscienceinnovationforum.org/sponsors/">"Sponsors"</a>. <i>World Neuroscience Innovation Forum</i>. Archived from the original on 15 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">15 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Neuroscience+Innovation+Forum&amp;rft.atitle=Sponsors&amp;rft_id=https%3A%2F%2Fneuroscienceinnovationforum.org%2Fsponsors%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-167"><span class="mw-cite-backlink"><b><a href="#cite_ref-167">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20130128213106/http://nationalpress.org/about/our-funders/">"Our Funders"</a>. <i><a href="/wiki/National_Press_Foundation" title="National Press Foundation">National Press Foundation</a></i>. 2013. Archived from <a rel="nofollow" class="external text" href="http://nationalpress.org/about/our-funders/">the original</a> on 28 January 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Press+Foundation&amp;rft.atitle=Our+Funders&amp;rft.date=2013&amp;rft_id=http%3A%2F%2Fnationalpress.org%2Fabout%2Four-funders%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-168"><span class="mw-cite-backlink"><b><a href="#cite_ref-168">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.hematology.org:443/about/corporate-support">"Corporate Support"</a>. <i><a href="/wiki/American_Society_of_Hematology" title="American Society of Hematology">American Society of Hematology</a></i>. 2022. <a rel="nofollow" class="external text" href="https://archive.today/20220610180740/https://www.hematology.org/about/corporate-support">Archived</a> from the original on 10 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=American+Society+of+Hematology&amp;rft.atitle=Corporate+Support&amp;rft.date=2022&amp;rft_id=https%3A%2F%2Fwww.hematology.org%3A443%2Fabout%2Fcorporate-support&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-169"><span class="mw-cite-backlink"><b><a href="#cite_ref-169">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://arthritis.ca/about-us/partners">"Partners"</a>. <i>The Arthritis Society</i>. <a rel="nofollow" class="external text" href="https://archive.today/20220514211808/https://arthritis.ca/about-us/partners">Archived</a> from the original on 14 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">14 May</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Arthritis+Society&amp;rft.atitle=Partners&amp;rft_id=https%3A%2F%2Farthritis.ca%2Fabout-us%2Fpartners&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-170"><span class="mw-cite-backlink"><b><a href="#cite_ref-170">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.endocrine.org/membership/corporate-liaison-board">"Corporate Liaison Board"</a>. <i><a href="/wiki/Endocrine_Society" title="Endocrine Society">Endocrine Society</a></i>. <a rel="nofollow" class="external text" href="https://archive.today/20220610234024/https://www.endocrine.org/membership/corporate-liaison-board">Archived</a> from the original on 10 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">10 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Endocrine+Society&amp;rft.atitle=Corporate+Liaison+Board&amp;rft_id=https%3A%2F%2Fwww.endocrine.org%2Fmembership%2Fcorporate-liaison-board&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-171"><span class="mw-cite-backlink"><b><a href="#cite_ref-171">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.escardio.org/Research/Registries-&amp;-surveys/Sponsorship,%20https://www.escardio.org/Research/Registries-&amp;-surveys/Sponsorship">"Why sponsor the EURObservational Registry Programme"</a>. <i><a href="/wiki/European_Society_of_Cardiology" title="European Society of Cardiology">European Society of Cardiology</a></i>. <a rel="nofollow" class="external text" href="https://archive.today/20220615200912/https://www.escardio.org/Research/Registries-&amp;-surveys/Sponsorship">Archived</a> from the original on 15 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">15 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=European+Society+of+Cardiology&amp;rft.atitle=Why+sponsor+the+EURObservational+Registry+Programme&amp;rft_id=https%3A%2F%2Fwww.escardio.org%2FResearch%2FRegistries-%26-surveys%2FSponsorship%2C%2520https%3A%2F%2Fwww.escardio.org%2FResearch%2FRegistries-%26-surveys%2FSponsorship&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-172"><span class="mw-cite-backlink"><b><a href="#cite_ref-172">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.hopeww.org/about-us/who-we-are/partners">"Partners"</a>. <i><a href="/wiki/HOPE_Worldwide" class="mw-redirect" title="HOPE Worldwide">HOPE Worldwide</a></i>. 2022. <a rel="nofollow" class="external text" href="https://archive.today/20220511073959/https://www.hopeww.org/about-us/who-we-are/partners">Archived</a> from the original on 11 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=HOPE+Worldwide&amp;rft.atitle=Partners&amp;rft.date=2022&amp;rft_id=https%3A%2F%2Fwww.hopeww.org%2Fabout-us%2Fwho-we-are%2Fpartners&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-173"><span class="mw-cite-backlink"><b><a href="#cite_ref-173">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://actontaxreform.com/about-us/">"About Us"</a>. <i>Alliance for Competitive Taxation</i>. 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220701005932/https://actontaxreform.com/about-us/">Archived</a> from the original on 1 July 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Alliance+for+Competitive+Taxation&amp;rft.atitle=About+Us&amp;rft.date=2022&amp;rft_id=https%3A%2F%2Factontaxreform.com%2Fabout-us%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-174"><span class="mw-cite-backlink"><b><a href="#cite_ref-174">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biotech.ca/about/member-listings/">"Member Listings"</a>. <i>BIOTECanada</i>. 23 December 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220502074149/https://www.biotech.ca/about/member-listings/">Archived</a> from the original on 2 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">18 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BIOTECanada&amp;rft.atitle=Member+Listings&amp;rft.date=2021-12-23&amp;rft_id=https%3A%2F%2Fwww.biotech.ca%2Fabout%2Fmember-listings%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-175"><span class="mw-cite-backlink"><b><a href="#cite_ref-175">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWilson2000" class="citation news cs1">Wilson, Barry (5 October 2000). <a rel="nofollow" class="external text" href="https://www.producer.com/news/biotech-lobby-group-at-heart-of-ethics-complaint/">"Biotech lobby group at heart of ethics complaint"</a>. <i><a href="/wiki/The_Western_Producer" title="The Western Producer">The Western Producer</a></i>. <a rel="nofollow" class="external text" href="https://archive.today/20220618172657/https://www.producer.com/news/biotech-lobby-group-at-heart-of-ethics-complaint/">Archived</a> from the original on 18 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">18 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Western+Producer&amp;rft.atitle=Biotech+lobby+group+at+heart+of+ethics+complaint&amp;rft.date=2000-10-05&amp;rft.aulast=Wilson&amp;rft.aufirst=Barry&amp;rft_id=https%3A%2F%2Fwww.producer.com%2Fnews%2Fbiotech-lobby-group-at-heart-of-ethics-complaint%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-176"><span class="mw-cite-backlink"><b><a href="#cite_ref-176">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://2020-annual-report.fnih.org/donors/">"2020 Donors"</a>. <i>FNIH 2020 Annual Report</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220402180716/https://2020-annual-report.fnih.org/donors/">Archived</a> from the original on 2 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FNIH+2020+Annual+Report&amp;rft.atitle=2020+Donors&amp;rft_id=https%3A%2F%2F2020-annual-report.fnih.org%2Fdonors%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-177"><span class="mw-cite-backlink"><b><a href="#cite_ref-177">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://innovativemedicines.ca/about/member-companies/">"Member Companies"</a>. <i>Innovative Medicines Canada</i>. <a rel="nofollow" class="external text" href="https://archive.today/20211103040804/http://innovativemedicines.ca/about/member-companies/">Archived</a> from the original on 3 November 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">8 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Innovative+Medicines+Canada&amp;rft.atitle=Member+Companies&amp;rft_id=http%3A%2F%2Finnovativemedicines.ca%2Fabout%2Fmember-companies%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-178"><span class="mw-cite-backlink"><b><a href="#cite_ref-178">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://lobbyist.oico.on.ca/Pages/Public/PublicSearch/">"Consultant Lobbyist Registration No. CL4899-20200917025456"</a>. <i>Office of the Integrity Commissioner of Ontario</i>. 22 September 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220308181206/https://lobbyist.oico.on.ca/Pages/Public/PublicSearch/">Archived</a> from the original on 8 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">8 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Office+of+the+Integrity+Commissioner+of+Ontario&amp;rft.atitle=Consultant+Lobbyist+Registration+No.+CL4899-20200917025456&amp;rft.date=2021-09-22&amp;rft_id=https%3A%2F%2Flobbyist.oico.on.ca%2FPages%2FPublic%2FPublicSearch%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-179"><span class="mw-cite-backlink"><b><a href="#cite_ref-179">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMaher2019" class="citation web cs1">Maher, Stephen (29 January 2019). <a rel="nofollow" class="external text" href="https://www.macleans.ca/politics/for-access-to-the-ford-government-two-names-matter-most/">"For access to the Ford government, two names matter most"</a>. <i>MacLean's</i>. <a rel="nofollow" class="external text" href="https://archive.today/20210322062629/https://www.macleans.ca/politics/for-access-to-the-ford-government-two-names-matter-most/">Archived</a> from the original on 22 March 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">8 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MacLean%27s&amp;rft.atitle=For+access+to+the+Ford+government%2C+two+names+matter+most&amp;rft.date=2019-01-29&amp;rft.aulast=Maher&amp;rft.aufirst=Stephen&amp;rft_id=https%3A%2F%2Fwww.macleans.ca%2Fpolitics%2Ffor-access-to-the-ford-government-two-names-matter-most%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-180"><span class="mw-cite-backlink"><b><a href="#cite_ref-180">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/clntSmmry?clientOrgCorpNumber=367878&amp;sMdKy=1621857998861">"Innovative Medicines Canada/Médicaments Novateurs Canada / Andrew Balfour, Consultant"</a>. <i>Registry of Lobbyists</i>. 28 March 2022. <a rel="nofollow" class="external text" href="https://archive.today/20220408060852/https://lobbycanada.gc.ca/app/secure/ocl/lrs/do/clntSmmry?clientOrgCorpNumber=367878&amp;sMdKy=1621857998861">Archived</a> from the original on 8 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">8 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Registry+of+Lobbyists&amp;rft.atitle=Innovative+Medicines+Canada%2FM%C3%A9dicaments+Novateurs+Canada+%2F+Andrew+Balfour%2C+Consultant&amp;rft.date=2022-03-28&amp;rft_id=https%3A%2F%2Flobbycanada.gc.ca%2Fapp%2Fsecure%2Focl%2Flrs%2Fdo%2FclntSmmry%3FclientOrgCorpNumber%3D367878%26sMdKy%3D1621857998861&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-181"><span class="mw-cite-backlink"><b><a href="#cite_ref-181">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ifpma.org/who-we-are/our-membership/full-members/companies/">"Companies"</a>. <i><a href="/wiki/International_Federation_of_Pharmaceutical_Manufacturers_and_Associations" class="mw-redirect" title="International Federation of Pharmaceutical Manufacturers and Associations">International Federation of Pharmaceutical Manufacturers and Associations</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220701150736/https://www.ifpma.org/who-we-are/our-membership/full-members/companies/#!/">Archived</a> from the original on 1 July 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=International+Federation+of+Pharmaceutical+Manufacturers+and+Associations&amp;rft.atitle=Companies&amp;rft_id=https%3A%2F%2Fwww.ifpma.org%2Fwho-we-are%2Four-membership%2Ffull-members%2Fcompanies%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-182"><span class="mw-cite-backlink"><b><a href="#cite_ref-182">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://nationalhealthcouncil.org/members/">"Our Members"</a>. <i>National Health Council</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220406081753/https://nationalhealthcouncil.org/members/?m_cat=74&amp;m_key=">Archived</a> from the original on 6 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Health+Council&amp;rft.atitle=Our+Members&amp;rft_id=https%3A%2F%2Fnationalhealthcouncil.org%2Fmembers%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-183"><span class="mw-cite-backlink"><b><a href="#cite_ref-183">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.npcnow.org/about/members">"Members"</a>. <i>National Pharmaceutical Council</i>. <a rel="nofollow" class="external text" href="https://archive.today/20220407004632/https://www.npcnow.org/about/members">Archived</a> from the original on 7 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">7 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Pharmaceutical+Council&amp;rft.atitle=Members&amp;rft_id=https%3A%2F%2Fwww.npcnow.org%2Fabout%2Fmembers&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-184"><span class="mw-cite-backlink"><b><a href="#cite_ref-184">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.personalizedmedicinecoalition.org/Members/Current_Members">"Current Members"</a>. <i>Personalized Medicine Coalition</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210815032705/https://personalizedmedicinecoalition.org/Members/Current_Members">Archived</a> from the original on 15 August 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Personalized+Medicine+Coalition&amp;rft.atitle=Current+Members&amp;rft_id=https%3A%2F%2Fwww.personalizedmedicinecoalition.org%2FMembers%2FCurrent_Members&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-185"><span class="mw-cite-backlink"><b><a href="#cite_ref-185">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.pharmavoice.com/news/2021-04-precision-medicine/612084/">"SHOWCASE: Precision Medicine: Expanding the Frontiers of Precision Medicine"</a>. <i>PharmaVoice</i>. 1 April 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220408054844/https://www.pharmavoice.com/news/2021-04-precision-medicine/612084/">Archived</a> from the original on 8 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">8 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PharmaVoice&amp;rft.atitle=SHOWCASE%3A+Precision+Medicine%3A+Expanding+the+Frontiers+of+Precision+Medicine&amp;rft.date=2021-04-01&amp;rft_id=https%3A%2F%2Fwww.pharmavoice.com%2Fnews%2F2021-04-precision-medicine%2F612084%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-186"><span class="mw-cite-backlink"><b><a href="#cite_ref-186">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.phrma.org/about">"About"</a>. <i>PhRMA</i>. <a rel="nofollow" class="external text" href="https://archive.today/20220406052447/https://www.phrma.org/about">Archived</a> from the original on 6 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PhRMA&amp;rft.atitle=About&amp;rft_id=https%3A%2F%2Fwww.phrma.org%2Fabout&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-187"><span class="mw-cite-backlink"><b><a href="#cite_ref-187">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSchwartz2021" class="citation web cs1">Schwartz, Brian (1 June 2021). <a rel="nofollow" class="external text" href="https://www.cnbc.com/2021/06/01/big-pharma-launches-campaign-against-biden-over-covid-vaccine-patent-waiver.html">"Big Pharma lobbyists launch campaign against Biden over Covid vaccine patent waiver"</a>. <i>CNBC</i>. <a rel="nofollow" class="external text" href="https://archive.today/20210602022055/https://www.cnbc.com/2021/06/01/big-pharma-launches-campaign-against-biden-over-covid-vaccine-patent-waiver.html">Archived</a> from the original on 2 June 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">8 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNBC&amp;rft.atitle=Big+Pharma+lobbyists+launch+campaign+against+Biden+over+Covid+vaccine+patent+waiver&amp;rft.date=2021-06-01&amp;rft.aulast=Schwartz&amp;rft.aufirst=Brian&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2F2021%2F06%2F01%2Fbig-pharma-launches-campaign-against-biden-over-covid-vaccine-patent-waiver.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-188"><span class="mw-cite-backlink"><b><a href="#cite_ref-188">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.researchamerica.org/about-us/member-organizations">"Member Organizations"</a>. <i>Research!America</i>. 28 September 2007. <a rel="nofollow" class="external text" href="https://archive.today/20220406092643/https://www.researchamerica.org/about-us/member-organizations">Archived</a> from the original on 6 April 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Research%21America&amp;rft.atitle=Member+Organizations&amp;rft.date=2007-09-28&amp;rft_id=https%3A%2F%2Fwww.researchamerica.org%2Fabout-us%2Fmember-organizations&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-189"><span class="mw-cite-backlink"><b><a href="#cite_ref-189">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1 cs1-prop-unfit"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20140713182356/http://advamed.org/page/33/members">"Members"</a>. <i><a href="/wiki/AdvaMed" title="AdvaMed">AdvaMed</a></i>. 2014. Archived from the original on 13 July 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=AdvaMed&amp;rft.atitle=Members&amp;rft.date=2014&amp;rft_id=http%3A%2F%2Fadvamed.org%2Fpage%2F33%2Fmembers&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-190"><span class="mw-cite-backlink"><b><a href="#cite_ref-190">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://rheum.ca/wp-content/uploads/2022/01/CRA_20-21_AnnualReport_EN.pdf">"2020-2021 Annual Report: Collaboration, Resilience and Advancement"</a> <span class="cs1-format">(PDF)</span>. <i>Canadian Rheumatology Association</i>. January 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220301043916/https://rheum.ca/wp-content/uploads/2022/01/CRA_20-21_AnnualReport_EN.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 1 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">11 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Rheumatology+Association&amp;rft.atitle=2020-2021+Annual+Report%3A+Collaboration%2C+Resilience+and+Advancement&amp;rft.date=2022-01&amp;rft_id=https%3A%2F%2Frheum.ca%2Fwp-content%2Fuploads%2F2022%2F01%2FCRA_20-21_AnnualReport_EN.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-191"><span class="mw-cite-backlink"><b><a href="#cite_ref-191">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMcLorie2000" class="citation web cs1">McLorie, Gordon (2000). <a rel="nofollow" class="external text" href="http://history.cua.org/sites/default/files/2018-07/2000-02_en.pdf">"Fall 2000 Newsletter"</a> <span class="cs1-format">(PDF)</span>. <i>Canadian Urological Association</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220701072809/http://history.cua.org/sites/default/files/2018-07/2000-02_en.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 1 July 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Urological+Association&amp;rft.atitle=Fall+2000+Newsletter&amp;rft.date=2000&amp;rft.aulast=McLorie&amp;rft.aufirst=Gordon&amp;rft_id=http%3A%2F%2Fhistory.cua.org%2Fsites%2Fdefault%2Ffiles%2F2018-07%2F2000-02_en.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-192"><span class="mw-cite-backlink"><b><a href="#cite_ref-192">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://mooddisorders.ca/support-us/our-supporters">"Our Supporters"</a>. <i>Mood Disorders Association of Ontario</i>. <a rel="nofollow" class="external text" href="https://archive.today/20220302051300/https://mooddisorders.ca/support-us/our-supporters">Archived</a> from the original on 2 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Mood+Disorders+Association+of+Ontario&amp;rft.atitle=Our+Supporters&amp;rft_id=https%3A%2F%2Fmooddisorders.ca%2Fsupport-us%2Four-supporters&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-193"><span class="mw-cite-backlink"><b><a href="#cite_ref-193">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.camh.ca/-/media/files/camhf-2020-21-annual-report-donor-listing.pdf">"Thank you to our donors"</a> <span class="cs1-format">(PDF)</span>. <i><a href="/wiki/Centre_for_Addiction_and_Mental_Health" title="Centre for Addiction and Mental Health">Centre for Addiction and Mental Health</a></i>. 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220619084300/https://www.camh.ca/-/media/files/camhf-2020-21-annual-report-donor-listing.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 19 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Centre+for+Addiction+and+Mental+Health&amp;rft.atitle=Thank+you+to+our+donors&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.camh.ca%2F-%2Fmedia%2Ffiles%2Fcamhf-2020-21-annual-report-donor-listing.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-194"><span class="mw-cite-backlink"><b><a href="#cite_ref-194">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.sickkidsfoundation.com/annual-report-2020/">"2020-21 SickKids Annual Report"</a>. <i><a href="/wiki/SickKids" class="mw-redirect" title="SickKids">SickKids Foundation</a></i>. 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220620073404/https://web.sickkidsfoundation.com/annual-report-2020/">Archived</a> from the original on 20 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=SickKids+Foundation&amp;rft.atitle=2020-21+SickKids+Annual+Report&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fweb.sickkidsfoundation.com%2Fannual-report-2020%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-195"><span class="mw-cite-backlink"><b><a href="#cite_ref-195">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://fdocuments.in/document/years-of-success-anna-greenberg-richard-hill-michael-jewett-david-mccready-hans.html">"The 8th Princess Margaret Hospital Conference: Developments in Cancer Management"</a>. <i>FDocuments India</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220620072213/https://fdocuments.in/document/years-of-success-anna-greenberg-richard-hill-michael-jewett-david-mccready-hans.html?page=1">Archived</a> from the original on 20 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FDocuments+India&amp;rft.atitle=The+8th+Princess+Margaret+Hospital+Conference%3A+Developments+in+Cancer+Management&amp;rft_id=https%3A%2F%2Ffdocuments.in%2Fdocument%2Fyears-of-success-anna-greenberg-richard-hill-michael-jewett-david-mccready-hans.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-196"><span class="mw-cite-backlink"><b><a href="#cite_ref-196">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://thepmcf.ca/getmedia/9b96649e-83ba-490a-bacc-f961904b94c8/Annual-Report-2021_Digital.pdf">"2021 Annual Report"</a> <span class="cs1-format">(PDF)</span>. <i>Princess Margaret Cancer Foundation</i>. 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20211120191604/https://thepmcf.ca/getmedia/9b96649e-83ba-490a-bacc-f961904b94c8/Annual-Report-2021_Digital.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 20 November 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Princess+Margaret+Cancer+Foundation&amp;rft.atitle=2021+Annual+Report&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fthepmcf.ca%2Fgetmedia%2F9b96649e-83ba-490a-bacc-f961904b94c8%2FAnnual-Report-2021_Digital.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-197"><span class="mw-cite-backlink"><b><a href="#cite_ref-197">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.shnfoundation.ca/our-donors/">"Our Donors"</a>. <i><a href="/wiki/Scarborough_Health_Network" title="Scarborough Health Network">Scarborough Health Network Foundation</a></i>. 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220620072949/https://www.shnfoundation.ca/our-donors/">Archived</a> from the original on 20 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Scarborough+Health+Network+Foundation&amp;rft.atitle=Our+Donors&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.shnfoundation.ca%2Four-donors%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-198"><span class="mw-cite-backlink"><b><a href="#cite_ref-198">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.sinaihealthannualreport.ca/donor-list-cumulative">"Donor List - Cumulative"</a>. <i>Sinai Health Annual Report</i>. 31 March 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220620153313/https://www.sinaihealthannualreport.ca/donor-list-cumulative">Archived</a> from the original on 20 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Sinai+Health+Annual+Report&amp;rft.atitle=Donor+List+-+Cumulative&amp;rft.date=2021-03-31&amp;rft_id=https%3A%2F%2Fwww.sinaihealthannualreport.ca%2Fdonor-list-cumulative&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-199"><span class="mw-cite-backlink"><b><a href="#cite_ref-199">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://sunnybrook.ca/foundation/your-impact/our-donors-2021.html">"Our donors - Your Impact"</a>. <i><a href="/wiki/Sunnybrook_Health_Sciences_Centre" title="Sunnybrook Health Sciences Centre">Sunnybrook Foundation</a></i>. 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220620153915/https://sunnybrook.ca/foundation/your-impact/our-donors-2021.html">Archived</a> from the original on 20 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Sunnybrook+Foundation&amp;rft.atitle=Our+donors+-+Your+Impact&amp;rft.date=2022&amp;rft_id=https%3A%2F%2Fsunnybrook.ca%2Ffoundation%2Fyour-impact%2Four-donors-2021.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-200"><span class="mw-cite-backlink"><b><a href="#cite_ref-200">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://arthritisaustralia.com.au/about-us/our-supporters/">"Our Supporters"</a>. <i><a href="/wiki/Arthritis_Australia" title="Arthritis Australia">Arthritis Australia</a></i>. 2017. <a rel="nofollow" class="external text" href="https://archive.today/20220613065711/https://arthritisaustralia.com.au/about-us/our-supporters/">Archived</a> from the original on 13 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Arthritis+Australia&amp;rft.atitle=Our+Supporters&amp;rft.date=2017&amp;rft_id=https%3A%2F%2Farthritisaustralia.com.au%2Fabout-us%2Four-supporters%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-201"><span class="mw-cite-backlink"><b><a href="#cite_ref-201">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.biofit-event.com/partnering-biofit/2017-participants/">"2017 Participants"</a>. <i>BioFIT</i>. <a rel="nofollow" class="external text" href="https://archive.today/20220612195815/https://www.biofit-event.com/partnering-biofit/2017-participants/">Archived</a> from the original on 12 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioFIT&amp;rft.atitle=2017+Participants&amp;rft_id=https%3A%2F%2Fwww.biofit-event.com%2Fpartnering-biofit%2F2017-participants%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-202"><span class="mw-cite-backlink"><b><a href="#cite_ref-202">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFItzhak" class="citation web cs1">Itzhak, Inbal. <a rel="nofollow" class="external text" href="https://ccna-ccnv.ca/partner-organizations-phase-1/">"Partner Organizations - CCNA Phase I (2014-2019)"</a>. <i>CCNA-CCNV</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220328174527/http://ccna-ccnv.ca/partner-organizations-phase-1/">Archived</a> from the original on 28 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CCNA-CCNV&amp;rft.atitle=Partner+Organizations+-+CCNA+Phase+I+%282014-2019%29&amp;rft.aulast=Itzhak&amp;rft.aufirst=Inbal&amp;rft_id=https%3A%2F%2Fccna-ccnv.ca%2Fpartner-organizations-phase-1%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-203"><span class="mw-cite-backlink"><b><a href="#cite_ref-203">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.colorectalcancercanada.com/what-we-do/our-partnerships/">"Our Partnerships"</a>. <i>Colorectal Cancer Canada</i>. 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220516082302/https://www.colorectalcancercanada.com/what-we-do/our-partnerships/">Archived</a> from the original on 16 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">16 May</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Colorectal+Cancer+Canada&amp;rft.atitle=Our+Partnerships&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.colorectalcancercanada.com%2Fwhat-we-do%2Four-partnerships%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-204"><span class="mw-cite-backlink"><b><a href="#cite_ref-204">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFStaines2020" class="citation web cs1">Staines, Richard (26 March 2020). <a rel="nofollow" class="external text" href="https://pharmaphorum.com/news/collaborate-covid19-therapies/">"Pharma giants including Novartis collaborate on COVID-19 therapies"</a>. <i>Pharmaphorum</i>. <a rel="nofollow" class="external text" href="https://archive.today/20220118165943/https://pharmaphorum.com/news/collaborate-covid19-therapies/">Archived</a> from the original on 18 January 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">6 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pharmaphorum&amp;rft.atitle=Pharma+giants+including+Novartis+collaborate+on+COVID-19+therapies&amp;rft.date=2020-03-26&amp;rft.aulast=Staines&amp;rft.aufirst=Richard&amp;rft_id=https%3A%2F%2Fpharmaphorum.com%2Fnews%2Fcollaborate-covid19-therapies%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-205"><span class="mw-cite-backlink"><b><a href="#cite_ref-205">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.diabetes.ca/get-involved/corporate-partnerships/corporate-recognition">"Corporate recognition"</a>. <i><a href="/wiki/Diabetes_Canada" title="Diabetes Canada">Diabetes Canada</a></i>. February 2021. <a rel="nofollow" class="external text" href="https://archive.today/20220501062929/https://www.diabetes.ca/get-involved/corporate-partnerships/corporate-recognition">Archived</a> from the original on 1 May 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Diabetes+Canada&amp;rft.atitle=Corporate+recognition&amp;rft.date=2021-02&amp;rft_id=https%3A%2F%2Fwww.diabetes.ca%2Fget-involved%2Fcorporate-partnerships%2Fcorporate-recognition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-206"><span class="mw-cite-backlink"><b><a href="#cite_ref-206">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.giant.health/the-digital-pharma-show">"GIANT Health London 6th-7th December 2022"</a>. <i>GIANT Health</i>. <a rel="nofollow" class="external text" href="https://archive.today/20220615232403/https://www.giant.health/the-digital-pharma-show">Archived</a> from the original on 15 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GIANT+Health&amp;rft.atitle=GIANT+Health+London+6th-7th+December+2022&amp;rft_id=https%3A%2F%2Fwww.giant.health%2Fthe-digital-pharma-show&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-207"><span class="mw-cite-backlink"><b><a href="#cite_ref-207">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.jdrf.ca/who-we-are/our-corporate-partners/">"Our Corporate Partners"</a>. <i><a href="/wiki/JDRF" class="mw-redirect" title="JDRF">JDRF</a> Canada</i>. <a rel="nofollow" class="external text" href="https://archive.today/20220312033411/https://www.jdrf.ca/who-we-are/our-corporate-partners/">Archived</a> from the original on 12 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=JDRF+Canada&amp;rft.atitle=Our+Corporate+Partners&amp;rft_id=https%3A%2F%2Fwww.jdrf.ca%2Fwho-we-are%2Four-corporate-partners%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-208"><span class="mw-cite-backlink"><b><a href="#cite_ref-208">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://nbhrf.com/wp-content/uploads/2021/11/NBHRF-Annual-Report-2016-Inside-Pages-English-PART-1-O.pdf">"Annual Report 2015-2016"</a> <span class="cs1-format">(PDF)</span>. <i>New Brunswick Health Research Foundation</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220328050134/https://nbhrf.com/wp-content/uploads/2021/11/NBHRF-Annual-Report-2016-Inside-Pages-English-PART-1-O.pdf">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 28 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=New+Brunswick+Health+Research+Foundation&amp;rft.atitle=Annual+Report+2015-2016&amp;rft_id=https%3A%2F%2Fnbhrf.com%2Fwp-content%2Fuploads%2F2021%2F11%2FNBHRF-Annual-Report-2016-Inside-Pages-English-PART-1-O.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-209"><span class="mw-cite-backlink"><b><a href="#cite_ref-209">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.pinnacletrials.com/sponsors/">"Sponsors and CRO's"</a>. <i>Pinnacle Research Group</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220612095624/http://www.pinnacletrials.com/sponsors/">Archived</a> from the original on 12 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">12 June</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pinnacle+Research+Group&amp;rft.atitle=Sponsors+and+CRO%27s&amp;rft_id=http%3A%2F%2Fwww.pinnacletrials.com%2Fsponsors%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-210"><span class="mw-cite-backlink"><b><a href="#cite_ref-210">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.radcliffecardiology.com/products-services/a-z">"A-Z"</a>. <i>Radcliffe Cardiology</i>. 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220612062914/https://www.radcliffecardiology.com/products-services/a-z">Archived</a> from the original on 12 June 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">1 July</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Radcliffe+Cardiology&amp;rft.atitle=A-Z&amp;rft.date=2022&amp;rft_id=https%3A%2F%2Fwww.radcliffecardiology.com%2Fproducts-services%2Fa-z&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-211"><span class="mw-cite-backlink"><b><a href="#cite_ref-211">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 105&#8211;6.</span>
</li>
<li id="cite_note-212"><span class="mw-cite-backlink"><b><a href="#cite_ref-212">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLovelace_Jr.2023" class="citation web cs1">Lovelace Jr., Berkeley (March 2023). <a rel="nofollow" class="external text" href="https://www.nbcnews.com/health/health-news/eli-lilly-caps-cost-insulin-35-month-rcna72713">"Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions"</a>. <i>NBC News</i>. NBC Universal<span class="reference-accessdate">. Retrieved <span class="nowrap">1 March</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NBC+News&amp;rft.atitle=Drugmaker+Eli+Lilly+caps+the+cost+of+insulin+at+%2435+a+month%2C+bringing+relief+for+millions&amp;rft.date=2023-03&amp;rft.aulast=Lovelace+Jr.&amp;rft.aufirst=Berkeley&amp;rft_id=https%3A%2F%2Fwww.nbcnews.com%2Fhealth%2Fhealth-news%2Feli-lilly-caps-cost-insulin-35-month-rcna72713&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-213"><span class="mw-cite-backlink"><b><a href="#cite_ref-213">^</a></b></span> <span class="reference-text">With its television advertisement for Cialis during the <a href="/wiki/Super_Bowl_XXXVIII" title="Super Bowl XXXVIII">2004 Super Bowl Halftime Show</a>, Eli Lilly was one of several companies whose costly 2004 <a href="/wiki/Super_Bowl" title="Super Bowl">Super Bowl</a> Halftime advertisements were largely overshadowed by the <a href="/wiki/Janet_Jackson" title="Janet Jackson">Janet Jackson</a> and <a href="/wiki/Justin_Timberlake" title="Justin Timberlake">Justin Timberlake</a> <a href="/wiki/Super_Bowl_XXXVIII_halftime_show_controversy" title="Super Bowl XXXVIII halftime show controversy">Super Bowl XXXVIII halftime show controversy</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (July 2018)">citation needed</span></a></i>&#93;</sup></span>
</li>
<li id="cite_note-214"><span class="mw-cite-backlink"><b><a href="#cite_ref-214">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHunt2023" class="citation web cs1">Hunt, Katie (9 May 2023). <a rel="nofollow" class="external text" href="https://edition.cnn.com/2023/05/09/health/chronic-pain-anti-depressants-wellness/index.html">"Millions of people are prescribed antidepressants for chronic pain. Do they work?"</a>. <i>CNN</i><span class="reference-accessdate">. Retrieved <span class="nowrap">23 October</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNN&amp;rft.atitle=Millions+of+people+are+prescribed+antidepressants+for+chronic+pain.+Do+they+work%3F&amp;rft.date=2023-05-09&amp;rft.aulast=Hunt&amp;rft.aufirst=Katie&amp;rft_id=https%3A%2F%2Fedition.cnn.com%2F2023%2F05%2F09%2Fhealth%2Fchronic-pain-anti-depressants-wellness%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-215"><span class="mw-cite-backlink"><b><a href="#cite_ref-215">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.cbsnews.com/news/duloxetine-recall-2024-name-brand-cymbalta-fda-chemical/">"Thousands of duloxetine bottles, an antidepressant sold as Cymbalta, recalled over toxic chemical - CBS News"</a>. <i>www.cbsnews.com</i>. 23 October 2024<span class="reference-accessdate">. Retrieved <span class="nowrap">23 October</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.cbsnews.com&amp;rft.atitle=Thousands+of+duloxetine+bottles%2C+an+antidepressant+sold+as+Cymbalta%2C+recalled+over+toxic+chemical+-+CBS+News&amp;rft.date=2024-10-23&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fduloxetine-recall-2024-name-brand-cymbalta-fda-chemical%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-216"><span class="mw-cite-backlink"><b><a href="#cite_ref-216">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFSamantha2024" class="citation web cs1">Samantha (3 July 2024). <a rel="nofollow" class="external text" href="https://clarah.co/eli-lillys-groundbreaking-alzheimers-drug-kisunla-gains-fda-approval/">"Eli Lilly's Groundbreaking Alzheimer's Drug, Kisunla, Gains FDA Approval"</a>. <i>CLARAH</i><span class="reference-accessdate">. Retrieved <span class="nowrap">9 November</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CLARAH&amp;rft.atitle=Eli+Lilly%27s+Groundbreaking+Alzheimer%27s+Drug%2C+Kisunla%2C+Gains+FDA+Approval&amp;rft.date=2024-07-03&amp;rft.au=Samantha&amp;rft_id=https%3A%2F%2Fclarah.co%2Feli-lillys-groundbreaking-alzheimers-drug-kisunla-gains-fda-approval%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-217"><span class="mw-cite-backlink"><b><a href="#cite_ref-217">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-alzheimers-drug-approved-uk-2024-10-23/">"UK approves Lilly's Alzheimer's drug, but deemed 'too expensive' for wide use"</a>. <i>reuters.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=reuters.com&amp;rft.atitle=UK+approves+Lilly%27s+Alzheimer%27s+drug%2C+but+deemed+%27too+expensive%27+for+wide+use&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fbusiness%2Fhealthcare-pharmaceuticals%2Flillys-alzheimers-drug-approved-uk-2024-10-23%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-218"><span class="mw-cite-backlink"><b><a href="#cite_ref-218">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFToschiCappuzzo2009" class="citation journal cs1">Toschi, L.; Cappuzzo, F. (2009). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886326">"Gemcitabine for the treatment of advanced nonsmall cell lung cancer"</a>. <i>OncoTargets and Therapy</i>. <b>2</b>: <span class="nowrap">209–</span>217. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2147%2Fott.s4645">10.2147/ott.s4645</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886326">2886326</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20616908">20616908</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=OncoTargets+and+Therapy&amp;rft.atitle=Gemcitabine+for+the+treatment+of+advanced+nonsmall+cell+lung+cancer&amp;rft.volume=2&amp;rft.pages=209-217&amp;rft.date=2009&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2886326%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20616908&amp;rft_id=info%3Adoi%2F10.2147%2Fott.s4645&amp;rft.aulast=Toschi&amp;rft.aufirst=L.&amp;rft.au=Cappuzzo%2C+F.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2886326&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-219"><span class="mw-cite-backlink"><b><a href="#cite_ref-219">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFFacher2024" class="citation web cs1">Facher, Lev (1 February 2024). <a rel="nofollow" class="external text" href="https://www.statnews.com/2024/02/01/opioid-addiction-methadone-clinic-regulations/">"Methadone treatment gets first major update in over 20 years"</a>. <i>STAT</i><span class="reference-accessdate">. Retrieved <span class="nowrap">23 October</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=STAT&amp;rft.atitle=Methadone+treatment+gets+first+major+update+in+over+20+years&amp;rft.date=2024-02-01&amp;rft.aulast=Facher&amp;rft.aufirst=Lev&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2024%2F02%2F01%2Fopioid-addiction-methadone-clinic-regulations%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-220"><span class="mw-cite-backlink"><b><a href="#cite_ref-220">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFO&#39;DonnellVogenberg2011" class="citation journal cs1">O'Donnell, J.; Vogenberg, F. R. (2011). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278176">"Applying Legal Risk Management to the Clinical Use of Methadone"</a>. <i>P &amp; T: A Peer-Reviewed Journal for Formulary Management</i>. <b>36</b> (12): <span class="nowrap">813–</span>822. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278176">3278176</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22346315">22346315</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=P+%26+T%3A+A+Peer-Reviewed+Journal+for+Formulary+Management&amp;rft.atitle=Applying+Legal+Risk+Management+to+the+Clinical+Use+of+Methadone&amp;rft.volume=36&amp;rft.issue=12&amp;rft.pages=813-822&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3278176%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22346315&amp;rft.aulast=O%27Donnell&amp;rft.aufirst=J.&amp;rft.au=Vogenberg%2C+F.+R.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3278176&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-221"><span class="mw-cite-backlink"><b><a href="#cite_ref-221">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFCurrent" class="citation book cs1">Current, John D. <a rel="nofollow" class="external text" href="https://books.google.com/books?id=_Du2bfrO9FwC&amp;pg=PA386"><i>Pharmacology for Anesthetists:Anesthetics and Adjuvants</i></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200801093229/https://books.google.com/books?id=_Du2bfrO9FwC&amp;pg=PA386">Archived</a> from the original on 1 August 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">19 July</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmacology+for+Anesthetists%3AAnesthetics+and+Adjuvants&amp;rft.aulast=Current&amp;rft.aufirst=John+D.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D_Du2bfrO9FwC%26pg%3DPA386&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-222"><span class="mw-cite-backlink"><b><a href="#cite_ref-222">^</a></b></span> <span class="reference-text">Homeland Security Act 2002, Public Law 107-296 <a rel="nofollow" class="external autonumber" href="https://www.dhs.gov/xlibrary/assets/hr_5005_enr.pdf">[1]</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20171210060743/https://www.dhs.gov/xlibrary/assets/hr_5005_enr.pdf">Archived</a> 10 December 2017 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-223"><span class="mw-cite-backlink"><b><a href="#cite_ref-223">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWilson2010" class="citation news cs1">Wilson, Duff (2 October 2010). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2010/10/03/business/03psych.html">"Side Effects May Include Lawsuits"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110425033212/http://www.nytimes.com/2010/10/03/business/03psych.html">Archived</a> from the original on 25 April 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">21 February</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Side+Effects+May+Include+Lawsuits&amp;rft.date=2010-10-02&amp;rft.aulast=Wilson&amp;rft.aufirst=Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F10%2F03%2Fbusiness%2F03psych.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-MLilly112-224"><span class="mw-cite-backlink"><b><a href="#cite_ref-MLilly112_224-0">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 112.</span>
</li>
<li id="cite_note-wsj-225"><span class="mw-cite-backlink">^ <a href="#cite_ref-wsj_225-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-wsj_225-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-wsj_225-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Hagerty, James R., <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/eli-lilly-ceo-richard-wood-oversaw-prozac-launch-11588250679">"Eli Lilly CEO Richard Wood Oversaw Prozac Launch"</a>, <i>Wall Street Journal</i>, 3 May 2020. Retrieved 23 May 2020. <span style="font-size:0.95em; font-size:95%; color: var( --color-subtle, #555 )">(subscription required)</span> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200523030532/https://www.wsj.com/articles/eli-lilly-ceo-richard-wood-oversaw-prozac-launch-11588250679">Archived</a> 23 May 2020 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-226"><span class="mw-cite-backlink"><b><a href="#cite_ref-226">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAssociated_Press1977" class="citation news cs1">Associated Press (29 March 1977). "Lilly Director Dies in Hawaii". <i>Anderson Herald</i>. Anderson, IN.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Anderson+Herald&amp;rft.atitle=Lilly+Director+Dies+in+Hawaii&amp;rft.date=1977-03-29&amp;rft.au=Associated+Press&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-227"><span class="mw-cite-backlink"><b><a href="#cite_ref-227">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAssociated_Press1991" class="citation news cs1">Associated Press (18 September 1991). "Lilly Move No Big Surprise". <i>Kokomo Tribune</i>. Kokomi, IN.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=Lilly+Move+No+Big+Surprise&amp;rft.date=1991-09-18&amp;rft.au=Associated+Press&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-228"><span class="mw-cite-backlink"><b><a href="#cite_ref-228">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.gpo.gov/fdsys/pkg/CREC-2006-03-29/pdf/CREC-2006-03-29-pt1-PgS2546-3.pdf">"Congressional Record, March 29, 2006, S2546"</a> <span class="cs1-format">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Congressional+Record%2C+March+29%2C+2006%2C+S2546&amp;rft_id=http%3A%2F%2Fwww.gpo.gov%2Ffdsys%2Fpkg%2FCREC-2006-03-29%2Fpdf%2FCREC-2006-03-29-pt1-PgS2546-3.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-IHSHBR9-229"><span class="mw-cite-backlink"><b><a href="#cite_ref-IHSHBR9_229-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. p.&#160;9. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">26 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pages=9&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-TaurelRetires-230"><span class="mw-cite-backlink"><b><a href="#cite_ref-TaurelRetires_230-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAssociated_Press2007" class="citation news cs1">Associated Press (19 December 2007). "Lechleiter Named Lilly CEO". <i>Kokomo Tribune</i>. p.&#160;A7.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kokomo+Tribune&amp;rft.atitle=Lechleiter+Named+Lilly+CEO&amp;rft.pages=A7&amp;rft.date=2007-12-19&amp;rft.au=Associated+Press&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-231"><span class="mw-cite-backlink"><b><a href="#cite_ref-231">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFCNBC2016" class="citation news cs1">CNBC (27 July 2016). <a rel="nofollow" class="external text" href="http://web.archive.org/web/20160904170401/https://www.cnbc.com/amp/2016/07/27/john-lechleiter-to-retire-as-lilly-ceo-david-ricks-named-as-successor.html">"Lilly CEO John Lechleiter to retire; David Ricks named as successor"</a>. <i>CNBC</i>. Archived from <a rel="nofollow" class="external text" href="https://www.cnbc.com/amp/2016/07/27/john-lechleiter-to-retire-as-lilly-ceo-david-ricks-named-as-successor.html">the original</a> on 4 September 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">29 December</span> 2024</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNBC&amp;rft.atitle=Lilly+CEO+John+Lechleiter+to+retire%3B+David+Ricks+named+as+successor&amp;rft.date=2016-07-27&amp;rft.au=CNBC&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2Famp%2F2016%2F07%2F27%2Fjohn-lechleiter-to-retire-as-lilly-ceo-david-ricks-named-as-successor.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-b399-232"><span class="mw-cite-backlink"><b><a href="#cite_ref-b399_232-0">^</a></b></span> <span class="reference-text">Bodenhamer and Barrows, eds., p. 399.</span>
</li>
<li id="cite_note-233"><span class="mw-cite-backlink"><b><a href="#cite_ref-233">^</a></b></span> <span class="reference-text">Bodenhamer and Barrows, eds., pp. 402&#8211;03, 911&#8211;12, and 560&#8211;61.</span>
</li>
<li id="cite_note-b91012-234"><span class="mw-cite-backlink"><b><a href="#cite_ref-b91012_234-0">^</a></b></span> <span class="reference-text">Bodenhamer and Barrows, eds., pp. 910&#8211;12.</span>
</li>
<li id="cite_note-MLilly20506-235"><span class="mw-cite-backlink"><b><a href="#cite_ref-MLilly20506_235-0">^</a></b></span> <span class="reference-text">Madison, <i>Eli Lilly</i>, p. 205&#8211;6.</span>
</li>
<li id="cite_note-236"><span class="mw-cite-backlink"><b><a href="#cite_ref-236">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMeek" class="citation web cs1">Meek, Heather. <a rel="nofollow" class="external text" href="http://learningtogive.org/papers/paper108.html">"Lilly, Eli"</a>. LearningToGive.org and the Center on Philanthropy at Indiana University. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130516162608/http://learningtogive.org/papers/paper108.html">Archived</a> from the original on 16 May 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Lilly%2C+Eli&amp;rft.pub=LearningToGive.org+and+the+Center+on+Philanthropy+at+Indiana+University&amp;rft.aulast=Meek&amp;rft.aufirst=Heather&amp;rft_id=http%3A%2F%2Flearningtogive.org%2Fpapers%2Fpaper108.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-237"><span class="mw-cite-backlink"><b><a href="#cite_ref-237">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.bizjournals.com/stlouis/stories/2008/08/18/daily41.html">"Eli Lilly division to buy Monsanto's cow growth hormone business for $300M"</a>. <i>www.bizjournals.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022707/https://www.bizjournals.com/stlouis/stories/2008/08/18/daily41.html">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">19 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.bizjournals.com&amp;rft.atitle=Eli+Lilly+division+to+buy+Monsanto%27s+cow+growth+hormone+business+for+%24300M&amp;rft_id=https%3A%2F%2Fwww.bizjournals.com%2Fstlouis%2Fstories%2F2008%2F08%2F18%2Fdaily41.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-238"><span class="mw-cite-backlink"><b><a href="#cite_ref-238">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.bizjournals.com/stlouis/stories/2008/08/04/daily68.html">"Monsanto to divest bovine growth hormone"</a>. <i>www.bizjournals.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180629222446/https://www.bizjournals.com/stlouis/stories/2008/08/04/daily68.html">Archived</a> from the original on 29 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">23 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.bizjournals.com&amp;rft.atitle=Monsanto+to+divest+bovine+growth+hormone&amp;rft_id=https%3A%2F%2Fwww.bizjournals.com%2Fstlouis%2Fstories%2F2008%2F08%2F04%2Fdaily68.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-:0-239"><span class="mw-cite-backlink"><b><a href="#cite_ref-:0_239-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.healthcarefinancenews.com/news/eli-lilly-files-motion-prevent-giving-340b-drug-discounts-contract-pharmacies">"Eli Lilly files motion to prevent giving 340B drug discounts to contract pharmacies"</a>. <i>Healthcare Finance News</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210707181953/https://www.healthcarefinancenews.com/news/eli-lilly-files-motion-prevent-giving-340b-drug-discounts-contract-pharmacies">Archived</a> from the original on 7 July 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Healthcare+Finance+News&amp;rft.atitle=Eli+Lilly+files+motion+to+prevent+giving+340B+drug+discounts+to+contract+pharmacies&amp;rft_id=https%3A%2F%2Fwww.healthcarefinancenews.com%2Fnews%2Feli-lilly-files-motion-prevent-giving-340b-drug-discounts-contract-pharmacies&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-240"><span class="mw-cite-backlink"><b><a href="#cite_ref-240">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.lilly.com/news/stories/sustainability-in-340b-puts-patients-back-in-center">"Lilly.com"</a>. <i>Eli Lilly and Company</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022713/https://www.lilly.com/news/stories/sustainability-in-340b-puts-patients-back-in-center">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Eli+Lilly+and+Company&amp;rft.atitle=Lilly.com&amp;rft_id=https%3A%2F%2Fwww.lilly.com%2Fnews%2Fstories%2Fsustainability-in-340b-puts-patients-back-in-center&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-241"><span class="mw-cite-backlink"><b><a href="#cite_ref-241">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://340binformed.org/2021/11/eli-lilly-again-reports-big-revenue-gains-from-340b-denials/">"Eli Lilly Again Reports Big Revenue Gains From 340B Denials"</a>. <i>340binformed.org</i>. 1 November 2021. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221020051500/https://340binformed.org/2021/11/eli-lilly-again-reports-big-revenue-gains-from-340b-denials/">Archived</a> from the original on 20 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=340binformed.org&amp;rft.atitle=Eli+Lilly+Again+Reports+Big+Revenue+Gains+From+340B+Denials&amp;rft.date=2021-11-01&amp;rft_id=https%3A%2F%2F340binformed.org%2F2021%2F11%2Feli-lilly-again-reports-big-revenue-gains-from-340b-denials%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-242"><span class="mw-cite-backlink"><b><a href="#cite_ref-242">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWolfson" class="citation web cs1">Wolfson, Andrew. <a rel="nofollow" class="external text" href="https://www.usatoday.com/story/news/nation/2019/09/12/prozac-makers-secret-payment-mass-shooting-lawsuit-revealed/2302888001/">"Prozac maker paid millions to secure favorable verdict in mass shooting lawsuit, victims say"</a>. <i>USA TODAY</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221020051459/https://www.usatoday.com/story/news/nation/2019/09/12/prozac-makers-secret-payment-mass-shooting-lawsuit-revealed/2302888001/">Archived</a> from the original on 20 October 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=USA+TODAY&amp;rft.atitle=Prozac+maker+paid+millions+to+secure+favorable+verdict+in+mass+shooting+lawsuit%2C+victims+say&amp;rft.aulast=Wolfson&amp;rft.aufirst=Andrew&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fnation%2F2019%2F09%2F12%2Fprozac-makers-secret-payment-mass-shooting-lawsuit-revealed%2F2302888001%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-243"><span class="mw-cite-backlink"><b><a href="#cite_ref-243">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.drugwatch.com/ssri/prozac/lawsuits/">"Prozac Litigation - Link to Suicide, Birth Defects &amp; Class Action"</a>. <i>Drugwatch.com</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220321001151/https://www.drugwatch.com/ssri/prozac/lawsuits/">Archived</a> from the original on 21 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Drugwatch.com&amp;rft.atitle=Prozac+Litigation+-+Link+to+Suicide%2C+Birth+Defects+%26+Class+Action&amp;rft_id=https%3A%2F%2Fwww.drugwatch.com%2Fssri%2Fprozac%2Flawsuits%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-244"><span class="mw-cite-backlink"><b><a href="#cite_ref-244">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAngier1990" class="citation news cs1">Angier, Natalie (16 August 1990). <a rel="nofollow" class="external text" href="https://www.nytimes.com/1990/08/16/us/health-eli-lilly-facing-million-dollar-suits-on-its-antidepressant-drug-prozac.html">"HEALTH; Eli Lilly Facing Million-Dollar Suits On Its Antidepressant Drug Prozac"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/issn/0362-4331">0362-4331</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220320133424/https://www.nytimes.com/1990/08/16/us/health-eli-lilly-facing-million-dollar-suits-on-its-antidepressant-drug-prozac.html">Archived</a> from the original on 20 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=HEALTH%3B+Eli+Lilly+Facing+Million-Dollar+Suits+On+Its+Antidepressant+Drug+Prozac&amp;rft.date=1990-08-16&amp;rft.issn=0362-4331&amp;rft.aulast=Angier&amp;rft.aufirst=Natalie&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1990%2F08%2F16%2Fus%2Fhealth-eli-lilly-facing-million-dollar-suits-on-its-antidepressant-drug-prozac.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-245"><span class="mw-cite-backlink"><b><a href="#cite_ref-245">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.ft.com/content/903824a4-5a98-11d9-aa6e-00000e2511c8">"Eli Lilly in storm over Prozac evidence"</a>. <i>Financial Times</i>. 30 December 2004. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220320133423/https://www.ft.com/content/903824a4-5a98-11d9-aa6e-00000e2511c8">Archived</a> from the original on 20 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Financial+Times&amp;rft.atitle=Eli+Lilly+in+storm+over+Prozac+evidence&amp;rft.date=2004-12-30&amp;rft_id=https%3A%2F%2Fwww.ft.com%2Fcontent%2F903824a4-5a98-11d9-aa6e-00000e2511c8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-246"><span class="mw-cite-backlink"><b><a href="#cite_ref-246">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLeslieNewmanChesneyPerrin2005" class="citation journal cs1">Leslie, Laurel K.; Newman, Thomas B.; Chesney, P. Joan; Perrin, James M. (1 July 2005). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550709">"The Food and Drug Administration's Deliberations on Antidepressant Use in Pediatric Patients"</a>. <i>Pediatrics</i>. <b>116</b> (1): <span class="nowrap">195–</span>204. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1542%2Fpeds.2005-0074">10.1542/peds.2005-0074</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550709">1550709</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15995053">15995053</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatrics&amp;rft.atitle=The+Food+and+Drug+Administration%27s+Deliberations+on+Antidepressant+Use+in+Pediatric+Patients&amp;rft.volume=116&amp;rft.issue=1&amp;rft.pages=195-204&amp;rft.date=2005-07-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1550709%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15995053&amp;rft_id=info%3Adoi%2F10.1542%2Fpeds.2005-0074&amp;rft.aulast=Leslie&amp;rft.aufirst=Laurel+K.&amp;rft.au=Newman%2C+Thomas+B.&amp;rft.au=Chesney%2C+P.+Joan&amp;rft.au=Perrin%2C+James+M.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1550709&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-247"><span class="mw-cite-backlink"><b><a href="#cite_ref-247">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFFornaroAnastasiaValcheraCarano2019" class="citation journal cs1">Fornaro, Michele; Anastasia, Annalisa; Valchera, Alessandro; Carano, Alessandro; Orsolini, Laura; Vellante, Federica; et&#160;al. (3 May 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510161">"The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?"</a>. <i>Frontiers in Psychiatry</i>. <b>10</b>: 294. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffpsyt.2019.00294">10.3389/fpsyt.2019.00294</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="id-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510161">6510161</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31130881">31130881</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Psychiatry&amp;rft.atitle=The+FDA+%22Black+Box%22+Warning+on+Antidepressant+Suicide+Risk+in+Young+Adults%3A+More+Harm+Than+Benefits%3F&amp;rft.volume=10&amp;rft.pages=294&amp;rft.date=2019-05-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6510161%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31130881&amp;rft_id=info%3Adoi%2F10.3389%2Ffpsyt.2019.00294&amp;rft.aulast=Fornaro&amp;rft.aufirst=Michele&amp;rft.au=Anastasia%2C+Annalisa&amp;rft.au=Valchera%2C+Alessandro&amp;rft.au=Carano%2C+Alessandro&amp;rft.au=Orsolini%2C+Laura&amp;rft.au=Vellante%2C+Federica&amp;rft.au=Rapini%2C+Gabriella&amp;rft.au=Olivieri%2C+Luigi&amp;rft.au=Di+Natale%2C+Serena&amp;rft.au=Perna%2C+Giampaolo&amp;rft.au=Martinotti%2C+Giovanni&amp;rft.au=Di+Giannantonio%2C+Massimo&amp;rft.au=De+Berardis%2C+Domenico&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6510161&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-248"><span class="mw-cite-backlink"><b><a href="#cite_ref-248">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFResearch2018" class="citation journal cs1">Research, Center for Drug Evaluation and (3 November 2018). <a rel="nofollow" class="external text" href="https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medications">"Suicidality in Children and Adolescents Being Treated With Antidepressant Medications"</a>. <i>FDA</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20200823034643/https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medications">Archived</a> from the original on 23 August 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FDA&amp;rft.atitle=Suicidality+in+Children+and+Adolescents+Being+Treated+With+Antidepressant+Medications&amp;rft.date=2018-11-03&amp;rft.aulast=Research&amp;rft.aufirst=Center+for+Drug+Evaluation+and&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fpostmarket-drug-safety-information-patients-and-providers%2Fsuicidality-children-and-adolescents-being-treated-antidepressant-medications&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-NYT200101-249"><span class="mw-cite-backlink">^ <a href="#cite_ref-NYT200101_249-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NYT200101_249-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBerenson2007" class="citation news cs1">Berenson A (5 January 2007). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2007/01/05/business/05drug.html">"Lilly Settles With 18,000 Over Zyprexa"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170219132706/http://www.nytimes.com/2007/01/05/business/05drug.html">Archived</a> from the original on 19 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Lilly+Settles+With+18%2C000+Over+Zyprexa&amp;rft.date=2007-01-05&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2007%2F01%2F05%2Fbusiness%2F05drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-250"><span class="mw-cite-backlink"><b><a href="#cite_ref-250">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBerenson2007" class="citation news cs1">Berenson A (4 January 2007). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2007/01/04/business/04drug.html">"Mother Wonders if Psychosis Drug Helped Kill Son"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120901081344/http://www.nytimes.com/2007/01/04/business/04drug.html">Archived</a> from the original on 1 September 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">21 May</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Mother+Wonders+if+Psychosis+Drug+Helped+Kill+Son&amp;rft.date=2007-01-04&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2007%2F01%2F04%2Fbusiness%2F04drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-timeso-251"><span class="mw-cite-backlink"><b><a href="#cite_ref-timeso_251-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPagnamenta2007" class="citation news cs1">Pagnamenta, Robin (23 January 2007). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20070220232729/http://www.timesonline.co.uk/tol/life_and_style/health/article1295456.ece">"Eli Lilly was concerned by Zyprexa side-effects from 1998"</a>. <i>The Times (London)</i>. Archived from <a rel="nofollow" class="external text" href="http://www.timesonline.co.uk/tol/life_and_style/health/article1295456.ece">the original</a> on 20 February 2007.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Times+%28London%29&amp;rft.atitle=Eli+Lilly+was+concerned+by+Zyprexa+side-effects+from+1998&amp;rft.date=2007-01-23&amp;rft.aulast=Pagnamenta&amp;rft.aufirst=Robin&amp;rft_id=http%3A%2F%2Fwww.timesonline.co.uk%2Ftol%2Flife_and_style%2Fhealth%2Farticle1295456.ece&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-252"><span class="mw-cite-backlink"><b><a href="#cite_ref-252">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBerenson2008" class="citation news cs1">Berenson A (26 March 2008). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/03/26/business/26cnd-zyprexa.html">"Lilly Settles Alaska Suit Over Zyprexa"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170215125127/http://www.nytimes.com/2008/03/26/business/26cnd-zyprexa.html">Archived</a> from the original on 15 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">2 August</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Lilly+Settles+Alaska+Suit+Over+Zyprexa&amp;rft.date=2008-03-26&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2008%2F03%2F26%2Fbusiness%2F26cnd-zyprexa.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-NYT2009-01-253"><span class="mw-cite-backlink"><b><a href="#cite_ref-NYT2009-01_253-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHarrisBerenson2009" class="citation news cs1">Harris G, Berenson A (14 January 2009). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/01/15/business/15drug.html">"Lilly Said to Be Near $1.4 Billion U.S. Settlement"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170219132710/http://www.nytimes.com/2009/01/15/business/15drug.html">Archived</a> from the original on 19 February 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">2 August</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Lilly+Said+to+Be+Near+%241.4+Billion+U.S.+Settlement&amp;rft.date=2009-01-14&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft.au=Berenson%2C+Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F01%2F15%2Fbusiness%2F15drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-254"><span class="mw-cite-backlink"><b><a href="#cite_ref-254">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.nbcnews.com/health/health-news/eli-lilly-settles-zyprexa-lawsuit-1-42-billion-flna1C9453543">"Eli Lilly settles Zyprexa lawsuit for $1.42 billion"</a>. <i>NBC News</i>. 15 January 2009. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220823181557/https://www.nbcnews.com/health/health-news/eli-lilly-settles-zyprexa-lawsuit-1-42-billion-flna1C9453543">Archived</a> from the original on 23 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">2 August</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NBC+News&amp;rft.atitle=Eli+Lilly+settles+Zyprexa+lawsuit+for+%241.42+billion&amp;rft.date=2009-01-15&amp;rft_id=http%3A%2F%2Fwww.nbcnews.com%2Fhealth%2Fhealth-news%2Feli-lilly-settles-zyprexa-lawsuit-1-42-billion-flna1C9453543&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-255"><span class="mw-cite-backlink"><b><a href="#cite_ref-255">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWilson2010" class="citation news cs1">Wilson, Duff (2 October 2010). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2010/10/03/business/03psych.html">"Side Effects May Include Lawsuits"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110425033212/http://www.nytimes.com/2010/10/03/business/03psych.html">Archived</a> from the original on 25 April 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">23 September</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Side+Effects+May+Include+Lawsuits&amp;rft.date=2010-10-02&amp;rft.aulast=Wilson&amp;rft.aufirst=Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F10%2F03%2Fbusiness%2F03psych.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-Berenson-256"><span class="mw-cite-backlink"><b><a href="#cite_ref-Berenson_256-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBerenson2008" class="citation news cs1">Berenson, Alex (15 March 2008). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/03/15/business/15drug.html">"Eli Lilly E-Mail Discussed Unapproved Use of Drug"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022946/https://www.nytimes.com/2008/03/15/business/15drug.html">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">24 August</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Eli+Lilly+E-Mail+Discussed+Unapproved+Use+of+Drug&amp;rft.date=2008-03-15&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2008%2F03%2F15%2Fbusiness%2F15drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-257"><span class="mw-cite-backlink"><b><a href="#cite_ref-257">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFGottstein2021" class="citation book cs1">Gottstein, James (2021). <i>The Zyreza Papers</i>. Samizdat Health Writer's Cooperative 2021.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Zyreza+Papers&amp;rft.pub=Samizdat+Health+Writer%27s+Cooperative+2021&amp;rft.date=2021&amp;rft.aulast=Gottstein&amp;rft.aufirst=James&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span> <a rel="nofollow" class="external free" href="https://thezyprexapapers.com/">https://thezyprexapapers.com/</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220404200609/https://thezyprexapapers.com/">Archived</a> 4 April 2022 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a>. Retrieved 21-10-26.</span>
</li>
<li id="cite_note-258"><span class="mw-cite-backlink"><b><a href="#cite_ref-258">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.psychiatrictimes.com/view/the-fight-for-pharma-accountability-and-psychiatric-rights-jim-gottstein-esq">"The Fight for Pharma Accountability and Psychiatric Rights: Jim Gottstein, Esq"</a>. <i>Psychiatric Times</i>. 2 August 2022. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220803034135/https://www.psychiatrictimes.com/view/the-fight-for-pharma-accountability-and-psychiatric-rights-jim-gottstein-esq">Archived</a> from the original on 3 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">2 August</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Psychiatric+Times&amp;rft.atitle=The+Fight+for+Pharma+Accountability+and+Psychiatric+Rights%3A+Jim+Gottstein%2C+Esq&amp;rft.date=2022-08-02&amp;rft_id=https%3A%2F%2Fwww.psychiatrictimes.com%2Fview%2Fthe-fight-for-pharma-accountability-and-psychiatric-rights-jim-gottstein-esq&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-259"><span class="mw-cite-backlink"><b><a href="#cite_ref-259">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.forbes.com/sites/carlieporterfield/2021/03/30/eli-lilly-is-facing-a-lawsuit-alleging-a-sexually-hostile-work-environment-from-a-former-lobbyist/">"Eli Lilly is Facing a Lawsuit Alleging A 'Sexually Hostile Work Environment' from a Former Lobbyist"</a>. <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022947/https://www.forbes.com/sites/carlieporterfield/2021/03/30/eli-lilly-is-facing-a-lawsuit-alleging-a-sexually-hostile-work-environment-from-a-former-lobbyist/">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Eli+Lilly+is+Facing+a+Lawsuit+Alleging+A+%27Sexually+Hostile+Work+Environment%27+from+a+Former+Lobbyist&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fcarlieporterfield%2F2021%2F03%2F30%2Feli-lilly-is-facing-a-lawsuit-alleging-a-sexually-hostile-work-environment-from-a-former-lobbyist%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-260"><span class="mw-cite-backlink"><b><a href="#cite_ref-260">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFHiggins-Dunn2021" class="citation news cs1">Higgins-Dunn, Noah (30 June 2021). <a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/amid-rush-scandals-eli-lilly-resolves-sex-discrimination-harassment-suit-former-lobbyist">"Amid rush of scandals, Eli Lilly settles sex discrimination, harassment suit with former lobbyist"</a>. <i>Fierce Pharma</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20210630153148/https://www.fiercepharma.com/pharma/amid-rush-scandals-eli-lilly-resolves-sex-discrimination-harassment-suit-former-lobbyist">Archived</a> from the original on 30 June 2021<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Fierce+Pharma&amp;rft.atitle=Amid+rush+of+scandals%2C+Eli+Lilly+settles+sex+discrimination%2C+harassment+suit+with+former+lobbyist&amp;rft.date=2021-06-30&amp;rft.aulast=Higgins-Dunn&amp;rft.aufirst=Noah&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Famid-rush-scandals-eli-lilly-resolves-sex-discrimination-harassment-suit-former-lobbyist&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-261"><span class="mw-cite-backlink"><b><a href="#cite_ref-261">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTerrell" class="citation web cs1">Terrell, Kenneth. <a rel="nofollow" class="external text" href="https://www.aarp.org/work/age-discrimination/eli-lilly/">"Older Workers Sue Eli Lilly for Age Discrimination"</a>. <i>AARP</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220801022946/https://www.aarp.org/work/age-discrimination/eli-lilly/">Archived</a> from the original on 1 August 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=AARP&amp;rft.atitle=Older+Workers+Sue+Eli+Lilly+for+Age+Discrimination&amp;rft.aulast=Terrell&amp;rft.aufirst=Kenneth&amp;rft_id=https%3A%2F%2Fwww.aarp.org%2Fwork%2Fage-discrimination%2Feli-lilly%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-262"><span class="mw-cite-backlink"><b><a href="#cite_ref-262">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFStastna2013" class="citation web cs1">Stastna, Kazi (13 September 2013). <a rel="nofollow" class="external text" href="http://www.cbc.ca/news/business/eli-lilly-files-500m-nafta-suit-against-canada-over-drug-patents-1.1829854">"Eli Lilly files $500M NAFTA suit against Canada over drug patents"</a>. CBC. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150326105247/http://www.cbc.ca/news/business/eli-lilly-files-500m-nafta-suit-against-canada-over-drug-patents-1.1829854">Archived</a> from the original on 26 March 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">1 April</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+files+%24500M+NAFTA+suit+against+Canada+over+drug+patents&amp;rft.pub=CBC&amp;rft.date=2013-09-13&amp;rft.aulast=Stastna&amp;rft.aufirst=Kazi&amp;rft_id=http%3A%2F%2Fwww.cbc.ca%2Fnews%2Fbusiness%2Feli-lilly-files-500m-nafta-suit-against-canada-over-drug-patents-1.1829854&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-263"><span class="mw-cite-backlink"><b><a href="#cite_ref-263">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMelnitzer2017" class="citation news cs1">Melnitzer, Julius (27 March 2017). <a rel="nofollow" class="external text" href="https://financialpost.com/legal-post/eli-lilly-loses-nafta-challenge-brought-against-canada">"Eli Lilly loses NAFTA challenge brought against Canada"</a>. <i>Financial Post</i><span class="reference-accessdate">. Retrieved <span class="nowrap">8 March</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Financial+Post&amp;rft.atitle=Eli+Lilly+loses+NAFTA+challenge+brought+against+Canada&amp;rft.date=2017-03-27&amp;rft.aulast=Melnitzer&amp;rft.aufirst=Julius&amp;rft_id=https%3A%2F%2Ffinancialpost.com%2Flegal-post%2Feli-lilly-loses-nafta-challenge-brought-against-canada&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-264"><span class="mw-cite-backlink"><b><a href="#cite_ref-264">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.justice.gov/archive/opa/pr/2005/December/05_civ_685.html">"#05-685: 12-21-05 Eli Lilly and Company to Pay U.S. $36 Million Relating to Off-Label Promotion"</a>. <i>www.justice.gov</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20220320144612/https://www.justice.gov/archive/opa/pr/2005/December/05_civ_685.html">Archived</a> from the original on 20 March 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.justice.gov&amp;rft.atitle=%2305-685%3A+12-21-05+Eli+Lilly+and+Company+to+Pay+U.S.+%2436+Million+Relating+to+Off-Label+Promotion&amp;rft_id=https%3A%2F%2Fwww.justice.gov%2Farchive%2Fopa%2Fpr%2F2005%2FDecember%2F05_civ_685.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-265"><span class="mw-cite-backlink"><b><a href="#cite_ref-265">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFAbutaleb2019" class="citation news cs1">Abutaleb, Yasmeen (30 January 2019). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-usa-healthcare-insulin/u-s-lawmakers-request-info-from-insulin-makers-on-rising-prices-idUSKCN1PO2LQ">"U.S. lawmakers request info from insulin makers on rising prices"</a>. Reuters. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20190131230558/https://www.reuters.com/article/us-usa-healthcare-insulin/u-s-lawmakers-request-info-from-insulin-makers-on-rising-prices-idUSKCN1PO2LQ">Archived</a> from the original on 31 January 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">1 February</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=U.S.+lawmakers+request+info+from+insulin+makers+on+rising+prices&amp;rft.date=2019-01-30&amp;rft.aulast=Abutaleb&amp;rft.aufirst=Yasmeen&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-usa-healthcare-insulin%2Fu-s-lawmakers-request-info-from-insulin-makers-on-rising-prices-idUSKCN1PO2LQ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-thestar-266"><span class="mw-cite-backlink"><b><a href="#cite_ref-thestar_266-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFJiang2022" class="citation web cs1">Jiang, Kevin (11 November 2022). <a rel="nofollow" class="external text" href="https://www.thestar.com/business/technology/2022/11/11/eli-lilly-loses-billions-in-market-cap-after-verified-twitter-impostor-promises-free-insulin.html">"Eli Lilly loses billions in market cap after 'verified' Twitter impostor promises free insulin"</a>. <i><a href="/wiki/Toronto_Star" title="Toronto Star">TheStar.com</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221114120039/https://www.thestar.com/business/technology/2022/11/11/eli-lilly-loses-billions-in-market-cap-after-verified-twitter-impostor-promises-free-insulin.html">Archived</a> from the original on 14 November 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">14 November</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=TheStar.com&amp;rft.atitle=Eli+Lilly+loses+billions+in+market+cap+after+%27verified%27+Twitter+impostor+promises+free+insulin&amp;rft.date=2022-11-11&amp;rft.aulast=Jiang&amp;rft.aufirst=Kevin&amp;rft_id=https%3A%2F%2Fwww.thestar.com%2Fbusiness%2Ftechnology%2F2022%2F11%2F11%2Feli-lilly-loses-billions-in-market-cap-after-verified-twitter-impostor-promises-free-insulin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-forbes1-267"><span class="mw-cite-backlink"><b><a href="#cite_ref-forbes1_267-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFLee2022" class="citation web cs1">Lee, Bruce Y. (12 November 2022). <a rel="nofollow" class="external text" href="https://www.forbes.com/sites/brucelee/2022/11/12/fake-eli-lilly-twitter-account-claims-insulin-is-free-stock-falls-43/?sh=5c04b4b941a3">"Fake Eli Lilly Twitter Account Claims Insulin Is Free, Stock Falls 4.37%"</a>. <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221114120515/https://www.forbes.com/sites/brucelee/2022/11/12/fake-eli-lilly-twitter-account-claims-insulin-is-free-stock-falls-43/">Archived</a> from the original on 14 November 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">14 November</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Fake+Eli+Lilly+Twitter+Account+Claims+Insulin+Is+Free%2C+Stock+Falls+4.37%25&amp;rft.date=2022-11-12&amp;rft.aulast=Lee&amp;rft.aufirst=Bruce+Y.&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fbrucelee%2F2022%2F11%2F12%2Ffake-eli-lilly-twitter-account-claims-insulin-is-free-stock-falls-43%2F%3Fsh%3D5c04b4b941a3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-forbes2-268"><span class="mw-cite-backlink"><b><a href="#cite_ref-forbes2_268-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFDellatto2022" class="citation web cs1">Dellatto, Marisa (10 November 2022). <a rel="nofollow" class="external text" href="https://www.forbes.com/sites/marisadellatto/2022/11/10/eli-lilly-clarifies-its-not-offering-free-insulin-after-tweet-from-fake-verified-account-as-chaos-unfolds-on-twitter/?sh=2cceedcb51a3">"Eli Lilly Clarifies It's Not Offering Free Insulin After Tweet From Fake Verified Account—As Chaos Unfolds On Twitter"</a>. <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20221114120223/https://www.forbes.com/sites/marisadellatto/2022/11/10/eli-lilly-clarifies-its-not-offering-free-insulin-after-tweet-from-fake-verified-account-as-chaos-unfolds-on-twitter/">Archived</a> from the original on 14 November 2022<span class="reference-accessdate">. Retrieved <span class="nowrap">14 November</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Eli+Lilly+Clarifies+It%27s+Not+Offering+Free+Insulin+After+Tweet+From+Fake+Verified+Account%E2%80%94As+Chaos+Unfolds+On+Twitter&amp;rft.date=2022-11-10&amp;rft.aulast=Dellatto&amp;rft.aufirst=Marisa&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fmarisadellatto%2F2022%2F11%2F10%2Feli-lilly-clarifies-its-not-offering-free-insulin-after-tweet-from-fake-verified-account-as-chaos-unfolds-on-twitter%2F%3Fsh%3D2cceedcb51a3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
<li id="cite_note-Robbins_2023-269"><span class="mw-cite-backlink"><b><a href="#cite_ref-Robbins_2023_269-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="Robbins_2023" class="citation news cs1">Robbins, Rebecca (1 March 2023). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2023/03/01/business/insulin-price-cap-eli-lilly.html?smid=tw-nytimes&amp;smtyp=cur">"Eli Lilly Says It Will Cut the Price of Insulin"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i><span class="reference-accessdate">. Retrieved <span class="nowrap">1 March</span> 2023</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Eli+Lilly+Says+It+Will+Cut+the+Price+of+Insulin&amp;rft.date=2023-03-01&amp;rft.aulast=Robbins&amp;rft.aufirst=Rebecca&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2023%2F03%2F01%2Fbusiness%2Finsulin-price-cap-eli-lilly.html%3Fsmid%3Dtw-nytimes%26smtyp%3Dcur&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></span>
</li>
</ol></div></div>
<div class="mw-heading mw-heading2"><h2 id="Bibliography">Bibliography</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=43" title="Edit section: Bibliography"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<ul><li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFBodenhamerBarrows1994" class="citation book cs1">Bodenhamer, David J; Barrows, Robert G, eds. (1994). <i>The Encyclopedia of Indianapolis</i>. Bloomington and Indianapolis: Indiana University Press. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-253-31222-8" title="Special:BookSources/978-0-253-31222-8"><bdi>978-0-253-31222-8</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Encyclopedia+of+Indianapolis&amp;rft.place=Bloomington+and+Indianapolis&amp;rft.pub=Indiana+University+Press&amp;rft.date=1994&amp;rft.isbn=978-0-253-31222-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160729072945/http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">"Eli Lilly &amp; Company"</a> <span class="cs1-format">(PDF)</span>. Indiana Historical Society. Archived from <a rel="nofollow" class="external text" href="http://www.indianahistory.org/our-services/books-publications/hbr/eli-lilly.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 29 July 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">24 October</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Eli+Lilly+%26+Company&amp;rft.pub=Indiana+Historical+Society&amp;rft_id=http%3A%2F%2Fwww.indianahistory.org%2Four-services%2Fbooks-publications%2Fhbr%2Feli-lilly.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFKahn1975" class="citation book cs1">Kahn, E. J. (1975). <i>All In A Century: The First 100 Years of Eli Lilly and Company</i>. West Cornwall, CT. <a href="/wiki/OCLC_(identifier)" class="mw-redirect" title="OCLC (identifier)">OCLC</a>&#160;<a rel="nofollow" class="external text" href="https://search.worldcat.org/oclc/5288809">5288809</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=All+In+A+Century%3A+The+First+100+Years+of+Eli+Lilly+and+Company&amp;rft.place=West+Cornwall%2C+CT&amp;rft.date=1975&amp;rft_id=info%3Aoclcnum%2F5288809&amp;rft.aulast=Kahn&amp;rft.aufirst=E.+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span><span class="cs1-maint citation-comment"><code class="cs1-code">{{<a href="/wiki/Template:Cite_book" title="Template:Cite book">cite book</a>}}</code>:  CS1 maint: location missing publisher (<a href="/wiki/Category:CS1_maint:_location_missing_publisher" title="Category:CS1 maint: location missing publisher">link</a>)</span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMadison1989" class="citation book cs1">Madison, James H. (1989). <a rel="nofollow" class="external text" href="https://archive.org/details/elilillylife188500madi"><i>Eli Lilly: A Life, 1885&#8211;1977</i></a>. Indianapolis: Indiana Historical Society. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-87195-047-5" title="Special:BookSources/978-0-87195-047-5"><bdi>978-0-87195-047-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Eli+Lilly%3A+A+Life%2C+1885%26ndash%3B1977&amp;rft.place=Indianapolis&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-047-5&amp;rft.aulast=Madison&amp;rft.aufirst=James+H.&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Felilillylife188500madi&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFMadison1989" class="citation journal cs1">Madison, James H. (1989). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20130514134313/http://thebhc.org/publications/BEHprint/v018/p0072-p0078.pdf">"Manufacturing Pharmaceuticals: Eli Lilly and Company, 1876–1948"</a> <span class="cs1-format">(PDF)</span>. <i>Business and Economic History</i>. <b>18</b>. Business History Conference: 72. Archived from <a rel="nofollow" class="external text" href="https://www.thebhc.org/publications/BEHprint/v018/p0072-p0078.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 14 May 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">20 February</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+and+Economic+History&amp;rft.atitle=Manufacturing+Pharmaceuticals%3A+Eli+Lilly+and+Company%2C+1876%E2%80%931948&amp;rft.volume=18&amp;rft.pages=72&amp;rft.date=1989&amp;rft.aulast=Madison&amp;rft.aufirst=James+H.&amp;rft_id=http%3A%2F%2Fwww.thebhc.org%2Fpublications%2FBEHprint%2Fv018%2Fp0072-p0078.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPodczeckJones2004" class="citation book cs1">Podczeck, Fridrun; Jones, Brian E. (2004). <i>Pharmaceutical Capsules</i>. Chicago: Pharmaceutical Press. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-85369-568-4" title="Special:BookSources/978-0-85369-568-4"><bdi>978-0-85369-568-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmaceutical+Capsules&amp;rft.place=Chicago&amp;rft.pub=Pharmaceutical+Press&amp;rft.date=2004&amp;rft.isbn=978-0-85369-568-4&amp;rft.aulast=Podczeck&amp;rft.aufirst=Fridrun&amp;rft.au=Jones%2C+Brian+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFPrice1997" class="citation book cs1">Price, Nelson (1997). <i>Indiana Legends: Famous Hoosiers From Johnny Appleseed to David Letterman</i>. Indianapolis: Guild Press of Indiana. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-57860-006-9" title="Special:BookSources/978-1-57860-006-9"><bdi>978-1-57860-006-9</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana+Legends%3A+Famous+Hoosiers+From+Johnny+Appleseed+to+David+Letterman&amp;rft.place=Indianapolis&amp;rft.pub=Guild+Press+of+Indiana&amp;rft.date=1997&amp;rft.isbn=978-1-57860-006-9&amp;rft.aulast=Price&amp;rft.aufirst=Nelson&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTaylor_Jr.StevensPonderBrockman1989" class="citation book cs1">Taylor Jr., Robert M.; Stevens, Errol Wayne; Ponder, Mary Ann; Brockman, Paul (1989). <i>Indiana: A New Historical Guide</i>. Indianapolis: Indiana Historical Society. p.&#160;481. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-87195-048-2" title="Special:BookSources/978-0-87195-048-2"><bdi>978-0-87195-048-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Indiana%3A+A+New+Historical+Guide&amp;rft.place=Indianapolis&amp;rft.pages=481&amp;rft.pub=Indiana+Historical+Society&amp;rft.date=1989&amp;rft.isbn=978-0-87195-048-2&amp;rft.aulast=Taylor+Jr.&amp;rft.aufirst=Robert+M.&amp;rft.au=Stevens%2C+Errol+Wayne&amp;rft.au=Ponder%2C+Mary+Ann&amp;rft.au=Brockman%2C+Paul&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFTobiasTobias2003" class="citation book cs1">Tobias, Randall; Tobias, Todd (2003). <a rel="nofollow" class="external text" href="https://archive.org/details/putmooseontablel0000tobi"><i>Put the Moose on the Table: Lessons in Leadership from a CEO's Journey through Business and Life</i></a>. Indiana University Press. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-253-11011-4" title="Special:BookSources/978-0-253-11011-4"><bdi>978-0-253-11011-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Put+the+Moose+on+the+Table%3A+Lessons+in+Leadership+from+a+CEO%27s+Journey+through+Business+and+Life&amp;rft.pub=Indiana+University+Press&amp;rft.date=2003&amp;rft.isbn=978-0-253-11011-4&amp;rft.aulast=Tobias&amp;rft.aufirst=Randall&amp;rft.au=Tobias%2C+Todd&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fputmooseontablel0000tobi&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></li>
<li><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1238218222" /><cite id="CITEREFWeintrautNolan" class="citation journal cs1">Weintraut, Linda; Nolan, Jane R. "The Secret Life of Building 314". <i>Traces of Indiana and Midwestern History</i>. <b>8</b> (3). Indianapolis: Indiana Historical Society: <span class="nowrap">16–</span>27.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Traces+of+Indiana+and+Midwestern+History&amp;rft.atitle=The+Secret+Life+of+Building+314&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=16-27&amp;rft.aulast=Weintraut&amp;rft.aufirst=Linda&amp;rft.au=Nolan%2C+Jane+R.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AEli+Lilly+and+Company" class="Z3988"></span></li></ul>
<div class="mw-heading mw-heading2"><h2 id="External_links">External links</h2><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Eli_Lilly_and_Company&amp;action=edit&amp;section=44" title="Edit section: External links"><span>edit</span></a><span class="mw-editsection-bracket">]</span></span></div>
<style data-mw-deduplicate="TemplateStyles:r1235681985">.mw-parser-output .side-box{margin:4px 0;box-sizing:border-box;border:1px solid #aaa;font-size:88%;line-height:1.25em;background-color:var(--background-color-interactive-subtle,#f8f9fa);display:flow-root}.mw-parser-output .side-box-abovebelow,.mw-parser-output .side-box-text{padding:0.25em 0.9em}.mw-parser-output .side-box-image{padding:2px 0 2px 0.9em;text-align:center}.mw-parser-output .side-box-imageright{padding:2px 0.9em 2px 0;text-align:center}@media(min-width:500px){.mw-parser-output .side-box-flex{display:flex;align-items:center}.mw-parser-output .side-box-text{flex:1;min-width:0}}@media(min-width:720px){.mw-parser-output .side-box{width:238px}.mw-parser-output .side-box-right{clear:right;float:right;margin-left:1em}.mw-parser-output .side-box-left{margin-right:1em}}</style><style data-mw-deduplicate="TemplateStyles:r1237033735">@media print{body.ns-0 .mw-parser-output .sistersitebox{display:none!important}}@media screen{html.skin-theme-clientpref-night .mw-parser-output .sistersitebox img[src*="Wiktionary-logo-en-v2.svg"]{background-color:white}}@media screen and (prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .sistersitebox img[src*="Wiktionary-logo-en-v2.svg"]{background-color:white}}</style><div class="side-box side-box-right plainlinks sistersitebox"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1126788409" />
<div class="side-box-flex">
<div class="side-box-image"><span class="noviewer" typeof="mw:File"><a href="/wiki/File:Commons-logo.svg" class="mw-file-description"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/40px-Commons-logo.svg.png" decoding="async" width="30" height="40" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/60px-Commons-logo.svg.png 1.5x" data-file-width="1024" data-file-height="1376" /></a></span></div>
<div class="side-box-text plainlist">Wikimedia Commons has media related to <span style="font-weight: bold; font-style: italic;"><a href="https://commons.wikimedia.org/wiki/Category:Eli_Lilly_and_Company" class="extiw" title="commons:Category:Eli Lilly and Company">Eli Lilly and Company</a></span>.</div></div>
</div>
<ul><li><span class="official-website"><span class="url"><a rel="nofollow" class="external text" href="http://www.lilly.com/">Official website</a></span></span> <span class="mw-valign-text-top" typeof="mw:File/Frameless"><a href="https://www.wikidata.org/wiki/Q632240#P856" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" class="mw-file-element" data-file-width="20" data-file-height="20" /></a></span></li>
<li><i><a rel="nofollow" class="external text" href="https://digital.sciencehistory.org/works/k0698840f">Hand book of pharmacy and therapeutics</a></i>, <a href="/wiki/Science_History_Institute" title="Science History Institute">Science History Institute</a>, <abbr title="circa">c.</abbr><span style="white-space:nowrap;">&#8201;1919</span></li>
<li>Business data for Eli Lilly and Company: <style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><div class="hlist inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance/quote/LLY:NYSE">Google</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=59478">SEC filings</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/quote/LLY">Yahoo!</a></li></ul></div></li></ul>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><style data-mw-deduplicate="TemplateStyles:r1236075235">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}body.skin--responsive .mw-parser-output .navbox-image img{max-width:none!important}@media print{body.ns-0 .mw-parser-output .navbox{display:none!important}}</style></div><div role="navigation" class="navbox" aria-labelledby="Eli_Lilly_and_Company91" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><style data-mw-deduplicate="TemplateStyles:r1239400231">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}html.skin-theme-clientpref-night .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}@media(prefers-color-scheme:dark){html.skin-theme-clientpref-os .mw-parser-output .navbar li a abbr{color:var(--color-base)!important}}@media print{.mw-parser-output .navbar{display:none!important}}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Eli_Lilly_and_Company" title="Template:Eli Lilly and Company"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Eli_Lilly_and_Company" title="Template talk:Eli Lilly and Company"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Eli_Lilly_and_Company" title="Special:EditPage/Template:Eli Lilly and Company"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Eli_Lilly_and_Company91" style="font-size:114%;margin:0 4em"><a class="mw-selflink selflink">Eli Lilly and Company</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Corporation" title="Corporation">Corporate</a> <a href="/wiki/Board_of_directors" title="Board of directors">directors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/John_C._Lechleiter" title="John C. Lechleiter">John C. Lechleiter</a></li>
<li><a href="/wiki/Ralph_Alvarez" title="Ralph Alvarez">Ralph Alvarez</a></li>
<li><a href="/wiki/Winfried_Bischoff" title="Winfried Bischoff">Sir Winfried Bischoff</a></li>
<li><a href="/wiki/Michael_L._Eskew" title="Michael L. Eskew">Michael L. Eskew</a></li>
<li><a href="/wiki/Martin_Feldstein" title="Martin Feldstein">Martin S. Feldstein</a></li>
<li><a href="/w/index.php?title=J._Erik_Fyrwald&amp;action=edit&amp;redlink=1" class="new" title="J. Erik Fyrwald (page does not exist)">J. Erik Fyrwald</a></li>
<li><a href="/wiki/Alfred_G._Gilman" title="Alfred G. Gilman">Alfred G. Gilman</a></li>
<li><a href="/wiki/Karen_N._Horn" title="Karen N. Horn">Karen N. Horn</a></li>
<li><a href="/w/index.php?title=Ellen_R._Marram&amp;action=edit&amp;redlink=1" class="new" title="Ellen R. Marram (page does not exist)">Ellen R. Marram</a></li>
<li><a href="/wiki/Douglas_R._Oberhelman" class="mw-redirect" title="Douglas R. Oberhelman">Douglas R. Oberhelman</a></li>
<li><a href="/w/index.php?title=Franklyn_G._Prendergast&amp;action=edit&amp;redlink=1" class="new" title="Franklyn G. Prendergast (page does not exist)">Franklyn G. Prendergast</a></li>
<li><a href="/wiki/Kathi_Seifert" title="Kathi Seifert">Kathi P. Seifert</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Products</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Adcirca" class="mw-redirect" title="Adcirca">Adcirca</a></li>
<li><a href="/wiki/Pemetrexed" title="Pemetrexed">Alimta</a></li>
<li><a href="/wiki/Amyvid" class="mw-redirect" title="Amyvid">Amyvid</a></li>
<li><a href="/wiki/Bamlanivimab" title="Bamlanivimab">Bamlanivimab</a></li>
<li><a href="/wiki/Baqsimi" class="mw-redirect" title="Baqsimi">Baqsimi</a></li>
<li><a href="/wiki/Baricitinib" title="Baricitinib">Baricitinib</a></li>
<li><a href="/wiki/Basaglar" class="mw-redirect" title="Basaglar">Basaglar</a></li>
<li><a href="/wiki/Tadalafil" title="Tadalafil">Cialis</a></li>
<li><a href="/wiki/Duloxetine" title="Duloxetine">Cymbalta</a></li>
<li><a href="/wiki/Cyramza" class="mw-redirect" title="Cyramza">Cyramza</a></li>
<li><a href="/wiki/Emgality" class="mw-redirect" title="Emgality">Emgality</a></li>
<li><a href="/wiki/Erbitux" class="mw-redirect" title="Erbitux">Erbitux</a></li>
<li><a href="/wiki/Etesevimab" class="mw-redirect" title="Etesevimab">Etesevimab</a></li>
<li><a href="/wiki/Raloxifene" title="Raloxifene">Evista</a></li>
<li><a href="/wiki/Teriparatide" title="Teriparatide">Forteo</a></li>
<li><a href="/wiki/Gemcitabine" title="Gemcitabine">Gemzar</a></li>
<li><a href="/wiki/Glucagon_(medication)" title="Glucagon (medication)">Glucagon</a></li>
<li><a href="/wiki/Glyxambi" class="mw-redirect" title="Glyxambi">Glyxambi</a></li>
<li><a href="/wiki/Insulin_lispro" title="Insulin lispro">Humalog</a></li>
<li><a href="/wiki/Humatrope" class="mw-redirect" title="Humatrope">Humatrope</a></li>
<li><a href="/wiki/Humulin" class="mw-redirect" title="Humulin">Humulin</a></li>
<li><a href="/wiki/Jardiance" class="mw-redirect" title="Jardiance">Jardiance</a></li>
<li><a href="/wiki/Jaypirca" class="mw-redirect" title="Jaypirca">Jaypirca</a></li>
<li><a href="/wiki/Jentadueto" class="mw-redirect" title="Jentadueto">Jentadueto</a></li>
<li><a href="/wiki/Kisunla" class="mw-redirect" title="Kisunla">Kisunla</a></li>
<li><a href="/wiki/Lyumjev" class="mw-redirect" title="Lyumjev">Lyumjev</a></li>
<li><a href="/wiki/Olumiant" class="mw-redirect" title="Olumiant">Olumiant</a></li>
<li><a href="/wiki/Portrazza" class="mw-redirect" title="Portrazza">Portrazza</a></li>
<li><a href="/wiki/Fluoxetine" title="Fluoxetine">Prozac</a></li>
<li><a href="/wiki/Retevmo" class="mw-redirect" title="Retevmo">Retevmo</a></li>
<li><a href="/wiki/Reyvow" class="mw-redirect" title="Reyvow">Reyvow</a></li>
<li><a href="/wiki/Atomoxetine" title="Atomoxetine">Strattera</a></li>
<li><a href="/wiki/Olanzapine/fluoxetine" title="Olanzapine/fluoxetine">Symbyax</a></li>
<li><a href="/wiki/Synjardy" class="mw-redirect" title="Synjardy">Synjardy</a></li>
<li><a href="/wiki/Taltz" class="mw-redirect" title="Taltz">Taltz</a></li>
<li><a href="/wiki/Tradjenta" class="mw-redirect" title="Tradjenta">Tradjenta</a></li>
<li><a href="/wiki/Trijardy" class="mw-redirect" title="Trijardy">Trijardy</a></li>
<li><a href="/wiki/Trulicity" class="mw-redirect" title="Trulicity">Trulicity</a></li>
<li><a href="/wiki/Verzenio" class="mw-redirect" title="Verzenio">Verzenio</a></li>
<li><a href="/wiki/Drotrecogin_alfa" title="Drotrecogin alfa">Xigris</a></li>
<li><a href="/wiki/Olanzapine" title="Olanzapine">Zyprexa</a></li></ul>
</div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235" /></div><div role="navigation" class="navbox" aria-labelledby="Pharmaceutical_companies_of_the_United_States156" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1239400231" /><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Pharmaceutical_companies_of_the_United_States" title="Template:Pharmaceutical companies of the United States"><abbr title="View this template">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Pharmaceutical_companies_of_the_United_States" title="Template talk:Pharmaceutical companies of the United States"><abbr title="Discuss this template">t</abbr></a></li><li class="nv-edit"><a href="/wiki/Special:EditPage/Template:Pharmaceutical_companies_of_the_United_States" title="Special:EditPage/Template:Pharmaceutical companies of the United States"><abbr title="Edit this template">e</abbr></a></li></ul></div><div id="Pharmaceutical_companies_of_the_United_States156" style="font-size:114%;margin:0 4em"><a href="/wiki/Category:Pharmaceutical_companies_of_the_United_States" title="Category:Pharmaceutical companies of the United States">Pharmaceutical companies of the United States</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Current</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Abbott_Laboratories" title="Abbott Laboratories">Abbott Laboratories</a></li>
<li><a href="/wiki/AbbVie" title="AbbVie">AbbVie Inc.</a></li>
<li><a href="/wiki/Acorda_Therapeutics" title="Acorda Therapeutics">Acorda Therapeutics</a></li>
<li><a href="/wiki/Advaxis" title="Advaxis">Advaxis</a></li>
<li><a href="/wiki/Alcon" title="Alcon">Alcon</a></li>
<li><a href="/wiki/Alexion_Pharmaceuticals" title="Alexion Pharmaceuticals">Alexion</a></li>
<li><a href="/wiki/Alnylam" class="mw-redirect" title="Alnylam">Alnylam</a></li>
<li><a href="/wiki/Amgen" title="Amgen">Amgen</a></li>
<li><a href="/wiki/Amneal_Pharmaceuticals" title="Amneal Pharmaceuticals">Amneal Pharmaceuticals</a></li>
<li><a href="/wiki/Avax_Technologies" title="Avax Technologies">Avax Technologies</a></li>
<li><a href="/wiki/Baxter_International" title="Baxter International">Baxter</a></li>
<li><a href="/wiki/BioCryst_Pharmaceuticals" title="BioCryst Pharmaceuticals">BioCryst</a></li>
<li><a href="/wiki/Biogen" title="Biogen">Biogen</a></li>
<li><a href="/wiki/Bioverativ" title="Bioverativ">Bioverativ</a></li>
<li><a href="/wiki/Biovest" title="Biovest">Biovest</a></li>
<li><a href="/wiki/Biovista" title="Biovista">Biovista</a></li>
<li><a href="/wiki/Bristol_Myers_Squibb" title="Bristol Myers Squibb">Bristol Myers Squibb</a></li>
<li><a href="/wiki/Century_Pharmaceuticals" title="Century Pharmaceuticals">Century</a></li>
<li><a href="/wiki/Ceragenix_Pharmaceuticals" title="Ceragenix Pharmaceuticals">Ceragenix</a></li>
<li><a href="/wiki/Combe_Incorporated" title="Combe Incorporated">Combe</a></li>
<li><a href="/wiki/CytoSport" title="CytoSport">CytoSport</a></li>
<li><a href="/wiki/CytRx" title="CytRx">CytRx</a></li>
<li><a href="/wiki/Danco_Laboratories" title="Danco Laboratories">Danco Laboratories</a></li>
<li><a class="mw-selflink selflink">Eli Lilly</a></li>
<li><a href="/wiki/Galena_Biopharma" title="Galena Biopharma">Galena Biopharma</a></li>
<li><a href="/wiki/Genentech" title="Genentech">Genentech</a></li>
<li><a href="/wiki/Gilead_Sciences" title="Gilead Sciences">Gilead Sciences</a></li>
<li><a href="/wiki/Ionis_Pharmaceuticals" title="Ionis Pharmaceuticals">Ionis</a></li>
<li><a href="/wiki/Institute_for_OneWorld_Health" class="mw-redirect" title="Institute for OneWorld Health">Institute for OneWorld Health</a></li>
<li><a href="/wiki/Intercept_Pharmaceuticals" title="Intercept Pharmaceuticals">Intercept</a></li>
<li><a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">Johnson &amp; Johnson</a>
<ul><li><a href="/wiki/Ethicon" title="Ethicon">Ethicon</a></li>
<li><a href="/wiki/Janssen_Biotech" class="mw-redirect" title="Janssen Biotech">Janssen Biotech</a></li>
<li><a href="/wiki/McNeil_Consumer_Healthcare" title="McNeil Consumer Healthcare">McNeil Consumer Healthcare</a></li>
<li><a href="/wiki/Ortho-McNeil_Pharmaceutical" title="Ortho-McNeil Pharmaceutical">Ortho-McNeil</a></li></ul></li>
<li><a href="/wiki/Kinetic_Concepts" title="Kinetic Concepts">Kinetic Concepts</a></li>
<li><a href="/wiki/McKesson_Corporation" title="McKesson Corporation">McKesson</a></li>
<li><a href="/wiki/Melinta_Therapeutics" title="Melinta Therapeutics">Melinta Therapeutics</a></li>
<li><a href="/wiki/Melior_Discovery" title="Melior Discovery">Melior Discovery</a></li>
<li><a href="/wiki/Mentholatum" title="Mentholatum">Mentholatum</a></li>
<li><a href="/wiki/Merck_%26_Co." title="Merck &amp; Co.">Merck &amp; Co.</a></li>
<li><a href="/wiki/Merrimack_Pharmaceuticals" title="Merrimack Pharmaceuticals">Merrimack Pharmaceuticals</a></li>
<li><a href="/wiki/Myriad_Genetics" title="Myriad Genetics">Myriad Genetics</a></li>
<li><a href="/wiki/Moderna" title="Moderna">Moderna</a></li>
<li><a href="/wiki/Northwest_Biotherapeutics" title="Northwest Biotherapeutics">Northwest Biotherapeutics</a></li>
<li><a href="/wiki/Norwich_Pharma_Services" title="Norwich Pharma Services">Norwich Pharma</a></li>
<li><a href="/wiki/NovaBay_Pharmaceuticals" title="NovaBay Pharmaceuticals">NovaBay</a></li>
<li><a href="/wiki/Organon_%26_Co." title="Organon &amp; Co.">Organon</a></li>
<li><a href="/wiki/Ovation_Pharmaceuticals" title="Ovation Pharmaceuticals">Ovation</a></li>
<li><a href="/wiki/Pfizer" title="Pfizer">Pfizer</a>
<ul><li><a href="/wiki/Hospira" title="Hospira">Hospira</a></li>
<li><a href="/wiki/G.D._Searle,_LLC" title="G.D. Searle, LLC">Searle</a></li></ul></li>
<li><a href="/wiki/PPD,_Inc." title="PPD, Inc.">Pharmaceutical Product Development</a></li>
<li><a href="/wiki/Prasco_Laboratories" title="Prasco Laboratories">Prasco Laboratories</a></li>
<li><a href="/wiki/Procter_%26_Gamble" title="Procter &amp; Gamble">Procter &amp; Gamble</a></li>
<li><a href="/wiki/Proteon_Therapeutics" title="Proteon Therapeutics">Proteon Therapeutics</a></li>
<li><a href="/wiki/Purdue_Pharma" title="Purdue Pharma">Purdue Pharma</a></li>
<li><a href="/wiki/Quark_Pharmaceuticals" title="Quark Pharmaceuticals">Quark</a></li>
<li><a href="/wiki/Regeneron_Pharmaceuticals" title="Regeneron Pharmaceuticals">Regeneron</a></li>
<li><a href="/wiki/RespireRx" title="RespireRx">RespireRx</a></li>
<li><a href="/wiki/Sarepta_Therapeutics" title="Sarepta Therapeutics">Sarepta Therapeutics</a></li>
<li><a href="/wiki/Sheffield_Pharmaceuticals" title="Sheffield Pharmaceuticals">Sheffield</a></li>
<li><a href="/wiki/Spectrum_Pharmaceuticals" title="Spectrum Pharmaceuticals">Spectrum</a></li>
<li><a href="/wiki/Tec_Laboratories" title="Tec Laboratories">Tec Laboratories</a></li>
<li><a href="/wiki/Titan_Pharmaceuticals" title="Titan Pharmaceuticals">Titan</a></li>
<li><a href="/wiki/Trevena_Inc" class="mw-redirect" title="Trevena Inc">Trevena Inc</a></li>
<li><a href="/wiki/Ultragenyx" title="Ultragenyx">Ultragenyx</a></li>
<li><a href="/wiki/Upsher-Smith_Laboratories" title="Upsher-Smith Laboratories">Upsher-Smith</a></li>
<li><a href="/wiki/Ventria_Bioscience" title="Ventria Bioscience">Ventria Bioscience</a></li>
<li><a href="/wiki/Vertex_Pharmaceuticals" title="Vertex Pharmaceuticals">Vertex</a></li>
<li><a href="/wiki/Viatris" title="Viatris">Viatris</a></li>
<li><a href="/wiki/West_Pharmaceutical_Services" title="West Pharmaceutical Services">West Pharmaceutical Services</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Former</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Tax_inversion22" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Tax_inversion" title="Tax inversion">Tax inversion</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Actavis" title="Actavis">Actavis</a> (<a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">Ireland</a>, 2013)</li>
<li><a href="/wiki/Alkermes_(company)" class="mw-redirect" title="Alkermes (company)">Alkermes</a> (<a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">Ireland</a>, 2011)</li>
<li><a href="/wiki/Allergan" title="Allergan">Allergan</a> (<a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">Ireland</a>, 2015)</li>
<li><a href="/wiki/Covidien" title="Covidien">Covidien</a> (<a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">Ireland</a>, 2007)</li>
<li><a href="/wiki/Endo_International" title="Endo International">Endo International</a> (<a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">Ireland</a>, 2014)</li>
<li><a href="/wiki/Horizon_Therapeutics" title="Horizon Therapeutics">Horizon Therapeutics</a> (<a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">Ireland</a>, 2014)</li>
<li><a href="/wiki/Jazz_Pharmaceuticals" title="Jazz Pharmaceuticals">Jazz Pharmaceuticals</a> (<a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">Ireland</a>, 2012)</li>
<li><a href="/wiki/Mallinckrodt" title="Mallinckrodt">Mallinckrodt</a> (<a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">Ireland</a>, 2013)</li>
<li><a href="/wiki/Perrigo" title="Perrigo">Perrigo</a> (<a href="/wiki/Corporation_tax_in_the_Republic_of_Ireland#List_of_inversions" title="Corporation tax in the Republic of Ireland">Ireland</a>, 2013)</li>
<li><a href="/wiki/Bausch_Health" title="Bausch Health">Bausch Health</a> (Canada, 2010)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Alza" title="Alza">Alza</a></li>
<li><a href="/wiki/Allergan,_Inc." title="Allergan, Inc.">Allergan, Inc.</a></li>
<li><a href="/wiki/Amylin_Pharmaceuticals" title="Amylin Pharmaceuticals">Amylin</a></li>
<li><a href="/wiki/ARIAD_Pharmaceuticals" title="ARIAD Pharmaceuticals">ARIAD</a></li>
<li><a href="/wiki/Barr_Pharmaceuticals" title="Barr Pharmaceuticals">Barr</a></li>
<li><a href="/wiki/Biolex" title="Biolex">Biolex</a></li>
<li><a href="/wiki/Bradley_Pharmaceuticals" title="Bradley Pharmaceuticals">Bradley</a></li>
<li><a href="/wiki/CancerVax" title="CancerVax">CancerVax</a></li>
<li><a href="/wiki/Cephalon" title="Cephalon">Cephalon</a></li>
<li><a href="/wiki/CoTherix" class="mw-redirect" title="CoTherix">CoTherix</a></li>
<li><a href="/wiki/Cubist_Pharmaceuticals" title="Cubist Pharmaceuticals">Cubist</a></li>
<li><a href="/wiki/Cutter_Laboratories" title="Cutter Laboratories">Cutter Laboratories</a></li>
<li><a href="/wiki/DNAPrint_Genomics" title="DNAPrint Genomics">DNAPrint Genomics</a></li>
<li><a href="/wiki/Epix_Pharmaceuticals" title="Epix Pharmaceuticals">Epix</a></li>
<li><a href="/wiki/Forest_Laboratories" title="Forest Laboratories">Forest Laboratories</a></li>
<li><a href="/wiki/Genta_(company)" title="Genta (company)">Genta</a></li>
<li><a href="/wiki/ImClone_Systems" title="ImClone Systems">ImClone Systems</a></li>
<li><a href="/wiki/ISTA_Pharmaceuticals" title="ISTA Pharmaceuticals">ISTA</a></li>
<li><a href="/wiki/King_Pharmaceuticals" title="King Pharmaceuticals">King</a></li>
<li><a href="/wiki/KV_Pharmaceutical" title="KV Pharmaceutical">KV</a></li>
<li><a href="/wiki/Leiner_Health_Products" title="Leiner Health Products">Leiner Health Products</a></li>
<li><a href="/wiki/Martek_Biosciences_Corporation" title="Martek Biosciences Corporation">Martek Biosciences</a></li>
<li><a href="/wiki/S._E._Massengill_Company" title="S. E. Massengill Company">Massengill</a></li>
<li><a href="/wiki/Miles_Laboratories" title="Miles Laboratories">Miles Laboratories</a></li>
<li><a href="/wiki/Mylan" title="Mylan">Mylan</a></li>
<li><a href="/wiki/Naurex" class="mw-redirect" title="Naurex">Naurex</a></li>
<li><a href="/wiki/Nereus_Pharmaceuticals" title="Nereus Pharmaceuticals">Nereus</a></li>
<li><a href="/wiki/Nuvelo" title="Nuvelo">Nuvelo</a></li>
<li><a href="/wiki/Ortho_Pharmaceutical" title="Ortho Pharmaceutical">Ortho</a></li>
<li><a href="/wiki/OSI_Pharmaceuticals" title="OSI Pharmaceuticals">OSI</a></li>
<li><a href="/wiki/Parke-Davis" title="Parke-Davis">Parke-Davis</a></li>
<li><a href="/wiki/Repros_Therapeutics" title="Repros Therapeutics">Repros Therapeutics</a></li>
<li><a href="/wiki/Qualitest" class="mw-redirect" title="Qualitest">Qualitest</a></li>
<li><a href="/wiki/Melinta_Therapeutics" title="Melinta Therapeutics">Rib-X</a></li>
<li><a href="/wiki/Schering-Plough" title="Schering-Plough">Schering-Plough</a></li>
<li><a href="/wiki/Smith,_Kline_%26_French" title="Smith, Kline &amp; French">Smith, Kline &amp; French</a></li>
<li><a href="/wiki/Sterling_Drug" title="Sterling Drug">Sterling Drug</a></li>
<li><a href="/wiki/Tanox" title="Tanox">Tanox</a></li>
<li><a href="/wiki/TAP_Pharmaceuticals" title="TAP Pharmaceuticals">TAP</a></li>
<li><a href="/wiki/Trubion" title="Trubion">Trubion</a></li>
<li><a href="/wiki/Upjohn" title="Upjohn">Upjohn</a></li>
<li><a href="/wiki/Verus_Pharmaceuticals" title="Verus Pharmaceuticals">Verus</a></li>
<li><a href="/wiki/ViroPharma" title="ViroPharma">ViroPharma</a></li>
<li><a href="/wiki/Wyeth" title="Wyeth">Wyeth</a></li>
<li><a href="/wiki/Zonite_Products_Corporation" title="Zonite Products Corporation">Zonite</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2"><div>
<ul><li><a href="/wiki/List_of_pharmaceutical_companies" title="List of pharmaceutical companies">List of pharmaceutical companies</a></li></ul>
</div></td></tr></tbody></table></div>
<style data-mw-deduplicate="TemplateStyles:r1130092004">.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;justify-content:center;align-items:baseline}.mw-parser-output .portal-bar-bordered{padding:0 2em;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em auto 0}.mw-parser-output .portal-bar-related{font-size:100%;justify-content:flex-start}.mw-parser-output .portal-bar-unbordered{padding:0 1.7em;margin-left:0}.mw-parser-output .portal-bar-header{margin:0 1em 0 0.5em;flex:0 0 auto;min-height:24px}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;flex:0 1 auto;padding:0.15em 0;column-gap:1em;align-items:baseline;margin:0;list-style:none}.mw-parser-output .portal-bar-content-related{margin:0;list-style:none}.mw-parser-output .portal-bar-item{display:inline-block;margin:0.15em 0.2em;min-height:24px;line-height:24px}@media screen and (max-width:768px){.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;flex-flow:column wrap;align-items:baseline}.mw-parser-output .portal-bar-header{text-align:center;flex:0;padding-left:0.5em;margin:0 auto}.mw-parser-output .portal-bar-related{font-size:100%;align-items:flex-start}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:center;flex:0;column-gap:1em;border-top:1px solid #a2a9b1;margin:0 auto;list-style:none}.mw-parser-output .portal-bar-content-related{border-top:none;margin:0;list-style:none}}.mw-parser-output .navbox+link+.portal-bar,.mw-parser-output .navbox+style+.portal-bar,.mw-parser-output .navbox+link+.portal-bar-bordered,.mw-parser-output .navbox+style+.portal-bar-bordered,.mw-parser-output .sister-bar+link+.portal-bar,.mw-parser-output .sister-bar+style+.portal-bar,.mw-parser-output .portal-bar+.navbox-styles+.navbox,.mw-parser-output .portal-bar+.navbox-styles+.sister-bar{margin-top:-1px}</style><div class="portal-bar noprint metadata noviewer portal-bar-bordered" role="navigation" aria-label="Portals"><span class="portal-bar-header"><a href="/wiki/Wikipedia:Contents/Portals" title="Wikipedia:Contents/Portals">Portals</a>:</span><ul class="portal-bar-content"><li class="portal-bar-item"><span class="nowrap"><span class="mw-image-border" typeof="mw:File"><span><img alt="flag" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/ac/Flag_of_Indiana.svg/40px-Flag_of_Indiana.svg.png" decoding="async" width="21" height="14" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/a/ac/Flag_of_Indiana.svg/60px-Flag_of_Indiana.svg.png 2x" data-file-width="750" data-file-height="500" /></span></span> </span><a href="/wiki/Portal:Indiana" title="Portal:Indiana">Indiana</a></li><li class="portal-bar-item"><span class="nowrap"><span typeof="mw:File"><span><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/20px-Industry5.svg.png" decoding="async" width="19" height="19" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2a/Industry5.svg/40px-Industry5.svg.png 1.5x" data-file-width="512" data-file-height="512" /></span></span> </span><a href="/wiki/Portal:Companies" title="Portal:Companies">Companies</a></li></ul></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374" /><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1236075235" /><style data-mw-deduplicate="TemplateStyles:r1038841319">.mw-parser-output .tooltip-dotted{border-bottom:1px dotted;cursor:help}</style></div><div role="navigation" class="navbox authority-control" aria-labelledby="Authority_control_databases_frameless&amp;#124;text-top&amp;#124;10px&amp;#124;alt=Edit_this_at_Wikidata&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q632240#identifiers&amp;#124;class=noprint&amp;#124;Edit_this_at_Wikidata1302" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Authority_control_databases_frameless&amp;#124;text-top&amp;#124;10px&amp;#124;alt=Edit_this_at_Wikidata&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q632240#identifiers&amp;#124;class=noprint&amp;#124;Edit_this_at_Wikidata1302" style="font-size:114%;margin:0 4em"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control databases</a> <span class="mw-valign-text-top noprint" typeof="mw:File/Frameless"><a href="https://www.wikidata.org/wiki/Q632240#identifiers" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" class="mw-file-element" data-file-width="20" data-file-height="20" /></a></span></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">International</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><ul><li><span class="uid"><a rel="nofollow" class="external text" href="https://isni.org/isni/0000000121110100">ISNI</a></span></li><li><span class="uid"><a rel="nofollow" class="external text" href="https://viaf.org/viaf/142527899">VIAF</a></span></li></ul></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">National</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><ul><li><span class="uid"><a rel="nofollow" class="external text" href="https://d-nb.info/gnd/279435-4">Germany</a></span></li><li><span class="uid"><a rel="nofollow" class="external text" href="https://id.loc.gov/authorities/n82137073">United States</a></span></li><li><span class="uid"><a rel="nofollow" class="external text" href="https://catalogue.bnf.fr/ark:/12148/cb11587650q">France</a></span></li><li><span class="uid"><a rel="nofollow" class="external text" href="https://data.bnf.fr/ark:/12148/cb11587650q">BnF data</a></span></li><li><span class="uid"><span class="rt-commentedText tooltip tooltip-dotted" title="Eli Lilly and Company"><a rel="nofollow" class="external text" href="https://aleph.nkp.cz/F/?func=find-c&amp;local_base=aut&amp;ccl_term=ica=nlk20030134109&amp;CON_LNG=ENG">Czech Republic</a></span></span></li><li><span class="uid"><a rel="nofollow" class="external text" href="https://www.nli.org.il/en/authorities/987007260881905171">Israel</a></span></li></ul></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><ul><li><span class="uid"><a rel="nofollow" class="external text" href="https://www.idref.fr/086270508">IdRef</a></span></li></ul></div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw‐web.codfw.main‐569b47bd4c‐ww2z9
Cached time: 20250422174136
Cache expiry: 713911
Reduced expiry: true
Complications: [vary‐revision‐sha1, show‐toc]
CPU time usage: 2.062 seconds
Real time usage: 2.316 seconds
Preprocessor visited node count: 19130/1000000
Post‐expand include size: 528943/2097152 bytes
Template argument size: 10776/2097152 bytes
Highest expansion depth: 19/100
Expensive parser function count: 26/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 904307/5000000 bytes
Lua time usage: 1.277/10.000 seconds
Lua memory usage: 10413620/52428800 bytes
Number of Wikibase entities loaded: 1/500
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 1985.407      1 -total
 62.83% 1247.340      1 Template:Reflist
 30.20%  599.628    140 Template:Cite_web
 16.24%  322.485     59 Template:Cite_news
  6.33%  125.774      1 Template:Infobox_company
  5.94%  117.891      1 Template:Infobox
  5.59%  110.955     22 Template:Cite_book
  4.23%   83.921      1 Template:Short_description
  4.18%   83.050      7 Template:Citation_needed
  3.85%   76.438      8 Template:Fix
-->

<!-- Saved in parser cache with key enwiki:pcache:758905:|#|:idhash:canonical and timestamp 20250422174136 and revision id 1286104250. Rendering was triggered because: page-view
 -->
</div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="https://en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;usesul3=1" alt="" width="1" height="1" style="border: none; position: absolute;"></noscript>
<div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Eli_Lilly_and_Company&amp;oldid=1286104250">https://en.wikipedia.org/w/index.php?title=Eli_Lilly_and_Company&amp;oldid=1286104250</a>"</div></div>
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Eli_Lilly_and_Company" title="Category:Eli Lilly and Company">Eli Lilly and Company</a></li><li><a href="/wiki/Category:1876_establishments_in_Indiana" title="Category:1876 establishments in Indiana">1876 establishments in Indiana</a></li><li><a href="/wiki/Category:American_companies_established_in_1876" title="Category:American companies established in 1876">American companies established in 1876</a></li><li><a href="/wiki/Category:Biotechnology_companies_of_the_United_States" title="Category:Biotechnology companies of the United States">Biotechnology companies of the United States</a></li><li><a href="/wiki/Category:Clinical_trial_organizations" title="Category:Clinical trial organizations">Clinical trial organizations</a></li><li><a href="/wiki/Category:Companies_formerly_listed_on_the_Tokyo_Stock_Exchange" title="Category:Companies formerly listed on the Tokyo Stock Exchange">Companies formerly listed on the Tokyo Stock Exchange</a></li><li><a href="/wiki/Category:Companies_listed_on_the_New_York_Stock_Exchange" title="Category:Companies listed on the New York Stock Exchange">Companies listed on the New York Stock Exchange</a></li><li><a href="/wiki/Category:Life_sciences_industry" title="Category:Life sciences industry">Life sciences industry</a></li><li><a href="/wiki/Category:Manufacturing_companies_based_in_Indianapolis" title="Category:Manufacturing companies based in Indianapolis">Manufacturing companies based in Indianapolis</a></li><li><a href="/wiki/Category:Multinational_companies_headquartered_in_the_United_States" title="Category:Multinational companies headquartered in the United States">Multinational companies headquartered in the United States</a></li><li><a href="/wiki/Category:Pharmaceutical_companies_established_in_1876" title="Category:Pharmaceutical companies established in 1876">Pharmaceutical companies established in 1876</a></li><li><a href="/wiki/Category:Research_and_development_in_the_United_States" title="Category:Research and development in the United States">Research and development in the United States</a></li><li><a href="/wiki/Category:Technology_companies_established_in_1876" title="Category:Technology companies established in 1876">Technology companies established in 1876</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Pages_with_non-numeric_formatnum_arguments" title="Category:Pages with non-numeric formatnum arguments">Pages with non-numeric formatnum arguments</a></li><li><a href="/wiki/Category:CS1_maint:_location_missing_publisher" title="Category:CS1 maint: location missing publisher">CS1 maint: location missing publisher</a></li><li><a href="/wiki/Category:Source_attribution" title="Category:Source attribution">Source attribution</a></li><li><a href="/wiki/Category:All_articles_with_dead_external_links" title="Category:All articles with dead external links">All articles with dead external links</a></li><li><a href="/wiki/Category:Articles_with_dead_external_links_from_September_2017" title="Category:Articles with dead external links from September 2017">Articles with dead external links from September 2017</a></li><li><a href="/wiki/Category:Articles_with_permanently_dead_external_links" title="Category:Articles with permanently dead external links">Articles with permanently dead external links</a></li><li><a href="/wiki/Category:CS1:_unfit_URL" title="Category:CS1: unfit URL">CS1: unfit URL</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_July_2018" title="Category:Articles with unsourced statements from July 2018">Articles with unsourced statements from July 2018</a></li><li><a href="/wiki/Category:Webarchive_template_wayback_links" title="Category:Webarchive template wayback links">Webarchive template wayback links</a></li><li><a href="/wiki/Category:Pages_containing_links_to_subscription-only_content" title="Category:Pages containing links to subscription-only content">Pages containing links to subscription-only content</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_matches_Wikidata" title="Category:Short description matches Wikidata">Short description matches Wikidata</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_June_2024" title="Category:Use dmy dates from June 2024">Use dmy dates from June 2024</a></li><li><a href="/wiki/Category:Use_American_English_from_June_2024" title="Category:Use American English from June 2024">Use American English from June 2024</a></li><li><a href="/wiki/Category:All_Wikipedia_articles_written_in_American_English" title="Category:All Wikipedia articles written in American English">All Wikipedia articles written in American English</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_March_2022" title="Category:Articles with unsourced statements from March 2022">Articles with unsourced statements from March 2022</a></li><li><a href="/wiki/Category:Commons_category_link_is_on_Wikidata" title="Category:Commons category link is on Wikidata">Commons category link is on Wikidata</a></li></ul></div></div>
				</div>
			</main>
			
		</div>
		<div class="mw-footer-container">
			
<footer id="footer" class="mw-footer" >
	<ul id="footer-info">
	<li id="footer-info-lastmod"> This page was last edited on 17 April 2025, at 19:29<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a href="/wiki/Wikipedia:Text_of_the_Creative_Commons_Attribution-ShareAlike_4.0_International_License" title="Wikipedia:Text of the Creative Commons Attribution-ShareAlike 4.0 International License">Creative Commons Attribution-ShareAlike 4.0 License</a>;
additional terms may apply. By using this site, you agree to the <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Terms_of_Use" class="extiw" title="foundation:Special:MyLanguage/Policy:Terms of Use">Terms of Use</a> and <a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy" class="extiw" title="foundation:Special:MyLanguage/Policy:Privacy policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a rel="nofollow" class="external text" href="https://wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places">
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Universal_Code_of_Conduct">Code of Conduct</a></li>
	<li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Eli_Lilly_and_Company&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://www.wikimedia.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><picture><source media="(min-width: 500px)" srcset="/static/images/footer/wikimedia-button.svg" width="84" height="29"><img src="/static/images/footer/wikimedia.svg" width="25" height="25" alt="Wikimedia Foundation" lang="en" loading="lazy"></picture></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><picture><source media="(min-width: 500px)" srcset="/w/resources/assets/poweredby_mediawiki.svg" width="88" height="31"><img src="/w/resources/assets/mediawiki_compact.svg" alt="Powered by MediaWiki" lang="en" width="25" height="25" loading="lazy"></picture></a></li>
</ul>

</footer>

		</div>
	</div> 
</div> 
<div class="vector-header-container vector-sticky-header-container">
	<div id="vector-sticky-header" class="vector-sticky-header">
		<div class="vector-sticky-header-start">
			<div class="vector-sticky-header-icon-start vector-button-flush-left vector-button-flush-right" aria-hidden="true">
				<button class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-sticky-header-search-toggle" tabindex="-1" data-event-name="ui.vector-sticky-search-form.icon"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span>

<span>Search</span>
			</button>
		</div>
			
		<div role="search" class="vector-search-box-vue  vector-search-box-show-thumbnail vector-search-box">
			<div class="vector-typeahead-search-container">
				<div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail">
					<form action="/w/index.php" id="vector-sticky-search-form" class="cdx-search-input cdx-search-input--has-end-button">
						<div  class="cdx-search-input__input-wrapper"  data-search-loc="header-moved">
							<div class="cdx-text-input cdx-text-input--has-start-icon">
								<input
									class="cdx-text-input__input"
									
									type="search" name="search" placeholder="Search Wikipedia">
								<span class="cdx-text-input__icon cdx-text-input__start-icon"></span>
							</div>
							<input type="hidden" name="title" value="Special:Search">
						</div>
						<button class="cdx-button cdx-search-input__end-button">Search</button>
					</form>
				</div>
			</div>
		</div>
		<div class="vector-sticky-header-context-bar">
				<nav aria-label="Contents" class="vector-toc-landmark">
						
					<div id="vector-sticky-header-toc" class="vector-dropdown mw-portlet mw-portlet-sticky-header-toc vector-sticky-header-toc vector-button-flush-left"  >
						<input type="checkbox" id="vector-sticky-header-toc-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-sticky-header-toc" class="vector-dropdown-checkbox "  aria-label="Toggle the table of contents"  >
						<label id="vector-sticky-header-toc-label" for="vector-sticky-header-toc-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true"  ><span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span>

<span class="vector-dropdown-label-text">Toggle the table of contents</span>
						</label>
						<div class="vector-dropdown-content">
					
						<div id="vector-sticky-header-toc-unpinned-container" class="vector-unpinned-container">
						</div>
					
						</div>
					</div>
			</nav>
				<div class="vector-sticky-header-context-bar-primary" aria-hidden="true" ><span class="mw-page-title-main">Eli Lilly and Company</span></div>
			</div>
		</div>
		<div class="vector-sticky-header-end" aria-hidden="true">
			<div class="vector-sticky-header-icons">
				<a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-talk-sticky-header" tabindex="-1" data-event-name="talk-sticky-header"><span class="vector-icon mw-ui-icon-speechBubbles mw-ui-icon-wikimedia-speechBubbles"></span>

<span></span>
			</a>
			<a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-subject-sticky-header" tabindex="-1" data-event-name="subject-sticky-header"><span class="vector-icon mw-ui-icon-article mw-ui-icon-wikimedia-article"></span>

<span></span>
			</a>
			<a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-history-sticky-header" tabindex="-1" data-event-name="history-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-history mw-ui-icon-wikimedia-wikimedia-history"></span>

<span></span>
			</a>
			<a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only mw-watchlink" id="ca-watchstar-sticky-header" tabindex="-1" data-event-name="watch-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-star mw-ui-icon-wikimedia-wikimedia-star"></span>

<span></span>
			</a>
			<a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-edit-sticky-header" tabindex="-1" data-event-name="wikitext-edit-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-wikiText mw-ui-icon-wikimedia-wikimedia-wikiText"></span>

<span></span>
			</a>
			<a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-ve-edit-sticky-header" tabindex="-1" data-event-name="ve-edit-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-edit mw-ui-icon-wikimedia-wikimedia-edit"></span>

<span></span>
			</a>
			<a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only" id="ca-viewsource-sticky-header" tabindex="-1" data-event-name="ve-edit-protected-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-editLock mw-ui-icon-wikimedia-wikimedia-editLock"></span>

<span></span>
			</a>
		</div>
			<div class="vector-sticky-header-buttons">
				<button class="cdx-button cdx-button--weight-quiet mw-interlanguage-selector" id="p-lang-btn-sticky-header" tabindex="-1" data-event-name="ui.dropdown-p-lang-btn-sticky-header"><span class="vector-icon mw-ui-icon-wikimedia-language mw-ui-icon-wikimedia-wikimedia-language"></span>

<span>34 languages</span>
			</button>
			<a href="#" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive" id="ca-addsection-sticky-header" tabindex="-1" data-event-name="addsection-sticky-header"><span class="vector-icon mw-ui-icon-speechBubbleAdd-progressive mw-ui-icon-wikimedia-speechBubbleAdd-progressive"></span>

<span>Add topic</span>
			</a>
		</div>
			<div class="vector-sticky-header-icon-end">
				<div class="vector-user-links">
				</div>
			</div>
		</div>
	</div>
</div>
<div class="mw-portlet mw-portlet-dock-bottom emptyPortlet" id="p-dock-bottom">
	<ul>
		
	</ul>
</div>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw-web.codfw.main-569b47bd4c-mcfl7","wgBackendResponseTime":327,"wgPageParseReport":{"limitreport":{"cputime":"2.062","walltime":"2.316","ppvisitednodes":{"value":19130,"limit":1000000},"postexpandincludesize":{"value":528943,"limit":2097152},"templateargumentsize":{"value":10776,"limit":2097152},"expansiondepth":{"value":19,"limit":100},"expensivefunctioncount":{"value":26,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":904307,"limit":5000000},"entityaccesscount":{"value":1,"limit":500},"timingprofile":["100.00% 1985.407      1 -total"," 62.83% 1247.340      1 Template:Reflist"," 30.20%  599.628    140 Template:Cite_web"," 16.24%  322.485     59 Template:Cite_news","  6.33%  125.774      1 Template:Infobox_company","  5.94%  117.891      1 Template:Infobox","  5.59%  110.955     22 Template:Cite_book","  4.23%   83.921      1 Template:Short_description","  4.18%   83.050      7 Template:Citation_needed","  3.85%   76.438      8 Template:Fix"]},"scribunto":{"limitreport-timeusage":{"value":"1.277","limit":"10.000"},"limitreport-memusage":{"value":10413620,"limit":52428800}},"cachereport":{"origin":"mw-web.codfw.main-569b47bd4c-ww2z9","timestamp":"20250422174136","ttl":713911,"transientcontent":true}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Eli Lilly and Company","url":"https:\/\/en.wikipedia.org\/wiki\/Eli_Lilly_and_Company","sameAs":"http:\/\/www.wikidata.org\/entity\/Q632240","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q632240","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-06-27T20:28:27Z","dateModified":"2025-04-17T19:29:29Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/2\/2b\/Eli_Lilly_and_Company.svg","headline":"American pharmaceutical company"}</script>
</body>
</html>